Medical Surgical Nursing Assessment and Management of Clinical Problems 9th Edition Lewis Test Bank

$26.99$50.00 (-46%)

In stock

Medical Surgical Nursing Assessment and Management of Clinical Problems 9th Edition Lewis Test Bank.

Download sample

This is completed downloadable of Medical Surgical Nursing Assessment and Management of Clinical Problems 9th Edition Lewis Test Bank

Product Details:

Over the past three decades, more and more nursing educators have turned to Lewis: Medical-Surgical Nursing for its accurate and up-to-date coverage of the latest trends, hot topics, and clinical developments in the field of medical-surgical nursing ― and the new ninth edition is no exception! Written by a dedicated team of expert authors led by Sharon Lewis, Medical-Surgical Nursing, 9th Edition offers the same easy-to-read style that students have come to love, along with the timely and thoroughly accurate content that educators have come to trust. Completely revised and updated content explores patient care in various clinical settings and focuses on key topics such as prioritization, critical thinking, patient safety, and NCLEX® exam preparation. Best of all ― a complete collection of interactive student resources creates a more engaging learning environment to prepare you for clinical practice.

 

Table of Content:

  1. Sharon L. Lewis, RN, PhD, FAAN
  2. Shannon Ruff Dirksen, RN, PhD, FAAN
  3. Margaret McLean Heitkemper, RN, PhD, FAAN
  4. Linda Bucher, RN, PhD, CEN, CNE
  5. Contributors
  6. Reviewers
  7. To the Profession of Nursing and to the Important People in Our Lives
  8. Preface
  9. Organization
  10. Classic Features
  11. New Features
  12. Learning Supplements for Students
  13. Teaching Supplements for Instructors
  14. Acknowledgments
  15. Authors of Teaching and Learning Resources
  16. Special Features
  17. Assessment Abnormalities Tables
  18. Case Studies
  19. End-of-Chapter Case Studies
  20. Managing Multiple Patients Case Studies
  21. Assessment Case Studies
  22. Collaborative Care Tables
  23. Complementary & Alternative Therapies Boxes
  24. Cultural & Ethnic Health Disparities Boxes
  25. Delegation Decisions Boxes
  26. Diagnostic Studies Tables
  27. Drug Therapy Tables
  28. Emergency Management Tables
  29. Ethical/Legal Dilemmas Boxes
  30. Evidence-Based Practice
  31. Applying the Evidence Boxes
  32. Evidence-Based Practice
  33. Translating Research Into Practice Boxes
  34. Focused Assessment Boxes
  35. Gender Differences Boxes
  36. Genetics in Clinical Practice Boxes
  37. Gerontologic Assessment Differences Tables
  38. Health History Tables
  39. Healthy People Boxes
  40. Informatics in Practice Boxes
  41. Nursing Assessment Tables
  42. Nursing Care Plans
  43. Nutritional Therapy Tables
  44. Patient & Caregiver Teaching Guide Tables
  45. Pre-Test – Medical-Surgical Nursing
  46. Interactive Review – Medical-Surgical Nursing
  47. Volume 1
  48. Section 1 Concepts in Nursing Practice
  49. Concepts in Nursing Practice
  50. Pre-Test – Section 1
  51. Interactive Review – Section 1
  52. Chapter 1 Professional Nursing Practice
  53. Learning Outcomes
  54. Key Terms
  55. eFigures
  56. eTables
  57. Professional Nursing Practice
  58. Domain of Nursing Practice
  59. FIG. 1-1 Nurses are frontline professionals of health care.
  60. Definitions of Nursing
  61. Nursing’s View of Humanity
  62. Scope of Nursing Practice
  63. Influences on Professional Nursing Practice
  64. Complex Health Care Environments
  65. Expanding Knowledge and Technology.
  66. Diverse Populations.
  67. Consumerism.
  68. Influences on Health Care Systems
  69. Health Care Financing.
  70. Ethical/Legal Dilemmas: Social Networking: HIPAA Violation
  71. Situation
  72. Ethical/Legal Points for Consideration
  73. Discussion Questions
  74. FIG. 1-2 The patient, family, and nurse collaborate as part of coordinating high-quality care.
  75. Healthy People Initiative.
  76. Supporting Professional Practice
  77. Professional Nursing Organizations.
  78. TABLE 1-1 HEALTHY PEOPLE 2020
  79. QSEN.
  80. Patient-Centered Care
  81. Delivery of Nursing Care
  82. Continuum of Patient Care
  83. Critical Thinking
  84. Nursing Process
  85. FIG. 1-3 Nursing process.
  86. Standardized Nursing Terminologies
  87. TABLE 1-2 ANA-RECOGNIZED NURSING TERMINOLOGIES
  88. NANDA-I Nursing Diagnoses.
  89. Nursing Outcomes Classification (NOC).
  90. Nursing Interventions Classification (NIC).
  91. TABLE 1-3 EXAMPLE OF NANDA-NOC-NIC LINKAGE
  92. NANDA-NOC-NIC Linkages.
  93. Nursing Care Plans
  94. FIG. 1-4 Integration of NANDA, NIC, and NOC into the nursing process.
  95.  Nursing Care Plan 1-1 Patient with Heart Failure*
  96. Nursing Diagnosis
  97. Patient Goal
  98. FIG. 1-5 Concept map.
  99. Informatics and Technology
  100. Information and Technology in Practice
  101. Clinical Information Systems and Electronic Health Records
  102. Nursing Informatics
  103. Computer Languages
  104. Telehealth
  105. FIG. 1-6 Telemonitoring. A, Remote blood pressure monitoring. B, Videoconference with health care provider.
  106. Evidence-Based Practice
  107. Steps of EBP Process
  108. Step 0 of EBP.
  109. Step 1 of EBP.
  110. Step 2 of EBP.
  111. TABLE 1-4 STEPS OF EVIDENCE-BASED PRACTICE (EBP) PROCESS
  112. Step 3 of EBP.
  113. Step 4 of EBP.
  114. Step 5 of EBP.
  115. Step 6 of EBP.
  116. Implementing EBP
  117. Safety and Quality Improvement
  118. FIG. 1-7 Quality improvement system.
  119. National Patient Safety Goals
  120. Teamwork and Collaboration
  121. Interdisciplinary Team Members
  122. TABLE 1-5 NATIONAL PATIENT SAFETY GOALS*
  123. TABLE 1-6 INTERDISCIPLINARY TEAM MEMBERS
  124. Coordinating Care Among Health Care Team Members
  125. Communication.
  126. Case Management.
  127. TABLE 1-7 GUIDELINES FOR COMMUNICATING USING SBAR
  128. Clinical Pathways.
  129. Delegation and Assignment.
  130. TABLE 1-8 FIVE RIGHTS OF NURSING DELEGATION
  131. Delegation Decisions Delegation Decisions Boxes Throughout Book
  132. Bridge to NCLEX Examination
  133. References
  134. Resources
  135. Pageburst Integrated Resources
  136. Answer Keys
  137. Concept Map Creator
  138. Content Updates
  139. eFigures
  140. eTables
  141. Glossary
  142. Key Points
  143. Chapter 2 Health Disparities and Culturally Competent Care
  144. Learning Outcomes
  145. Key Terms
  146. eTables
  147. Determinants of Health
  148. FIG. 2-1 Determinants of health.
  149. Healthy People Access to Health Services
  150. Health Disparities and Health Equity
  151. Factors and Conditions Leading to Health Disparities
  152. Ethical/Legal Dilemmas Health Disparities
  153. Situation
  154. Ethical/Legal Points for Consideration
  155. Discussion Questions
  156. TABLE 2-1 FACTORS AND CONDITIONS LEADING TO HEALTH DISPARITIES
  157. Ethnicity and Race.
  158.  Cultural & Ethnic Health Disparities Cultural & Ethnic Health Disparities Boxes Throughout Book
  159. Place and Health.
  160. Income, Education, and Occupation.
  161. FIG. 2-2 Percentage of adults ages 18 to 64 years old who skipped or delayed medical care because of cost. The data are displayed by disability and insurance coverage status.
  162. Gender.
  163. Age.
  164. Sexual Orientation.
  165. FIG. 2-3 Older Asian women are especially at risk for health disparities.
  166. Health Care Provider Attitudes.
  167. Culture
  168. TABLE 2-2 BASIC CHARACTERISTICS OF CULTURE
  169. TABLE 2-3 DISTINCT CULTURAL CHARACTERISTICS OF DIFFERENT ETHNIC GROUPS IN THE UNITED STATES
  170. Native American
  171. Hispanic/Latino
  172. African American
  173. European American
  174. Asian American
  175. Pacific Islander American
  176. FIG. 2-4 Members of this family share a common heritage.
  177. Cultural Competence
  178. TABLE 2-4 HOW TO DEVELOP CULTURAL COMPETENCE
  179. Cultural Diversity in the Health Care Workplace
  180. FIG. 2-5 Nurses working together in a multicultural health care environment.
  181. Cultural Factors Affecting Health and Health Care
  182. Folk Healers
  183. Spirituality and Religion
  184. TABLE 2-5 CULTURAL FACTORS AFFECTING HEALTH AND HEALTH CARE
  185. Cross-Cultural Communication
  186. FIG. 2-6 Co-workers from different cultures communicate with verbal and nonverbal cues.
  187. TABLE 2-6 HEALTH-RELATED BELIEFS AND PRACTICES OF SELECTED RELIGIOUS GROUPS
  188. Family Roles and Relationships
  189. FIG. 2-7 Family roles and relationships differ from one culture to another.
  190. Personal Space
  191. Touch
  192. Nutrition
  193. Immigrants and Immigration
  194. FIG. 2-8 Recently arrived immigrants join a neighbor for a barbecue, a common American tradition.
  195. Medications
  196. Psychologic Factors
  197. TABLE 2-7 CULTURAL ASSESSMENT*
  198. Nursing Management Reducing Health Disparities and Increasing Cultural Competency
  199. Nurse’s Self-Assessment
  200. TABLE 2-8 CULTURE-BOUND SYNDROMES
  201. Patient Assessment
  202. Nursing Implementation
  203. Advocacy.
  204. TABLE 2-9 NURSING INTERVENTIONS TO REDUCE HEALTH DISPARITIES
  205. FIG. 2-9 A Navajo nurse instructs a Navajo patient.
  206. Standardized Guidelines.
  207. Communication.
  208. TABLE 2-10 USING A MEDICAL INTERPRETER
  209. TABLE 2-11 GUIDELINES FOR COMMUNICATING WHEN NO INTERPRETER IS AVAILABLE
  210. Informatics in Practice Use of Translation Applications
  211. Case Study Health Disparities
  212. Patient Profile
  213. Discussion Questions
  214. Bridge to NCLEX Examination
  215. References
  216. Resources
  217. Pageburst Integrated Resources
  218. Answer Keys
  219. Concept Map Creator
  220. Content Updates
  221. eTables
  222. Glossary
  223. Key Points
  224. Chapter 3 Health History and Physical Examination
  225. Learning Outcomes
  226. Key Terms
  227. eTables
  228. Data Collection
  229. Medical Focus
  230. Nursing Focus
  231. Types of Data
  232. FIG. 3-1 Obtaining and recording data from a nursing history and physical examination using a computer.
  233. Interview Considerations
  234. Symptom Investigation
  235. TABLE 3-1 INVESTIGATION OF PATIENT-REPORTED SYMPTOM
  236. Data Organization
  237. Culturally Competent Care
  238. Assessment
  239. Nursing History: Subjective Data
  240. Important Health Information
  241. Delegation Decisions Assessment and Data Collection
  242. Role of Registered Nurse (RN)
  243. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  244. Role of Unlicensed Assistive Personnel (UAP)
  245. Past Health History.
  246. Medications.
  247.  Complementary & Alternative Therapies Assessment of Use of Herbs and Dietary Supplements
  248. Why Assessment Is Important
  249. Nurse’s Role
  250. Allergies.
  251. Surgery or Other Treatments.
  252. Functional Health Patterns
  253. Health Perception–Health Management Pattern.
  254. Nutritional-Metabolic Pattern.
  255. Elimination Pattern.
  256. Activity-Exercise Pattern.
  257. Sleep-Rest Pattern.
  258. Cognitive-Perceptual Pattern.
  259. Self-Perception–Self-Concept Pattern.
  260. TABLE 3-2 HEALTH HISTORY: Functional Health Pattern Format
  261. Role-Relationship Pattern.
  262. Sexuality-Reproductive Pattern.
  263. Coping–Stress Tolerance Pattern.
  264. Value-Belief Pattern.
  265. Physical Examination: Objective Data
  266. General Survey
  267. Physical Examination
  268. Techniques.
  269. Inspection.
  270. Palpation.
  271. Percussion.
  272. Auscultation.
  273. FIG. 3-2 Palpation is the examination of the body using touch.
  274. FIG. 3-3 Percussion technique. Tapping the interphalangeal joint. Only the middle finger of the nondominant hand should be in contact with the skin surface.
  275. Equipment.
  276. Organization of Examination.
  277. FIG. 3-4 Auscultation is listening to sounds produced by the body to assess normal conditions and deviations from normal.
  278. TABLE 3-3 EQUIPMENT FOR PHYSICAL EXAMINATION*
  279. Recording Physical Examination.
  280. Types of Assessment
  281. Comprehensive Assessment
  282. TABLE 3-4 OUTLINE FOR PHYSICAL EXAMINATION
  283. TABLE 3-5 GERONTOLOGIC ASSESSMENT DIFFERENCES: Adaptations in Physical Assessment Techniques
  284. Focused Assessment
  285. Emergency Assessment
  286. Using Assessment Approaches
  287. TABLE 3-6 TYPES OF ASSESSMENT
  288. Problem Identification and Nursing Diagnoses
  289. TABLE 3-7 CLINICAL APPLICATION OF VARIOUS TYPES OF ASSESSMENT
  290. Bridge to NCLEX Examination
  291. References
  292. Pageburst Integrated Resources
  293. Answer Keys
  294. Concept Map Creator
  295. Content Updates
  296. eTables
  297. Glossary
  298. Key Points
  299. Videos
  300. Chapter 4 Patient and Caregiver Teaching
  301. Learning Outcomes
  302. Key Terms
  303. eFigures
  304. eTable
  305. Role of Patient and Caregiver Teaching
  306. Teaching-Learning Process
  307. Adult Learner
  308. Adult Learning Principles.
  309. Models to Promote Health.
  310. TABLE 4-1 ADULT LEARNING PRINCIPLES APPLIED TO PATIENT AND CAREGIVER TEACHING
  311. TABLE 4-2 STAGES OF CHANGE IN TRANSTHEORETICAL MODEL
  312. TABLE 4-3 KEY ASPECTS OF MOTIVATIONAL INTERVIEWING
  313. Nurse as Teacher
  314. Required Competencies
  315. Knowledge of Subject Matter.
  316. Communication Skills.
  317. Challenges to Nurse-Teacher Effectiveness.
  318. FIG. 4-1 Open, relaxed positioning of patient, spouse, and nurse at eye level promotes communication in teaching and learning.
  319. Caregiver Support in the Teaching-Learning Process
  320. TABLE 4-4 ASSESSMENT OF CAREGIVER NEEDS
  321. Caregiver Stress.
  322. TABLE 4-5 CAREGIVER STRESSORS
  323. Regulatory Mandates for Patient Teaching
  324. TABLE 4-6 THE JOINT COMMISSION’S SPEAK UP™ INITIATIVE
  325. Process of Patient Teaching
  326. Assessment
  327. Physical Factors.
  328. TABLE 4-7 ASSESSMENT OF FACTORS AFFECTING PATIENT TEACHING: Factors and Key Questions
  329. Psychologic Factors.
  330. Sociocultural Factors
  331. Health Literacy.
  332. Cultural Considerations.
  333. FIG. 4-2 Nurse communicating with a non-English-speaking patient using a translation phone service.
  334. Socioeconomic Considerations.
  335. Learner Factors.
  336. Learning Needs.
  337. Readiness to Learn.
  338. Learning Style.
  339. Planning
  340. Setting Goals.
  341. Evidence-Based Practice Translating Research Into Practice
  342. Are Decision Aids Helpful in Making Decisions About Health Care?
  343. Clinical Question
  344. Best Available Evidence
  345. Critical Appraisal and Synthesis of Evidence
  346. Conclusion
  347. Implications for Nursing Practice
  348. Reference for Evidence
  349. Selecting Teaching Strategies.
  350. Learning Materials.
  351. TABLE 4-8 LEARNER CHARACTERISTICS AND TEACHING STRATEGIES BY GENERATION
  352. TABLE 4-9 COMPARISON OF TEACHING STRATEGIES
  353. FIG. 4-3 Effective teaching using a variety of strategies (written materials, video-based patient education programs).
  354. Implementation
  355. Evaluation
  356. FIG. 4-4 Teaching using demonstration and return demonstration (“show back”) increases successful learning by the patient.
  357. TABLE 4-10 TECHNIQUES TO EVALUATE PATIENT AND CAREGIVER LEARNING
  358. Case Study Patient and Caregiver Teaching
  359. Patient Profile
  360. Subjective Data
  361. Objective Data
  362. Physical Examination
  363. Diagnostic Studies
  364. Collaborative Care
  365. Discussion Questions
  366. Bridge to NCLEX Examination
  367. References
  368. Resources
  369. Pageburst Integrated Resources
  370. Answer Keys
  371. Concept Map Creator
  372. Content Updates
  373. eFigures
  374. eTables
  375. Glossary
  376. Key Points
  377. Chapter 5 Chronic Illness and Older Adults
  378. Learning Outcomes
  379. Key Terms
  380. eTable
  381. Chronic Illness
  382. TABLE 5-1 CHARACTERISTICS OF ACUTE AND CHRONIC ILLNESS
  383. TABLE 5-2 IMPACT OF CHRONIC ILLNESSES
  384. TABLE 5-3 CHRONIC ILLNESS TRAJECTORY
  385. Trajectory of Chronic Illness
  386. FIG. 5-1 The Chronic Illness Trajectory is a theoretical model of chronic illness. The trajectory model of chronic illness recognizes that chronic illness will have many phases (see Table 5-3).
  387. TABLE 5-4 SEVEN TASKS OF PEOPLE WITH CHRONIC ILLNESS
  388. TABLE 5-5 CHARACTERISTICS OF TREATMENT REGIMENS
  389. Preventing and Managing a Crisis.
  390. Carrying Out Prescribed Treatment Regimens.
  391. Controlling Symptoms.
  392. Reordering Time.
  393. Adjusting to Changes in Course of Disease.
  394. Preventing Social Isolation.
  395. Attempting to Normalize Interactions With Others.
  396. Prevention of Chronic Illness
  397. Nursing Management Chronic Illness
  398. Older Adults
  399. Demographics of Aging
  400. Evidence-Based Practice Translating Research Into Practice
  401. What Is the Effectiveness of Chronic Illness Strategies for Asian/Pacific Islanders?
  402. Clinical Question
  403. Best Available Evidence
  404. Critical Appraisal and Synthesis of Evidence
  405. Conclusion
  406. Implications for Nursing Practice
  407. Reference for Evidence
  408. Attitudes Toward Aging
  409. FIG. 5-2 The aging process can be viewed as a balance between negative and positive factors.
  410. Biologic Aging
  411. Age-Related Physiologic Changes
  412. TABLE 5-6 GERONTOLOGIC ASSESSMENT DIFFERENCES: Summary of Tables
  413. Special Older Adult Populations
  414. Chronically Ill Older Adults
  415. Older Adult Women
  416. TABLE 5-7 GERONTOLOGIC ASSESSMENT DIFFERENCES: Cognitive Function
  417. Gender Differences
  418. Men
  419. Women
  420. Cognitively Impaired Older Adults
  421. Rural Older Adults
  422. FIG. 5-3 Older adults living in rural areas often enjoy outside activities, such as gardening.
  423. FIG. 5-4 Older adults are using computers more frequently and accessing health care information on the Internet.
  424. Informatics in Practice Older Adults and Internet Use
  425. Homeless Older Adults
  426. Frail Older Adults
  427. TABLE 5-8 SCALES: NUTRITIONAL ASSESSMENT OF OLDER ADULTS
  428. Culturally Competent Care
  429. Older Adults
  430. Social Support for Older Adults
  431. Family Caregivers
  432. Elder Mistreatment or Abuse
  433. Self-Neglect
  434. Social Services for Older Adults
  435. Medicare and Medicaid
  436. TABLE 5-9 TYPES OF ELDER MISTREATMENT
  437. TABLE 5-10 NURSING ASSESSMENT: Mistreatment
  438. Care Alternatives for Older Adults
  439. Adult Day Care and Adult Day Health Care
  440. Home Health Care.
  441. FIG. 5-5 Senior centers offer places for older adults who live independently to meet and gather with friends.
  442. Long-Term Care Facilities
  443. Legal and Ethical Issues
  444. FIG. 5-6 Social interaction and acceptance are important for older adults.
  445. Nursing Management Older Adults
  446. Nursing Assessment
  447. Planning
  448. Nursing Implementation
  449. FIG. 5-7 SPICES.
  450. Health Promotion.
  451. Acute Care.
  452. FIG. 5-8 Water aerobics is an example of a health promotion activity for older adults.
  453. Care Transitions.
  454. Rehabilitation.
  455. TABLE 5-11 CARE OF THE HOSPITALIZED OLDER ADULT
  456. FIG. 5-9 The nurse assists a patient in a geriatric rehabilitation facility.
  457. Assistive Devices.
  458. Safety.
  459. Medication Use.
  460. TABLE 5-12 DRUG THERAPY: Common Causes of Medication Errors by Older Adults
  461. FIG. 5-10 The effects of aging on drug metabolism.
  462. Depression.
  463. TABLE 5-13 DRUG THERAPY: Medication Use by Older Adults
  464. Use of Restraints.
  465. Sleep.
  466. Evaluation
  467. TABLE 5-14 EVALUATING NURSING CARE FOR OLDER ADULTS
  468. Case Study Older Adults
  469. Patient Profile
  470. Subjective Data
  471. Psychosocial Data
  472. Objective Data
  473. Discussion Questions
  474. Bridge to NCLEX Examination
  475. References
  476. Resources
  477. Pageburst Integrated Resources
  478. Answer Keys
  479. Concept Map Creator
  480. Content Updates
  481. eTables
  482. Glossary
  483. Key Points
  484. Chapter 6 Complementary and Alternative Therapies
  485. Learning Outcomes
  486. Key Terms
  487. TABLE 6-1 COMPARISON OF CONVENTIONAL AND INTEGRATIVE HEALTH CARE MODELS
  488. Complementary and Alternative Therapies
  489. NCCAM Categories
  490. TABLE 6-2 NCCAM CATEGORIES OF COMPLEMENTARY AND ALTERNATIVE THERAPIES
  491. Natural Products
  492. TABLE 6-3 WHOLE MEDICAL SYSTEMS
  493. TABLE 6-4 PATIENT & CAREGIVER TEACHING GUIDE: Herbal Therapies
  494.  Complementary & Alternative Therapies
  495. TABLE 6-5 COMMONLY USED HERBS*
  496. Mind-Body Medicine
  497. FIG. 6-1 Yoga is an example of both mind-body medicine and manipulative and body-based practices.
  498.  Complementary & Alternative Therapies
  499. Yoga
  500. Scientific Evidence
  501. Nursing Implications
  502. FIG. 6-2 Herbs are most commonly administered as a pill or capsule, but the source is a plant, such as echinacea.
  503. Acupuncture.
  504. FIG. 6-3 Acupuncture showing the placement of acupuncture needles.
  505. Manipulative and Body-Based Practices
  506. Massage.
  507. TABLE 6-6 COMMONLY USED DIETARY SUPPLEMENTS*
  508. Massage Techniques.
  509. FIG. 6-4 Hand massage can be a helpful tool to calm down an agitated or nervous patient.
  510. Other CAT Practices
  511. Energy Therapies.
  512. Gerontologic Considerations
  513. Complementary and Alternative Therapies
  514. Nursing Management Complementary and Alternative Therapies
  515. Professional Practice
  516. Knowledge of Therapies.
  517. Assessment of Complementary and Alternative Therapy Use.
  518. Promoting Safe Use of Therapies.
  519. Incorporating Therapies in Practice.
  520. TABLE 6-7 NURSES CAN USE COMPLEMENTARY AND ALTERNATIVE THERAPIES
  521. Self-Care Practice
  522. Bridge to NCLEX Examination
  523. References
  524. Resources
  525. Pageburst Integrated Resources
  526. Answer Keys
  527. Concept Map Creator
  528. Content Updates
  529. Glossary
  530. Key Points
  531. Stress-Busting Kit for Nursing Students
  532. Chapter 7 Stress and Stress Management
  533. Learning Outcomes
  534. Key Terms
  535. eTable
  536. Definition of Stress
  537. FIG. 7-1 Stressors can be physiologic or emotional/psychologic. Your perception of these stressors will determine whether they cause stress. Events or circumstances become stressful when you perceive them to be.
  538. FIG. 7-2 During stressful situations, the demands seem to exceed the resources.
  539. Factors Affecting Response to Stress
  540. TABLE 7-1 FACTORS AFFECTING PERSON’S RESPONSE TO STRESS
  541. FIG. 7-3 Neurochemical links among the nervous, endocrine, and immune systems. The communication among these three systems is bidirectional.
  542. Physiologic Response to Stress
  543. Nervous System
  544. Cerebral Cortex.
  545. Limbic System.
  546. Reticular Formation.
  547. Hypothalamus.
  548. Endocrine System
  549. FIG. 7-4 Hypothalamic-pituitary-adrenal axis. ACTH, Adrenocorticotropic hormone; CRH, corticotropin-releasing hormone.
  550. Summary of Stress Response
  551. FIG. 7-5 “Fight-or-flight” reaction. Alarm reaction responses resulting from increased sympathetic nervous system (SNS) activity.
  552. Immune System
  553. FIG. 7-6 The cerebral cortex processes stressful stimuli and relays the information via the limbic system to the hypothalamus. Corticotropin-releasing hormone (CRH) stimulates the release of adrenocorticotropic hormone (ACTH) from the pituitary gland. ACTH stimulates the adrenal cortex to release corticosteroids. The sympathetic nervous system is also stimulated, resulting in the release of epinephrine and norepinephrine from the adrenal medulla. The end result is the inhibition of the immune system.
  554. Effects of Stress on Health
  555. TABLE 7-2 DISORDERS WITH A STRESS COMPONENT*
  556. Coping
  557. TABLE 7-3 PROBLEM- AND EMOTION-FOCUSED COPING
  558. TABLE 7-4 COPING STRATEGIES
  559. Relaxation Strategies
  560. TABLE 7-5 RELAXATION BREATHING TECHNIQUES*
  561. Relaxation Breathing
  562. Meditation
  563. TABLE 7-6 GUIDE TO MEDITATION*
  564. Imagery
  565. TABLE 7-7 IMAGERY: CREATING YOUR SPECIAL PLACE*
  566. Music for Relaxation
  567. FIG. 7-7 In imagery, special places are created involving all the senses, such as a place where one can hear rustling water, smell flowers, feel the wind, and see a colorful landscape.
  568. TABLE 7-8 EXAMPLES OF IMAGERY
  569. Massage
  570. Nursing Management Stress
  571. Nursing Assessment
  572. FIG. 7-8 As a nurse, you have an important role in helping patients deal with stress.
  573.  Complementary & Alternative Therapies
  574. Scientific Evidence
  575. Nursing Implications
  576. Nursing Implementation
  577. TABLE 7-9 PERSONAL TIPS FOR HANDLING STRESS
  578. TABLE 7-10 HOW TO IMPLEMENT STRESS MANAGEMENT IN PRACTICE
  579.  Complementary & Alternative Therapies
  580. Scientific Evidence
  581. Nursing Implications
  582. Case Study Stress-Induced Complaints
  583. Patient Profile
  584. Discussion Questions
  585. Bridge to NCLEX Examination
  586. References
  587. Resources
  588. Pageburst Integrated Resources
  589. Answer Keys
  590. Concept Map Creator
  591. Content Updates
  592. eTables
  593. Glossary
  594. Key Points
  595. Stress-Busting Kit for Nursing Students
  596. Chapter 8 Sleep and Sleep Disorders
  597. Learning Outcomes
  598. Key Terms
  599. eFigure
  600. eTables
  601. Sleep
  602. FIG. 8-1 Sleep disorders are common in our society.
  603. TABLE 8-1 SELECTED SLEEP DISORDERS
  604. Physiologic Sleep Mechanisms
  605. Sleep-Wake Cycle
  606. FIG. 8-2 Excessive daytime sleepiness can occur in people with sleep disorders.
  607. Wake Behavior.
  608. Sleep Behavior.
  609. Circadian Rhythms.
  610. Sleep Architecture
  611. NREM Sleep.
  612. REM Sleep.
  613. Insufficient Sleep and Sleep Disorders
  614. FIG. 8-3 Effects of sleep deprivation and sleep disorders on the body.
  615. Insomnia
  616. Etiology and Pathophysiology
  617. TABLE 8-2 RELATIONSHIP OF SLEEP DISTURBANCES TO DISEASES AND DISORDERS
  618. Clinical Manifestations
  619. Diagnostic Studies
  620. Self-Report.
  621. Actigraphy.
  622. Polysomnography.
  623. Collaborative Care
  624. Cognitive-Behavioral Therapy for Insomnia.
  625. TABLE 8-3 COLLABORATIVE CARE: Insomnia
  626. TABLE 8-4 PATIENT TEACHING GUIDE: Sleep Hygiene
  627. TABLE 8-5 DRUG THERAPY: Insomnia
  628. Benzodiazepines
  629. Benzodiazepine-Receptor–like Agents
  630. Melatonin-Receptor Agonist
  631. Antidepressants
  632. Antihistamines
  633. Drug Therapy.
  634. Benzodiazepines.
  635. Benzodiazepine-Receptor–like Agents.
  636. Melatonin-Receptor Agonist.
  637. Antidepressants.
  638. Antihistamines.
  639. Complementary and Alternative Therapies.
  640.  Complementary & Alternative Therapies
  641. Scientific Evidence
  642. Nursing Implications
  643. Nursing Management Insomnia
  644. Nursing Assessment
  645. TABLE 8-6 NURSING ASSESSMENT: Sleep
  646. Nursing Diagnoses
  647. Nursing Implementation
  648. TABLE 8-7 CAFFEINE CONTENT OF SELECTED FOODS AND BEVERAGES
  649. Sleep Disturbances in the Hospital
  650. Narcolepsy
  651. Etiology and Pathophysiology
  652. Clinical Manifestations and Diagnostic Studies
  653. TABLE 8-8 DRUG THERAPY: Narcolepsy
  654. Nursing and Collaborative Management
  655. Drug Therapy.
  656. Behavioral Therapy.
  657. Circadian Rhythm Disorders
  658. Sleep-Disordered Breathing
  659. Obstructive Sleep Apnea
  660. FIG. 8-4 How sleep apnea occurs. A, The patient predisposed to obstructive sleep apnea (OSA) has a small pharyngeal airway. B, During sleep, the pharyngeal muscles relax, allowing the airway to close. Lack of airflow results in repeated apneic episodes. C, Continuous positive airway pressure (CPAP) splints the airway open, preventing airflow obstruction.
  661. Informatics in Practice Sleep Apnea Diagnosis and Monitoring
  662. Clinical Manifestations and Diagnostic Studies.
  663. Nursing and Collaborative Management Sleep Apnea
  664. Conservative Treatment
  665. FIG. 8-5 Examples of positive airwave pressure devices for sleep apnea. A, Patient wearing a nasal mask and headgear (positive pressure only through nose). B, Patient wearing nasal pillows (positive pressure only through nose). C, Patient wearing a full face mask (positive pressure to both nose and mouth).
  666. Surgical Treatment
  667. Periodic Limb Movement Disorder
  668. Gerontologic Considerations
  669. Sleep
  670. FIG. 8-6 Many older people have sleep problems.
  671. Parasomnias
  672. Special Sleep Needs of Nurses
  673. Case Study Insomnia
  674. Patient Profile
  675. Subjective Data
  676. Objective Data
  677. Physical Examination
  678. Diagnostic Studies
  679. Collaborative Care
  680. Discussion Questions
  681. Bridge to NCLEX Examination
  682. References
  683. Resources
  684. Pageburst Integrated Resources
  685. Answer Keys
  686. Concept Map Creator
  687. Content Updates
  688. eFigures
  689. eTables
  690. Glossary
  691. Key Points
  692. Chapter 9 Pain
  693. Learning Outcomes
  694. Key Terms
  695. eFigures
  696. Magnitude of Pain Problem
  697. TABLE 9-1 HARMFUL EFFECTS OF UNRELIEVED ACUTE PAIN
  698. Definitions and Dimensions of Pain
  699. TABLE 9-2 DIMENSIONS OF PAIN
  700. Gender Differences
  701. Men
  702. Women
  703. Pain Mechanisms
  704. Transduction.
  705. FIG. 9-1 Nociceptive pain originates when the tissue is injured. 1, Transduction occurs when there is release of chemical mediators. 2, Transmission involves the conduct of the action potential from the periphery (injury site) to the spinal cord and then to the brainstem, thalamus, and cerebral cortex. 3, Perception is the conscious awareness of pain. 4, Modulation involves signals from the brain going back down the spinal cord to modify incoming impulses.
  706. Transmission.
  707. Transmission to Spinal Cord.
  708. Dorsal Horn Processing.
  709. Transmission to Thalamus and Cortex.
  710. Perception.
  711. FIG. 9-2 Typical areas of referred pain.
  712. Modulation.
  713. Classification of Pain
  714. TABLE 9-3 COMPARISON OF NOCICEPTIVE AND NEUROPATHIC PAIN
  715. Nociceptive Pain
  716. Neuropathic Pain
  717. TABLE 9-4 DIFFERENCES BETWEEN ACUTE AND CHRONIC PAIN
  718. Acute and Chronic Pain
  719. TABLE 9-5 CORE PRINCIPLES OF PAIN ASSESSMENT
  720. Pain Assessment
  721. Elements of a Pain Assessment
  722. Pain Pattern.
  723. TABLE 9-6 NURSING ASSESSMENT: Pain
  724. Location.
  725. Intensity.
  726. FIG. 9-3 Pain thermometer scale. Ask the patient to circle words next to the thermometer or to mark the area on the thermometer to indicate the intensity of pain.
  727. Quality.
  728. Associated Symptoms.
  729. Management Strategies.
  730. Impact of Pain.
  731. Patient’s Beliefs, Expectations, and Goals.
  732. Documentation
  733. Reassessment
  734. Pain Treatment
  735. Basic Principles
  736. TABLE 9-7 DRUG THERAPY: Managing Side Effects of Pain Medications
  737. Drug Therapy for Pain
  738. Nonopioids.
  739. TABLE 9-8 DRUG THERAPY: Selected Nonopioid Analgesics
  740. FIG. 9-4 Arachidonic acid is oxidized by two different pathways: lipoxygenase and cyclooxygenase. The cyclooxygenase pathway leads to two forms of the enzyme cyclooxygenase: COX-1 and COX-2. COX-1 is known as constitutive (always present), and COX-2 is known as inducible (its expression varies markedly depending on the stimulus). Nonsteroidal antiinflammatory drugs (NSAIDs) differ in their actions, with some having more effects on COX-1 and others more on COX-2. Indomethacin acts primarily on COX-1, whereas ibuprofen is equipotent on COX-1 and COX-2. Celecoxib primarily inhibits COX-2.
  741. Drug Alert
  742. Opioids.
  743. Types of Opioids.
  744. Drug Alert
  745. Drug Alert
  746. Mixed Mu Agonist Opioid and Dual Mechanism Agents.
  747. TABLE 9-9 DRUG THERAPY: Opioid Analgesics
  748. TABLE 9-10 OPIOID EQUIANALGESIC DOSES*
  749. Opioids to Avoid.
  750. Drug Alert
  751. Side Effects of Opioids.
  752. Safety Alert
  753. TABLE 9-11 PASERO OPIOID-INDUCED SEDATION SCALE (POSS) WITH INTERVENTIONS
  754. Adjuvant Analgesic Therapy.
  755. Corticosteroids.
  756. Antidepressants.
  757. Antiseizure Drugs.
  758. GABA Receptor Agonist.
  759. α2-Adrenergic Agonists.
  760. Local Anesthetics.
  761. TABLE 9-12 DRUG THERAPY: Adjuvant Drugs Used for Pain
  762. Cannabinoids.
  763. Administration
  764. Scheduling.
  765. Titration.
  766. Equianalgesic Dosing.
  767. Administration Routes.
  768. Oral.
  769. Transmucosal and Buccal Routes.
  770. Intranasal Route.
  771. Rectal.
  772. Transdermal Route.
  773. Drug Alert
  774. Parenteral Routes.
  775. FIG. 9-5 Spinal anatomy. The spinal cord extends from the foramen magnum to the first or second lumbar vertebral space. The subarachnoid space (intrathecal space) is filled with cerebrospinal fluid that continuously circulates and bathes the spinal cord. The epidural space is a potential space filled with blood vessels, fat, and a network of nerve extensions.
  776. Intraspinal Delivery.
  777. Implantable Pumps.
  778. Patient-Controlled Analgesia.
  779. Interventional Therapy
  780. Therapeutic Nerve Blocks.
  781. Neuroablative Techniques.
  782. Neuroaugmentation.
  783. FIG. 9-6 Sites of neurosurgical procedures for pain relief.
  784. Nondrug Therapies for Pain
  785. Physical Pain Relief Strategies
  786. Massage.
  787. Exercise.
  788. TABLE 9-13 NONDRUG THERAPIES FOR PAIN
  789. Transcutaneous Electrical Nerve Stimulation.
  790. Acupuncture.
  791. Heat Therapy.
  792. FIG. 9-7 Transcutaneous electrical nerve stimulation (TENS) treatment being given for treatment of pain after shoulder surgery.
  793. TABLE 9-14 PATIENT & CAREGIVER TEACHING GUIDE: Heat and Cold Therapy
  794. Cold Therapy.
  795. Cognitive Therapies.
  796. Distraction.
  797. Hypnosis.
  798. Relaxation Strategies.
  799. Nursing and Collaborative Management Pain
  800. Effective Communication
  801. Challenges to Effective Pain Management
  802. Tolerance.
  803. TABLE 9-15 PATIENT & CAREGIVER TEACHING GUIDE: Pain Management
  804. Physical Dependence.
  805. Pseudoaddiction.
  806. Addiction.
  807. TABLE 9-16 MANIFESTATIONS OF OPIOID WITHDRAWAL SYNDROME
  808. Delegation Decisions Pain
  809. Role of Registered Nurse (RN)
  810. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  811. Role of Unlicensed Assistive Personnel (UAP)
  812. TABLE 9-17 PATIENT & CAREGIVER TEACHING GUIDE: Reducing Barriers to Pain Management
  813. Institutionalizing Pain Education and Management
  814. Ethical Issues in Pain Management
  815. Fear of Hastening Death by Administering Analgesics
  816. Requests for Assisted Suicide
  817. Use of Placebos in Pain Assessment and Treatment
  818. Gerontologic Considerations
  819. Pain
  820. Managing Pain in Special Populations
  821. Patients Unable to Self-Report Pain
  822. TABLE 9-18 ASSESSING PAIN IN NONVERBAL PATIENTS
  823. Patients With Substance Abuse Problems
  824. Case Study Pain
  825. Patient Profile
  826. Subjective Data
  827. Objective Data
  828. Discussion Questions
  829. Bridge to NCLEX Examination
  830. References
  831. Resources
  832. Pageburst Integrated Resources
  833. Answer Keys
  834. Case Studies
  835. Concept Map Creator
  836. Content Updates
  837. eFigures
  838. Glossary
  839. Key Points
  840. Stress-Busting Kit for Nursing Students
  841. Chapter 10 Palliative Care at End of Life
  842. Learning Outcomes
  843. Key Terms
  844. Palliative Care
  845. TABLE 10-1 GOALS OF PALLIATIVE CARE
  846. FIG. 10-1 One goal of palliative care is to improve the quality of the patient’s remaining life.
  847. FIG. 10-2 Integrated model of curative care, palliative and end-of-life care, and bereavement care.
  848. Hospice Care
  849. FIG. 10-3 Relationship of palliative care, end-of-life care, and hospice care.
  850. FIG. 10-4 Hospice care is designed to provide compassion, concern, and support for the dying.
  851. FIG. 10-5 Inpatient hospice settings have been deinstitutionalized to make the atmosphere as relaxed and homelike as possible.
  852. Death
  853. End-of-Life Care
  854. Physical Manifestations at End of Life
  855. TABLE 10-2 PHYSICAL MANIFESTATIONS AT END OF LIFE
  856. Psychosocial Manifestations at End of Life
  857. TABLE 10-3 PSYCHOSOCIAL MANIFESTATIONS AT END OF LIFE
  858. TABLE 10-4 KÜBLER-ROSS MODEL OF GRIEF
  859. Bereavement and Grief
  860. FIG. 10-6 The grief wheel model begins with the normal state at the bottom. After a person goes through the grief process, eventually the grief will resolve. However, because of the loss, the normal state is not the same as before. The challenge is to accept the “new normal.”
  861. Spiritual Needs
  862. TABLE 10-5 SPIRITUAL ASSESSMENT
  863. FIG. 10-7 Spiritual needs are an important consideration in end-of-life care.
  864. Culturally Competent Care
  865. End of Life
  866. Legal and Ethical Issues Affecting End-of-Life Care
  867. Organ and Tissue Donation
  868. Advance Care Planning and Advance Directives
  869. Resuscitation
  870. TABLE 10-6 COMMON DOCUMENTS USED IN END-OF-LIFE CARE
  871. Ethical/Legal Dilemmas End-of-Life Care
  872. Situation
  873. Ethical/Legal Points for Consideration
  874. Discussion Questions
  875. Nursing Management End of Life
  876. Nursing Assessment
  877. Planning
  878. Nursing Implementation
  879. Psychosocial Care.
  880. Anxiety and Depression.
  881. Anger.
  882. TABLE 10-7 NURSING ASSESSMENT: Psychosocial Care at End of Life
  883. Hopelessness and Powerlessness.
  884. Fear.
  885. Fear of Pain.
  886. FIG. 10-8 Dying patients typically want someone whom they know and trust to stay with them.
  887. Fear of Shortness of Breath.
  888. Fear of Loneliness and Abandonment.
  889. Fear of Meaninglessness.
  890. Communication.
  891. Physical Care.
  892. Postmortem Care.
  893. Special Needs of Caregivers and Nurses in End-of-Life Care
  894. Special Needs of Family Caregivers
  895. TABLE 10-8 NURSING MANAGEMENT: Physical Care at End of Life
  896. Special Needs of Nurses
  897. Bridge to NCLEX Examination
  898. References
  899. Resources
  900. Pageburst Integrated Resources
  901. Answer Keys
  902. Case Studies
  903. Concept Map Creator
  904. Content Updates
  905. Glossary
  906. Key Points
  907. Chapter 11 Substance Abuse
  908. Learning Outcomes
  909. Key Terms
  910. eTable
  911. TABLE 11-1 TERMINOLOGY OF SUBSTANCE ABUSE
  912. TABLE 11-2 COMMON HEALTH PROBLEMS RELATED TO SUBSTANCE ABUSE
  913. Common Drugs of Abuse
  914. Nicotine
  915. Effects of Use and Complications
  916. TABLE 11-3 CLINICAL PRACTICE GUIDELINE: Treating Tobacco Use and Dependence
  917. Nursing and Collaborative Care Tobacco Use
  918. Tobacco Cessation
  919. FIG. 11-1 Clinical practice guidelines: treating tobacco use and dependence.
  920. TABLE 11-4 INPATIENT TOBACCO CESSATION INTERVENTIONS
  921. TABLE 11-5 PATIENT TEACHING GUIDE: Smoking and Tobacco Use Cessation
  922. TABLE 11-6 DRUG THERAPY: Smoking Cessation*
  923. Drug Alert
  924. Alcohol
  925. Effects of Use and Complications
  926. FIG. 11-2 Alcohol is often used to cope with the stresses of life.
  927. Nursing and Collaborative Care Alcohol Dependence
  928. Alcohol Intoxication
  929. TABLE 11-7 EFFECTS OF CHRONIC ALCOHOL ABUSE
  930. TABLE 11-8 CLINICAL MANIFESTATIONS AND TREATMENT OF ALCOHOL WITHDRAWAL
  931. Alcohol Withdrawal Syndrome
  932.  Nursing Care Plan 11-1
  933. Nursing Diagnosis
  934. Patient Goals
  935. Substance Withdrawal Severity
  936. Distorted Thought Self-Control
  937. Substance Use Treatment: Alcohol Withdrawal
  938. Seizure Precautions
  939. Delirium Management
  940. Nursing Diagnosis
  941. Patient Goals
  942. Alcohol Abuse Cessation Behavior
  943. Substance Use Treatment
  944. TABLE 11-9 CLINICAL INSTITUTE WITHDRAWAL ASSESSMENT OF ALCOHOL SCALE, REVISED (CIWA-Ar)*
  945. Other Drugs of Abuse
  946. Stimulants
  947. Nursing and Collaborative Care Stimulant Abuse
  948. Overdose
  949. Withdrawal
  950. Depressants
  951. Sedative-Hypnotics
  952. Opioids
  953. TABLE 11-10 COMMONLY ABUSED ADDICTIVE SUBSTANCES
  954. Nursing and Collaborative Care Depressant Abuse
  955. Overdose
  956. Sedative-Hypnotics.
  957. FIG. 11-3 Use of oxycodone injections has increased rapidly.
  958. Opioids.
  959.  TABLE 11-11 EMERGENCY MANAGEMENT: Cocaine and Amphetamine Toxicity
  960. Cardiovascular
  961. Central Nervous System
  962. Other
  963.  TABLE 11-12 EMERGENCY MANAGEMENT: Depressant Drug Overdose
  964. Withdrawal
  965. Sedative-Hypnotics.
  966. Opioids.
  967. Cannabis
  968. Nursing Management Substance Abuse
  969. Nursing Assessment
  970. TABLE 11-13 ALCOHOL USE DISORDERS IDENTIFICATION TEST (AUDIT)
  971. TABLE 11-14 DRUG ABUSE SCREENING TEST (DAST-10)
  972. TABLE 11-15 SIGNS SUGGESTING SUBSTANCE ABUSE
  973. Nursing Diagnoses
  974. Planning
  975. Nursing Implementation
  976. Health Promotion.
  977. Acute Intervention.
  978. Ambulatory and Home Care.
  979. Gerontologic Considerations
  980. Substance Abuse
  981. Case Study Substance Misuse and Abuse
  982. iStockphoto/Thinkstock
  983. Patient Profile
  984. Subjective Data
  985. Objective Data
  986. Physical Examination
  987. Diagnostic Tests
  988. Discussion Questions
  989. Bridge to NCLEX Examination
  990. References
  991. Resources
  992. Managing Multiple Patients
  993. Introduction
  994. Patients
  995. iStockphoto/Thinkstock
  996. Thomas M. Perkins/Shutterstock.com
  997. iStockphoto/Thinkstock
  998. Ryan McVay/Photodisc/Thinkstock
  999. iStockphoto/Thinkstock
  1000. Management Discussion Questions
  1001. Case Study Progression
  1002. Pageburst Integrated Resources
  1003. Answer Keys
  1004. Care Plans
  1005. Concept Map Creator
  1006. Content Updates
  1007. eTables
  1008. Glossary
  1009. Key Points
  1010. Section 2 Pathophysiologic Mechanisms of Disease
  1011. Pathophysiologic Mechanisms of Disease
  1012. Pre-Test – Section 2
  1013. Interactive Review – Section 2
  1014. Chapter 12 Inflammation and Wound Healing
  1015. Learning Outcomes
  1016. Key Terms
  1017. eFigures
  1018. eTables
  1019. Inflammatory Response
  1020. FIG. 12-1 Vascular and cellular responses to tissue injury.
  1021. Vascular Response
  1022. Cellular Response
  1023. Neutrophils.
  1024. Monocytes.
  1025. TABLE 12-1 MEDIATORS OF INFLAMMATION
  1026. Lymphocytes.
  1027. Chemical Mediators
  1028. Complement System.
  1029. Prostaglandins and Leukotrienes.
  1030. FIG. 12-2 Pathway of generation of prostaglandins, thromboxane, and leukotrienes. Corticosteroids, nonsteroidal antiinflammatory drugs (NSAIDs), and acetylsalicylic acid (ASA) act to inhibit various steps in this pathway.
  1031. Exudate Formation
  1032. Clinical Manifestations
  1033. Fever.
  1034. TABLE 12-2 TYPES OF INFLAMMATORY EXUDATE
  1035. TABLE 12-3 LOCAL MANIFESTATIONS OF INFLAMMATION
  1036. FIG. 12-3 Production of fever. When monocytes/macrophages are activated, they secrete cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor (TNF), which reach the hypothalamic temperature-regulating center. These cytokines promote the synthesis and secretion of prostaglandin E2 (PGE2) in the anterior hypothalamus. PGE2 increases the thermostatic set point, and the autonomic nervous system is stimulated, resulting in shivering, muscle contraction, and peripheral vasoconstriction.
  1037. Types of Inflammation
  1038. Nursing and Collaborative Management Inflammation
  1039. Nursing Implementation
  1040. Health Promotion.
  1041. Acute Intervention
  1042. Observation and Vital Signs.
  1043. Fever.
  1044. Drug Therapy.
  1045. TABLE 12-4 DRUG THERAPY: Inflammation and Healing
  1046. RICE.
  1047. Rest.
  1048. Cold and Heat.
  1049. Compression and Immobilization.
  1050. Elevation.
  1051. Healing Process
  1052. Regeneration
  1053. Repair
  1054. TABLE 12-5 REGENERATIVE ABILITY OF DIFFERENT TYPES OF TISSUES
  1055. FIG. 12-4 Types of wound healing. A, Primary intention. B, Secondary intention. C, Tertiary intention.
  1056. Primary Intention.
  1057. Initial Phase.
  1058. TABLE 12-6 PHASES IN PRIMARY INTENTION HEALING
  1059. Granulation Phase.
  1060. Maturation Phase and Scar Contraction.
  1061. Secondary Intention.
  1062. Tertiary Intention.
  1063. Wound Classification
  1064. Complications of Healing
  1065. Nursing and Collaborative Management Wound Healing
  1066. Nursing Assessment
  1067. TABLE 12-7 RED-YELLOW-BLACK CONCEPT OF WOUND CARE
  1068. Nursing Implementation
  1069. TABLE 12-8 COMPLICATIONS OF WOUND HEALING
  1070. FIG. 12-5 Dehiscence following a cholecystectomy.
  1071. FIG. 12-6 Postoperative deep wound infection following wrist surgery.
  1072. FIG. 12-7 Hypertrophic scarring.
  1073. FIG. 12-8 Keloid scarring.
  1074. Red, Yellow, and Black Wounds.
  1075. Red Wounds.
  1076. FIG. 12-9 Wound measurements are made in centimeters. The first measurement is oriented from head to toe, the second is from side to side, and the third is the depth (if any). If there is any tunneling (when cotton-tipped applicator is placed in wound, there is movement) or undermining (when cotton-tipped applicator is placed in wound, there is a “lip” around the wound), this is charted in respect to a clock, with 12 o’clock being toward the patient’s head. This wound would be charted as a full-thickness, red wound, 7 × 5 × 3 cm, with a 3-cm tunnel at 7 o’clock and 2 cm undermining from 3 o’clock to 5 o’clock.
  1077. FIG. 12-10 Jackson-Pratt drainage device.
  1078. TABLE 12-9 FACTORS DELAYING WOUND HEALING
  1079. Yellow Wounds.
  1080. Black Wounds.
  1081. Negative-Pressure Wound Therapy.
  1082. Evidence-Based Practice Translating Research Into Practice
  1083. What Is the Effect of Tap Water on Wound Cleansing?
  1084. Clinical Question
  1085. Best Available Evidence
  1086. Critical Appraisal and Synthesis of Evidence
  1087. Conclusion
  1088. Implications for Nursing Practice
  1089. Reference for Evidence
  1090. TABLE 12-10 TYPES OF WOUND DRESSINGS
  1091. Hyperbaric Oxygen Therapy.
  1092. FIG. 12-11 Negative-pressure wound therapy. A, Femoral wound that is not healing. B, Negative-pressure wound therapy in place. C, Granulation tissue formation after therapy.
  1093. Delegation Decisions Wound Care
  1094. Role of Registered Nurse (RN)
  1095. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  1096. Role of Unlicensed Assistive Personnel (UAP)
  1097. TABLE 12-11 TYPES OF DEBRIDEMENT
  1098. Drug Therapy.
  1099. Nutritional Therapy.
  1100. Infection Prevention and Control.
  1101. Psychologic Implications.
  1102. Patient Teaching.
  1103. Pressure Ulcers
  1104. Etiology and Pathophysiology
  1105. Clinical Manifestations
  1106. TABLE 12-12 RISK FACTORS FOR PRESSURE ULCERS
  1107. Nursing and Collaborative Management Pressure Ulcers
  1108. TABLE 12-13 STAGING OF PRESSURE ULCERS
  1109. Nursing Assessment
  1110. Safety Alert
  1111. Nursing Diagnoses
  1112. Planning
  1113. Nursing Implementation
  1114. Health Promotion.
  1115. Safety Alert
  1116. Acute Intervention.
  1117. TABLE 12-14 ASSESSING PATIENTS WITH DARK SKIN
  1118. TABLE 12-15 NURSING ASSESSMENT: Pressure Ulcers
  1119. Evidence-Based Practice Applying the Evidence
  1120. Your Decision and Action
  1121. Reference for Evidence
  1122. Informatics in Practice Digital Images
  1123. TABLE 12-16 PATIENT & CAREGIVER TEACHING GUIDE: Pressure Ulcer
  1124. Ambulatory and Home Care.
  1125. Evaluation
  1126. Case Study Inflammation and Infection
  1127. iStockphoto/Thinkstock
  1128. Patient Profile
  1129. Subjective Data
  1130. Objective Data
  1131. Physical Examination
  1132. Laboratory Studies
  1133. Collaborative Care
  1134. Discussion Questions
  1135. Bridge to NCLEX Examination
  1136. References
  1137. Resources
  1138. Pageburst Integrated Resources
  1139. Answer Keys
  1140. Care Plans
  1141. Case Studies
  1142. Concept Map Creator
  1143. Content Updates
  1144. eFigures
  1145. eTables
  1146. Glossary
  1147. Key Points
  1148. Chapter 13 Genetics and Genomics
  1149. Learning Outcomes
  1150. Key Terms
  1151. eFigure
  1152. Genetics and Genomics
  1153. Basic Principles of Genetics
  1154. Genes.
  1155. TABLE 13-1 GLOSSARY OF GENETIC AND GENOMIC TERMS
  1156. Chromosomes.
  1157. DNA.
  1158. FIG. 13-1 The long, stringy DNA that makes up genes is spooled within chromosomes inside the nucleus of a cell. (Note that a gene would actually be a much longer stretch of DNA than what is shown here.)
  1159. RNA.
  1160. Protein Synthesis.
  1161. FIG. 13-2 DNA consists of two long, twisted chains made up of nucleotides. Each nucleotide contains one base, one phosphate molecule (P), and the sugar molecule deoxyribose (S). The bases in DNA nucleotides are adenine (A), thymine (T), cytosine (C), and guanine (G).
  1162. Mitosis.
  1163. Meiosis.
  1164. Genetic Mutations
  1165. FIG. 13-3 In sickle cell disease a single gene mutation leads to mutant (incorrect) protein. The substitution of valine (VAL) for glutamic acid on the β-globin chain of hemoglobin produces abnormal hemoglobin, hemoglobin S (Hb S). In response to low O2 levels, the erythrocytes with Hb S stiffen and elongate, taking on a sickle shape (see Fig. 31-3).
  1166. Types of Mutations.
  1167. Inheritance Patterns
  1168. TABLE 13-2 COMPARISON OF GENETIC DISORDERS
  1169. FIG. 13-4 Examples of family pedigrees showing inheritance of (A) autosomal dominant, (B) autosomal recessive, and (C) X-linked recessive disorders.
  1170. FIG. 13-5 Family pedigrees showing three generations. A, Family pedigree suggestive of an autosomal dominant disorder. B, Family pedigree suggestive of an autosomal recessive disorder. C, Family pedigree suggestive of an X-linked recessive disorder.
  1171. Human Genome Project
  1172. Genetic Disorders
  1173. Classification of Genetic Disorders
  1174. Single Gene Disorders.
  1175. Multifactorial Genetic Disorders.
  1176. Epigenetics.
  1177. FIG. 13-6 A, Genetic disorders can be caused by a mutation in a single gene (e.g., sickle cell disease, cystic fibrosis, hemophilia). B, Most genetic disorders are multifactorial genetic disorders caused by a combination of mutations in multiple genes, often interacting with environmental factors. Examples include cancer, diabetes mellitus, obesity, and hypertension.
  1178. Chromosome Disorders.
  1179.  Genetics in Clinical Practice
  1180. Genetic Testing
  1181. TABLE 13-3 USE OF GENETIC TESTS*
  1182.  Genetics in Clinical Practice
  1183. What Is GINA?
  1184. Why Was GINA Needed?
  1185. What Is a Genetic Test?
  1186. What Is Genetic Information?
  1187. What Does GINA Do?
  1188. Interpreting Genetic Test Results
  1189. Ethical/Legal Dilemmas Genetic Testing
  1190. Situation
  1191. Ethical/Legal Points for Consideration
  1192. Discussion Questions
  1193. Direct-to-Consumer Genetic Tests
  1194. Genetic Technology
  1195. DNA Finger Printing.
  1196. DNA Microarray (DNA Chip).
  1197. TABLE 13-4 PATIENT & FAMILY TEACHING GUIDE: Genetic Testing
  1198. Genome-Wide Association Study (GWAS)
  1199. Pharmacogenetics and Pharmacogenomics
  1200. TABLE 13-5 EXAMPLES OF PHARMACOGENETICS
  1201. FIG. 13-7 Individuals respond differently to the drug warfarin (Coumadin). The diversity of responses is partially due to genetic variants in one of the cytochrome P450 genes.
  1202. Gene Therapy
  1203. FIG. 13-8 Gene therapy for adenosine deaminase (ADA) deficiency attempts to correct this immunodeficiency state. The viral vector containing the therapeutic ADA gene is inserted into the patient’s lymphocytes. These cells can then make the ADA enzyme.
  1204. Stem Cell Therapy
  1205. Nursing Management Genetics and Genomics
  1206. FIG. 13-9 Punnett squares illustrate inheritance possibilities. A, If the mother and father are both carriers for cystic fibrosis, there is a 25% chance that offspring will have cystic fibrosis. B, If the mother is a carrier for the hemophilia gene and the father has a normal genotype, there is a 50% chance that any male offspring will have hemophilia. There is a 50% chance that any female offspring will be a carrier. C, If the mother has a normal genotype and the father has Huntington’s disease, there is a 50% chance that offspring will have the disease.
  1207. Nursing Assessment Family History
  1208. Bridge to NCLEX Examination
  1209. References
  1210. Resources
  1211. Pageburst Integrated Resources
  1212. Answer Keys
  1213. Concept Map Creator
  1214. Content Updates
  1215. eFigures
  1216. Glossary
  1217. Key Points
  1218. Chapter 14 Altered Immune Responses and Transplantation
  1219. Learning Outcomes
  1220. Key Terms
  1221. eFigures
  1222. eTables
  1223. Normal Immune Response
  1224. Antigens
  1225. Types of Immunity
  1226. Innate Immunity.
  1227. Acquired Immunity.
  1228. Active Acquired Immunity.
  1229. Passive Acquired Immunity.
  1230. Lymphoid Organs
  1231. TABLE 14-1 TYPES OF ACQUIRED SPECIFIC IMMUNITY
  1232. Healthy People
  1233. Cells Involved in Immune Response
  1234. Mononuclear Phagocytes.
  1235. FIG. 14-1 Organs of the immune system.
  1236. Lymphocytes.
  1237. B Lymphocytes.
  1238. T Lymphocytes.
  1239. T Cytotoxic Cells.
  1240. T Helper Cells.
  1241. Natural Killer Cells.
  1242. FIG. 14-2 The immune response to a virus. A, A virus invades the body through a break in the skin or another portal of entry. The virus must make its way inside a cell to replicate itself. B, A macrophage recognizes the antigens on the surface of the virus. The macrophage digests the virus and displays pieces of the virus (antigens) on its surface. C, A T helper cell recognizes the antigen displayed and binds to the macrophage. This binding stimulates the production of cytokines (interleukin-1 [IL-1] and tumor necrosis factor [TNF]  ) by the macrophage and interleukin-2 (IL-2) and γ-interferon (γ-IFN) by the T cell. These cytokines are intracellular messengers that provide communication among the cells. D, IL-2 instructs other T helper cells and T cytotoxic cells to proliferate (multiply). T helper cells release cytokines, causing B cells to multiply and produce antibodies. E, T cytotoxic cells and natural killer cells destroy infected body cells. F, The antibodies bind to the virus and mark it for macrophage destruction. G, Memory B and T cells remain behind to respond quickly if the same virus attacks again.
  1243. FIG. 14-3 Relationships and functions of macrophages, B lymphocytes, and T lymphocytes in an immune response.
  1244. TABLE 14-2 CHARACTERISTICS OF IMMUNOGLOBULINS
  1245. Dendritic Cells.
  1246. Cytokines
  1247. TABLE 14-3 TYPES AND FUNCTIONS OF CYTOKINES*
  1248. Comparison of Humoral and Cell-Mediated Immunity
  1249. FIG. 14-4 Mechanism of action of interferon (IFN). When a virus attacks a cell, the cell begins to synthesize viral DNA and interferon. Interferon serves as an intercellular messenger and induces the production of antiviral proteins. Then the virus is not able to replicate in the cell.
  1250. Humoral Immunity.
  1251. TABLE 14-4 CLINICAL USES OF CYTOKINES
  1252. TABLE 14-5 COMPARISON OF HUMORAL AND CELL-MEDIATED IMMUNITY
  1253. FIG. 14-5 Primary and secondary immune responses. The introduction of antigen induces a response dominated by two classes of immunoglobulins, IgM and IgG. IgM predominates in the primary response, with some IgG appearing later. After the host’s immune system is primed, another challenge with the same antigen induces the secondary response, in which some IgM and large amounts of IgG are produced.
  1254. Cell-Mediated Immunity.
  1255. Gerontologic Considerations
  1256. Effects of Aging on the Immune System
  1257. TABLE 14-6 GERONTOLOGIC ASSESSMENT DIFFERENCES: Effects of Aging on the Immune System
  1258. Altered Immune Response
  1259. Hypersensitivity Reactions
  1260. Type I: IgE-Mediated Reactions.
  1261. TABLE 14-7 TYPES OF HYPERSENSITIVITY REACTIONS
  1262. FIG. 14-6 Steps in a type I allergic reaction.
  1263. TABLE 14-8 MEDIATORS OF ALLERGIC RESPONSE*
  1264. Anaphylaxis.
  1265. Atopic Reactions.
  1266. FIG. 14-7 Clinical manifestations of a systemic anaphylactic reaction.
  1267. TABLE 14-9 ALLERGENS CAUSING ANAPHYLACTIC SHOCK
  1268. Drugs
  1269. Foods
  1270. Treatment Measures
  1271. Insect Venoms
  1272. Animal Sera
  1273. FIG. 14-8 Atopic dermatitis of the lower leg.
  1274. Type II: Cytotoxic and Cytolytic Reactions.
  1275. Hemolytic Transfusion Reactions.
  1276. Goodpasture Syndrome.
  1277. Type III: Immune-Complex Reactions.
  1278. Type IV: Delayed Hypersensitivity Reactions.
  1279. Contact Dermatitis.
  1280. FIG. 14-9 Contact dermatitis to rubber.
  1281. Microbial Hypersensitivity Reactions.
  1282. Allergic Disorders
  1283. Assessment
  1284. Diagnostic Studies
  1285. Skin Tests.
  1286. TABLE 14-10 NURSING ASSESSMENT: Allergies
  1287. Procedure.
  1288. Results.
  1289. Precautions.
  1290. Collaborative Care
  1291. Anaphylaxis.
  1292. Chronic Allergies.
  1293. Allergen Recognition and Control.
  1294.  TABLE 14-11 EMERGENCY MANAGEMENT: Anaphylactic Shock
  1295. Drug Therapy.
  1296. Antihistamines.
  1297. Sympathomimetic/Decongestant Drugs.
  1298. Corticosteroids.
  1299. Antipruritic Drugs.
  1300. Mast Cell–Stabilizing Drug.
  1301. Leukotriene Receptor Antagonists.
  1302. Immunotherapy.
  1303. Mechanism of Action.
  1304. Method of Administration.
  1305. Subcutaneous Immunotherapy.
  1306. Sublingual Immunotherapy.
  1307. Nursing Management Immunotherapy
  1308. Latex Allergies
  1309. Types of Latex Allergies.
  1310. Latex-Food Syndrome.
  1311. Nursing and Collaborative Management Latex Allergies
  1312. Multiple Chemical Sensitivity
  1313. TABLE 14-12 GUIDELINES FOR PREVENTING ALLERGIC LATEX REACTIONS
  1314. Autoimmunity
  1315. TABLE 14-13 EXAMPLES OF AUTOIMMUNE DISEASES*
  1316. Autoimmune Diseases
  1317. Apheresis
  1318. Plasmapheresis.
  1319. Immunodeficiency Disorders
  1320. Primary Immunodeficiency Disorders
  1321. Secondary Immunodeficiency Disorders
  1322. TABLE 14-14 PRIMARY IMMUNODEFICIENCY DISORDERS
  1323. TABLE 14-15 CAUSES OF SECONDARY IMMUNODEFICIENCY
  1324. Drug-Induced Immunodeficiency
  1325. Age
  1326. Malnutrition
  1327. Therapies
  1328. Diseases or Disorders
  1329. Stress
  1330. Human Leukocyte Antigen System
  1331. Human Leukocyte Antigen and Disease Associations
  1332. FIG. 14-10 Patterns of human leukocyte antigen (HLA) inheritance. A, HLA genes are located on chromosome 6. B, The two haplotypes of the father are labeled P1 and P2, and the haplotypes of the mother are labeled M1 and M2. Each child inherits two haplotypes, one from each parent. C, Therefore only four combinations—P1M1, P1M2, P2M1, and P2M2—are possible, and 25% of the offspring will have identical HLA haplotypes.
  1333. Organ Transplantation
  1334. FIG. 14-11 Tissues and organs that can be transplanted.
  1335. Tissue Typing
  1336. HLA Typing.
  1337. Panel of Reactive Antibodies.
  1338. Crossmatch.
  1339. Transplant Rejection
  1340. Hyperacute Rejection.
  1341. Acute Rejection.
  1342. Chronic Rejection.
  1343. FIG. 14-12 Mechanism of action of T cytotoxic lymphocyte activation and attack of transplanted tissue. The transplanted organ (e.g., kidney) is recognized as foreign and activates the immune system. T helper cells are activated to produce interleukin-2 (IL-2), and T cytotoxic lymphocytes are sensitized. After the T cytotoxic cells proliferate, they attack the transplanted organ.
  1344. Immunosuppressive Therapy
  1345. TABLE 14-16 DRUG THERAPY: Immunosuppressive Therapy
  1346. Calcineurin Inhibitors.
  1347. FIG. 14-13 Sites of action for immunosuppressive agents.
  1348. Drug Alert
  1349. Sirolimus.
  1350. Mycophenolate Mofetil.
  1351. Drug Alert
  1352. Monoclonal Antibodies.
  1353. Polyclonal Antibody.
  1354. Graft-Versus-Host Disease
  1355. Bridge to NCLEX Examination
  1356. References
  1357. Resource
  1358. Pageburst Integrated Resources
  1359. Animations
  1360. Answer Keys
  1361. Concept Map Creator
  1362. Content Updates
  1363. eFigures
  1364. eTables
  1365. Glossary
  1366. Key Points
  1367. Chapter 15 Infection and Human Immunodeficiency Virus Infection
  1368. Learning Outcomes
  1369. Key Terms
  1370. eTables
  1371. Infections
  1372. Types of Pathogens
  1373. TABLE 15-1 DISEASE-CAUSING BACTERIA
  1374. TABLE 15-2 DISEASE-CAUSING VIRUSES
  1375. TABLE 15-3 DISEASE-CAUSING FUNGI
  1376. Emerging Infections
  1377. TABLE 15-4 EMERGING INFECTIONS
  1378. Reemerging Infections
  1379. TABLE 15-5 REEMERGING INFECTIONS
  1380. Antibiotic-Resistant Organisms
  1381. TABLE 15-6 ANTIBIOTIC-RESISTANT ORGANISMS AND TREATMENT
  1382. TABLE 15-7 PATIENT & CAREGIVER TEACHING GUIDE: Decrease Risk for Antibiotic-Resistant Infection
  1383. Health Care–Associated Infections
  1384. TABLE 15-8 OSHA REQUIREMENTS FOR PERSONAL PROTECTIVE EQUIPMENT
  1385. Gerontologic Considerations
  1386. Infections in Older Adults
  1387. Safety Alert
  1388. Infection Prevention and Control
  1389. Occupational Safety and Health Administration (OSHA) Guidelines
  1390. Infection Precautions
  1391. Human Immunodeficiency Virus Infection
  1392. Significance of Problem
  1393. Transmission of HIV
  1394. FIG. 15-1 Viral load in the blood in relationship to number of CD4+ T cells over the spectrum of untreated HIV infection.
  1395. Sexual Transmission.
  1396. Contact With Blood and Blood Products.
  1397. FIG. 15-2 HIV is surrounded by an envelope made up of proteins (including gp120) and contains a core of viral RNA and proteins.
  1398. Perinatal Transmission.
  1399. Pathophysiology
  1400. FIG. 15-3 HIV has gp120 glycoproteins that attach to CD4 and chemokine CXCR4 and CCR5 receptors on the surface of CD4+ T cells. Viral RNA then enters the cell, produces viral DNA in the presence of reverse transcriptase, and incorporates itself into the cellular genome in the presence of integrase, causing permanent cellular infection and the production of new virions. New viral RNA develops initially in long strands that are cut in the presence of protease and leave the cell through a budding process that ultimately contributes to cellular destruction.
  1401. Clinical Manifestations and Complications
  1402. Acute Infection.
  1403. FIG. 15-4 Timeline for the spectrum of untreated HIV infection. The timeline represents the course of untreated illness from the time of infection to clinical manifestations of disease.
  1404. Chronic HIV Infection
  1405. Asymptomatic Infection.
  1406. Symptomatic Infection.
  1407. FIG. 15-5 Oral thrush involving hard and soft palate.
  1408. FIG. 15-6 Kaposi sarcoma (KS). The malignant vascular lesions of KS can appear anywhere on the skin surface or on internal organs. Lesions vary in size from pinpoint to large and may appear in a variety of shades.
  1409. AIDS.
  1410. FIG. 15-7 Oral hairy leukoplakia on the lateral aspect of the tongue.
  1411. TABLE 15-9 DIAGNOSTIC CRITERIA FOR AIDS
  1412. Diagnostic Studies
  1413. Diagnosis of HIV Infection.
  1414. Laboratory Studies in HIV Infection.
  1415. Collaborative Care
  1416. TABLE 15-10 OPPORTUNISTIC DISEASES ASSOCIATED WITH HIV INFECTION*
  1417. TABLE 15-11 HIV-ANTIBODY TESTS
  1418. Drug Therapy for HIV Infection.
  1419. TABLE 15-12 DRUG THERAPY: HIV Infection
  1420. Drug Alert
  1421. Drug Therapy for Opportunistic Diseases.
  1422. Preventing Transmission of HIV.
  1423. Nursing Management HIV Infection
  1424. Nursing Assessment
  1425. Planning
  1426. Nursing Implementation
  1427. Health Promotion.
  1428. Healthy People
  1429. Prevention of HIV Infection.
  1430. TABLE 15-13 NURSING ASSESSMENT: HIV-Infected Patient
  1431. TABLE 15-14 PATIENT & CAREGIVER TEACHING GUIDE: Antiretroviral Drugs
  1432. Evidence-Based Practice Applying the Evidence
  1433. Your Decision and Action
  1434. Reference for Evidence
  1435. Decreasing Risks Related to Sexual Intercourse.
  1436. Decreasing Risks Related to Drug Use.
  1437. Ethical/Legal Dilemmas Individual Versus Public Health Protection
  1438. Situation
  1439. Ethical/Legal Points for Consideration
  1440. Discussion Questions
  1441. Decreasing Risks of Perinatal Transmission.
  1442. Decreasing Risks at Work.
  1443. HIV Testing.
  1444. Acute Intervention
  1445. Early Intervention.
  1446. Initial Response to Diagnosis of HIV.
  1447. Informatics in Practice Use of Internet and Mobile Devices to Manage HIV
  1448. Antiretroviral Therapy.
  1449. TABLE 15-15 PATIENT & CAREGIVER TEACHING GUIDE: Improving Adherence to Antiretroviral Therapy
  1450. Delaying Disease Progression.
  1451. Acute Exacerbations.
  1452. TABLE 15-16 PATIENT & CAREGIVER TEACHING GUIDE: Signs and Symptoms HIV Patients Need to Report
  1453. FIG. 15-8 Chest x-ray showing interstitial infiltrates as the result of Pneumocystis jiroveci pneumonia.
  1454. Ambulatory and Home Care.
  1455. Stigma of HIV.
  1456. Disease and Drug Side Effects.
  1457. FIG. 15-9 Lipodystrophy manifestations.
  1458. End-of-Life Care.
  1459. Evaluation
  1460. Gerontologic Considerations
  1461. HIV Infection
  1462. Case Study HIV Infection
  1463. iStockphoto/Thinkstock
  1464. Patient Profile
  1465. Subjective Data
  1466. Objective Data
  1467. Physical Examination
  1468. Laboratory Studies
  1469. Collaborative Care
  1470. Discussion Questions
  1471. Bridge to NCLEX Examination
  1472. References
  1473. Resources
  1474. Pageburst Integrated Resources
  1475. Answer Keys
  1476. Case Studies
  1477. Concept Map Creator
  1478. Content Updates
  1479. eTables
  1480. Glossary
  1481. Key Points
  1482. Chapter 16 Cancer
  1483. Learning Outcomes
  1484. Key Terms
  1485. eFigure
  1486. eTables
  1487. TABLE 16-1 CANCER INCIDENCE BY SITE AND GENDER*
  1488. TABLE 16-2 CANCER DEATHS BY SITE AND GENDER*
  1489. Gender Differences Cancer
  1490. Men
  1491. Women
  1492. Informatics in Practice Managing Cancer Patients’ Symptoms
  1493. Biology of Cancer
  1494. Defect in Cell Proliferation
  1495. FIG. 16-1 Cell life cycle and metabolic activity. Generation time is the period from M phase to M phase. Cells not in the cycle but capable of division are in the resting phase (G0).
  1496. Defect in Cell Differentiation
  1497.  Genetic Link
  1498. Development of Cancer
  1499. Initiation.
  1500.  Genetic Link
  1501. Carcinogens.
  1502. Chemical Carcinogens.
  1503. FIG. 16-2 Process of cancer development.
  1504. Radiation.
  1505. Viral Carcinogens.
  1506. Promotion.
  1507. FIG. 16-3 Main sites of metastasis.
  1508. Progression.
  1509. FIG. 16-4 The pathogenesis of cancer metastasis. To produce metastases, tumor cells must detach from the primary tumor and enter the circulation, survive in the circulation to arrest in the capillary bed, adhere to capillary basement membrane, gain entrance into the organ parenchyma, respond to growth factors, proliferate and induce angiogenesis, and evade host defenses.
  1510. Role of the Immune System
  1511. FIG. 16-5 Tumor-associated antigens appear on the cell surface of malignant cells.
  1512. Escape Mechanisms From Immunologic Surveillance.
  1513. Oncofetal Antigens and Tumor Markers.
  1514. FIG. 16-6 Blocking antibodies prevent T cells from interacting with tumor-associated antigens and from destroying the malignant cell.
  1515. Benign Versus Malignant Neoplasms
  1516. Classification of Cancer
  1517. TABLE 16-3 COMPARISON OF BENIGN AND MALIGNANT NEOPLASMS
  1518. Anatomic Site Classification
  1519. Histologic Classification
  1520. TABLE 16-4 ANATOMIC CLASSIFICATION OF TUMORS
  1521. Extent of Disease Classification
  1522. Clinical Staging.
  1523. TNM Classification System.
  1524. TABLE 16-5 TNM CLASSIFICATION SYSTEM
  1525. Prevention and Early Detection of Cancer
  1526. TABLE 16-6 SEVEN WARNING SIGNS OF CANCER
  1527. Healthy People Prevention and Early Detection of Cancer
  1528. Diagnosis of Cancer
  1529. Biopsy.
  1530. FIG. 16-7 Positron emission tomography (PET) scan before treatment (A) indicating metastasis throughout the body. PET scan after treatment (B) indicates the effects of therapy. More radioactive material accumulates in areas that have higher levels of activity. This often corresponds to areas of disease and shows up as brighter spots on the PET scan.
  1531. Collaborative Care
  1532. Treatment Goals
  1533. FIG. 16-8 Goals of cancer treatment.
  1534. Cure.
  1535. Control.
  1536. Palliation.
  1537. Surgical Therapy
  1538. Prevention
  1539. Cure or Control
  1540. Supportive and Palliative Care
  1541. Chemotherapy
  1542. FIG. 16-9 Role of surgery in the treatment of cancer.
  1543. FIG. 16-10 Goals of chemotherapy.
  1544. Effect on Cells
  1545. Classification of Chemotherapy Drugs
  1546. TABLE 16-7 DRUG THERAPY Chemotherapy Drugs
  1547. Preparation of Chemotherapy
  1548. Methods of Administration
  1549. TABLE 16-8 DRUG THERAPY: Methods of Chemotherapy Administration
  1550. FIG. 16-11 Extravasation injury from infiltration of chemotherapy drug.
  1551. Regional Chemotherapy Administration
  1552. Intraarterial Chemotherapy.
  1553. Intraperitoneal Chemotherapy.
  1554. Intrathecal or Intraventricular Chemotherapy.
  1555. Intravesical Bladder Chemotherapy.
  1556. Effects of Chemotherapy on Normal Tissues
  1557. TABLE 16-9 CELLS WITH RAPID RATE OF PROLIFERATION
  1558. Treatment Plan
  1559. Radiation Therapy
  1560. Effects of Radiation
  1561. Principles of Radiobiology
  1562. TABLE 16-10 TUMOR RADIOSENSITIVITY*
  1563. High Radiosensitivity
  1564. Moderate Radiosensitivity
  1565. Mild Radiosensitivity
  1566. Poor Radiosensitivity
  1567. Simulation and Treatment Planning
  1568. FIG. 16-12 Immobilization device. A head holder and an immobilization mask may be used to ensure accurate positioning for daily treatment of head and neck cancer.
  1569. Treatment
  1570. External Radiation.
  1571. FIG. 16-13 Linear accelerator. Varian Clinac EX linear accelerator with multiple photon and electron energies available for use according to the treatment plan. Patient is positioned on radiation treatment table for treatment of head and neck cancer.
  1572. Internal Radiation.
  1573. Nursing Management Chemotherapy and Radiation Therapy
  1574. Nursing Implementation
  1575. Bone Marrow Suppression.
  1576. Fatigue.
  1577. Gastrointestinal Effects.
  1578. TABLE 16-11 NURSING MANAGEMENT OF PROBLEMS CAUSED BY CHEMOTHERAPY AND RADIATION THERAPY
  1579. Nausea and Vomiting.
  1580. Diarrhea.
  1581. Mucositis.
  1582. Anorexia.
  1583. Skin Reactions
  1584. Radiation Skin Changes.
  1585. FIG. 16-14 Dry desquamation.
  1586. Chemotherapy Skin Changes.
  1587. FIG. 16-15 Wet desquamation.
  1588. TABLE 16-12 PATIENT & CAREGIVER TEACHING GUIDE: Radiation Skin Reactions
  1589. Pulmonary Effects.
  1590. Cardiovascular Effects.
  1591. Reproductive Effects.
  1592. Coping with Therapy.
  1593. Late Effects of Radiation and Chemotherapy
  1594. Biologic and Targeted Therapy
  1595. FIG. 16-16 Sites of action of targeted therapy. EGFR, Epidermal growth factor receptor; HER-2, human epidermal growth factor receptor 2; VEGF, vascular endothelial growth factor.
  1596. TABLE 16-13 DRUG THERAPY: Biologic and Targeted Therapy*
  1597. Side Effects of Biologic and Targeted Therapy
  1598. Nursing Management Biologic and Targeted Therapy
  1599. Hematopoietic Growth Factors
  1600. TABLE 16-14 DRUG THERAPY: Hematopoietic Growth Factors Used in Cancer Treatment
  1601. Hematopoietic Stem Cell Transplantation
  1602. TABLE 16-15 INDICATIONS FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION
  1603. Malignant Diseases
  1604. Nonmalignant Diseases
  1605. Types of Hematopoietic Stem Cell Transplants
  1606. FIG. 16-17 Autologous stem cell transplant.
  1607. Procedures
  1608. Harvest Procedures.
  1609. Preparative Regimens and Stem Cell Infusions.
  1610. Complications.
  1611. TABLE 16-16 NUTRITIONAL THERAPY Protein Foods With High Biologic Value
  1612. Gene Therapy
  1613. Complications Resulting From Cancer
  1614. Nutritional Problems
  1615. Malnutrition
  1616. TABLE 16-17 NUTRITIONAL THERAPY: High-Calorie Foods
  1617. Altered Taste Sensation (Dysgeusia)
  1618. Infection
  1619. Oncologic Emergencies
  1620. Obstructive Emergencies
  1621. Superior Vena Cava Syndrome.
  1622. FIG. 16-18 Superior vena caval obstruction in bronchial carcinoma. Note the swelling of the face and neck and the development of collateral circulation in the veins.
  1623. Spinal Cord Compression.
  1624. Third Space Syndrome.
  1625. Metabolic Emergencies
  1626. Syndrome of Inappropriate Antidiuretic Hormone Secretion.
  1627. Hypercalcemia.
  1628. Tumor Lysis Syndrome.
  1629. Infiltrative Emergencies
  1630. Cardiac Tamponade.
  1631. Carotid Artery Rupture.
  1632. Cancer Pain
  1633. Pain Assessment
  1634. Pain Management
  1635. TABLE 16-18 PAIN ASSESSMENT IN CANCER PATIENTS
  1636. Psychologic Support
  1637. TABLE 16-19 FACTORS AFFECTING HOW PATIENTS COPE WITH CANCER
  1638. Ethical/Legal Dilemmas Medical Futility
  1639. Situation
  1640. Ethical/Legal Points for Consideration
  1641. Discussion Questions
  1642. Gerontologic Considerations
  1643. Cancer
  1644. Cancer Survivorship
  1645. TABLE 16-20 RESOURCES FOR CANCER SURVIVORS
  1646. Culturally Competent Care
  1647. Cancer
  1648.  Cultural & Ethnic Health Disparities Cancer
  1649. Bridge to NCLEX Examination
  1650. References
  1651. Resources
  1652. Pageburst Integrated Resources
  1653. Answer Keys
  1654. Concept Map Creator
  1655. Content Updates
  1656. eFigures
  1657. eTables
  1658. Glossary
  1659. Key Points
  1660. Chapter 17 Fluid, Electrolyte, and Acid-Base Imbalances
  1661. Learning Outcomes
  1662. Key Terms
  1663. Homeostasis
  1664. FIG. 17-1 Body water over the life span.
  1665. Water Content of the Body
  1666. Body Fluid Compartments
  1667. FIG. 17-2 Relative volumes of three body fluids. Values represent fluid distribution in a young male adult.
  1668. Calculation of Fluid Gain or Loss
  1669. Electrolytes
  1670. Measurement of Electrolytes
  1671. Electrolyte Composition of Fluid Compartments
  1672. FIG. 17-3 The relative concentrations of the major cations and anions in the intracellular space and the plasma.
  1673. TABLE 17-1 NORMAL SERUM ELECTROLYTE VALUES
  1674. Mechanisms Controlling Fluid and Electrolyte Movement
  1675. Diffusion
  1676. FIG. 17-4 Diffusion is the movement of molecules from an area of high concentration to an area of low concentration. Eventually the sugar molecules are evenly distributed.
  1677. Facilitated Diffusion
  1678. Active Transport
  1679. Osmosis
  1680. FIG. 17-5 Sodium-potassium pump. As sodium (Na+) diffuses into the cell and potassium (K +) diffuses out of the cell, an active transport system supplied with energy delivers Na+ back to the extracellular compartment and K+ to the intracellular compartment. ATP, Adenosine triphosphate.
  1681. FIG. 17-6 Osmosis is the process of water movement through a semipermeable membrane from an area of low solute concentration to an area of high solute concentration.
  1682. Measurement of Osmolality.
  1683. Osmotic Movement of Fluids.
  1684. FIG. 17-7 Effects of water status on red blood cells. A, Hypotonic solution (H2O excess) results in cellular swelling. B, Isotonic solution (normal H2O balance) results in no change. C, Hypertonic solution (H2O deficit) results in cellular shrinking.
  1685. Hydrostatic Pressure
  1686. Oncotic Pressure
  1687. Fluid Movement in Capillaries
  1688. FIG. 17-8 Dynamics of fluid exchange between a capillary and tissue. An equilibrium exists between forces filtering fluid out of the capillary and forces absorbing fluid back into the capillary. Note that the hydrostatic pressure is greater at the arterial end of the capillary than at the venous end. The net effect of pressures at the arterial end of the capillary causes a movement of fluid into the tissue. At the venous end of the capillary, there is net movement of fluid back into the capillary.
  1689. Fluid Shifts
  1690. Shifts of Plasma to Interstitial Fluid.
  1691. Elevation of Venous Hydrostatic Pressure.
  1692. Decrease in Plasma Oncotic Pressure.
  1693. Elevation of Interstitial Oncotic Pressure.
  1694. Shifts of Interstitial Fluid to Plasma.
  1695. Fluid Spacing
  1696. Regulation of Water Balance
  1697. Hypothalamic-Pituitary Regulation
  1698. Renal Regulation
  1699. Adrenal Cortical Regulation
  1700. FIG. 17-9 Factors affecting aldosterone secretion. ACTH, Adrenocorticotropic hormone.
  1701. Cardiac Regulation
  1702. Gastrointestinal Regulation
  1703. TABLE 17-2 NORMAL FLUID BALANCE IN THE ADULT
  1704. FIG. 17-10 Effects of stress on fluid and electrolyte balance. ACTH, Adrenocorticotropic hormone; ADH, antidiuretic hormone; CRH, corticotropin-releasing hormone.
  1705. Insensible Water Loss
  1706. Gerontologic Considerations
  1707. Fluid and Electrolytes
  1708. Fluid and Electrolyte Imbalances
  1709. Extracellular Fluid Volume Imbalances
  1710. Fluid Volume Deficit
  1711. Collaborative Care
  1712. Fluid Volume Excess
  1713. Collaborative Care
  1714. TABLE 17-3 EXTRACELLULAR FLUID IMBALANCES: CAUSES AND CLINICAL MANIFESTATIONS
  1715. Nursing Management Extracellular Fluid Volume Imbalances
  1716. Nursing Diagnoses
  1717. Nursing Implementation
  1718. Intake and Output.
  1719. Cardiovascular Changes.
  1720. Respiratory Changes.
  1721. Neurologic Changes.
  1722. Daily Weights.
  1723. FIG. 17-11 Assessment of skin turgor. A and B, When normal skin is pinched, it resumes shape in seconds. C, If the skin remains wrinkled for 20 to 30 seconds, the patient has poor skin turgor.
  1724. Skin Assessment and Care.
  1725. Other Nursing Measures.
  1726. Sodium Imbalances
  1727. FIG. 17-12 Differential assessment of extracellular fluid (ECF) volume.
  1728. Hypernatremia
  1729. Clinical Manifestations.
  1730. FIG. 17-13 Isotonic gains and losses affect mainly the extracellular fluid (ECF) compartment with little or no water movement into the cells. Hypertonic imbalances cause water to move from inside the cell into ECF to dilute the concentrated sodium, causing cell shrinkage. Hypotonic imbalances cause water to move into the cell, causing cell swelling.
  1731. TABLE 17-4 SODIUM IMBALANCES: CAUSES AND CLINICAL MANIFESTATIONS
  1732. Nursing and Collaborative Management Hypernatremia
  1733. Nursing Diagnoses
  1734. Nursing Implementation
  1735. Hyponatremia
  1736. Clinical Manifestations.
  1737. Nursing and Collaborative Management Hyponatremia
  1738. Nursing Diagnoses
  1739. Nursing Implementation
  1740. Potassium Imbalances
  1741. Hyperkalemia
  1742. TABLE 17-5 POTASSIUM IMBALANCES: CAUSES AND CLINICAL MANIFESTATIONS
  1743. FIG. 17-14 Electrocardiographic changes associated with alterations in potassium status.
  1744. Clinical Manifestations.
  1745. Nursing and Collaborative Management Hyperkalemia
  1746. Nursing Diagnoses
  1747. Nursing Implementation
  1748. Hypokalemia
  1749. Clinical Manifestations.
  1750. Nursing and Collaborative Management Hypokalemia
  1751. Nursing Diagnoses
  1752. Nursing Implementation
  1753. Safety Alert
  1754. TABLE 17-6 PATIENT & CAREGIVER TEACHING GUIDE: Prevention of Hypokalemia
  1755. Calcium Imbalances
  1756. TABLE 17-7 CALCIUM IMBALANCES: CAUSES AND CLINICAL MANIFESTATIONS
  1757. Hypercalcemia
  1758. Nursing and Collaborative Management Hypercalcemia
  1759. Nursing Diagnoses
  1760. Nursing Implementation
  1761. Hypocalcemia
  1762. FIG. 17-15 Tests for hypocalcemia. A, Chvostek’s sign is contraction of facial muscles in response to a light tap over the facial nerve in front of the ear. B, Trousseau’s sign is a carpal spasm induced by, C, inflating a blood pressure cuff above the systolic pressure for a few minutes.
  1763. Nursing and Collaborative Management Hypocalcemia
  1764. Nursing Diagnoses
  1765. Nursing Implementation
  1766. Phosphate Imbalances
  1767. Hyperphosphatemia
  1768. TABLE 17-8 PHOSPHATE IMBALANCES: CAUSES AND CLINICAL MANIFESTATIONS
  1769. Hypophosphatemia
  1770. Magnesium Imbalances
  1771. Hypermagnesemia
  1772. TABLE 17-9 MAGNESIUM IMBALANCES: CAUSES AND CLINICAL MANIFESTATIONS
  1773. Hypomagnesemia
  1774. FIG. 17-16 The normal range of plasma pH is 7.35 to 7.45. A normal pH is maintained by a ratio of 1 part carbonic acid to 20 parts bicarbonate.
  1775. Acid-Base Imbalances
  1776. pH and Hydrogen Ion Concentration
  1777. Acid-Base Regulation
  1778. Buffer System.
  1779. Respiratory System.
  1780. Renal System.
  1781. Alterations in Acid-Base Balance
  1782. Respiratory Acidosis.
  1783. TABLE 17-10 ACID-BASE IMBALANCES
  1784. FIG. 17-17 Kinds of acid-base imbalances. A, Respiratory imbalances caused by carbonic acid (CA) excess and carbonic acid deficit. B, Metabolic imbalances caused by base bicarbonate (BB) deficit and base bicarbonate excess.
  1785. Respiratory Alkalosis.
  1786. Metabolic Acidosis.
  1787. Metabolic Alkalosis.
  1788. Mixed Acid-Base Disorders.
  1789. Clinical Manifestations
  1790. Blood Gas Values.
  1791. TABLE 17-11 CLINICAL MANIFESTATIONS OF ACIDOSIS
  1792. TABLE 17-12 CLINICAL MANIFESTATIONS OF ALKALOSIS
  1793. Assessment of Fluid, Electrolyte, and Acid-Base Imbalances
  1794. TABLE 17-13 NORMAL ARTERIAL BLOOD GAS VALUES*
  1795. Subjective Data
  1796. Important Health Information
  1797. Past Health History.
  1798. Medications.
  1799. Surgery or Other Treatments.
  1800. TABLE 17-14 ARTERIAL BLOOD GAS (ABG) ANALYSIS
  1801. TABLE 17-15 ROME: MEMORY DEVICE FOR ACID-BASE IMBALANCES
  1802. Functional Health Patterns
  1803. Health Perception–Health Management Pattern.
  1804. Nutritional-Metabolic Pattern.
  1805. Elimination Pattern.
  1806. Activity-Exercise Pattern.
  1807. Cognitive-Perceptual Pattern.
  1808. Objective Data
  1809. Physical Examination.
  1810. Laboratory Values.
  1811. TABLE 17-16 ASSESSMENT ABNORMALITIES: Fluid and Electrolyte Imbalances
  1812. Oral Fluid and Electrolyte Replacement
  1813. Intravenous Fluid and Electrolyte Replacement
  1814. Solutions
  1815. Hypotonic.
  1816. Isotonic.
  1817. TABLE 17-17 COMMONLY USED CRYSTALLOID SOLUTIONS
  1818. Hypertonic.
  1819. Intravenous Additives.
  1820. Plasma Expanders.
  1821. Delegation Decisions Intravenous Therapy
  1822. Role of Registered Nurse (RN)
  1823. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  1824. Role of Unlicensed Assistive Personnel (UAP)
  1825. Central Venous Access Devices
  1826. TABLE 17-18 INDICATIONS FOR CENTRAL VENOUS ACCESS DEVICE (CVAD)*
  1827. Centrally Inserted Catheters
  1828. FIG. 17-18 Tunneled central venous catheter. Note tip of the catheter in the superior vena cava.
  1829. Peripherally Inserted Central Catheters
  1830. FIG. 17-19 Peripherally inserted central catheter (PICC) can be inserted using the basilic or cephalic vein.
  1831. TABLE 17-19 COMPLICATIONS OF CENTRAL VENOUS ACCESS DEVICES (CVADs)
  1832. Local
  1833. Systemic
  1834. Implanted Infusion Ports
  1835. Complications
  1836. Nursing Management Central Venous Access Devices
  1837. FIG. 17-20 A, Cross section of implantable port displaying access of the port with the Huber-point needle. Note the deflected point of the Huber-point needle, which prevents coring of the port’s septum. B, Two Huber-point needles used to enter the implanted port. The 90-degree needle is used for top-entry ports for continuous infusion.
  1838. Removal of CVADs
  1839. Case Study Fluid and Electrolyte Imbalance
  1840. iStockphoto/Thinkstock
  1841. Patient Profile
  1842. Subjective Data
  1843. Objective Data
  1844. Discussion Questions
  1845. Bridge to NCLEX Examination
  1846. References
  1847. Resource
  1848. Case Study Managing Multiple Patients
  1849. Patients
  1850. Management Discussion Questions
  1851. Case Study Progression
  1852. Pageburst Integrated Resources
  1853. Answer Keys
  1854. Case Studies
  1855. Concept Map Creator
  1856. Content Updates
  1857. Glossary
  1858. Key Points
  1859. Tutorials
  1860. Section 3 Perioperative Care
  1861. Perioperative Care
  1862. Pre-Test – Section 3
  1863. Interactive Review – Section 3
  1864. Chapter 18 Nursing Management: Preoperative Care
  1865. Learning Outcomes
  1866. Key Terms
  1867. TABLE 18-1 SUFFIXES DESCRIBING SURGICAL PROCEDURES
  1868. Surgical Settings
  1869. Patient Interview
  1870. Nursing Assessment of Preoperative Patient
  1871. Subjective Data
  1872. Psychosocial Assessment.
  1873. TABLE 18-2 PSYCHOSOCIAL ASSESSMENT OF PREOPERATIVE PATIENT
  1874. Anxiety.
  1875. Common Fears.
  1876. Hope.
  1877. Past Health History.
  1878. Medications.
  1879.  Complementary & Alternative Therapies
  1880. Helpful Herbs and Vitamins
  1881. Allergies.
  1882. Review of Systems.
  1883. Cardiovascular System.
  1884. Respiratory System.
  1885. Neurologic System.
  1886. Genitourinary System.
  1887. Hepatic System.
  1888. Integumentary System.
  1889. Musculoskeletal System.
  1890. Endocrine System.
  1891. Immune System.
  1892. Fluid and Electrolyte Status.
  1893. Nutritional Status.
  1894. Objective Data
  1895. Physical Examination.
  1896. TABLE 18-3 AMERICAN SOCIETY OF ANESTHESIOLOGISTS’ PHYSICAL CLASSIFICATION SYSTEM
  1897. Laboratory and Diagnostic Testing.
  1898. Nursing Management Preoperative Patient
  1899. Preoperative Teaching
  1900. TABLE 18-4 HEALTH ASSESSMENT AND PHYSICAL EXAMINATION OF PREOPERATIVE PATIENT*
  1901. General Surgery Information.
  1902. TABLE 18-5 COMMON PREOPERATIVE LABORATORY AND DIAGNOSTIC TESTS
  1903. Ambulatory Surgery Information.
  1904. TABLE 18-6 PATIENT & CAREGIVER TEACHING GUIDE: Preoperative Preparation
  1905. Legal Preparation For Surgery
  1906. Consent for Surgery.
  1907. TABLE 18-7 PREOPERATIVE FASTING RECOMMENDATIONS*
  1908. Evidence-Based Practice Applying the Evidence
  1909. Your Decision and Action
  1910. References for Evidence
  1911. Ethical/Legal Dilemmas Informed Consent
  1912. Situation
  1913. Ethical/Legal Points for Consideration
  1914. Discussion Questions
  1915. Day-of-Surgery Preparation
  1916. Nursing Role.
  1917. FIG. 18-1 The nurse performs a safety check by verifying that the patient has an identification band (wristband) as part of the preoperative preparations before she goes to surgery.
  1918. Safety Alert
  1919. Preoperative Medications.
  1920. Informatics in Practice Computer-Based Timing for Antibiotic Administration
  1921. TABLE 18-8 PREOPERATIVE CHECKLIST
  1922. Transportation to the Operating Room
  1923. Culturally Competent Care
  1924. Preoperative Patient
  1925. TABLE 18-9 DRUG THERAPY: Commonly Used Preoperative Medications
  1926. Gerontologic Considerations
  1927. Preoperative Patient
  1928. Case Study Preoperative Patient
  1929. Patient Profile
  1930. Subjective Data
  1931. Objective Data
  1932. Physical Examination
  1933. Diagnostic Studies
  1934. Collaborative Care
  1935. Discussion Questions
  1936. Bridge to NCLEX Examination
  1937. References
  1938. Resources
  1939. Pageburst Integrated Resources
  1940. Answer Keys
  1941. Concept Map Creator
  1942. Content Updates
  1943. Glossary
  1944. Key Points
  1945. Chapter 19 Nursing Management: Intraoperative Care
  1946. Learning Outcomes
  1947. Key Terms
  1948. eFigures
  1949. eTable
  1950. Physical Environment of Operating Room
  1951. Department Layout
  1952. Holding Area
  1953. Operating Room
  1954. FIG. 19-1 Typical operating room.
  1955. Surgical Team
  1956. Registered Nurse
  1957. TABLE 19-1 INTRAOPERATIVE ACTIVITIES OF PERIOPERATIVE NURSE
  1958. FIG. 19-2 The complexity of surgery requires maintaining asepsis.
  1959. Licensed Practical/Vocational Nurse and Surgical Technologist
  1960. Surgeon and Assistant
  1961. TABLE 19-2 NURSING ACTIVITIES DURING SURGICAL EXPERIENCE*
  1962. Registered Nurse First Assistant
  1963. Anesthesia Care Provider
  1964. Nursing Management Patient before Surgery
  1965. Psychosocial Assessment
  1966. Physical Assessment
  1967. Chart Review
  1968. Admitting the Patient
  1969.  Complementary & Alternative Therapies
  1970. Scientific Evidence
  1971. Nursing Implications
  1972. Nursing Management Patient During Surgery
  1973. Room Preparation
  1974. FIG. 19-3 Surgical attire is worn by all people entering the operating room.
  1975. Transferring Patient
  1976. Scrubbing, Gowning, and Gloving
  1977. FIG. 19-4 A sterile field is created before surgery.
  1978. Basic Aseptic Technique
  1979. Assisting Anesthesia Care Provider
  1980. TABLE 19-3 PRINCIPLES OF ASEPTIC TECHNIQUE IN OPERATING ROOM
  1981. Safety Considerations
  1982. FIG. 19-5 When an electrosurgical unit is used, the patient must be properly grounded to prevent unintended injury. A well-vascularized muscle mass is an optimal site. Safety can be compromised by excessive hair, adipose tissue, bony prominences, fluid (edema), adhesive failure, and scar tissue.
  1983. Safety Alert
  1984. Positioning Patient
  1985. Preventing Hypothermia
  1986. Preparing Surgical Site
  1987. Patient After Surgery
  1988. Anesthesia
  1989. Classification of Anesthesia
  1990. TABLE 19-4 CLASSIFICATION OF ANESTHESIA AND PATIENT EFFECTS
  1991. General Anesthesia
  1992. Intravenous Agents.
  1993. Inhalation Agents.
  1994. Adjuncts to General Anesthesia.
  1995. TABLE 19-5 PHASES OF GENERAL ANESTHESIA
  1996. Dissociative Anesthesia.
  1997. Local and Regional Anesthesia
  1998. TABLE 19-6 DRUG THERAPY: General Anesthesia
  1999. TABLE 19-7 DRUG THERAPY: Adjuncts to General Anesthesia
  2000. Methods of Administration.
  2001. FIG. 19-6 Location of needle point and injected anesthetic relative to dura and spinal cord. A, Spinal anesthesia. B, Single-injection epidural. C, Epidural catheter. (Interspaces most commonly used are L2-3, L4-5, L3-4.)
  2002. Spinal and Epidural Anesthesia.
  2003. Gerontologic Considerations
  2004. Patient during Surgery
  2005. Catastrophic Events in Operating Room
  2006. Anaphylactic Reactions
  2007. Malignant Hyperthermia
  2008. Future Considerations
  2009. Bridge to NCLEX Examination
  2010. References
  2011. Resources
  2012. Pageburst Integrated Resources
  2013. Answer Keys
  2014. Concept Map Creator
  2015. Content Updates
  2016. eFigures
  2017. eTables
  2018. Glossary
  2019. Key Points
  2020. Chapter 20 Nursing Management: Postoperative Care
  2021. Learning Outcomes
  2022. Key Terms
  2023. eTable
  2024. Postoperative Care of the Surgical Patient
  2025. Postanesthesia Care Unit Admission
  2026. PACU Progression.
  2027. TABLE 20-1 PHASES OF POSTANESTHESIA CARE
  2028. Phase I Initial Assessment.
  2029. TABLE 20-2 PACU ADMISSION REPORT
  2030. TABLE 20-3 INITIAL PACU ASSESSMENT
  2031. Airway
  2032. Breathing
  2033. Circulation
  2034. Neurologic
  2035. Gastrointestinal
  2036. Genitourinary
  2037. Surgical Site
  2038. Pain
  2039. TABLE 20-4 MANIFESTATIONS OF INADEQUATE OXYGENATION
  2040. Central Nervous System
  2041. Cardiovascular System
  2042. Integumentary System
  2043. Respiratory System
  2044. Renal System
  2045. FIG. 20-1 Potential problems in the postoperative period.
  2046. Respiratory Problems
  2047. Etiology
  2048. PACU.
  2049. TABLE 20-5 POSTOPERATIVE RESPIRATORY COMPLICATIONS
  2050. FIG. 20-2 Etiology and relief of airway obstruction.
  2051. FIG. 20-3 Postoperative atelectasis. A, Normal bronchiole and alveoli. B, Mucous plug in bronchiole. C, Collapse of alveoli resulting from atelectasis after absorption of air.
  2052. Clinical Unit.
  2053. Nursing Management Respiratory Problems
  2054. Nursing Assessment
  2055. Delegation Decisions Postoperative Patient
  2056. Nursing Diagnoses
  2057. Nursing Implementation
  2058. Safety Alert
  2059. FIG. 20-4 Position of patient during recovery from general anesthesia.
  2060. FIG. 20-5 Proper use of an incentive spirometer.
  2061. FIG. 20-6 Techniques for splinting incision when coughing.
  2062. Cardiovascular Problems
  2063. Etiology
  2064. PACU.
  2065. Clinical Unit.
  2066. Nursing Management Cardiovascular Problems
  2067. Nursing Assessment
  2068. Nursing Diagnoses
  2069. Nursing Implementation
  2070. PACU.
  2071. Clinical Unit.
  2072. Neurologic and Psychologic Problems
  2073. Etiology
  2074. PACU.
  2075. Clinical Unit.
  2076. Nursing Management Neurologic and Psychologic Problems
  2077. Nursing Assessment
  2078. Nursing Diagnoses
  2079. Nursing Implementation
  2080. PACU.
  2081. Clinical Unit.
  2082. Pain and Discomfort
  2083. Etiology
  2084. Nursing Management Pain
  2085. Nursing Assessment
  2086. Nursing Diagnoses
  2087. Nursing Implementation
  2088. Alterations in Temperature
  2089. Etiology
  2090. Hypothermia.
  2091. TABLE 20-6 POSTOPERATIVE TEMPERATURE CHANGES
  2092. Fever.
  2093. Nursing Management Altered Temperature
  2094. Nursing Assessment
  2095. Nursing Diagnoses
  2096. Nursing Implementation
  2097. Gastrointestinal Problems
  2098. Etiology
  2099. Nursing Management Gastrointestinal Problems
  2100. Nursing Assessment
  2101. Nursing Diagnoses
  2102. Nursing Implementation
  2103. Urinary Problems
  2104. Etiology
  2105. Nursing Management Urinary Problems
  2106. Nursing Assessment
  2107. Nursing Diagnoses
  2108. Nursing Implementation
  2109. Integumentary Problems
  2110. Etiology
  2111. Nursing Management Surgical Wounds
  2112. Nursing Assessment
  2113. Nursing Diagnoses
  2114. Nursing Implementation
  2115. TABLE 20-7 DRAINAGE FROM TUBES AND CATHETERS
  2116. Discharge From the PACU
  2117. Discharge to the Clinical Unit
  2118. TABLE 20-8 SURGERY DISCHARGE CRITERIA
  2119. Ambulatory Surgery
  2120. Phase II and Extended Observation
  2121. Ambulatory Surgery Discharge
  2122. TABLE 20-9 POSTOPERATIVE SBAR HANDOFF COMMUNICATION
  2123. TABLE 20-10 NURSING ASSESSMENT: Care of Patient on Admission to Clinical Unit
  2124. Informatics in Practice Discharge Teaching
  2125. Planning for Discharge and Follow-up Care
  2126. Gerontologic Considerations
  2127. Postoperative Patient
  2128. Case Study Postoperative Patient
  2129. Patient Profile
  2130. Subjective Data
  2131. Objective Data
  2132. Collaborative Care
  2133. Postoperative Orders
  2134. Discussion Questions
  2135. Bridge to NCLEX Examination
  2136. References
  2137. Resources
  2138. Case Study Managing Multiple Patients
  2139. Patients
  2140. Stockbyte/Thinkstock
  2141. Ryan McVay/Photodisc/Thinkstock
  2142. Ryan McVay/Digital Vision/Thinkstock
  2143. Management Discussion Questions
  2144. Case Study Progression
  2145. Pageburst Integrated Resources
  2146. Answer Keys
  2147. Care Plans
  2148. Case Studies
  2149. Concept Map Creator
  2150. Content Updates
  2151. eTables
  2152. Glossary
  2153. Key Points
  2154. Section 4 Problems Related to Altered Sensory Input
  2155. Problems Related to Altered Sensory Input
  2156. Pre-Test – Section 4
  2157. Interactive Review – Section 4
  2158. Chapter 21 Nursing Assessment: Visual and Auditory Systems
  2159. Learning Outcomes
  2160. Key Terms
  2161. eFigures
  2162. eTable
  2163. Visual System
  2164. Structures and Functions of Visual System
  2165. FIG. 21-1 The human eye.
  2166. Structures and Functions of Vision
  2167. Eyeball.
  2168. Refractive Media.
  2169. Refractive Errors.
  2170. Visual Pathways.
  2171. External Structures and Functions
  2172. FIG. 21-2 The visual pathway. Fibers from the nasal portion of each retina cross over to the opposite side of the optic chiasma, terminating in the lateral geniculate body of the opposite side. Location of a lesion in the visual pathway determines the resulting visual defect.
  2173. FIG. 21-3 External eye and lacrimal apparatus. Tears produced in the lacrimal gland pass over the surface of the eye and enter the lacrimal canal.
  2174. Internal Structures and Functions
  2175. TABLE 21-1 GERONTOLOGIC ASSESSMENT DIFFERENCES: Visual System
  2176. Gerontologic Considerations
  2177. Effects of Aging on Visual System
  2178. Focused Assessment
  2179. Assessment of Visual System
  2180. Subjective Data
  2181. Important Health Information
  2182. Past Health History.
  2183. FIG. 21-4 Arcus senilis, or age-related degeneration of the cornea.
  2184. Case Study Patient Introduction
  2185. Jack Hollingsworth/Photodisc/Thinkstock
  2186. Critical Thinking
  2187. Medications.
  2188. Surgery or Other Treatments.
  2189. Functional Health Patterns.
  2190. Health Perception–Health Management Pattern.
  2191. TABLE 21-2 HEALTH HISTORY: Visual System
  2192.  Genetic Risk Alert
  2193. Glaucoma
  2194. Age-Related Macular Degeneration (AMD)
  2195. Nutritional-Metabolic Pattern.
  2196. Elimination Pattern.
  2197. Activity-Exercise Pattern.
  2198. Sleep-Rest Pattern.
  2199. Cognitive-Perceptual Pattern.
  2200. Self-Perception–Self-Concept Pattern.
  2201. Role-Relationship Pattern.
  2202. Case Study Subjective Data
  2203. Jack Hollingsworth/Photodisc/Thinkstock
  2204. Sexuality-Reproductive Pattern.
  2205. Coping–Stress Tolerance Pattern.
  2206. Value-Belief Pattern.
  2207. Objective Data
  2208. Physical Examination.
  2209. TABLE 21-3 NORMAL PHYSICAL ASSESSMENT OF VISUAL SYSTEM
  2210. Initial Observation.
  2211. Assessing Functional Status
  2212. Visual Acuity.
  2213. TABLE 21-4 NURSING ASSESSMENT: Assessment Techniques: Visual System
  2214. Extraocular Muscle Functions.
  2215. Pupil Function and Intraocular Pressure.
  2216. Assessing Structures.
  2217. Eyebrows, Eyelashes, and Eyelids.
  2218. Conjunctiva and Sclera.
  2219. TABLE 21-5 ASSESSMENT ABNORMALITIES: Visual System
  2220. FIG. 21-5 Magnified view of retina through the ophthalmoscope.
  2221. Cornea.
  2222. Iris.
  2223. Retina and Optic Nerve.
  2224. Special Assessment Techniques
  2225. Color Vision.
  2226. Stereopsis.
  2227. Case Study Objective Data
  2228. Jack Hollingsworth/Photodisc/Thinkstock
  2229. Physical Examination
  2230. Diagnostic Studies
  2231. Diagnostic Studies of Visual System
  2232. Auditory System
  2233. Structures and Functions of Auditory System
  2234. External Ear
  2235. TABLE 21-6 DIAGNOSTIC STUDIES: Visual System
  2236. Middle Ear
  2237. Inner Ear
  2238. Transmission of Sound.
  2239. FIG. 21-6 External, middle, and inner ear.
  2240. Gerontologic Considerations
  2241. Effects of Aging on Auditory System
  2242. Focused Assessment
  2243. Assessment of Auditory System
  2244. Subjective Data
  2245. Important Health Information
  2246. Past Health History.
  2247. TABLE 21-7 GERONTOLOGIC ASSESSMENT DIFFERENCES: Auditory System
  2248. Medications.
  2249. TABLE 21-8 HEALTH HISTORY: Auditory System
  2250. Surgery or Other Treatments.
  2251. Functional Health Patterns.
  2252. Health Perception–Health Management Pattern.
  2253. Nutritional-Metabolic Pattern.
  2254. Elimination Pattern.
  2255. Activity-Exercise Pattern.
  2256. Sleep-Rest Pattern.
  2257. Cognitive-Perceptual Pattern.
  2258. Self-Perception–Self-Concept Pattern.
  2259. Role-Relationship Pattern.
  2260. Sexuality-Reproductive Pattern.
  2261. Coping–Stress Tolerance Pattern.
  2262. Value-Belief Pattern.
  2263. Objective Data
  2264. Physical Examination.
  2265. TABLE 21-9 NORMAL PHYSICAL ASSESSMENT OF AUDITORY SYSTEM
  2266. External Ear.
  2267. External Auditory Canal and Tympanum.
  2268. FIG. 21-7 The tympanic membrane. A, Landmarks of right tympanic membrane. B, Normal-appearing tympanic membrane. C, Perforated tympanic membrane.
  2269. Diagnostic Studies of Auditory System
  2270. Tests for Hearing Acuity
  2271. Tuning Fork Tests.
  2272. Audiometry.
  2273. TABLE 21-10 ASSESSMENT ABNORMALITIES: Auditory System
  2274. TABLE 21-11 DIAGNOSTIC STUDIES: Auditory System
  2275. Screening Audiometry.
  2276. Specialized Tests
  2277. Test for Vestibular Function
  2278. Bridge to NCLEX Examination
  2279. References
  2280. Resources
  2281. Pageburst Integrated Resources
  2282. Animations
  2283. Answer Keys
  2284. Concept Map Creator
  2285. Content Updates
  2286. eFigures
  2287. eTables
  2288. Glossary
  2289. Key Points
  2290. Videos
  2291. Chapter 22 Nursing Management: Visual and Auditory Problems
  2292. Learning Outcomes
  2293. Key Terms
  2294. eFigures
  2295. eTables
  2296. Visual Problems
  2297. Correctable Refractive Errors
  2298. Nonsurgical Corrections
  2299. Corrective Glasses.
  2300. Contact Lenses.
  2301. Surgical Therapy
  2302. Laser.
  2303. Implant.
  2304.  Cultural & Ethnic Health Disparities
  2305. Uncorrectable Visual Impairment
  2306. Nursing Management Visual Impairment
  2307. Nursing Assessment
  2308. Planning
  2309. Nursing Implementation
  2310. Health Promotion.
  2311. Acute Intervention.
  2312. Ambulatory and Home Care.
  2313. Optical Devices for Vision Enhancement.
  2314. Nonoptical Methods for Vision Enhancement.
  2315. Evaluation
  2316. Healthy People
  2317. Gerontologic Considerations
  2318. Visual Impairment
  2319. Eye Trauma
  2320. Extraocular Disorders
  2321. Inflammation and Infection
  2322.  TABLE 22-1 EMERGENCY MANAGEMENT: Eye Injury
  2323. Trauma
  2324. Chemical Burn
  2325. Thermal Burn
  2326. Foreign Bodies
  2327. Initial
  2328. Ongoing Monitoring
  2329. FIG. 22-1 Hordeolum (sty) on the upper eyelid caused by staphylococcal infection.
  2330. Conjunctivitis
  2331. Bacterial Infections.
  2332. Viral Infections.
  2333. Chlamydial Infections.
  2334. Allergic Conjunctivitis.
  2335. Keratitis
  2336. Bacterial Infections.
  2337. Viral Infections.
  2338. Other Causes of Keratitis.
  2339. Corneal Ulcer.
  2340. FIG. 22-2 Corneal ulcer. Infection associated with poor contact lens care.
  2341. Nursing Management Inflammation and Infection
  2342. Dry Eye Disorders
  2343. Strabismus
  2344. Corneal Disorders
  2345. Corneal Scars and Opacities
  2346. Keratoconus
  2347. FIG. 22-3 Sutures on a donated cornea after penetrating keratoplasty (corneal transplant).
  2348. Intraocular Disorders
  2349. Cataract
  2350. Etiology and Pathophysiology
  2351. Clinical Manifestations and Diagnostic Studies
  2352. Collaborative Care
  2353. Nonsurgical Therapy.
  2354. TABLE 22-2 COLLABORATIVE CARE: Cataract
  2355. Surgical Therapy.
  2356. Preoperative Phase.
  2357. Drug Alert
  2358. Intraoperative Phase.
  2359. Postoperative Phase.
  2360. FIG. 22-4 Intraocular lens implant after cataract surgery.
  2361. Nursing Management Cataracts
  2362. Nursing Assessment
  2363. Nursing Diagnoses
  2364. Planning
  2365. Nursing Implementation
  2366. Health Promotion.
  2367. Acute Intervention.
  2368. TABLE 22-3 PATIENT & CAREGIVER TEACHING GUIDE: After Eye Surgery
  2369. Ambulatory and Home Care.
  2370. Evaluation
  2371. Gerontologic Considerations
  2372. Cataracts
  2373. Retinopathy
  2374. FIG. 22-5 Diabetic retinopathy. Intraretinal dot or blot hemorrhages.
  2375. Retinal Detachment
  2376. Etiology and Pathophysiology
  2377. Clinical Manifestations and Diagnostic Studies
  2378. TABLE 22-4 RISK FACTORS FOR RETINAL DETACHMENT
  2379. TABLE 22-5 COLLABORATIVE CARE: Retinal Detachment
  2380. Collaborative Care
  2381. Surgical Therapy
  2382. Laser Photocoagulation and Cryopexy.
  2383. Scleral Buckling.
  2384. Intraocular Procedures.
  2385. FIG. 22-6 Retinal break with detachment and surgical repair by scleral buckling technique.
  2386. Postoperative Considerations.
  2387. Age-Related Macular Degeneration
  2388. Etiology and Pathophysiology
  2389. Clinical Manifestations and Diagnostic Studies
  2390. Collaborative Care
  2391. Glaucoma
  2392. Etiology and Pathophysiology
  2393. Clinical Manifestations
  2394. Diagnostic Studies
  2395. Collaborative Care
  2396. Chronic Open-Angle Glaucoma
  2397. FIG. 22-7 A, In the normal eye the optic cup is pink with little cupping. B, In glaucoma the optic cup is bleached and optic cupping is present. (Note the appearance of the retinal vessels, which travel over the edge of the optic cup and appear to dip into it.)
  2398. TABLE 22-6 COLLABORATIVE CARE: Glaucoma
  2399. Acute Angle-Closure Glaucoma.
  2400. TABLE 22-7 DRUG THERAPY: Acute and Chronic Glaucoma
  2401. Drug Alert
  2402. Nursing Management Glaucoma
  2403. Nursing Assessment
  2404. Nursing Diagnoses
  2405. Planning
  2406. Nursing Implementation
  2407. Health Promotion.
  2408. Acute Intervention.
  2409. Ambulatory and Home Care.
  2410. Evaluation
  2411. Gerontologic Considerations
  2412. Glaucoma
  2413. Intraocular Inflammation and Infection
  2414. Ocular Tumors
  2415. FIG. 22-8 Uveal melanoma. A large tumor in the choroid, the most common location in the eye for melanoma.
  2416. Enucleation
  2417. Ocular Manifestations of Systemic Diseases
  2418. Auditory Problems External Ear and Canal
  2419. Trauma
  2420. External Otitis
  2421. Nursing and Collaborative Management External Otitis
  2422. TABLE 22-8 PATIENT & CAREGIVER TEACHING GUIDE: Prevention of External Otitis
  2423. Cerumen and Foreign Bodies in External Ear Canal
  2424. Malignancy of External Ear
  2425. Middle Ear and Mastoid
  2426. Otitis Media
  2427. Acute Otitis Media
  2428. Otitis Media With Effusion
  2429. Chronic Otitis Media and Mastoiditis
  2430. Nursing and Collaborative Management Chronic Otitis Media
  2431. TABLE 22-9 COLLABORATIVE CARE: Chronic Otitis Media
  2432. Diagnostic
  2433. Collaborative Therapy
  2434. FIG. 22-9 Perforation of the tympanic membrane (TM).
  2435. Otosclerosis
  2436. TABLE 22-10 COLLABORATIVE CARE: Otosclerosis
  2437. Diagnostic
  2438. Collaborative Therapy
  2439. Inner Ear Problems
  2440. Ménière’s Disease
  2441. Nursing and Collaborative Management Ménière’s Disease
  2442. TABLE 22-11 COLLABORATIVE CARE: Ménière’s Disease
  2443. Benign Paroxysmal Positional Vertigo
  2444. Acoustic Neuroma
  2445. Hearing Loss and Deafness
  2446. Types of Hearing Loss
  2447. Conductive Hearing Loss.
  2448. FIG. 22-10 Causes of hearing loss.
  2449. Sensorineural Hearing Loss.
  2450. Mixed Hearing Loss.
  2451. Central and Functional Hearing Loss.
  2452. TABLE 22-12 CLASSIFICATION OF HEARING LOSS
  2453. Classification of Hearing Loss.
  2454. Clinical Manifestations
  2455. Tinnitus and Hearing Loss.
  2456. Nursing and Collaborative Management Hearing Loss and Deafness
  2457. Health Promotion
  2458. Environmental Noise Control.
  2459. Healthy People
  2460. Immunizations.
  2461. FIG. 22-11 Range of common environmental sounds.
  2462. Ototoxic Substances.
  2463. Assistive Devices and Techniques
  2464. Hearing Aids.
  2465. TABLE 22-13 TYPES OF HEARING AIDS
  2466. TABLE 22-14 COMMUNICATION WITH HEARING-IMPAIRED PATIENT
  2467. Nonverbal Aids
  2468. Verbal Aids
  2469. Speech Reading.
  2470. Sign Language.
  2471. Cochlear Implant.
  2472. FIG. 22-12 Cochlear implant.
  2473. Assisted Listening Devices.
  2474. Gerontologic Considerations
  2475. Hearing Loss
  2476. TABLE 22-15 CLASSIFICATION OF PRESBYCUSIS
  2477. Delegation Decisions Corrective Lenses and Hearing Aids
  2478. Role of Registered Nurse (RN)
  2479. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  2480. Role of Unlicensed Assistive Personnel (UAP)
  2481. Case Study Glaucoma and Diabetic Retinopathy
  2482. Kevin Peterson/Stockbyte/Thinkstock
  2483. Patient Profile
  2484. Subjective Data
  2485. Objective Data
  2486. Collaborative Care
  2487. Discussion Questions
  2488. Bridge to NCLEX Examination
  2489. References
  2490. Resources
  2491. Pageburst Integrated Resources
  2492. Answer Keys
  2493. Care Plans
  2494. Case Studies
  2495. Concept Map Creator
  2496. Content Updates
  2497. eFigures
  2498. eTables
  2499. Glossary
  2500. Key Points
  2501. Chapter 23 Nursing Assessment: Integumentary System
  2502. Learning Outcomes
  2503. Key Terms
  2504. Structures and Functions of Skin and Appendages
  2505. Structures
  2506. Epidermis.
  2507. FIG. 23-1 Microscopic view of the skin in longitudinal section.
  2508. Dermis.
  2509. Subcutaneous Tissue.
  2510. Skin Appendages.
  2511. FIG. 23-2 Structure of a nail.
  2512. FIG. 23-3 Pigmented nail bed normally seen with dark skin color.
  2513. Functions of Integumentary System
  2514. Gerontologic Considerations
  2515. Effects of Aging on Integumentary System
  2516. TABLE 23-1 GERONTOLOGIC ASSESSMENT DIFFERENCES: Integumentary System
  2517. FIG. 23-4 Photoaging. Irregular pigmentation and keratoses occur on sun-damaged skin on forehead.
  2518. TABLE 23-2 NORMAL PHYSICAL ASSESSMENT OF INTEGUMENTARY SYSTEM
  2519. Assessment of Integumentary System
  2520. Subjective Data
  2521. Important Health Information
  2522. Past Health History.
  2523. Case Study Patient Introduction
  2524. Critical Thinking
  2525. Medications.
  2526. Surgery or Other Treatments.
  2527. Functional Health Patterns
  2528. Health Perception–Health Management Pattern.
  2529.  Genetic Risk Alert
  2530. TABLE 23-3 HEALTH HISTORY: Integumentary System
  2531. Nutritional-Metabolic Pattern.
  2532. Elimination Pattern.
  2533. Activity-Exercise Pattern.
  2534. Sleep-Rest Pattern.
  2535. Cognitive-Perceptual Pattern.
  2536. Self-Perception–Self-Concept Pattern.
  2537. Role-Relationship Pattern.
  2538. Sexuality-Reproductive Pattern.
  2539. Coping–Stress Tolerance Pattern.
  2540. Value-Belief Pattern.
  2541. Case Study—cont’d
  2542. Objective Data
  2543. Physical Examination.
  2544. Inspection.
  2545. TABLE 23-4 PRIMARY SKIN LESIONS
  2546. TABLE 23-5 SECONDARY SKIN LESIONS
  2547. TABLE 23-6 NURSING ASSESSMENT: Assessment Variations in Light- and Dark-Skinned Individuals
  2548. TABLE 23-7 LESION DISTRIBUTION TERMINOLOGY
  2549. FIG. 23-5 Intertrigo. Rash in body folds with Candida infection.
  2550. TABLE 23-8 ASSESSMENT ABNORMALITIES: Integumentary System
  2551. Palpation.
  2552. Focused Assessment
  2553. Subjective
  2554. Objective: Diagnostic
  2555. Objective: Physical Examination
  2556. Inspect
  2557. Palpate
  2558. Assessment of Dark Skin
  2559. FIG. 23-6 Keloid. Hypertrophic scarring after skin injury, which is more common in dark-skinned individuals.
  2560. FIG. 23-7 Vitiligo. Total loss of pigment in the affected area.
  2561. FIG. 23-8 Nevus of Ota. Flat gray to blue pigmentation in the upper trigeminal area, which is more common in dark-skinned individuals.
  2562. FIG. 23-9 Traction alopecia. Hair loss in scalp because of prolonged tension from hair rollers, braiding, or straightening combs.
  2563. FIG. 23-10 Patch test. Results from an application of possible allergens to the skin shows positive reactions in the sites labeled “standard” and “shoe.”
  2564. Case Study—cont’d
  2565. Physical Examination
  2566. Diagnostic Studies
  2567. Diagnostic Studies of Integumentary System
  2568. TABLE 23-9 DIAGNOSTIC STUDIES: Integumentary System
  2569. Bridge to NCLEX Examination
  2570. References
  2571. Resources
  2572. Pageburst Integrated Resources
  2573. Answer Keys
  2574. Concept Map Creator
  2575. Content Updates
  2576. Glossary
  2577. Key Points
  2578. Videos
  2579. Chapter 24 Nursing Management: Integumentary Problems
  2580. Learning Outcomes
  2581. Key Terms
  2582. eFigures
  2583. eTable
  2584. Health Promotion
  2585. Environmental Hazards
  2586. Sun Exposure.
  2587. TABLE 24-1 WAVELENGTHS OF SUN AND EFFECTS ON SKIN
  2588. Evidence-Based Practice Applying the Evidence
  2589. Your Decision and Action
  2590. Reference for Evidence
  2591. Evidence-Based Practice Translating Research Into Practice
  2592. Is Sun-Protective Counseling Effective?
  2593. Clinical Question
  2594. Best Available Evidence
  2595. Critical Appraisal and Synthesis of Evidence
  2596. Conclusion
  2597. Implications for Nursing Practice
  2598. Reference for Evidence
  2599.  Cultural & Ethnic Health Disparities
  2600. Irritants and Allergens.
  2601. TABLE 24-2 DRUG THERAPY: Drugs That May Cause Photosensitivity
  2602. FIG. 24-1 Intense eruption in areas exposed to sunlight after patient started on hydrochlorothiazide.
  2603. Radiation.
  2604. Rest and Sleep
  2605. Exercise
  2606. Hygiene
  2607. Nutrition
  2608. Self-Treatment
  2609. Malignant Skin Neoplasms
  2610. FIG. 24-2 The ABCDEs of melanoma. A, Asymmetry: one half unlike the other half. B, Border irregularity: edges are ragged, notched, or blurred. C, Color: varied pigmentation; shades of tan, brown, and black. D, Diameter: greater than 6 mm (diameter of a pencil eraser). E, (not pictured) Evolving; changing appearance (change in shape, size, color, or other characteristic is noted over time).
  2611. Risk Factors
  2612. Nonmelanoma Skin Cancers
  2613. Actinic Keratosis
  2614. Basal Cell Carcinoma
  2615. Squamous Cell Carcinoma
  2616. TABLE 24-3 PREMALIGNANT AND MALIGNANT CONDITIONS OF THE SKIN
  2617. Malignant Melanoma
  2618. FIG. 24-3 Dysplastic nevus. Irregular border and color.
  2619. FIG. 24-4 Basal cell carcinoma. Rolled, well-defined border and central erosion.
  2620. Clinical Manifestations
  2621. FIG. 24-5 Breslow measurement of tumor thickness. A, Thin (0.08 mm) superficial spreading melanoma, good prognosis. B, Thick nodular melanoma with lymph node involvement, poor prognosis.
  2622. Collaborative Care
  2623. Atypical or Dysplastic Nevus
  2624. TABLE 24-4 COMMON BACTERIAL INFECTIONS OF THE SKIN
  2625. Skin Infections and Infestations
  2626. Bacterial Infections
  2627. Viral Infections
  2628. FIG. 24-6 Cellulitis with characteristic erythema, tenderness, and edema.
  2629. FIG. 24-7 Herpes zoster (shingles) on the anterior chest, classic dermatomal distribution.
  2630. FIG. 24-8 Plantar wart. A, Keratotic lesion. B, After excision.
  2631. Fungal Infections
  2632. FIG. 24-9 Tinea unguium (onychomycosis). Fungal infection of toenails. Crumbly, discolored, and thickened nails.
  2633. TABLE 24-5 COMMON VIRAL INFECTIONS OF THE SKIN
  2634. TABLE 24-6 COMMON FUNGAL INFECTIONS OF THE SKIN
  2635. TABLE 24-7 COMMON INFESTATIONS AND INSECT BITES
  2636. Infestations and Insect Bites
  2637. Allergic Dermatologic Problems
  2638. Benign Dermatologic Problems
  2639. TABLE 24-8 COMMON ALLERGIC CONDITIONS OF THE SKIN
  2640. FIG. 24-10 Acne vulgaris. Papules and pustules.
  2641. Drug Alert
  2642. Diseases with Dermatologic Manifestations
  2643. FIG. 24-11 Psoriasis. Characteristic inflammation and scaling.
  2644. TABLE 24-9 COMMON BENIGN CONDITIONS OF THE SKIN
  2645. Collaborative Care Dermatologic Problems
  2646. Diagnostic Studies
  2647. Collaborative Therapy
  2648. Phototherapy.
  2649. TABLE 24-10 DRUG THERAPY: Common Bases for Topical Medications
  2650. Radiation Therapy.
  2651. Laser Technology.
  2652. TABLE 24-11 SKIN CONDITIONS TREATED BY LASER
  2653. Drug Therapy
  2654. Antibiotics.
  2655. Corticosteroids.
  2656. Antihistamines.
  2657. Topical Fluorouracil.
  2658. Immunomodulators.
  2659. Diagnostic and Surgical Therapy
  2660. Skin Scraping.
  2661. Electrodesiccation and Electrocoagulation.
  2662. Curettage.
  2663. Punch Biopsy.
  2664. FIG. 24-12 Punch biopsy. A, Removal of skin for diagnostic purposes. B, Specimen obtained.
  2665. Cryosurgery.
  2666. Excision.
  2667. FIG. 24-13 A, Removal of melanoma by Mohs’ surgery. B, After plastic surgery using a skin flap to repair defect.
  2668. Nursing Management Dermatologic Problems
  2669. Ambulatory and Home Care
  2670. Wet Dressings.
  2671. Baths.
  2672. Topical Medications.
  2673. Control of Pruritus.
  2674. Prevention of Spread.
  2675. Prevention of Secondary Infections.
  2676. Specific Skin Care.
  2677. Psychologic Effects of Chronic Dermatologic Problems.
  2678. Physiologic Effects of Chronic Dermatologic Problems.
  2679. TABLE 24-12 COMMON COSMETIC TOPICAL PROCEDURES
  2680. Cosmetic Procedures
  2681. Elective Surgery
  2682. Laser Surgery.
  2683. Face-Lift.
  2684. FIG. 24-14 Face-lift. A, Preoperative. B, Postoperative.
  2685. Liposuction.
  2686. Delegation Decisions Skin Care
  2687. Role of Registered Nurse (RN)
  2688. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  2689. Role of Unlicensed Assistive Personnel (UAP)
  2690. Nursing Management Cosmetic Surgery
  2691. Preoperative Management
  2692. Postoperative Management
  2693. Skin Grafts
  2694. Uses
  2695. Types
  2696. Case Study Malignant Melanoma and Dysplastic Nevi
  2697. Patient Profile
  2698. Subjective Data
  2699. Objective Data
  2700. Physical Examination
  2701. Diagnostic Studies
  2702. Discussion Questions
  2703. Bridge to NCLEX Examination
  2704. References
  2705. Resources
  2706. Pageburst Integrated Resources
  2707. Answer Keys
  2708. Care Plans
  2709. Concept Map Creator
  2710. Content Updates
  2711. eFigures
  2712. eTables
  2713. Glossary
  2714. Key Points
  2715. Chapter 25 Nursing Management: Burns
  2716. Learning Outcomes
  2717. Key Terms
  2718. eFigure
  2719. TABLE 25-1 SOURCES OF BURN INJURY*
  2720. Kitchen and Bathroom
  2721. General Household
  2722. TABLE 25-2 STRATEGIES TO REDUCE BURN INJURY
  2723. Types of Burn Injury
  2724. Thermal Burns
  2725. FIG. 25-1 Types of burn injury. A, Partial-thickness thermal hand burn. B, Full-thickness thermal hand burn. C, Full-thickness scald burn to the buttock and lower back secondary to immersion in hot water.
  2726. Chemical Burns
  2727. Smoke and Inhalation Injury
  2728. TABLE 25-3 MANIFESTATIONS OF LUNG INJURY ASSOCIATED WITH BURNS
  2729. Metabolic Asphyxiation.
  2730. Upper Airway Injury.
  2731. Lower Airway Injury.
  2732. Electrical Burns
  2733. FIG. 25-2 Electrical injury produces heat coagulation of blood supply and contact area as electric current passes through the skin. A, Back and buttock (arrows). B, Leg (arrow).
  2734. Cold Thermal Injury
  2735. TABLE 25-4 BURN CENTER REFERRAL CRITERIA
  2736. Classification of Burn Injury
  2737. Depth of Burn
  2738. FIG. 25-3 Cross section of skin indicating the depth of burn and structures involved.
  2739. Extent of Burn
  2740. Location of Burn
  2741. TABLE 25-5 CLASSIFICATION OF BURN INJURY DEPTH
  2742. FIG. 25-4 A, Lund-Browder chart. By convention, areas of partial-thickness injury are colored in blue and areas of full-thickness injury in red. Superficial partial-thickness burns are not calculated. B, Rule of Nines chart.
  2743. Patient Risk Factors
  2744. Phases of Burn Management
  2745. Prehospital Care
  2746.  TABLE 25-6 EMERGENCY MANAGEMENT: Thermal Burns
  2747. Partial-Thickness (superficial; first-degree) Burn
  2748. Partial-Thickness (deep; second-degree) Burn
  2749. Full-Thickness (third- and fourth-degree) Burns
  2750. Initial
  2751. Ongoing Monitoring
  2752. Emergent Phase
  2753.  TABLE 25-7 EMERGENCY MANAGEMENT: Inhalation Injury
  2754. Initial
  2755. Ongoing Monitoring
  2756.  TABLE 25-8 EMERGENCY MANAGEMENT Electrical Burns
  2757. Alternating Current
  2758. Direct Current
  2759. Initial
  2760. Ongoing Monitoring
  2761.  TABLE 25-9 EMERGENCY MANAGEMENT Chemical Burns
  2762. Initial
  2763. Ongoing Monitoring
  2764. Pathophysiology
  2765. Fluid and Electrolyte Shifts.
  2766. FIG. 25-5 At the time of major burn injury, there is increased capillary permeability. All fluid components of the blood begin to leak into the interstitium, causing edema and a decreased blood volume. Hematocrit increases, and the blood becomes more viscous. The combination of decreased blood volume and increased viscosity produces increased peripheral resistance. Burn shock, a type of hypovolemic shock, rapidly ensues and, if not corrected, can result in death.
  2767. Inflammation and Healing.
  2768. Immunologic Changes.
  2769. FIG. 25-6 A, Facial edema before fluid resuscitation. B, Facial edema after 24 hours.
  2770. FIG. 25-7 The effects of burn shock are shown above the blue line. As the capillary seal is lost, interstitial edema develops. The cellular integrity is also altered, with sodium (Na) moving into the cell in abnormal amounts and potassium (K) leaving the cell. The shifts after the resolution of burn shock are shown below the blue line. The water and sodium move back into the circulating volume through the capillary. The albumin remains in the interstitium. Potassium is transported into the cell and sodium is transported out as the cellular integrity returns.
  2771. Clinical Manifestations
  2772. Complications
  2773. Cardiovascular System.
  2774. FIG. 25-8 Escharotomies of the chest and arm (indicated by arrows).
  2775. Respiratory System.
  2776. Other Cardiopulmonary Problems.
  2777. Urinary System.
  2778. Nursing and Collaborative Management Emergent Phase
  2779. Airway Management
  2780. Fluid Therapy
  2781. TABLE 25-10 COLLABORATIVE CARE: Burn Injury
  2782. Fluid Therapy (see Table 25-11)
  2783. Wound Care
  2784. Pain and Anxiety
  2785. Physical and Occupational Therapy
  2786. Nutritional Therapy
  2787. Respiratory Therapy
  2788. Psychosocial Care
  2789. Fluid Therapy
  2790. Wound Care
  2791. Early Excision and Grafting
  2792. Pain and Anxiety
  2793. Physical and Occupational Therapy
  2794. Nutritional Therapy
  2795. Respiratory Therapy
  2796. Psychosocial Care
  2797. Drug Therapy (see Table 25-13)
  2798. TABLE 25-11 FLUID RESUSCITATION
  2799. Wound Care
  2800. FIG. 25-9 Cart shower. Showering presents an opportunity for physical therapy and wound care.
  2801. FIG. 25-10 Surgical debridement of full-thickness burns is necessary to prepare the wound for grafting.
  2802. FIG. 25-11 Application of silver sulfadiazine cream to saline-moistened gauze.
  2803. TABLE 25-12 SOURCES OF GRAFTS
  2804. Other Care Measures
  2805. Drug Therapy
  2806. Analgesics and Sedatives.
  2807. Tetanus Immunization.
  2808. Antimicrobial Agents.
  2809. Safety Alert
  2810. TABLE 25-13 DRUG THERAPY: Burn Care
  2811. Venous Thromboembolism Prophylaxis.
  2812. Evidence-Based Practice Translating Research Into Practice
  2813. Does the Type of Enteral Feeding Affect Outcomes in Burn Patients?
  2814. Clinical Question
  2815. Best Available Evidence
  2816. Critical Appraisal and Synthesis of Evidence
  2817. Conclusion
  2818. Implications for Nursing Practice
  2819. Reference for Evidence
  2820. Nutritional Therapy
  2821. Acute Phase
  2822. Pathophysiology
  2823. Clinical Manifestations
  2824. Laboratory Values
  2825. Sodium.
  2826. Potassium.
  2827. Complications
  2828. Infection.
  2829. Cardiovascular and Respiratory Systems.
  2830. Neurologic System.
  2831. Musculoskeletal System.
  2832. Gastrointestinal System.
  2833. Endocrine System.
  2834. Nursing and Collaborative Management Acute Phase
  2835. Wound Care
  2836. Excision and Grafting
  2837. FIG. 25-12 A, Freshly applied split-thickness sheet skin graft to the hand. B, Split-thickness skin graft is harvested from a patient’s thigh using a dermatome. C, Donor site is covered with a hydrophilic foam dressing after harvesting. D, Healed donor site.
  2838. Cultured Epithelial Autografts.
  2839. Artificial Skin.
  2840. FIG. 25-13 Patient with cultured epithelial autograft (CEA). A, Intraoperative application of CEA. B, Appearance of healed CEA.
  2841. Pain Management
  2842. Physical and Occupational Therapy
  2843. Nutritional Therapy
  2844. Rehabilitation Phase
  2845. Pathophysiologic Changes and Clinical Manifestations
  2846. FIG. 25-14 Neck contractures.
  2847. Complications
  2848. Nursing and Collaborative Management Rehabilitation Phase
  2849. Gerontologic Considerations
  2850. Burns
  2851. Emotional/Psychologic Needs of Patients and Caregivers
  2852. TABLE 25-14 EMOTIONAL RESPONSES OF BURN PATIENTS*
  2853. Special Needs of Nurses
  2854. Case Study Burn Injury
  2855. Patient Profile
  2856. Subjective Data
  2857. Objective Data
  2858. Physical Examination
  2859. Discussion Questions
  2860. Bridge to NCLEX Examination
  2861. References
  2862. Resources
  2863. Case Study Managing Multiple Patients
  2864. Introduction
  2865. Patients
  2866. Management Discussion Questions
  2867. Case Study Progression
  2868. Pageburst Integrated Resources
  2869. Answer Keys
  2870. Care Plans
  2871. Case Studies
  2872. Concept Map Creator
  2873. Content Updates
  2874. eFigures
  2875. Glossary
  2876. Key Points
  2877. Section 5 Problems of Oxygenation: Ventilation
  2878. Problems of Oxygenation: Ventilation
  2879. Pre-Test – Section 5
  2880. Interactive Review – Section 5
  2881. Chapter 26 Nursing Assessment: Respiratory System
  2882. Learning Outcomes
  2883. Key Terms
  2884. eFigures
  2885. eTable
  2886. Structures and Functions of Respiratory System
  2887. Upper Respiratory Tract
  2888. FIG. 26-1 Structures of the respiratory tract. A, Pulmonary functional unit. B, Ciliated mucous membrane.
  2889. FIG. 26-2 Landmarks and structures of the chest wall. A, Anterior view. B, Posterior view.
  2890. Lower Respiratory Tract
  2891. FIG. 26-3 Structures of lower airways.
  2892. Surfactant.
  2893. FIG. 26-4 Scanning electron micrograph of lung parenchyma. A, Alveoli (A) and alveolar-capillary membrane (arrow). B, Effects of atelectasis. Alveoli (A) are partially or totally collapsed.
  2894. FIG. 26-5 Partial pressure of respiratory gases in normal respiration. The pressures are shown in inhaled and exhaled air from the lungs and at the level of the alveoli and pulmonary venous and arterial blood vessels.
  2895. Blood Supply.
  2896. Chest Wall
  2897. Physiology of Respiration
  2898. Ventilation.
  2899. Compliance.
  2900. Diffusion.
  2901. Arterial Blood Gases.
  2902. TABLE 26-1 NORMAL ARTERIAL AND VENOUS BLOOD GAS VALUES*
  2903. TABLE 26-2 MANIFESTATIONS OF INADEQUATE OXYGENATION
  2904. Mixed Venous Blood Gases.
  2905. Oximetry.
  2906. Carbon Dioxide Monitoring.
  2907. TABLE 26-3 CRITICAL VALUES FOR PaO2 AND SpO2 *
  2908. Control of Respiration
  2909. Chemoreceptors.
  2910. Mechanical Receptors.
  2911. Respiratory Defense Mechanisms
  2912. Filtration of Air.
  2913. Mucociliary Clearance System.
  2914. Cough Reflex.
  2915. Reflex Bronchoconstriction.
  2916. Alveolar Macrophages.
  2917. Gerontologic Considerations
  2918. Effects of Aging on Respiratory System
  2919. TABLE 26-4 GERONTOLOGIC ASSESSMENT DIFFERENCES: Respiratory System
  2920. Assessment of Respiratory System
  2921. Case Study Patient Introduction
  2922. Critical Thinking
  2923. Subjective Data
  2924. Important Health Information
  2925. Past Health History.
  2926. Medications.
  2927. Surgery or Other Treatments.
  2928. Functional Health Patterns.
  2929. Health Perception–Health Management Pattern.
  2930. TABLE 26-5 HEALTH HISTORY: Respiratory System
  2931.  Genetic Risk Alert
  2932. Nutritional-Metabolic Pattern.
  2933. Elimination Pattern.
  2934. Activity-Exercise Pattern.
  2935. Sleep-Rest Pattern.
  2936. Cognitive-Perceptual Pattern.
  2937. Self-Perception–Self-Concept Pattern.
  2938. Role-Relationship Pattern.
  2939. Sexuality-Reproductive Pattern.
  2940. Case Study—cont’d
  2941. Coping–Stress Tolerance Pattern.
  2942. Value-Belief Pattern.
  2943. Objective Data
  2944. Physical Examination.
  2945. Nose.
  2946. Mouth and Pharynx.
  2947. Neck.
  2948. Thorax and Lungs.
  2949. Inspection.
  2950. Palpation.
  2951. FIG. 26-6 Estimation of thoracic expansion. A, Exhalation. B, Maximal inhalation.
  2952. Case Study—cont’d
  2953. Percussion.
  2954. FIG. 26-7 Sequence for examination of the chest. A, Anterior sequence. B, Lateral sequence. C, Posterior sequence. For palpation, place the palms of the hands in the position designated as “1” on the right and left sides of the chest. Compare the intensity of vibrations. Continue for all positions in each sequence. For percussion, tap the chest at each designated position, moving downward from side to side. Compare percussion sounds at all positions. For auscultation, place the stethoscope at each position and listen to at least one complete inspiratory and expiratory cycle. Keep in mind that, with a female patient, the breast tissue will modify the completeness of the anterior examination.
  2955. TABLE 26-6 PERCUSSION SOUNDS
  2956. FIG. 26-8 Diagram of percussion areas and sounds in the anterior side of the chest.
  2957. FIG. 26-9 Diagram of percussion areas and sounds in the posterior side of the chest. Percussion proceeds from the lung apices to the lung bases while comparing sounds in opposite areas of the chest.
  2958. Auscultation.
  2959. FIG. 26-10 Normal auscultatory sounds.
  2960. TABLE 26-7 NORMAL PHYSICAL ASSESSMENT OF THE RESPIRATORY SYSTEM
  2961. Focused Assessment
  2962. Subjective
  2963. Objective: Diagnostic
  2964. Objective: Physical Examination
  2965. Observe
  2966. Inspect
  2967. Palpate
  2968. Auscultate
  2969. TABLE 26-8 ASSESSMENT ABNORMALITIES: Respiratory System
  2970. TABLE 26-9 CHEST EXAMINATION FINDINGS IN PULMONARY PROBLEMS
  2971. Diagnostic Studies of Respiratory System
  2972. Sputum Studies
  2973. Skin Tests
  2974. Endoscopic Examinations
  2975. Bronchoscopy.
  2976. TABLE 26-10 DIAGNOSTIC STUDIES: Respiratory System
  2977. FIG. 26-11 Fiberoptic bronchoscope. A, The transbronchoscopic balloon-tipped catheter and the flexible fiberoptic bronchoscope. B, The catheter is introduced into a small airway and the balloon inflated with 1.5 to 2 mL of air to occlude the airway. Bronchoalveolar lavage is performed by injecting and withdrawing 30-mL aliquots of sterile saline solution, gently aspirating after each instillation. Specimens are sent to the laboratory for analysis.
  2978. Lung Biopsy
  2979. TABLE 26-11 INTERPRETING RESPONSES TO TUBERCULIN SKIN TESTING
  2980. Case Study—cont’d
  2981. FIG. 26-12 Transbronchial biopsy needle penetrating the bronchial wall and entering a mass of subcarinal lymph nodes or tumor.
  2982. FIG. 26-13 Thoracentesis. A catheter is positioned in the pleural space to remove accumulated fluid.
  2983. Thoracentesis
  2984. Pulmonary Function Tests
  2985. TABLE 26-12 LUNG VOLUMES AND CAPACITIES
  2986. TABLE 26-13 COMMON MEASURES OF PULMONARY FUNCTION AIRFLOW
  2987. Bridge to NCLEX Examination
  2988. References
  2989. Resources
  2990. Pageburst Integrated Resources
  2991. Animations
  2992. Answer Keys
  2993. Audio
  2994. Concept Map Creator
  2995. Content Updates
  2996. eFigures
  2997. eTables
  2998. Glossary
  2999. Key Points
  3000. Videos
  3001. Chapter 27 Nursing Management: Upper Respiratory Problems
  3002. Learning Outcomes
  3003. Key Terms
  3004. eFigure
  3005. Problems of Nose and Paranasal Sinuses
  3006. Deviated Septum
  3007. Nasal Fracture
  3008. Rhinoplasty
  3009. Nursing Management Nasal Surgery
  3010. Epistaxis
  3011. Nursing and Collaborative Management Epistaxis
  3012. Allergic Rhinitis
  3013. FIG. 27-1 A, Epistaxis balloon. The balloon is inflated after insertion. B, Epistaxis balloon in proper position in nares.
  3014. Clinical Manifestations
  3015. Nursing and Collaborative Management Allergic Rhinitis
  3016. TABLE 27-1 PATIENT & CAREGIVER TEACHING GUIDE: Avoiding Allergens in Allergic Rhinitis
  3017. Drug Alert
  3018. Drug Alert
  3019. Acute Viral Rhinitis
  3020. TABLE 27-2 DRUG THERAPY: Rhinitis and Sinusitis
  3021.  Complementary & Alternative Therapies
  3022. Scientific Evidence
  3023. Nursing Implications
  3024. Nursing and Collaborative Management Acute Viral Rhinitis
  3025. Evidence-Based Practice Translating Research Into Practice
  3026. Do Probiotics Prevent Upper Respiratory Tract Infections?
  3027. Clinical Question
  3028. Best Available Evidence
  3029. Critical Appraisal and Synthesis of Evidence
  3030. Conclusion
  3031. Implications for Nursing Practice
  3032. Reference for Evidence
  3033. Influenza
  3034. Etiology and Pathophysiology
  3035. Clinical Manifestations
  3036. Diagnostic Studies
  3037. Nursing and Collaborative Management Influenza
  3038. TABLE 27-3 TYPES OF INFLUENZA IMMUNIZATION
  3039. Safety Alert
  3040. Sinusitis
  3041.  Cultural & Ethnic Health Disparities
  3042. FIG. 27-2 Location of the sinuses.
  3043.  Complementary & Alternative Therapies
  3044. Scientific Evidence
  3045. Nursing Implications
  3046. Clinical Manifestations
  3047. Nursing and Collaborative Management Sinusitis
  3048. TABLE 27-4 PATIENT & CAREGIVER TEACHING GUIDE: Acute or Chronic Sinusitis
  3049. Obstruction of Nose and Sinuses
  3050. Nasal Polyps
  3051. Foreign Bodies
  3052. Problems of Pharynx
  3053. Acute Pharyngitis
  3054. Clinical Manifestations
  3055. Nursing and Collaborative Management Acute Pharyngitis
  3056. Peritonsillar Abscess
  3057. Problems of Trachea and Larynx
  3058. Airway Obstruction
  3059. Tracheostomy
  3060. FIG. 27-3 Tracheostomy tube. A, Parts of a tracheostomy tube. B, Tracheostomy tube inserted in airway with inflated cuff. (See Table 27-5 and eNursing Care Plan 27-1 [on the website for this chapter] for related nursing management.)
  3061. Nursing Management Tracheostomy
  3062. Providing Tracheostomy Care
  3063. TABLE 27-5 NURSING MANAGEMENT OF TRACHEOSTOMIES
  3064. TABLE 27-6 SUCTIONING A TRACHEOSTOMY TUBE
  3065. FIG. 27-4 Suctioning tracheostomy with closed system suction catheter.
  3066. FIG. 27-5 Changing tracheostomy ties. A, A slit is cut about 1 in (2.5 cm) from the end. The slit end is put into the opening of the cannula. B, A loop is made with the other end of the tape. C, The tapes are tied together with a double knot on the side of the neck. D, A Velcro tracheostomy tube holder can be used instead of twill ties to make tracheostomy tube stabilization more secure.
  3067. TABLE 27-7 TRACHEOSTOMY CARE
  3068. Swallowing Dysfunction
  3069. FIG. 27-6 Changing the tracheostomy tube at home. When a tracheostomy has been in place for several months, the tract will be well formed. The patient can be taught to change the tube using a clean technique at home.
  3070. TABLE 27-8 COMPLICATIONS OF TRACHEOSTOMY
  3071. Speech With a Tracheostomy Tube
  3072. FIG. 27-7 Speaking tracheostomy tubes. A, Fenestrated tracheostomy tube with cuff deflated, inner cannula removed, and tracheostomy tube capped to allow air to pass over the vocal cords. B, Speaking tracheostomy tube. One tube is used for cuff inflation. The second tube is connected to a source of compressed air or O2. When the port on the second tube is occluded, air flows up over the vocal cords, allowing speech with an inflated cuff. (See Table 27-5 and eNursing Care Plan 27-1 for related nursing management.)
  3073. FIG. 27-8 Passy-Muir speaking tracheostomy valve. The valve is placed over the hub of the tracheostomy tube after the cuff is deflated. Multiple options are available and can be used for ventilated and nonventilated patients. The one-way valve allows air to enter the lungs during inspiration and redirects air upward over the vocal cords into the mouth during expiration.
  3074. Informatics in Practice Communication Devices for Patient With Laryngectomy
  3075. Decannulation
  3076. Laryngeal Polyps
  3077. Head and Neck Cancer
  3078. Clinical Manifestations
  3079. Diagnostic Studies
  3080. Collaborative Care
  3081. FIG. 27-9 Excision of laryngeal cancer. This cancer of the right vocal cord meets criteria for resection by transoral cordectomy. The cord is fully mobile, and the lesion can be fully exposed. It does not approach or cross the anterior commissure.
  3082. FIG. 27-10 A, Normal airflow in and out of the lungs. B, Airflow in and out of the lungs after total laryngectomy. Patients using esophageal speech trap air in the esophagus and release it to create sound.
  3083. FIG. 27-11 Reconstructive surgery involving skin grafts may be needed after a radical neck dissection.
  3084. Nutritional Therapy.
  3085. Nursing Management Head and Neck Cancer
  3086. Nursing Assessment
  3087. TABLE 27-9 PATIENT TEACHING GUIDE: Supraglottic Swallow
  3088. TABLE 27-10 NURSING ASSESSMENT: Head and Neck Cancer
  3089. Nursing Diagnoses
  3090. Planning
  3091. Nursing Implementation
  3092. Health Promotion.
  3093. Acute Intervention.
  3094. Radiation Therapy.
  3095. Surgical Therapy.
  3096. Voice Rehabilitation.
  3097. FIG. 27-12 Artificial larynx. A, Battery-powered electronic artificial larynx for patient who has had a total laryngectomy. B, The sound waves created by the electrolarynx allow the person to speak.
  3098. FIG. 27-13 Blom-Singer voice prosthesis and tracheostoma valve. With this prosthesis and valve, patients with a laryngectomy can speak normally. Inset shows laryngectomy stoma and voice prosthesis with tracheostoma valve removed.
  3099. Stoma Care.
  3100. Depression.
  3101. Sexuality.
  3102. Delegation Decisions Suctioning and Tracheostomy Care
  3103. Role of Registered Nurse (RN)
  3104. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  3105. Role of Unlicensed Assistive Personnel (UAP)
  3106. Ambulatory and Home Care.
  3107. Evaluation
  3108. Case Study Laryngeal Cancer
  3109. Patient Profile
  3110. Subjective Data
  3111. Objective Data
  3112. Laryngoscopy
  3113. Physical Examination
  3114. Computed Tomography Scan
  3115. Collaborative Care
  3116. Discussion Questions
  3117. Bridge to NCLEX Examination
  3118. References
  3119. Resources
  3120. Pageburst Integrated Resources
  3121. Animations
  3122. Answer Keys
  3123. Care Plans
  3124. Case Studies
  3125. Concept Map Creator
  3126. Content Updates
  3127. eFigures
  3128. Glossary
  3129. Key Points
  3130. Chapter 28 Nursing Management: Lower Respiratory Problems
  3131. Learning Outcomes
  3132. Key Terms
  3133. eTables
  3134. Healthy People
  3135. Lower Respiratory Tract Infections
  3136. Acute Bronchitis
  3137. Pertussis
  3138. Pneumonia
  3139. Etiology
  3140. TABLE 28-1 RISK FACTORS FOR PNEUMONIA
  3141. Types of Pneumonia
  3142. Community-Acquired Pneumonia.
  3143. TABLE 28-2 ORGANISMS CAUSING PNEUMONIA
  3144. TABLE 28-3 ASSESSING PNEUMONIA USING CURB-65
  3145. Medical Care–Associated Pneumonia.
  3146. Aspiration Pneumonia.
  3147. Opportunistic Pneumonia.
  3148. FIG. 28-1 Pathophysiologic course of pneumonia.
  3149. Pathophysiology
  3150. Clinical Manifestations
  3151. Complications
  3152. Diagnostic Studies
  3153. TABLE 28-4 COLLABORATIVE CARE: Pneumonia
  3154. Diagnostic
  3155. Collaborative Therapy
  3156. Collaborative Care
  3157. TABLE 28-5 PNEUMOVAX VACCINATION
  3158. Drug Therapy.
  3159. TABLE 28-6 DRUG THERAPY: Bacterial Community-Acquired Pneumonia
  3160. Nutritional Therapy.
  3161. Nursing Management Pneumonia
  3162. Nursing Assessment
  3163. Nursing Diagnoses
  3164. Planning
  3165. Nursing Implementation
  3166. Health Promotion.
  3167. TABLE 28-7 NURSING ASSESSMENT: Pneumonia
  3168. Acute Intervention.
  3169. Ambulatory and Home Care.
  3170. Evaluation
  3171. Tuberculosis
  3172.  Cultural & Ethnic Health Disparities
  3173. Etiology and Pathophysiology
  3174. TABLE 28-8 CLASSIFICATION OF TUBERCULOSIS (TB)
  3175. Classification
  3176. TABLE 28-9 LATENT TUBERCULOSIS (TB) INFECTION COMPARED WITH TB DISEASE
  3177. Clinical Manifestations
  3178. Complications
  3179. Diagnostic Studies
  3180. Tuberculin Skin Test.
  3181. Interferon-γ Release Assays.
  3182. Chest X-Ray.
  3183. Bacteriologic Studies.
  3184. Collaborative Care
  3185. TABLE 28-10 COLLABORATIVE CARE: Pulmonary Tuberculosis
  3186. Diagnostic
  3187. Collaborative Therapy
  3188. TABLE 28-11 DRUG THERAPY: Tuberculosis (TB)
  3189. Drug Therapy
  3190. Active TB Disease.
  3191. TABLE 28-12 DRUG THERAPY: Tuberculosis Disease Regimens
  3192. Drug Alert
  3193. Ethical/Legal Dilemmas Patient Adherence
  3194. Situation
  3195. Ethical/Legal Points for Consideration
  3196. Discussion Questions
  3197. Latent Tuberculosis Infection.
  3198. TABLE 28-13 DRUG THERAPY: Latent Tuberculosis Infection Regimens
  3199. Vaccine.
  3200. Nursing Management Tuberculosis
  3201. Nursing Assessment
  3202. Nursing Diagnoses
  3203. Planning
  3204. Nursing Implementation
  3205. Health Promotion.
  3206. Acute Intervention.
  3207. Ambulatory and Home Care.
  3208. Evaluation
  3209. Atypical Mycobacteria
  3210. Pulmonary Fungal Infections
  3211. TABLE 28-14 FUNGAL INFECTIONS OF THE LUNG
  3212. Lung Abscess
  3213. Etiology and Pathophysiology
  3214. Clinical Manifestations and Complications
  3215. Diagnostic Studies
  3216. Nursing and Collaborative Management Lung Abscess
  3217. Environmental Lung Diseases
  3218. Clinical Manifestations
  3219. Collaborative Care
  3220. Lung Cancer
  3221. Etiology
  3222.  Cultural & Ethnic Health Disparities
  3223. African Americans
  3224. Whites
  3225. Asian/Pacific Islanders and Hispanics
  3226. Other
  3227. Gender Differences
  3228. FIG. 28-2 Lung cancer (peripheral adenocarcinoma). The tumor shows prominent black pigmentation, suggestive of having evolved in an anthracotic scar.
  3229. Pathophysiology
  3230. Paraneoplastic Syndrome.
  3231. TABLE 28-15 TYPES OF PRIMARY LUNG CANCER
  3232. FIG. 28-3 Lung carcinoma. The gray-white tumor tissue is infiltrating the lung. Histologically this tumor is identified as a squamous cell carcinoma.
  3233. Evidence-Based Practice Translating Research Into Practice
  3234. Which Interventions Improve Well-Being in Lung Cancer?
  3235. Clinical Question
  3236. Best Available Evidence
  3237. Critical Appraisal and Synthesis of Evidence
  3238. Conclusion
  3239. Implications for Nursing Practice
  3240. Reference for Evidence
  3241. Clinical Manifestations
  3242. TABLE 28-16 COLLABORATIVE CARE: Lung Cancer
  3243. Diagnostic
  3244. Collaborative Therapy
  3245. Diagnostic Studies
  3246. TABLE 28-17 STAGING OF NON–SMALL CELL LUNG CANCER
  3247. Staging.
  3248. Screening for Lung Cancer.
  3249. Collaborative Care
  3250. Surgical Therapy.
  3251. Radiation Therapy.
  3252. Stereotactic Body Radiotherapy.
  3253. Chemotherapy.
  3254. Targeted Therapy.
  3255. Other Therapies
  3256. Prophylactic Cranial Radiation.
  3257. Bronchoscopic Laser Therapy.
  3258. Photodynamic Therapy.
  3259. Airway Stenting.
  3260. Radiofrequency Ablation.
  3261. Nursing Management Lung Cancer
  3262. Nursing Assessment
  3263. Nursing Diagnoses
  3264. TABLE 28-18 NURSING ASSESSMENT: Lung Cancer
  3265. Planning
  3266. Nursing Implementation
  3267. Health Promotion.
  3268. Acute Intervention.
  3269. Ambulatory and Home Care.
  3270. Evaluation
  3271. Other Types of Lung Tumors
  3272. Chest Trauma and Thoracic Injuries
  3273.  TABLE 28-19 EMERGENCY MANAGEMENT: Chest Trauma
  3274. Blunt
  3275. Penetrating
  3276. Respiratory
  3277. Cardiovascular
  3278. Surface Findings
  3279. Initial
  3280. Ongoing Monitoring
  3281.  TABLE 28-20 EMERGENCY MANAGEMENT: Thoracic Injuries
  3282. Pneumothorax
  3283. Types of Pneumothorax
  3284. Spontaneous Pneumothorax.
  3285. Iatrogenic Pneumothorax.
  3286. FIG. 28-4 Open pneumothorax resulting from collapse of lung due to disruption of chest wall and outside air entering.
  3287. Traumatic Pneumothorax.
  3288. FIG. 28-5 Tension pneumothorax. As pleural pressure on the affected side increases, mediastinal displacement ensues with resultant respiratory and cardiovascular compromise. Tracheal deviation is an external manifestation of the mediastinal shift.
  3289. Tension Pneumothorax.
  3290. Hemothorax.
  3291. Chylothorax.
  3292. Collaborative Care
  3293. Fractured Ribs
  3294. Flail Chest
  3295. FIG. 28-6 Flail chest produces paradoxic respiration. On inspiration, the flail section sinks in with mediastinal shift to the uninjured side. On expiration, the flail section bulges outward with mediastinal shift to the injured side.
  3296. Chest Tubes and Pleural Drainage
  3297. FIG. 28-7 Placement of chest tubes.
  3298. Chest Tube Insertion
  3299. FIG. 28-8 Chest drainage unit. Both units have three chambers: (1) collection chamber; (2) water-seal chamber; and (3) suction control chamber. Suction control chamber requires a connection to a wall suction source that is dialed up higher than the prescribed suction for the suction to work. A, Water suction. This unit uses water in the suction control chamber to control the wall suction pressure. B, Dry suction. This unit controls wall suction by using a regulator control dial.
  3300. Flutter or Heimlich Valve
  3301. FIG. 28-9 A, Heimlich chest drain valve is a specially designed flutter valve that is used in place of a chest drainage unit for small uncomplicated pneumothorax with little or no drainage and no need for suction. The valve allows for escape of air but prevents the reentry of air into the pleural space. B, Placement of valve between chest tube and vented drainage bag, which can be worn under a person’s clothes.
  3302. Pleural Drainage
  3303. TABLE 28-21 CHEST TUBES AND WATER-SEAL DRAINAGE
  3304. Informatics in Practice Chest Drainage System
  3305. Nursing Management Chest Drainage
  3306. Chest Tube Removal
  3307. Chest Surgery
  3308. Preoperative Care
  3309. TABLE 28-22 CHEST SURGERIES
  3310. Surgical Procedures
  3311. Thoracotomy.
  3312. Video-Assisted Thoracic Surgery.
  3313. Postoperative Care
  3314. Restrictive Respiratory Disorders
  3315. TABLE 28-23 EXTRAPULMONARY CAUSES OF RESTRICTIVE LUNG DISEASE*
  3316. TABLE 28-24 INTRAPULMONARY CAUSES OF RESTRICTIVE LUNG DISEASE*
  3317. Pleural Effusion
  3318. Types
  3319. FIG. 28-10 Fibrothorax resulting from an organization of inflammatory exudate and pleural effusion.
  3320. Clinical Manifestations
  3321. Thoracentesis
  3322. Collaborative Care
  3323. Pleurisy
  3324. Atelectasis
  3325. Interstitial Lung Diseases
  3326. Idiopathic Pulmonary Fibrosis
  3327. Sarcoidosis
  3328. Vascular Lung Disorders
  3329. Pulmonary Edema
  3330. TABLE 28-25 CAUSES OF PULMONARY EDEMA
  3331. Pulmonary Embolism
  3332. Etiology and Pathophysiology
  3333. FIG. 28-11 Large embolus from the femoral vein lying in the main left and right pulmonary arteries.
  3334. Clinical Manifestations
  3335. Complications
  3336. Diagnostic Studies
  3337. TABLE 28-26 COLLABORATIVE CARE: Acute Pulmonary Embolism
  3338. Diagnostic
  3339. Collaborative Therapy
  3340. Collaborative Care
  3341. Drug Therapy.
  3342. Surgical Therapy.
  3343. Nursing Management Pulmonary Embolism
  3344. Nursing Implementation
  3345. Evaluation
  3346. Pulmonary Hypertension
  3347. Idiopathic Pulmonary Arterial Hypertension
  3348. Etiology and Pathophysiology
  3349. Clinical Manifestations and Diagnostic Studies
  3350. FIG. 28-12 Pathogenesis of pulmonary hypertension and cor pulmonale.
  3351. Nursing and Collaborative Management Pulmonary Hypertension
  3352. Secondary Pulmonary Arterial Hypertension
  3353. TABLE 28-27 DRUG THERAPY: Pulmonary Hypertension
  3354. FIG. 28-13 A patient with pulmonary hypertension who is on continuous epoprostenol infusion is being taught how to use the portable infusion pump.
  3355. Cor Pulmonale
  3356. Clinical Manifestations and Diagnostic Studies
  3357. Collaborative Care
  3358. TABLE 28-28 COLLABORATIVE CARE: Cor Pulmonale
  3359. Diagnostic
  3360. Collaborative Therapy
  3361. Lung Transplantation
  3362. Preoperative Care
  3363. TABLE 28-29 INDICATIONS FOR LUNG TRANSPLANTATION*
  3364. Surgical Procedure
  3365. Postoperative Care
  3366. Case Study Pneumonia and Lung Cancer
  3367. Patient Profile
  3368. Subjective Data
  3369. Objective Data
  3370. Physical Examination
  3371. Diagnostic Studies
  3372. Collaborative Care
  3373. Discussion Questions
  3374. Bridge to NCLEX Examination
  3375. References
  3376. Resources
  3377. Pageburst Integrated Resources
  3378. Answer Keys
  3379. Care Plans
  3380. Case Studies
  3381. Concept Map Creator
  3382. Content Updates
  3383. eTables
  3384. Glossary
  3385. Key Points
  3386. Chapter 29 Nursing Management: Obstructive Pulmonary Diseases
  3387. Learning Outcomes
  3388. Key Terms
  3389. eFigures
  3390. eTables
  3391.  Cultural & Ethnic Health Disparities
  3392. Asthma
  3393. Chronic Obstructive Pulmonary Disease (COPD)
  3394. Cystic Fibrosis
  3395. Gender Differences
  3396. Asthma
  3397. Risk Factors for Asthma and Triggers of Asthma Attacks
  3398. Genetics.
  3399. TABLE 29-1 TRIGGERS OF ASTHMA ATTACKS
  3400. Immune Response.
  3401. Allergens.
  3402. Exercise.
  3403. Air Pollutants.
  3404. Occupational Factors.
  3405. Respiratory Tract Infections.
  3406. Nose and Sinus Problems.
  3407. Drugs and Food Additives.
  3408. Gastroesophageal Reflux Disease.
  3409. Psychologic Factors.
  3410. Pathophysiology
  3411. FIG. 29-1 Pathophysiology of asthma. IL, Interleukin.
  3412. FIG. 29-2 Allergic asthma is triggered when an allergen cross-links IgE receptors on mast cells, which are then activated to release histamine and other inflammatory mediators (early-phase response). A late-phase response may occur due to further inflammation.
  3413. FIG. 29-3 Factors causing obstruction (especially expiratory obstruction) in asthma. A, Cross section of a bronchiole occluded by muscle spasm, swollen mucosa, and mucus in the lumen. B, Longitudinal section of a bronchiole.
  3414. Clinical Manifestations
  3415. TABLE 29-2 CLASSIFICATION OF ASTHMA SEVERITY
  3416. Classification of Asthma
  3417. Complications
  3418. Severe and Life-Threatening Asthma Exacerbations.
  3419. Safety Alert
  3420. Diagnostic Studies
  3421. TABLE 29-3 COMPARISON OF ASTHMA AND COPD*
  3422. TABLE 29-4 COLLABORATIVE CARE: Asthma
  3423. TABLE 29-5 COMPONENTS OF ASTHMA CONTROL
  3424. Collaborative Care
  3425. FIG. 29-4 Drug therapy: stepwise approach for managing asthma.
  3426. TABLE 29-6 DRUG THERAPY: Long-Term Control Versus Quick Relief of Asthma
  3427. Intermittent and Persistent Asthma.
  3428. Acute Asthma Exacerbations.
  3429. Severe and Life-Threatening Asthma Exacerbations.
  3430. Drug Therapy
  3431. Antiinflammatory Drugs
  3432. Corticosteroids.
  3433. TABLE 29-7 DRUG THERAPY Asthma and Chronic Obstructive Pulmonary Disease (COPD)*
  3434. FIG. 29-5 Example of an AeroChamber spacer used with a metered-dose inhaler.
  3435. Leukotriene Modifiers.
  3436. Anti-IgE.
  3437. Bronchodilators.
  3438. β2-Adrenergic Agonist Drugs.
  3439. Drug Alert
  3440. Drug Alert
  3441. Methylxanthines.
  3442. Drug Alert
  3443. Anticholinergic Drugs.
  3444. Inhalation Devices for Drug Delivery.
  3445. Inhalers.
  3446. FIG. 29-6 How to use your metered-dose inhaler correctly.
  3447. TABLE 29-8 PROBLEMS USING A METERED-DOSE INHALER (MDI)
  3448. FIG. 29-7 Example of a dry powder inhaler (DPI).
  3449. TABLE 29-9 PATIENT TEACHING GUIDE: How to Use a Dry Powder Inhaler (DPI)
  3450. TABLE 29-10 COMPARISON OF METERED-DOSE AND DRY POWDER INHALERS
  3451. Nebulizers.
  3452. Informatics in Practice Home Monitoring of Asthma
  3453. Patient Teaching Related to Drug Therapy.
  3454. Nonprescription Combination Drugs.
  3455. Nursing Management Asthma
  3456. Nursing Assessment
  3457. Nursing Diagnoses
  3458. Planning
  3459.  Nursing Care Plan 29-1
  3460. Patient With Asthma
  3461. Nursing Diagnosis*
  3462. Patient Goals
  3463. Respiratory Status: Airway Patency
  3464. Asthma Management
  3465. Nursing Diagnosis
  3466. Patient Goals
  3467. Anxiety Level
  3468. Anxiety Reduction
  3469. Nursing Diagnosis
  3470. Patient Goals
  3471. Asthma Self-Management
  3472. Asthma Management
  3473. TABLE 29-11 NURSING ASSESSMENT: Asthma
  3474. Nursing Implementation
  3475. Health Promotion.
  3476. Acute Intervention.
  3477. Ambulatory and Home Care.
  3478. TABLE 29-12 ASTHMA ACTION PLAN*
  3479. TABLE 29-13 PATIENT TEACHING GUIDE: Pursed-Lip Breathing (PLB)
  3480. TABLE 29-14 PATIENT TEACHING GUIDE: How to Use Your Peak Flow Meter
  3481. Evaluation
  3482. Chronic Obstructive Pulmonary Disease
  3483. Etiology
  3484. Cigarette Smoking.
  3485. Gender Differences
  3486. TABLE 29-15 PATIENT & CAREGIVER TEACHING GUIDE: Asthma
  3487. Occupational Chemicals and Dusts.
  3488. Air Pollution.
  3489. TABLE 29-16 EFFECTS OF TOBACCO SMOKE ON RESPIRATORY SYSTEM
  3490. Infection.
  3491. Genetics.
  3492.  Genetics in Clinical Practice
  3493. Genetic Basis
  3494. Incidence
  3495. Genetic Testing
  3496. Clinical Implications
  3497. α1-Antitrypsin (AAT) Deficiency.
  3498.  Genetic Link
  3499. Aging.
  3500. Pathophysiology
  3501. FIG. 29-8 Pathophysiology of chronic obstructive pulmonary disease (COPD).
  3502. FIG. 29-9 A, Normal lungs showing bronchioles and alveoli. B, Changes in the bronchioles and alveoli in the lungs of a patient with chronic obstructive pulmonary disease (COPD).
  3503. Clinical Manifestations
  3504. Classification of COPD.
  3505. Complications
  3506. Cor Pulmonale.
  3507. TABLE 29-17 CLASSIFICATION OF COPD SEVERITY*
  3508. FIG. 29-10 Mechanisms involved in the pathophysiology of pulmonary hypertension and cor pulmonale secondary to chronic obstructive pulmonary disease.
  3509. COPD Exacerbations.
  3510. Acute Respiratory Failure.
  3511. Depression and Anxiety.
  3512. Diagnostic Studies
  3513. TABLE 29-18 COLLABORATIVE CARE: Chronic Obstructive Pulmonary Disease (COPD)
  3514. Collaborative Care
  3515. FIG. 29-11 Rubric for chronic obstructive pulmonary disease (COPD) showing the association between symptoms, spirometric classification, and future risk of exacerbations. The following factors are considered in the rubric: (1) current level of patient’s symptoms as measured by one of two validated questionnaires (modified Medical Research Council [mMRC] Dyspnea Scale [see eTable 29-4] or the COPD Assessment Test [CAT] [see eTable 29-3]); (2) severity of the disease as measured by the FEV1; (3) exacerbation risk as reflected in the spirometric classification or patient’s history of exacerbations; and (4) presence of co-morbidities.
  3516. Smoking Cessation.
  3517. Drug Therapy.
  3518. TABLE 29-19 DRUG THERAPY: Medication Guidelines for Stable COPD
  3519. Oxygen Therapy.
  3520. Indications for Use.
  3521. Methods of Administration.
  3522. TABLE 29-20 METHODS OF OXYGEN ADMINISTRATION
  3523. FIG. 29-12 Golfer uses Helios liquid portable O2 system.
  3524. Humidification and Nebulization.
  3525. Complications
  3526. Combustion.
  3527. Carbon Dioxide Narcosis.
  3528. Oxygen Toxicity.
  3529. Absorption Atelectasis.
  3530. Infection.
  3531. Delegation Decisions Oxygen Administration
  3532. Role of Registered Nurse (RN)
  3533. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  3534. Role of Unlicensed Assistive Personnel (UAP)
  3535. Chronic Oxygen Therapy at Home.
  3536. TABLE 29-21 HOME OXYGEN DELIVERY SYSTEMS*
  3537. FIG. 29-13 A portable liquid O2 unit can be refilled from a liquid O2 reservoir unit.
  3538. TABLE 29-22 PATIENT & CAREGIVER TEACHING GUIDE: Home Oxygen Use
  3539. Breathing Retraining.
  3540. Airway Clearance Techniques.
  3541. Effective Coughing.
  3542. Chest Physiotherapy.
  3543. TABLE 29-23 PATIENT & CAREGIVER TEACHING GUIDE: Effective Huff Coughing
  3544. Postural Drainage.
  3545. Percussion.
  3546. Vibration.
  3547. FIG. 29-14 Cupped-hand position for percussion. The hand should be cupped as though scooping up water.
  3548. FIG. 29-15 Acapella airway clearance device.
  3549. Airway Clearance Devices.
  3550. High-Frequency Chest Wall Oscillation.
  3551. Nutritional Therapy.
  3552. TABLE 29-24 NUTRITIONAL THERAPY: Maximizing Food Intake in COPD
  3553. Surgical Therapy for COPD.
  3554. Nursing Management Chronic Obstructive Pulmonary Disease
  3555. Nursing Assessment
  3556. Nursing Diagnoses
  3557. Planning
  3558. Nursing Implementation
  3559. Health Promotion.
  3560. Acute Intervention.
  3561. TABLE 29-25 NURSING ASSESSMENT: Chronic Obstructive Pulmonary Disease
  3562. Ambulatory and Home Care.
  3563. Pulmonary Rehabilitation.
  3564. Informatics in Practice Texting for Chronic Obstructive Pulmonary Disease (COPD) Patients
  3565. Activity Considerations.
  3566.  Nursing Care Plan 29-2
  3567. Patient With Chronic Obstructive Pulmonary Disease
  3568. Nursing Diagnosis*
  3569. Patient Goals
  3570. Respiratory Status: Ventilation
  3571. Measurement Scale
  3572. Ventilation Assistance
  3573. Nursing Diagnosis
  3574. Patient Goals
  3575. Respiratory Status: Airway Patency
  3576. Cough Enhancement
  3577. Airway Management
  3578. Nursing Diagnosis
  3579. Patient Goals
  3580. Respiratory Status: Gas Exchange
  3581. Oxygen Therapy
  3582. TABLE 29-26 PATIENT & CAREGIVER TEACHING GUIDE: Chronic Obstructive Pulmonary Disease
  3583. Sexuality and Sexual Activity.
  3584. Sleep.
  3585. Ethical/Legal Dilemmas Advance Directives
  3586. Situation
  3587. Ethical/Legal Points for Consideration
  3588. Discussion Questions
  3589. Psychosocial Considerations.
  3590. Evaluation
  3591. Cystic Fibrosis
  3592. Etiology and Pathophysiology
  3593.  Genetic Link
  3594.  Genetics in Clinical Practice
  3595. Genetic Basis
  3596. Incidence
  3597. Genetic Testing
  3598. Clinical Implications
  3599. FIG. 29-16 People with cystic fibrosis inherit a defective gene on chromosome 7 called cystic fibrosis transmembrane regulator (CFTR). The protein produced by this gene normally helps sodium and chloride move in and out of cells. If the protein does not work correctly, then the movement of sodium and chloride is blocked and an abnormally thick sticky mucus is produced on the outside of the cell.
  3600. FIG. 29-17 Pathologic changes in bronchiectasis. A, Longitudinal section of bronchial wall where chronic infection has caused damage. B, Collection of purulent material in dilated bronchioles, leading to persistent infection. C, Bronchiectasis in a patient with cystic fibrosis who underwent lung transplantation. Cut surfaces of lung show markedly distended peripheral bronchi filled with mucopurulent secretions.
  3601. Clinical Manifestations
  3602. Complications
  3603. Diagnostic Studies
  3604. Collaborative Care
  3605. Nursing Management Cystic Fibrosis
  3606. Nursing Assessment
  3607. Nursing Diagnoses
  3608. TABLE 29-27 NURSING ASSESSMENT: Cystic Fibrosis
  3609. Planning
  3610. Nursing Implementation
  3611. Bronchiectasis
  3612. Etiology and Pathophysiology
  3613. Clinical Manifestations
  3614. Diagnostic Studies
  3615. Collaborative Care
  3616. Nursing Management Bronchiectasis
  3617. Case Study Chronic Obstructive Pulmonary Disease
  3618. Patient Profile
  3619. Subjective Data
  3620. Objective Data
  3621. Physical Examination
  3622. Diagnostic Studies
  3623. Collaborative Care
  3624. Discussion Questions
  3625. Bridge to NCLEX Examination
  3626. References
  3627. Resources
  3628. Case Study Managing Multiple Patients
  3629. Introduction
  3630. Patients
  3631. Management Discussion Questions
  3632. Case Study Progression
  3633. Pageburst Integrated Resources
  3634. Answer Keys
  3635. Care Plans
  3636. Case Studies
  3637. Concept Map
  3638. Concept Map Creator
  3639. Content Updates
  3640. eFigures
  3641. eTables
  3642. Glossary
  3643. Key Points
  3644. Section 6 Problems of Oxygenation: Transport
  3645. Problems of Oxygenation: Transport
  3646. Pre-Test – Section 6
  3647. Interactive Review – Section 6
  3648. Chapter 30 Nursing Assessment: Hematologic System
  3649. Learning Outcomes
  3650. Key Terms
  3651. eFigure
  3652. eTable
  3653. Structures and Functions of Hematologic System
  3654. Bone Marrow
  3655. FIG. 30-1 Development of blood cells. RBCs, Red blood cells; WBCs, white blood cells.
  3656. Blood
  3657. Plasma.
  3658. TABLE 30-1 FUNCTIONS OF BLOOD
  3659. Blood Cells.
  3660. FIG. 30-2 Approximate values for the components of blood in the adult. Normally, 45% of the blood is composed of blood cells and 55% is composed of plasma.
  3661. Erythrocytes.
  3662. Leukocytes.
  3663. Granulocytes.
  3664. Lymphocytes.
  3665. Monocytes.
  3666. Thrombocytes.
  3667. Normal Iron Metabolism
  3668. Normal Clotting Mechanisms
  3669. Vascular Response.
  3670. FIG. 30-3 Normal iron metabolism. Iron is ingested in the diet or from supplements. Macrophages break down ingested red blood cells (RBCs). Iron is returned to blood bound to transferrin or stored as ferritin or hemosiderin.
  3671. Platelet Plug Formation.
  3672. Plasma Clotting Factors.
  3673. FIG. 30-4 Coagulation mechanism showing steps in the intrinsic pathway and extrinsic pathway as they would occur in the test tube.
  3674. TABLE 30-2 COAGULATION FACTORS
  3675. Lysis of Clot.
  3676. FIG. 30-5 Fibrinolytic system.
  3677. Spleen
  3678. Lymph System
  3679. Liver
  3680. Gerontologic Considerations
  3681. Hematologic System
  3682. TABLE 30-3 GERONTOLOGIC ASSESSMENT DIFFERENCES: Effects of Aging on Hematologic Studies
  3683. Assessment of Hematologic System
  3684. Subjective Data
  3685. Important Health Information
  3686. Past Health History.
  3687. Medications.
  3688. Case Study Patient Introduction
  3689. Critical Thinking
  3690. Surgery or Other Treatments.
  3691. Functional Health Patterns.
  3692. Health Perception–Health Management Pattern.
  3693.  Genetic Risk Alert
  3694. Nutritional-Metabolic Pattern.
  3695. TABLE 30-4 HEALTH HISTORY: Hematologic System
  3696. Elimination Pattern.
  3697. Activity-Exercise Pattern.
  3698. Sleep-Rest Pattern.
  3699. Cognitive-Perceptual Pattern.
  3700. Self-Perception–Self-Concept Pattern.
  3701. Role-Relationship Pattern.
  3702. Sexuality-Reproductive Pattern.
  3703. Case Study Subjective Data
  3704. Coping–Stress Tolerance Pattern.
  3705. Value-Belief Pattern.
  3706. Objective Data
  3707. Physical Examination.
  3708. Lymph Node Assessment.
  3709. FIG. 30-6 Palpable superficial lymph nodes.
  3710. TABLE 30-5 ASSESSMENT ABNORMALITIES: Hematologic System
  3711. Palpation of Liver or Spleen.
  3712. Skin Assessment.
  3713. Focused Assessment
  3714. Subjective
  3715. Objective: Diagnostic
  3716. Objective: Physical Examination
  3717. Inspect
  3718. Auscultate
  3719. Palpate
  3720. Case Study Objective Data: Physical Examination
  3721. Diagnostic Studies of Hematologic System
  3722. Laboratory Studies
  3723. Complete Blood Count.
  3724. Red Blood Cells.
  3725. White Blood Cells.
  3726. TABLE 30-6 DIAGNOSTIC STUDIES: Complete Blood Count Studies
  3727. Platelet Count.
  3728. Blood Typing and Rh Factor.
  3729. TABLE 30-7 DIAGNOSTIC STUDIES: Clotting Studies
  3730. Iron Metabolism.
  3731. TABLE 30-8 ABO BLOOD GROUPS AND COMPATIBILITIES*
  3732. TABLE 30-9 DIAGNOSTIC STUDIES: Miscellaneous Blood Studies
  3733. Radiologic Studies
  3734. Biopsies
  3735. Bone Marrow Examination.
  3736. TABLE 30-10 DIAGNOSTIC STUDIES: Hematologic System
  3737. FIG. 30-7 Bone marrow aspiration from the posterior iliac crest.
  3738. Lymph Node Biopsy.
  3739. Case Study Objective Data: Diagnostic Studies
  3740. Molecular Cytogenetics and Gene Analysis
  3741. Bridge to NCLEX Examination
  3742. References
  3743. Resources
  3744. Pageburst Integrated Resources
  3745. Answer Keys
  3746. Concept Map Creator
  3747. Content Updates
  3748. eFigures
  3749. eTables
  3750. Glossary
  3751. Key Points
  3752. Videos
  3753. Chapter 31 Nursing Management: Hematologic Problems
  3754. Learning Outcomes
  3755. Key Terms
  3756.  Cultural & Ethnic Health Disparities
  3757. Anemia
  3758. Definition and Classification
  3759. FIG. 31-1 Causes of anemia.
  3760. Clinical Manifestations
  3761. Integumentary Changes.
  3762. Cardiopulmonary Manifestations.
  3763. TABLE 31-1 MORPHOLOGY AND ETIOLOGY OF ANEMIA
  3764. TABLE 31-2 CLASSIFICATION OF ANEMIA
  3765. Nursing Management Anemia
  3766. Nursing Assessment
  3767. Nursing Diagnoses
  3768. Planning
  3769. Nursing Implementation
  3770. Gerontologic Considerations
  3771. Anemia
  3772. TABLE 31-3 MANIFESTATIONS OF ANEMIA
  3773. TABLE 31-4 NURSING ASSESSMENT: Anemia
  3774.  Nursing Care Plan 31-1
  3775. Patient With Anemia
  3776. Nursing Diagnosis*
  3777. Patient Goals
  3778. Fatigue Level
  3779. Energy Conservation
  3780. Energy Management
  3781. Nursing Diagnosis
  3782. Patient Goals
  3783. Nutritional Status
  3784. Nutritional Status: Biochemical Measures
  3785. Nutrition Management
  3786. Nursing Diagnosis
  3787. Patient Goal
  3788. Knowledge: Diet
  3789. Knowledge: Medication
  3790. Nutritional Counseling
  3791. Teaching: Prescribed Medication
  3792. Anemia Caused by Decreased Erythrocyte Production
  3793. Iron-Deficiency Anemia
  3794. Etiology
  3795. Clinical Manifestations
  3796. TABLE 31-5 NUTRITIONAL THERAPY: Nutrients for Erythropoiesis
  3797. Diagnostic Studies
  3798. TABLE 31-6 LABORATORY STUDY FINDINGS IN ANEMIAS
  3799. TABLE 31-7 COLLABORATIVE CARE: Iron-Deficiency Anemia
  3800. Diagnostic
  3801. Collaborative Therapy
  3802. Collaborative Care
  3803. Drug Therapy.
  3804. Drug Alert
  3805. Nursing Management Iron-Deficiency Anemia
  3806. Evidence-Based Practice Translating Research Into Practice
  3807. Does Intermittent Iron Supplementation Improve Anemia?
  3808. Clinical Question
  3809. Best Available Evidence
  3810. Critical Appraisal and Synthesis of Evidence
  3811. Conclusion
  3812. Implications for Nursing Practice
  3813. Reference for Evidence
  3814. Thalassemia
  3815. Etiology
  3816.  Genetic Link
  3817. Clinical Manifestations
  3818. Collaborative Care
  3819. Megaloblastic Anemias
  3820. Cobalamin (Vitamin B12) Deficiency
  3821. Etiology
  3822. Pernicious Anemia.
  3823. TABLE 31-8 CLASSIFICATION OF MEGALOBLASTIC ANEMIA
  3824. Other Causes of Cobalamin Deficiency.
  3825. Clinical Manifestations
  3826. Diagnostic Studies
  3827. Collaborative Care
  3828. Folic Acid Deficiency
  3829. Nursing Management Megaloblastic Anemia
  3830. Anemia of Chronic Disease
  3831. Aplastic Anemia
  3832. Etiology
  3833. Clinical Manifestations
  3834. Diagnostic Studies
  3835. TABLE 31-9 CAUSES OF APLASTIC ANEMIA
  3836. Nursing and Collaborative Management Aplastic Anemia
  3837. Anemia Caused by Blood Loss
  3838. Acute Blood Loss
  3839. Clinical Manifestations
  3840. TABLE 31-10 MANIFESTATIONS OF ACUTE BLOOD LOSS
  3841. Diagnostic Studies
  3842. Collaborative Care
  3843. Nursing Management Acute Blood Loss
  3844. Chronic Blood Loss
  3845. Anemia Caused by Increased Erythrocyte Destruction
  3846. FIG. 31-2 Sequence of events in extravascular hemolysis.
  3847. Sickle Cell Disease
  3848. Etiology and Pathophysiology
  3849.  Genetic Link
  3850. FIG. 31-3 In sickle cell, the hemoglobin forms long inflexible chains and alters the shape of the red blood cells (RBCs). The sickled RBCs can become stuck in the capillaries and occlude the blood flow.
  3851. Sickling Episodes.
  3852.  Genetics in Clinical Practice
  3853. Genetic Basis
  3854. Incidence
  3855. Genetic Testing
  3856. Clinical Implications
  3857. Clinical Manifestations
  3858. Complications
  3859. Diagnostic Studies
  3860. Nursing and Collaborative Management Sickle Cell Disease
  3861. FIG. 31-4 Clinical manifestations and complications of sickle cell disease.
  3862. Ethical/Legal Dilemmas Pain Management
  3863. Situation
  3864. Ethical/Legal Points for Consideration
  3865. Discussion Questions
  3866. Acquired Hemolytic Anemia
  3867. Other Red Blood Cell Disorders
  3868. Hemochromatosis
  3869.  Genetics in Clinical Practice
  3870. Genetic Basis
  3871. Incidence
  3872. Genetic Testing
  3873. Clinical Implications
  3874.  Genetic Link
  3875. Polycythemia
  3876. Etiology and Pathophysiology
  3877. Primary Polycythemia.
  3878.  Genetic Link
  3879. Secondary Polycythemia.
  3880. FIG. 31-5 Differentiating between primary and secondary polycythemia. EPO, Erythropoietin; N, normal.
  3881. Clinical Manifestations and Complications
  3882. Diagnostic Studies
  3883. Collaborative Care
  3884. Nursing Management Polycythemia Vera
  3885. Problems of Hemostasis
  3886. Thrombocytopenia
  3887. Etiology and Pathophysiology
  3888. Immune Thrombocytopenic Purpura.
  3889. TABLE 31-11 CAUSES OF THROMBOCYTOPENIA
  3890. TABLE 31-12 DRUG AND HERBAL CAUSES OF THROMBOCYTOPENIA*
  3891. Thrombotic Thrombocytopenic Purpura.
  3892. Heparin-Induced Thrombocytopenia.
  3893. FIG. 31-6 Acute idiopathic thrombocytopenic purpura commonly manifests with purpuric lesions of this kind, although they may often be widespread by the time medical attention is sought.
  3894. Clinical Manifestations
  3895. Diagnostic Studies
  3896. TABLE 31-13 LABORATORY RESULTS IN THROMBOCYTOPENIA
  3897. Collaborative Care
  3898. Immune Thrombocytopenic Purpura.
  3899. TABLE 31-14 COLLABORATIVE CARE: Thrombocytopenia
  3900. Thrombotic Thrombocytopenic Purpura.
  3901. Heparin-lnduced Thrombocytopenia.
  3902. Acquired Thrombocytopenia From Decreased Platelet Production.
  3903. Nursing Management Thrombocytopenia
  3904. Nursing Assessment
  3905. Nursing Diagnoses
  3906. TABLE 31-15 NURSING ASSESSMENT: Thrombocytopenia
  3907. Planning
  3908. Nursing Implementation
  3909. Health Promotion.
  3910. Acute Intervention.
  3911. TABLE 31-16 PATIENT & CAREGIVER TEACHING GUIDE: Thrombocytopenia
  3912. Ambulatory and Home Care.
  3913. Evaluation
  3914. Hemophilia and Von Willebrand Disease
  3915.  Genetic Link
  3916. Clinical Manifestations and Complications
  3917. TABLE 31-17 TYPES OF HEMOPHILIA
  3918.  Genetics in Clinical Practice
  3919. Genetic Basis
  3920. Incidence
  3921. Genetic Testing
  3922. Clinical Implications
  3923. FIG. 31-7 Severe ecchymoses in a person with hemophilia after a fall.
  3924. FIG. 31-8 Acute hemarthrosis of the knee is a common complication of hemophilia.
  3925. Diagnostic Studies
  3926. Collaborative Care
  3927. TABLE 31-18 LABORATORY RESULTS IN HEMOPHILIA
  3928. TABLE 31-19 DRUG THERAPY: Replacement Factors for Hemophilia
  3929. Nursing Management Hemophilia
  3930. Nursing Implementation
  3931. Health Promotion.
  3932. Acute Intervention.
  3933. Ambulatory and Home Care.
  3934. Evaluation
  3935. Disseminated Intravascular Coagulation
  3936. Etiology and Pathophysiology
  3937. FIG. 31-9 The sequence of events that occur during disseminated intravascular coagulation (DIC).
  3938. TABLE 31-20 RISK FACTORS FOR DIC
  3939. Clinical Manifestations
  3940. FIG. 31-10 Disseminated intravascular coagulation (DIC) resulting from staphylococcal septicemia. Note the characteristic skin hemorrhage ranging from small purpuric lesions to larger ecchymoses.
  3941. Diagnostic Studies
  3942. TABLE 31-21 LABORATORY RESULTS IN ACUTE DIC
  3943. Collaborative Care
  3944. Nursing Management Disseminated Intravascular Coagulation
  3945. Nursing Diagnoses
  3946. Nursing Implementation
  3947. FIG. 31-11 Intended sites of action for therapies in disseminated intravascular coagulation (DIC). AT III, Antithrombin III; FSPs, fibrin split products.
  3948. Neutropenia
  3949. Clinical Manifestations
  3950. TABLE 31-22 CAUSES OF NEUTROPENIA
  3951. Safety Alert
  3952. Delegation Decisions Caring for the Patient With Neutropenia
  3953. Role of Registered Nurse (RN)
  3954. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  3955. Role of Unlicensed Assistive Personnel (UAP)
  3956. Diagnostic Studies
  3957. TABLE 31-23 COLLABORATIVE CARE: Neutropenia
  3958. Nursing and Collaborative Management Neutropenia
  3959. TABLE 31-24 PATIENT & CAREGIVER TEACHING GUIDE: Neutropenia
  3960. Myelodysplastic Syndrome
  3961. Informatics in Practice Use of Internet to Access Information on Unfamiliar Diseases
  3962. Etiology and Pathophysiology
  3963. Clinical Manifestations
  3964. Diagnostic Studies
  3965. Nursing and Collaborative Management Myelodysplastic Syndrome
  3966. Leukemia
  3967. Etiology and Pathophysiology
  3968. Classification
  3969. Acute Myelogenous Leukemia.
  3970. Acute Lymphocytic Leukemia.
  3971. Chronic Myelogenous Leukemia.
  3972. TABLE 31-25 TYPES OF LEUKEMIA
  3973.  Genetic Link
  3974. Chronic Lymphocytic Leukemia.
  3975. Other Leukemias.
  3976. Overlap Between Leukemia and Lymphoma.
  3977. Clinical Manifestations
  3978. FIG. 31-12 Pathophysiology of leukemia.
  3979. Diagnostic Studies
  3980. Collaborative Care
  3981. Stages of Chemotherapy.
  3982. Induction Therapy.
  3983. Postinduction or Postremission Therapy.
  3984. Maintenance Therapy.
  3985. Drug Therapy Regimens.
  3986. TABLE 31-26 DRUG THERAPY: Leukemia*
  3987. Other Treatments.
  3988. Hematopoietic Stem Cell Transplantation.
  3989. Nursing Management Leukemia
  3990. Nursing Assessment
  3991. Nursing Diagnoses
  3992. Planning
  3993. Nursing Implementation
  3994. Acute Intervention.
  3995. TABLE 31-27 NURSING ASSESSMENT: Leukemia
  3996. Ambulatory and Home Care.
  3997. Evaluation
  3998. TABLE 31-28 COMPARISON OF HODGKIN’S AND NON-HODGKIN’S LYMPHOMA
  3999. Lymphomas
  4000. Hodgkin’s Lymphoma
  4001. Etiology and Pathophysiology
  4002. FIG. 31-13 Hodgkin’s lymphoma (stage IIA). This patient has enlargement of the cervical lymph nodes.
  4003. Clinical Manifestations
  4004. Diagnostic and Staging Studies
  4005. Nursing and Collaborative Management Hodgkin’S Lymphoma
  4006. FIG. 31-14 Staging system for Hodgkin’s lymphoma and non-Hodgkin’s lymphoma. Stage I, involvement of single lymph node (e.g., cervical node). Stage II, involvement of two or more lymph nodes on one side of diaphragm. Stage III, lymph node involvement above and below the diaphragm. Stage IV, involvement outside of diaphragm (e.g., liver, bone marrow). The stage is followed by the letter A (absence) or B (presence) to indicate significant systemic symptoms (e.g., fever, night sweats, weight loss).
  4007. Non-Hodgkin’s Lymphoma
  4008. Etiology and Pathophysiology
  4009. FIG. 31-15 Non-Hodgkin’s lymphoma involving the spleen. The presence of an isolated mass is typical.
  4010. Clinical Manifestations
  4011. Diagnostic and Staging Studies
  4012. TABLE 31-29 CLASSIFICATION OF NON-HODGKIN’S LYMPHOMA*
  4013. Nursing and Collaborative Management Non-Hodgkin’s Lymphoma
  4014. Drug Alert
  4015. TABLE 31-30 TREATMENT OF NON-HODGKIN’S LYMPHOMA*
  4016. Multiple Myeloma
  4017. Etiology and Pathophysiology
  4018. Clinical Manifestations
  4019. Diagnostic Studies
  4020. Collaborative Care
  4021. Drug Alert
  4022. Nursing Management Multiple Myeloma
  4023. Disorders of the Spleen
  4024. TABLE 31-31 CAUSES OF SPLENOMEGALY
  4025. Blood Component Therapy
  4026. Ethical/Legal Dilemmas Religious Beliefs
  4027. Situation
  4028. Ethical/Legal Points for Consideration
  4029. Discussion Questions
  4030. TABLE 31-32 BLOOD PRODUCTS*
  4031. Administration Procedure
  4032. Safety Alert
  4033. Delegation Decisions Blood Transfusions
  4034. Role of Registered Nurse (RN)
  4035. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  4036. Role of Unlicensed Assistive Personnel (UAP)
  4037. Blood Transfusion Reactions
  4038. TABLE 31-33 ACUTE TRANSFUSION REACTIONS
  4039. TABLE 31-34 DELAYED TRANSFUSION REACTIONS
  4040. Acute Transfusion Reactions.
  4041. Delayed Transfusion Reactions.
  4042. Autotransfusion
  4043. Case Study Leukemia
  4044. Patient Profile
  4045. Subjective Data
  4046. Objective Data
  4047. Physical Examination
  4048. Laboratory Results
  4049. Bone Marrow Biopsy
  4050. Collaborative Care
  4051. Discussion Questions
  4052. Bridge to NCLEX Examination
  4053. References
  4054. Resources
  4055. Case Study Managing Multiple Patients
  4056. Introduction
  4057. Patients
  4058. Management Discussion Questions
  4059. Case Study Progression
  4060. Pageburst Integrated Resources
  4061. Answer Keys
  4062. Care Plans
  4063. Case Studies
  4064. Concept Map
  4065. Concept Map Creator
  4066. Content Updates
  4067. Glossary
  4068. Key Points
  4069. Section 7 Problems of Oxygenation: Perfusion
  4070. Problems of Oxygenation: Perfusion
  4071. Pre-Test – Section 7
  4072. Interactive Review – Section 7
  4073. Chapter 32 Nursing Assessment: Cardiovascular System
  4074. Learning Outcomes
  4075. Key Terms
  4076. eFigures
  4077. Structures and Functions of Cardiovascular System
  4078. Heart
  4079. Structure.
  4080. Blood Flow Through Heart.
  4081. Cardiac Valves.
  4082. FIG. 32-1 Schematic representation of blood flow through the heart. Arrows indicate direction of flow. 1, The right atrium receives venous blood from the inferior and superior venae cavae and the coronary sinus. The blood then passes through the tricuspid valve into the right ventricle. 2, With each contraction, the right ventricle pumps blood through the pulmonic valve into the pulmonary artery and to the lungs. 3, Oxygenated blood flows from the lungs to the left atrium by way of the pulmonary veins. 4, It then passes through the mitral valve and into the left ventricle. 5, As the heart contracts, blood is ejected through the aortic valve into the aorta and thus enters the systemic circulation.
  4083. Blood Supply to Myocardium.
  4084. Conduction System.
  4085. FIG. 32-2 Anatomic structures of the heart and heart valves.
  4086. FIG. 32-3 Coronary arteries and veins.
  4087. Electrocardiogram.
  4088. FIG. 32-4 A, Conduction system of the heart. AV, Atrioventricular; SA, sinoatrial. B, The normal electrocardiogram (ECG) pattern. The P wave represents depolarization of the atria. The QRS complex indicates depolarization of the ventricles. The T wave represents repolarization of the ventricles. The U wave, if present, may represent repolarization of the Purkinje fibers, or it may be associated with hypokalemia. The PR, QRS, and QT intervals reflect the time it takes for the impulse to travel from one area of the heart to another.
  4089. Mechanical System.
  4090. Factors Affecting Cardiac Output.
  4091. Cardiac Reserve.
  4092. Vascular System
  4093. Blood Vessels.
  4094. FIG. 32-5 Comparative thickness of layers of the artery, vein, and capillary.
  4095. Arteries and Arterioles.
  4096. Capillaries.
  4097. Veins and Venules.
  4098. Regulation of Cardiovascular System
  4099. Autonomic Nervous System.
  4100. Effect on Heart.
  4101. Effect on Blood Vessels.
  4102. Baroreceptors.
  4103. Chemoreceptors.
  4104. Blood Pressure
  4105. Measurement of Arterial Blood Pressure.
  4106. Pulse Pressure and Mean Arterial Pressure.
  4107. Gerontologic Considerations
  4108. Effects of Aging on the Cardiovascular System
  4109. TABLE 32-1 GERONTOLOGIC ASSESSMENT DIFFERENCES: Cardiovascular System
  4110. Assessment of Cardiovascular System
  4111. Subjective Data
  4112. Important Health Information
  4113. History of Present Illness.
  4114. Case Study Patient Introduction
  4115. Critical Thinking
  4116. Past Health History.
  4117. Medications.
  4118. Surgery or Other Treatments.
  4119. Functional Health Patterns.
  4120. Health Perception–Health Management Pattern.
  4121. TABLE 32-2 CARDIOVASCULAR EFFECTS OF NONCARDIAC DRUGS*
  4122.  Genetic Risk Alert
  4123. Coronary Artery Disease
  4124. Cardiomyopathy
  4125. Hypertension
  4126. TABLE 32-3 HEALTH HISTORY: Cardiovascular System
  4127. Nutritional-Metabolic Pattern.
  4128. Elimination Pattern.
  4129. Activity-Exercise Pattern.
  4130. Sleep-Rest Pattern.
  4131. Cognitive-Perceptual Pattern.
  4132. Self-Perception–Self-Concept Pattern.
  4133. Role-Relationship Pattern.
  4134. Sexuality-Reproductive Pattern.
  4135. Coping–Stress Tolerance Pattern.
  4136. Values-Belief Pattern.
  4137. Case Study cont’d
  4138. Objective Data
  4139. Physical Examination
  4140. Vital Signs.
  4141. Peripheral Vascular System
  4142. Inspection.
  4143. Palpation.
  4144. FIG. 32-6 Common sites for palpating arteries.
  4145. Auscultation.
  4146. Thorax
  4147. Inspection and Palpation.
  4148. FIG. 32-7 Orientation of the heart within the thorax and cardiac auscultatory areas. Red lines indicate the midsternal line (MSL), midclavicular line (MCL), and anterior axillary line (AAL). ICS, Intercostal space; PMI, point of maximal impulse.
  4149. TABLE 32-4 ASSESSMENT ABNORMALITIES: Cardiovascular System
  4150. Auscultation.
  4151. FIG. 32-8 Relationship of electrocardiogram, cardiac cycle, and heart sounds.
  4152. Case Study cont’d
  4153. TABLE 32-5 NORMAL PHYSICAL ASSESSMENT OF CARDIOVASCULAR SYSTEM
  4154. Focused Assessment
  4155. Subjective
  4156. Objective: Diagnostic
  4157. Objective: Physical Examination
  4158. Inspect and Palpate
  4159. Auscultate
  4160. Diagnostic Studies of Cardiovascular System
  4161. Blood Studies
  4162. Cardiac Biomarkers.
  4163. C-Reactive Protein.
  4164. Homocysteine.
  4165. Cardiac Natriuretic Peptide Markers.
  4166. Serum Lipids.
  4167. TABLE 32-6 DIAGNOSTIC STUDIES: Cardiovascular System
  4168. Lipoprotein-Associated Phospholipase A2.
  4169. Chest X-Ray
  4170. FIG. 32-9 Chest x-ray: standard posterior-anterior view.
  4171. Electrocardiogram
  4172. Event Monitor or Loop Recorder.
  4173. Exercise or Stress Testing
  4174. Echocardiogram
  4175. FIG. 32-10 Long-axis images of the aortic and mitral valve with the depth adjusted to optimize evaluation of valve anatomy and motion. The 2-D images (left) in diastole (top) and systole (bottom) show normal aortic and mitral opening and closure. The color flow images (right) show normal left ventricular inflow with no aortic regurgitation in diastole (top) and normal antegrade flow in the left ventricular outflow tract and no mitral regurgitation in systole (bottom).
  4176. Nuclear Cardiology
  4177. Cardiovascular Magnetic Resonance Imaging
  4178. Cardiac Computed Tomography
  4179. Cardiac Catheterization
  4180. FIG. 32-11 Examples of coronary calcification of the left anterior descending coronary artery (large arrow) and left circumflex artery (small arrow) as seen on electron beam computed tomography.
  4181. FIG. 32-12 Normal left coronary artery angiogram.
  4182. Intracoronary Ultrasound.
  4183. Fractional Flow Reserve.
  4184. Case Study cont’d
  4185. Electrophysiology Study
  4186. Bridge to NCLEX Examination
  4187. References
  4188. Resources
  4189. Pageburst Integrated Resources
  4190. Animations
  4191. Answer Keys
  4192. Audio
  4193. Concept Map Creator
  4194. Content Updates
  4195. eFigures
  4196. Glossary
  4197. Key Points
  4198. Videos
  4199. Chapter 33 Nursing Management: Hypertension
  4200. Learning Outcomes
  4201. Key Terms
  4202. eTables
  4203.  Cultural & Ethnic Health Disparities
  4204. African Americans
  4205. Mexican Americans
  4206. Gender Differences
  4207. Men
  4208. Women
  4209. Normal Regulation of Blood Pressure
  4210. Sympathetic Nervous System
  4211. FIG. 33-1 Factors influencing blood pressure (BP). Hypertension develops when one or more of the BP-regulating mechanisms are defective.
  4212. Baroreceptors.
  4213. TABLE 33-1 SYMPATHETIC NERVOUS SYSTEM RECEPTORS AFFECTING BLOOD PRESSURE
  4214. Vascular Endothelium
  4215. Renal System
  4216. Endocrine System
  4217. TABLE 33-2 CLASSIFICATION OF HYPERTENSION
  4218. Hypertension
  4219. Classification of Hypertension
  4220. Etiology
  4221. Primary Hypertension.
  4222. Secondary Hypertension.
  4223. TABLE 33-3 CAUSES OF SECONDARY HYPERTENSION*
  4224. Pathophysiology of Primary Hypertension
  4225.  Genetic Link
  4226. Water and Sodium Retention.
  4227. TABLE 33-4 RISK FACTORS FOR PRIMARY HYPERTENSION
  4228. Altered Renin-Angiotensin-Aldosterone Mechanism.
  4229. Stress and Increased Sympathetic Nervous System Activity.
  4230. Insulin Resistance and Hyperinsulinemia.
  4231. Endothelium Dysfunction.
  4232. Clinical Manifestations
  4233. Complications
  4234. Hypertensive Heart Disease
  4235. Coronary Artery Disease.
  4236. TABLE 33-5 MANIFESTATIONS OF TARGET ORGAN DISEASE
  4237. Left Ventricular Hypertrophy.
  4238. Heart Failure.
  4239. Cerebrovascular Disease.
  4240. FIG. 33-2 A, Massively enlarged heart caused by hypertrophy of the muscle in the left ventricle. B, Compare with the thickness of the normal left ventricle. The patient suffered from severe hypertension.
  4241. Peripheral Vascular Disease.
  4242. Nephrosclerosis.
  4243. Retinal Damage.
  4244. TABLE 33-6 COLLABORATIVE CARE: Hypertension
  4245. Diagnostic Studies
  4246. Ambulatory Blood Pressure Monitoring.
  4247. Collaborative Care
  4248. Lifestyle Modifications.
  4249. Weight Reduction.
  4250. DASH Eating Plan.
  4251. Dietary Sodium Reduction.
  4252.  Complementary & Alternative Therapies
  4253. Scientific Evidence
  4254. Nursing Implications
  4255. Moderation of Alcohol Consumption.
  4256. Physical Activity.
  4257. Avoidance of Tobacco Products.
  4258. Management of Psychosocial Risk Factors.
  4259. Drug Therapy.
  4260. TABLE 33-7 DRUG THERAPY*Hypertension
  4261. FIG. 33-3 Site and method of action of various antihypertensive drugs (bold type). ACE, Angiotensin-converting enzyme.
  4262. Patient and Caregiver Teaching Related to Drug Therapy.
  4263. TABLE 33-8 DRUG THERAPY: Combination Therapy for Hypertension
  4264. Evidence-Based Practice Applying the Evidence
  4265. Your Decision and Actions
  4266. Reference for Evidence
  4267. TABLE 33-9 CAUSES OF RESISTANT HYPERTENSION
  4268. Resistant Hypertension.
  4269. Nursing Management Primary Hypertension
  4270. Nursing Assessment
  4271. Nursing Diagnoses
  4272. TABLE 33-10 NURSING ASSESSMENT: Hypertension
  4273. Planning
  4274. Nursing Implementation
  4275. Health Promotion.
  4276. Individual Patient Evaluation.
  4277. Blood Pressure Measurement.
  4278. Safety Alert
  4279. TABLE 33-11 BLOOD PRESSURE MEASUREMENT
  4280. Drug Alert
  4281. Screening Programs.
  4282. Delegation Decisions Caring for the Patient With Hypertension
  4283. Role of Registered Nurse (RN)
  4284. Role of Licensed Practical Nurse (LPN)
  4285. Role of Unlicensed Assistive Personnel (UAP)
  4286. Cardiovascular Risk Factor Modification.
  4287. Ambulatory and Home Care
  4288. TABLE 33-12 PATIENT & CAREGIVER TEACHING GUIDE: Hypertension
  4289. Home BP Monitoring.
  4290. Informatics in Practice Monitoring Blood Pressure
  4291. Patient Adherence.
  4292. Evaluation
  4293. Gerontologic Considerations
  4294. Hypertension
  4295. TABLE 33-13 CAUSES OF HYPERTENSIVE CRISIS
  4296. Hypertensive Crisis
  4297. Clinical Manifestations
  4298. FIG. 33-4 Massive retinal exudates (indicated by arrows) from hypertensive retinopathy. To see what a normal retina looks like on ophthalmoscopic examination, see Fig. 21-5 on p. 377.
  4299. Nursing and Collaborative Management Hypertensive Crisis
  4300. Drug Alert
  4301. Drug Alert
  4302. Case Study Primary Hypertension
  4303. Patient Profile
  4304. Subjective Data
  4305. Objective Data
  4306. Physical Examination
  4307. Diagnostic Studies
  4308. Collaborative Care
  4309. Discussion Questions
  4310. Bridge to NCLEX Examination
  4311. References
  4312. Resources
  4313. Pageburst Integrated Resources
  4314. Answer Keys
  4315. Case Studies
  4316. Concept Map Creator
  4317. Content Updates
  4318. eTables
  4319. Glossary
  4320. Key Points
  4321. Chapter 34 Nursing Management: Coronary Artery Disease and Acute Coronary Syndrome
  4322. Learning Outcomes
  4323. Key Terms
  4324. eFigures
  4325. eTable
  4326. Coronary Artery Disease
  4327. Etiology and Pathophysiology
  4328. Developmental Stages.
  4329. Fatty Streak.
  4330. FIG. 34-1 Pathogenesis of atherosclerosis. A, Damaged endothelium. B, Fatty streak and lipid core formation. C, Fibrous plaque. Raised plaques are visible: some are yellow; others are white. D, Complicated lesion: thrombus is red; collagen is blue. Plaque is complicated by red thrombus deposition.
  4331. Fibrous Plaque.
  4332. Complicated Lesion.
  4333. Collateral Circulation.
  4334. Risk Factors for Coronary Artery Disease
  4335. Nonmodifiable Risk Factors
  4336. Age, Gender, and Ethnicity.
  4337. FIG. 34-2 Vessel occlusion with collateral circulation. A, Open, functioning coronary artery. B, Partial coronary artery closure with collateral circulation being established. C, Total coronary artery occlusion with collateral circulation bypassing the occlusion to supply blood to the myocardium.
  4338.  Cultural & Ethnic Health Disparities
  4339. Whites
  4340. African Americans
  4341. Native Americans
  4342. Hispanics
  4343. TABLE 34-1 RISK FACTORS FOR CORONARY ARTERY DISEASE
  4344. Gender Differences
  4345.  Genetic Link
  4346.  Genetics in Clinical Practice
  4347. Genetic Basis
  4348. Incidence
  4349. Genetic Testing
  4350. Clinical Implications
  4351. Major Modifiable Risk Factors
  4352. Elevated Serum Lipids.
  4353. Hypertension.
  4354. Tobacco Use.
  4355. Physical Inactivity.
  4356. Obesity.
  4357. Contributing Modifiable Risk Factors
  4358. Diabetes Mellitus.
  4359. Metabolic Syndrome.
  4360. Psychologic States.
  4361. Homocysteine.
  4362. Substance Abuse.
  4363. Nursing and Collaborative Management Coronary Artery Disease
  4364. Health Promotion
  4365. Identification of High-Risk People.
  4366. Management of High-Risk People.
  4367. TABLE 34-2 PATIENT & CAREGIVER TEACHING GUIDE: Reducing Risk Factors for Coronary Artery Disease
  4368. Physical Activity
  4369. Nutritional Therapy
  4370. TABLE 34-3 NUTRITIONAL THERAPY: Therapeutic Lifestyle Changes Diet
  4371. Lipid-Lowering Drug Therapy
  4372. TABLE 34-4 NUTRITIONAL THERAPY: Tips to Implement Diet and Lifestyle Recommendations
  4373. FIG. 34-3 Types of dietary fat.
  4374. Evidence-Based Practice Translating Research into Practice
  4375. Does Dietary Fat Modification Improve Cardiovascular Disease Outcomes?
  4376. Clinical Question
  4377. Best Available Evidence
  4378. Critical Appraisal and Synthesis of Evidence
  4379. Conclusion
  4380. Implications for Nursing Practice
  4381. Reference for Evidence
  4382.  Complementary & Alternative Therapies: Lipid-Lowering Agents*
  4383. Drugs That Restrict Lipoprotein Production.
  4384. TABLE 34-5 DRUG THERAPY: Hyperlipidemia
  4385. Drug Alert
  4386. Drug Alert
  4387. Drug Alert
  4388. Drugs That Increase Lipoprotein Removal.
  4389. Drugs That Decrease Cholesterol Absorption.
  4390. Antiplatelet Therapy
  4391. Gerontologic Considerations
  4392. Coronary Artery Disease
  4393. Chronic Stable Angina
  4394. TABLE 34-6 FACTORS INFLUENCING MYOCARDIAL OXYGEN NEEDS*
  4395. TABLE 34-7 PQRST ASSESSMENT OF ANGINA
  4396. FIG. 34-4 Common locations and patterns of pain during angina or myocardial infarction.
  4397. TABLE 34-8 PRECIPITATING FACTORS OF ANGINA
  4398. TABLE 34-9 COMPARISON OF MAJOR TYPES OF ANGINA
  4399. Silent Ischemia
  4400. Nocturnal Angina and Angina Decubitus
  4401. Prinzmetal’s Angina
  4402. TABLE 34-10 TREATMENT OF CHRONIC STABLE ANGINA
  4403. Microvascular Angina
  4404. Collaborative Care Chronic Stable Angina
  4405. FIG. 34-5 Collaborative care: chronic stable angina and acute coronary syndrome. ACE, Angiotensin-converting enzyme; ARBs, angiotensin II receptor blockers; CK, creatine kinase, see Table 34-11.†, see Table 34-5.‡, see Tables 34-2, 34-3, and 34-4.
  4406. Drug Therapy
  4407. Short-Acting Nitrates.
  4408. Sublingual Nitroglycerin.
  4409. Long-Acting Nitrates.
  4410. TABLE 34-11 DRUG THERAPY: Chronic Stable Angina and Acute Coronary Syndrome
  4411. Nitroglycerin Ointment.
  4412. Transdermal Controlled-Release Nitrates.
  4413. Drug Alert
  4414. Angiotensin-Converting Enzyme Inhibitors.
  4415. β-Adrenergic Blockers.
  4416. Calcium Channel Blockers.
  4417. Sodium Current Inhibitor.
  4418. Diagnostic Studies
  4419. Cardiac Catheterization.
  4420. Evidence-Based Practice Translating Research into Practice
  4421. Does Timing of Ambulation Affect Patient Safety After Percutaneous Coronary Intervention?
  4422. Clinical Question
  4423. Best Available Evidence
  4424. Critical Appraisal and Synthesis of Evidence
  4425. Conclusion
  4426. Implications for Nursing Practice
  4427. Reference for Evidence
  4428. FIG. 34-6 Placement of a coronary artery stent. A, The stent is positioned at the site of the lesion. B, The balloon is inflated, expanding the stent. The balloon is then deflated and removed. C, The implanted stent is left in place.
  4429. FIG. 34-7 A, A thrombotic occlusion of the right coronary artery is noted (arrows). B, Right coronary artery is opened and blood flow restored following angioplasty and placement of a 4-mm stent.
  4430. Acute Coronary Syndrome
  4431. FIG. 34-8 Relationships among coronary artery disease, chronic stable angina, and acute coronary syndrome.
  4432. Unstable Angina
  4433. Myocardial Infarction
  4434. FIG. 34-9 Occlusion of the left anterior descending coronary artery, resulting in a myocardial infarction.
  4435. FIG. 34-10 Acute myocardial infarction in the posterolateral wall of the left ventricle. This is demonstrated by the absence of staining in the areas of necrosis (white arrow). Note the scarring from a previous anterior wall myocardial infarction (black arrow).
  4436. Clinical Manifestations of Myocardial Infarction
  4437. Pain.
  4438. Sympathetic Nervous System Stimulation.
  4439. Cardiovascular Manifestations.
  4440. Nausea and Vomiting.
  4441. Fever.
  4442. Healing Process
  4443. Complications of Myocardial Infarction
  4444. Dysrhythmias.
  4445. Heart Failure.
  4446. Cardiogenic Shock.
  4447. Papillary Muscle Dysfunction.
  4448. Ventricular Aneurysm.
  4449. Pericarditis.
  4450. Dressler Syndrome.
  4451. Diagnostic Studies Acute Coronary Syndrome
  4452. Electrocardiogram Findings
  4453. Serum Cardiac Markers
  4454. FIG. 34-11 Serum cardiac markers found in the blood after myocardial infarction.
  4455.  TABLE 34-12 EMERGENCY MANAGEMENT: Chest Pain
  4456. Cardiovascular
  4457. Respiratory
  4458. Chest Trauma
  4459. Gastrointestinal
  4460. Others
  4461. Initial
  4462. Ongoing Monitoring
  4463. Coronary Angiography
  4464. Other Measures
  4465. Collaborative Care Acute Coronary Syndrome
  4466. Emergent PCI
  4467. Thrombolytic Therapy
  4468. Indications and Contraindications.
  4469. Procedure.
  4470. TABLE 34-13 CONTRAINDICATIONS FOR THROMBOLYTIC THERAPY
  4471. Safety Alert
  4472. Coronary Surgical Revascularization
  4473. Coronary Artery Bypass Graft Surgery.
  4474. FIG. 34-12 Distal end of the left internal mammary artery is grafted below the area of blockage in the left anterior descending artery. Proximal end of the saphenous vein is grafted to the aorta, and the distal end is grafted below the area of blockage in the right coronary artery.
  4475. Minimally Invasive Direct Coronary Artery Bypass.
  4476. Off-Pump Coronary Artery Bypass.
  4477. Robot-Assisted Cardiothoracic Surgery.
  4478. Transmyocardial Laser Revascularization.
  4479. Drug Therapy
  4480. IV Nitroglycerin.
  4481. Morphine Sulfate.
  4482. β-Adrenergic Blockers.
  4483. Angiotensin-Converting Enzyme Inhibitors.
  4484. Antidysrhythmic Drugs.
  4485. Lipid-Lowering Drugs.
  4486. Stool Softeners.
  4487. Nutritional Therapy
  4488. Nursing Management Chronic Stable Angina and Acute Coronary Syndrome
  4489. Nursing Assessment
  4490. Nursing Diagnoses
  4491. Planning
  4492. Nursing Implementation: Chronic Stable Angina
  4493. Health Promotion.
  4494. TABLE 34-14 NURSING ASSESSMENT: Acute Coronary Syndrome
  4495. Acute Intervention.
  4496. Ambulatory and Home Care.
  4497. Nursing Implementation Acute Coronary Syndrome
  4498. Acute Intervention.
  4499. Pain.
  4500.  Nursing Care Plan 34-1
  4501. Nursing Diagnosis*
  4502. Patient Goal
  4503. Nursing Diagnosis
  4504. Patient Goal
  4505. Pain Management
  4506. Nursing Diagnosis
  4507. Patient Goal
  4508. Nursing Diagnosis
  4509. Patient Goal
  4510. Energy Management
  4511. Nursing Diagnosis
  4512. Patient Goal
  4513. Monitoring.
  4514. Rest and Comfort.
  4515. TABLE 34-15 PHASES OF REHABILITATION AFTER ACUTE CORONARY SYNDROME
  4516. Anxiety.
  4517. Emotional and Behavioral Reactions.
  4518. TABLE 34-16 PSYCHOSOCIAL RESPONSES TO ACUTE CORONARY SYNDROME
  4519. Coronary Revascularization.
  4520. Delegation Decisions Cardiac Catheterization and Percutaneous Coronary Intervention (PCI)
  4521. Role of Registered Nurse (RN)
  4522. Preprocedure
  4523. Postprocedure
  4524. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  4525. Role of Unlicensed Assistive Personnel (UAP)
  4526. Ambulatory and Home Care.
  4527. Evidence-Based Practice Translating Research into Practice
  4528. Do Exercise-Based Cardiac Rehabilitation Programs Improve Outcomes?
  4529. Clinical Question
  4530. Best Available Evidence
  4531. Critical Appraisal and Synthesis of Evidence
  4532. Conclusion
  4533. Implications for Nursing Practice
  4534. Reference for Evidence
  4535. Evidence-Based Practice Applying the Evidence
  4536. Your Decision and Action
  4537. References for Evidence
  4538. Patient Teaching.
  4539. TABLE 34-17 PATIENT & CAREGIVER TEACHING GUIDE: Acute Coronary Syndrome
  4540. Physical Activity.
  4541. TABLE 34-18 ENERGY EXPENDITURE IN METABOLIC EQUIVALENTS
  4542. TABLE 34-19 BORG RATING OF PERCEIVED EXERTION SCALE® *
  4543. INSTRUCTIONS TO THE BORG RATING OF PERCEIVED EXERTION SCALE
  4544. TABLE 34-20 PATIENT & CAREGIVER TEACHING GUIDE: FITT Activity Guidelines After Acute Coronary Syndrome
  4545. Resumption of Sexual Activity.
  4546. TABLE 34-21 PATIENT TEACHING GUIDE: Sexual Activity After Acute Coronary Syndrome
  4547. Evaluation
  4548. Sudden Cardiac Death
  4549. Etiology and Pathophysiology
  4550. Clinical Manifestations and Complications
  4551. Nursing and Collaborative Management Sudden Cardiac Death
  4552. Case Study Myocardial Infarction
  4553. Patient Profile
  4554. Subjective Data
  4555. Objective Data
  4556. Physical Examination
  4557. Diagnostic Studies
  4558. Collaborative Care
  4559. Emergency Department
  4560. Discussion Questions
  4561. Bridge to NCLEX Examination
  4562. References
  4563. Resources
  4564. Pageburst Integrated Resources
  4565. Answer Keys
  4566. Care Plans
  4567. Case Studies
  4568. Concept Map
  4569. Concept Map Creator
  4570. Content Updates
  4571. eFigures
  4572. eTables
  4573. Glossary
  4574. Key Points
  4575. Chapter 35 Nursing Management: Heart Failure
  4576. Learning Outcomes
  4577. Key Terms
  4578. eTable
  4579. Heart Failure
  4580.  Cultural & Ethnic Health Disparities
  4581. Etiology and Pathophysiology
  4582.  Genetic Link
  4583. Pathophysiology of Ventricular Failure.
  4584. Systolic Failure.
  4585. Diastolic Failure.
  4586. TABLE 35-1 PRIMARY CAUSES OF HEART FAILURE
  4587. TABLE 35-2 PRECIPITATING CAUSES OF HEART FAILURE*
  4588. Mixed Systolic and Diastolic Failure.
  4589. Gender Differences
  4590. Compensatory Mechanisms.
  4591. Sympathetic Nervous System Activation.
  4592. Neurohormonal Response.
  4593. Dilation.
  4594. Hypertrophy.
  4595. Counterregulatory Mechanisms.
  4596. FIG. 35-1 A, Dilated heart chambers. B, Hypertrophied heart chambers.
  4597. Types of Heart Failure
  4598. Left-Sided Heart Failure.
  4599. Right-Sided Heart Failure.
  4600. Clinical Manifestations Acute Decompensated Heart Failure
  4601. FIG. 35-2 Pathophysiology of heart failure. Elevated systemic vascular resistance results in left-sided heart failure that leads to right-sided heart failure. Systemic vascular resistance and preload are exacerbated by the renin-angiotensin-aldosterone system. ADH, Antidiuretic hormone; LA, left atrium; LV, left ventricle; LVEDP, left ventricular end-diastolic pressure; RV, right ventricle.
  4602. TABLE 35-3 CLINICAL PROFILE IN ACUTE DECOMPENSATED HEART FAILURE
  4603. Clinical Manifestations Chronic Heart Failure
  4604. Fatigue.
  4605. Dyspnea.
  4606. FIG. 35-3 As pulmonary edema progresses, it inhibits oxygen and carbon dioxide exchange at the alveolar-capillary interface. A, Normal relationship. B, Increased pulmonary capillary hydrostatic pressure causes fluid to move from the vascular space into the pulmonary interstitial space. C, Lymphatic flow increases in an attempt to pull fluid back into the vascular or lymphatic space. D, Failure of lymphatic flow and worsening of left-sided heart failure result in further movement of fluid into the interstitial space and into the alveoli.
  4607. TABLE 35-4 MANIFESTATIONS OF HEART FAILURE
  4608. Tachycardia.
  4609. Edema.
  4610. Nocturia.
  4611. Skin Changes.
  4612. Behavioral Changes.
  4613. Chest Pain.
  4614. Weight Changes.
  4615. Complications of Heart Failure
  4616. Pleural Effusion.
  4617. Dysrhythmias.
  4618. Left Ventricular Thrombus.
  4619. Hepatomegaly.
  4620. Renal Failure.
  4621. Classification of Heart Failure
  4622. Diagnostic Studies
  4623. TABLE 35-5 NYHA FUNCTIONAL CLASSIFICATION OF HEART DISEASE AND ACCF/AHA STAGES OF HEART FAILURE
  4624. Collaborative Care Acute Decompensated Heart Failure
  4625. TABLE 35-6 COLLABORATIVE CARE: Heart Failure
  4626. Drug Therapy.
  4627. Diuretics.
  4628. TABLE 35-7 DRUG THERAPY: Heart Failure
  4629. Vasodilators.
  4630. Drug Alert
  4631. Morphine.
  4632. Positive Inotropes.
  4633. Drug Alert
  4634. Collaborative Care Chronic Heart Failure
  4635. Evidence-Based Practice Translating Research Into Practice
  4636. Can Exercise Help Depression in Heart Failure Patients?
  4637. Clinical Question
  4638. Best Available Evidence
  4639. Critical Appraisal and Synthesis of Evidence
  4640. Conclusion
  4641. Implications for Nursing Practice
  4642. Reference for Evidence
  4643. FIG. 35-4 Placement of pacing leads in cardiac resynchronization therapy.
  4644. Evidence-Based Practice Applying the Evidence
  4645. Your Decision and Action
  4646. Reference for Evidence
  4647. Drug Therapy.
  4648. Diuretics.
  4649. Renin-Angiotensin-Aldosterone System Inhibitors
  4650. Angiotensin-Converting Enzyme Inhibitors.
  4651. Drug Alert
  4652. Angiotensin II Receptor Blockers.
  4653. Aldosterone Antagonists.
  4654. Drug Alert
  4655. β-Adrenergic Blockers.
  4656.  Complementary & Alternative Therapies
  4657. Scientific Evidence*
  4658. Nursing Implications
  4659. Drug Alert
  4660. Vasodilators
  4661. Nitrates.
  4662. BiDil.
  4663. Positive Inotropes.
  4664. Drug Alert
  4665. Nutritional Therapy
  4666. TABLE 35-8 NUTRITIONAL THERAPY: Low-Sodium Diets
  4667. FIG. 35-5 Typical nutrition label. Note that a single serving (½ cup) provides more than one third of the daily recommended intake of sodium.
  4668. Nursing Management Heart Failure
  4669. Nursing Assessment
  4670. TABLE 35-9 NURSING ASSESSMENT: Heart Failure
  4671. Nursing Diagnoses
  4672. Planning
  4673. Nursing Implementation
  4674. Health Promotion.
  4675. Acute Intervention.
  4676. Ambulatory and Home Care.
  4677.  Nursing Care Plan 35-1
  4678. Patient With Heart Failure
  4679. Nursing Diagnosis*
  4680. Patient Goal
  4681. Respiratory Status: Gas Exchange
  4682. Measurement Scale
  4683. Respiratory Monitoring
  4684. Oxygen Therapy
  4685. Positioning
  4686. Nursing Diagnosis
  4687. Patient Goal
  4688. Cardiac Pump Effectiveness
  4689. Measurement Scale
  4690. Cardiac Care
  4691. Nursing Diagnosis
  4692. Patient Goal
  4693. Fluid Balance
  4694. Measurement Scale
  4695. Hypervolemia Management
  4696. Nursing Diagnosis
  4697. Patient Goal
  4698. Activity Tolerance
  4699. Energy Management
  4700. Activity Therapy
  4701. TABLE 35-10 PATIENT & CAREGIVER TEACHING GUIDE: Heart Failure
  4702. FIG. 35-6 Home-based telehealth monitoring unit.
  4703. Palliative and End-of-Life Care.
  4704. Evaluation
  4705. Cardiac Transplantation
  4706. TABLE 35-11 INDICATIONS AND CONTRAINDICATIONS FOR CARDIAC TRANSPLANTATION*
  4707. Criteria for Selection
  4708. Ethical/Legal Dilemmas Competence
  4709. Situation
  4710. Ethical/Legal Points for Consideration
  4711. Discussion Questions
  4712. Bridge to Transplantation
  4713. Surgical Procedure
  4714. Posttransplantation
  4715. Case Study Heart Failure
  4716. Patient Profile
  4717. Subjective Data
  4718. Objective Data
  4719. Physical Examination
  4720. Diagnostic Studies
  4721. Collaborative Care
  4722. Discussion Questions
  4723. Bridge to NCLEX Examination
  4724. References
  4725. Resources
  4726. Pageburst Integrated Resources
  4727. Answer Keys
  4728. Care Plans
  4729. Case Studies
  4730. Concept Map
  4731. Concept Map Creator
  4732. Content Updates
  4733. eTables
  4734. Glossary
  4735. Key Points
  4736. Chapter 36 Nursing Management: Dysrhythmias
  4737. Learning Outcomes
  4738. Key Terms
  4739. eFigure
  4740. eTable
  4741. Rhythm Identification and Treatment
  4742. Conduction System
  4743. Nervous Control of the Heart
  4744. TABLE 36-1 PROPERTIES OF CARDIAC CELLS
  4745. FIG. 36-1 Phases of the cardiac action potential. The electrical potential, measured in millivolts (mV), is indicated along the vertical axis of the graph. Time, measured in seconds (sec), is indicated along the horizontal axis. The action potential has five phases, labeled 0 through 4. Each phase represents a particular electrical event or combination of electrical events. Phase 0 is the upstroke of rapid depolarization and corresponds with ventricular contraction. Phases 1, 2, and 3 represent repolarization. Phase 4 is known as complete repolarization (or the polarized state) and corresponds to diastole. RP, Resting membrane potential; TP, threshold membrane potential.
  4746. FIG. 36-2 A, Limb leads I, II, and III. These bipolar leads are located on the extremities. Illustrated are the angles from which these leads view the heart. B, Limb leads aVR, aVL, and aVF. These unipolar leads use the center of the heart as their negative electrode. C, Placement for the unipolar chest leads: V1, fourth intercostal space at the right sternal border; V2, fourth intercostal space at the left sternal border; V3, halfway between V2 and V4; V4, fifth intercostal space at the left midclavicular line; V5, fifth intercostal space at the left anterior axillary line; V6, fifth intercostal space at the left midaxillary line.
  4747. Electrocardiographic Monitoring
  4748. FIG. 36-3 Twelve-lead electrocardiogram showing a normal sinus rhythm.
  4749. FIG. 36-4 A, Lead placement for V1 or V6 using a five-lead system. B, Typical ECG tracing in lead V1. C, Chest; LA, left arm; LL, left leg; RA, right arm; RL, right leg.
  4750. FIG. 36-5 Time and voltage on the electrocardiogram; 6-sec strip.
  4751. Telemetry Monitoring.
  4752. FIG. 36-6 When the rhythm is regular, heart rate can be easily determined. The estimated heart rate is 70 beats/min. NOTE: Recorded from lead II.
  4753. FIG. 36-7 Artifact. A, Muscle tremor. B, Loose electrodes.
  4754. Informatics in Practice Wireless ECG Monitoring
  4755. Assessment of Cardiac Rhythm
  4756. Electrophysiologic Mechanisms of Dysrhythmias
  4757. FIG. 36-8 Normal sinus rhythm. NOTE: Recorded from lead II.
  4758. FIG. 36-9 The ECG tracing as seen in normal sinus rhythm. 1, P wave; 2, PR interval; 3, QRS complex: Q wave, R wave, S wave; 4, ST segment; 5, T wave; 6, QT interval. Isoelectric (flat) line or baseline represents the absence of electrical activity in the cardiac cells. (See Table 36-2 for timing of intervals.)
  4759. TABLE 36-2 ECG WAVEFORMS AND INTERVALS*
  4760. TABLE 36-3 INTRINSIC RATES OF THE CONDUCTION SYSTEM
  4761. FIG. 36-10 Absolute and relative refractory periods correlated with the cardiac muscle’s action potential and with an ECG tracing.
  4762. Evaluation of Dysrhythmias
  4763. TABLE 36-4 COMMON CAUSES OF DYSRHYTHMIAS*
  4764. TABLE 36-5 APPROACH TO ASSESSING HEART RHYTHM
  4765.  TABLE 36-6 EMERGENCY MANAGEMENT: Dysrhythmias
  4766. Initial
  4767. Ongoing Monitoring
  4768. Types of Dysrhythmias
  4769. Sinus Bradycardia.
  4770. Clinical Associations.
  4771. ECG Characteristics.
  4772. Clinical Significance.
  4773. FIG. 36-11 A, Sinus bradycardia. B, Sinus tachycardia.
  4774. Treatment.
  4775. Sinus Tachycardia.
  4776. Clinical Associations.
  4777. TABLE 36-7 CHARACTERISTICS OF COMMON DYSRHYTHMIAS
  4778. ECG Characteristics.
  4779. Clinical Significance.
  4780. Treatment.
  4781. Premature Atrial Contraction.
  4782. Clinical Associations.
  4783. FIG. 36-12 Premature atrial contractions (arrows).
  4784. ECG Characteristics.
  4785. Clinical Significance.
  4786. Treatment.
  4787. Paroxysmal Supraventricular Tachycardia.
  4788. Clinical Associations.
  4789. FIG. 36-13 Paroxysmal supraventricular tachycardia (PSVT). Arrows indicate beginning and ending of PSVT.
  4790. ECG Characteristics.
  4791. Clinical Significance.
  4792. Treatment.
  4793. Drug Alert
  4794. Atrial Flutter.
  4795. Clinical Associations.
  4796. FIG. 36-14 A, Atrial flutter with a 4:1 conduction (four flutter [F] waves to each QRS complex). B, Atrial fibrillation with a controlled ventricular response. Note the chaotic fibrillatory (f) waves (arrows) between the RS complexes. NOTE: Recorded from lead V1.
  4797. ECG Characteristics.
  4798. Clinical Significance.
  4799. Treatment.
  4800. Atrial Fibrillation.
  4801. Clinical Associations.
  4802. ECG Characteristics.
  4803. Clinical Significance.
  4804. Treatment.
  4805. Evidence-Based Practice Applying the Evidence
  4806. Your Decision and Action
  4807. Reference for Evidence
  4808. TABLE 36-8 DRUG THERAPY: Anticoagulant Therapy for Atrial Fibrillation
  4809. FIG. 36-15 Junctional escape rhythm. P wave is hidden in the RS complex. NOTE: Recorded from lead V1.
  4810. Junctional Dysrhythmias.
  4811. Clinical Associations.
  4812. ECG Characteristics.
  4813. Clinical Significance.
  4814. Treatment.
  4815. First-Degree AV Block.
  4816. Clinical Associations.
  4817. FIG. 36-16 Heart block. A, First-degree atrioventricular (AV) block with a PR interval of 0.40 sec. B, Second-degree AV block, type I, with progressive lengthening of the PR interval until a QRS complex is blocked. C, Second-degree AV block, type II, with constant PR intervals and variable blocked QRS complexes. D, Third-degree AV block. Note that there is no relationship between P waves and QRS complexes.
  4818. ECG Characteristics.
  4819. Clinical Significance.
  4820. Treatment.
  4821. Second-Degree AV Block, Type I.
  4822. Clinical Associations.
  4823. ECG Characteristics.
  4824. Clinical Significance.
  4825. Treatment.
  4826. Second-Degree AV Block, Type II.
  4827. Clinical Associations.
  4828. ECG Characteristics.
  4829. Clinical Significance.
  4830. Treatment.
  4831. Third-Degree AV Block.
  4832. Clinical Associations.
  4833. ECG Characteristics.
  4834. FIG. 36-17 Various forms of premature ventricular contractions (PVCs).
  4835. FIG. 36-18 Ventricular tachycardia. A, Monomorphic. B, Torsades de pointes (polymorphic).
  4836. Clinical Significance.
  4837. Treatment.
  4838. Premature Ventricular Contractions.
  4839. Clinical Associations.
  4840. ECG Characteristics.
  4841. Clinical Significance.
  4842. Treatment.
  4843. Ventricular Tachycardia.
  4844. Ethical/Legal Dilemmas Scope and Standards of Practice
  4845. Situation
  4846. Ethical/Legal Points for Consideration
  4847. Discussion Questions
  4848. Clinical Associations.
  4849. ECG Characteristics.
  4850. Clinical Significance.
  4851. Treatment.
  4852. Ventricular Fibrillation.
  4853. Clinical Associations.
  4854. FIG. 36-19 Ventricular fibrillation.
  4855. ECG Characteristics.
  4856. Clinical Significance.
  4857. Treatment.
  4858. Asystole.
  4859. Clinical Associations.
  4860. Clinical Significance.
  4861. Treatment.
  4862. Pulseless Electrical Activity.
  4863. Sudden Cardiac Death.
  4864. Prodysrhythmia.
  4865. Antidysrhythmia Drugs
  4866. TABLE 36-9 DRUG THERAPY: Antidysrhythmia Drugs
  4867. Defibrillation
  4868. FIG. 36-20 Paddle placement and current flow in monophasic defibrillation (A) and biphasic defibrillation (B).
  4869. FIG. 36-21 LifePak contains a monitor, defibrillator, and transcutaneous pacemaker.
  4870. Synchronized Cardioversion.
  4871. Safety Alert
  4872. FIG. 36-22 A, The implantable cardioverter-defibrillator (ICD) pulse generator from Medtronic, Inc. B, The ICD is placed in a subcutaneous pocket over the pectoral muscle. A single-lead system is placed transvenously from the pulse generator to the endocardium. The single lead detects dysrhythmias and delivers an electric shock to the heart muscle.
  4873. Implantable Cardioverter-Defibrillator.
  4874. Pacemakers
  4875. FIG. 36-23 Ventricular capture (depolarization) secondary to signal (pacemaker spike) from pacemaker lead in the right ventricle.
  4876. TABLE 36-10 PATIENT & CAREGIVER TEACHING GUIDE: Implantable Cardioverter-Defibrillator (ICD)
  4877. FIG. 36-24 A, A dual-chamber rate-responsive pacemaker from Medtronic, Inc., is designed to treat patients with chronic heart problems in which the heart beats too slowly to adequately support the body’s circulation needs. B, Pacing leads in both the atrium and the ventricle enable a dual-chamber pacemaker to sense and pace in both heart chambers.
  4878. Permanent Pacemaker.
  4879. Cardiac Resynchronization Therapy.
  4880. TABLE 36-11 INDICATIONS FOR PERMANENT PACEMAKERS
  4881. FIG. 36-25 Temporary external, dual-chamber demand pacemaker.
  4882. Temporary Pacemaker.
  4883. TABLE 36-12 INDICATIONS FOR TEMPORARY PACEMAKERS*
  4884. FIG. 36-26 Temporary transvenous pacemaker catheter insertion. A single lead is positioned in the right ventricle through the brachial, subclavian, jugular, or femoral vein.
  4885. Monitoring of Patients With Pacemakers.
  4886. FIG. 36-27 Transcutaneous pacemaker. Pacing electrodes are placed on the patient’s anterior (A) and posterior (B) chest walls and attached to an external pacing unit (C).
  4887. Radiofrequency Catheter Ablation Therapy
  4888. TABLE 36-13 PATIENT & CAREGIVER TEACHING GUIDE: Pacemaker
  4889. ECG Changes Associated with Acute Coronary Syndrome
  4890. Ischemia
  4891. FIG. 36-28 Definitive ECG changes occur in leads that face the area of ischemia, injury, or infarction. Reciprocal changes may occur in leads facing opposite the area of ischemia, injury, or infarction.
  4892. FIG. 36-29 ST segment, T wave, and Q wave changes associated with myocardial ischemia (A), injury (B), and infarction (C).
  4893. TABLE 36-14 ECG EVIDENCE IN ACUTE CORONARY SYNDROME
  4894. FIG. 36-30 ECG findings with anteroseptal lateral wall myocardial infarction. Normally, leads I, aVL, and V1 to V3 have a positive R wave. Note the pathologic Q waves in these leads and the ST segment elevation in leads V2 to V5 (arrows).
  4895. Injury and Infarction
  4896. Patient Monitoring
  4897. Syncope
  4898. Case Study Dysrhythmia
  4899. Patient Profile
  4900. Subjective Data
  4901. Objective Data
  4902. Physical Examination
  4903. Diagnostic Studies
  4904. Collaborative Care
  4905. Discussion Questions
  4906. Bridge to NCLEX Examination
  4907. References
  4908. Resources
  4909. Pageburst Integrated Resources
  4910. Answer Keys
  4911. Case Studies
  4912. Concept Map Creator
  4913. Content Updates
  4914. ECG Exercises
  4915. eFigures
  4916. eTables
  4917. Glossary
  4918. Key Points
  4919. Chapter 37 Nursing Management: Inflammatory and Structural Heart Disorders
  4920. Learning Outcomes
  4921. Key Terms
  4922. eFigures
  4923. FIG. 37-1 Layers of the heart muscle and pericardium. The section of the heart wall shows the fibrous pericardium, the parietal and visceral layers of the serous pericardium (with the pericardial sac between them), the myocardium, and the endocardium.
  4924. Inflammatory Disorders of Heart
  4925. Infective Endocarditis
  4926. Classification
  4927. Etiology and Pathophysiology
  4928. FIG. 37-2 Bacterial endocarditis of the mitral valve. The valve is covered with large, irregular vegetations (arrow).
  4929. TABLE 37-1 RISK FACTORS FOR ENDOCARDITIS*
  4930. FIG. 37-3 Pathogenesis of infective endocarditis.
  4931. Clinical Manifestations
  4932. Diagnostic Studies
  4933. Collaborative Care
  4934. Prophylactic Treatment.
  4935. Drug Therapy.
  4936. TABLE 37-2 ANTIBIOTIC PROPHYLAXIS TO PREVENT ENDOCARDITIS
  4937. Nursing Management Infective Endocarditis
  4938. Nursing Assessment
  4939. Nursing Diagnoses
  4940. Planning
  4941. Nursing Implementation
  4942. Health Promotion.
  4943. TABLE 37-3 NURSING ASSESSMENT: Infective Endocarditis
  4944. Ambulatory and Home Care.
  4945. Evaluation
  4946. Acute Pericarditis
  4947. TABLE 37-4 COMMON CAUSES OF PERICARDITIS
  4948. Etiology and Pathophysiology
  4949. Clinical Manifestations
  4950. FIG. 37-4 Acute pericarditis. Note shaggy coat of fibers covering surface of heart.
  4951. Complications
  4952. Diagnostic Studies
  4953. FIG. 37-5 A, X-ray of a normal chest. B, Pericardial effusion is present, and the cardiac silhouette is enlarged with a globular shape (arrows).
  4954. TABLE 37-5 MEASUREMENT OF PULSUS PARADOXUS
  4955. TABLE 37-6 COLLABORATIVE CARE: Acute Pericarditis
  4956. Diagnostic
  4957. Collaborative Therapy
  4958. Collaborative Care
  4959. FIG. 37-6 Pericardiocentesis performed under sterile conditions in conjunction with electrocardiogram (ECG) and hemodynamic measurements.
  4960. Nursing Management Acute Pericarditis
  4961. Chronic Constrictive Pericarditis
  4962. Etiology and Pathophysiology
  4963. Clinical Manifestations and Diagnostic Studies
  4964. Nursing and Collaborative Management Chronic Constrictive Pericarditis
  4965. Myocarditis
  4966. Etiology and Pathophysiology
  4967. Clinical Manifestations
  4968. Diagnostic Studies and Collaborative Care
  4969. Drug Alert
  4970. Nursing Management Myocarditis
  4971. Rheumatic Fever and Rheumatic Heart Disease
  4972. Etiology and Pathophysiology
  4973. Cardiac Lesions and Valve Deformities.
  4974. TABLE 37-7 MODIFIED JONES CRITERIA FOR DIAGNOSING RHEUMATIC FEVER
  4975. Extracardiac Lesions.
  4976. Clinical Manifestations
  4977. Major Criteria.
  4978. TABLE 37-8 COLLABORATIVE CARE: Rheumatic Fever
  4979. Diagnostic
  4980. Collaborative Therapy
  4981. Minor Criteria.
  4982. Evidence of Infection.
  4983. Complications
  4984. Diagnostic Studies and Collaborative Care
  4985. Nursing Management Rheumatic Fever and Rheumatic Heart Disease
  4986. Nursing Assessment
  4987. TABLE 37-9 NURSING ASSESSMENT: Rheumatic Fever and Rheumatic Heart Disease
  4988. Nursing Diagnoses
  4989. Planning
  4990. Nursing Implementation
  4991. Health Promotion.
  4992. Acute Intervention.
  4993. Ambulatory and Home Care.
  4994. Evaluation
  4995. Valvular Heart Disease
  4996. FIG. 37-7 Valvular stenosis and regurgitation. A, Normal position of the valve leaflets, or cusps, when the valve is open and closed. B, Open position of a stenosed valve (left) and closed position of regurgitant valve (right). C, Hemodynamic effect of mitral stenosis. The stenosed valve is unable to open sufficiently during left atrial systole, inhibiting left ventricular filling. D, Hemodynamic effect of mitral regurgitation. The mitral valve does not close completely during left ventricular systole, permitting blood to reenter the left atrium. At the same time, blood is moving forward through the aortic valve.
  4997. Mitral Valve Stenosis
  4998. Etiology and Pathophysiology
  4999. TABLE 37-10 MANIFESTATIONS OF VALVULAR HEART DISEASE
  5000. Clinical Manifestations
  5001. Mitral Valve Regurgitation
  5002. Etiology and Pathophysiology
  5003. Clinical Manifestations
  5004. Mitral Valve Prolapse
  5005. Etiology and Pathophysiology
  5006. FIG. 37-8 Mitral valve prolapse. In this valvular abnormality, the mitral leaflets have prolapsed back into the left atrium. They also demonstrate hooding (arrow). The left ventricle is on the right.
  5007.  Genetic Link
  5008. Clinical Manifestations
  5009. Aortic Valve Stenosis
  5010. Etiology and Pathophysiology
  5011. TABLE 37-11 PATIENT & CAREGIVER TEACHING GUIDE: Mitral Valve Prolapse
  5012. Clinical Manifestations
  5013. Drug Alert
  5014. Aortic Valve Regurgitation
  5015. Etiology and Pathophysiology
  5016. Clinical Manifestations
  5017. Tricuspid and Pulmonic Valve Disease
  5018. Etiology and Pathophysiology
  5019. Diagnostic Studies for Valvular Heart Disease
  5020. TABLE 37-12 COLLABORATIVE CARE: Valvular Heart Disease
  5021. Nonsurgical
  5022. Surgical
  5023. Collaborative Care of Valvular Heart Disease
  5024. Conservative Therapy
  5025. Percutaneous Transluminal Balloon Valvuloplasty.
  5026. Surgical Therapy.
  5027. Valve Repair.
  5028. FIG. 37-9 Mitral valvuloplasty performed by the Inoue technique. The catheter is placed in the mitral valve and the distal part of the Inoue balloon inflated (A). The balloon is then pulled back in the mitral valve and inflated for 10 to 15 sec under fluoroscopic control (B) until the waist of the balloon is no longer visible (C) and the balloon falls back into the left atrium.
  5029. Informatics in Practice Heart Surgery DVD or CD
  5030. FIG. 37-10 Types of prosthetic heart valves. A, Starr-Edwards caged ball valve. B, St. Jude bi-leaflet valve. C, Carpentier-Edwards porcine valve.
  5031. Ethical/Legal Dilemmas Do Not Resuscitate
  5032. Situation
  5033. Ethical/Legal Points for Consideration
  5034. Discussion Questions
  5035. Valve Replacement.
  5036. Nursing Management Valvular Disorders
  5037. Nursing Assessment
  5038. Nursing Diagnoses
  5039. TABLE 37-13 NURSING ASSESSMENT: Valvular Heart Disease
  5040. Planning
  5041. Nursing Implementation
  5042. Health Promotion.
  5043. Acute Intervention and Ambulatory and Home Care.
  5044. Evaluation
  5045. Cardiomyopathy
  5046. TABLE 37-14 CAUSES OF CARDIOMYOPATHY
  5047. Dilated
  5048. Hypertrophic
  5049. Restrictive
  5050. TABLE 37-15 COMPARISON OF TYPES OF CARDIOMYOPATHY
  5051. Dilated Cardiomyopathy
  5052. Etiology and Pathophysiology
  5053. TABLE 37-16 COLLABORATIVE CARE: Cardiomyopathy
  5054. Diagnostic
  5055. Collaborative Therapy
  5056. Clinical Manifestations
  5057. Diagnostic Studies
  5058. FIG. 37-11 Dilated cardiomyopathy. The dilated left ventricular wall has thinned (arrow), and the chamber size and volume are increased.
  5059. Nursing and Collaborative Management Dilated Cardiomyopathy
  5060. Hypertrophic Cardiomyopathy
  5061. Etiology and Pathophysiology
  5062. FIG. 37-12 Hypertrophic cardiomyopathy. There is marked left ventricular hypertrophy (arrow), and the chamber size and volume are decreased.
  5063. Clinical Manifestations
  5064. Diagnostic Studies
  5065. Nursing and Collaborative Management Hypertrophic Cardiomyopathy
  5066. Restrictive Cardiomyopathy
  5067. Etiology and Pathophysiology
  5068. Clinical Manifestations and Diagnostic Studies
  5069. Nursing and Collaborative Management Restrictive Cardiomyopathy
  5070. TABLE 37-17 PATIENT & CAREGIVER TEACHING GUIDE: Cardiomyopathy
  5071. Case Study Valvular Heart Disease
  5072. Patient Profile
  5073. Subjective Data
  5074. Objective Data
  5075. Physical Examination
  5076. Diagnostic Studies
  5077. Discussion Questions
  5078. Bridge to NCLEX Examination
  5079. References
  5080. Resources
  5081. Pageburst Integrated Resources
  5082. Answer Keys
  5083. Audio
  5084. Care Plans
  5085. Case Studies
  5086. Concept Map Creator
  5087. Content Updates
  5088. eFigures
  5089. Glossary
  5090. Key Points
  5091. Chapter 38 Nursing Management: Vascular Disorders
  5092. Learning Outcomes
  5093. Key Terms
  5094. eTables
  5095. Peripheral Artery Disease
  5096. Gender Differences
  5097. Men
  5098. Women
  5099. Etiology and Pathophysiology
  5100. FIG. 38-1 Common anatomic locations of atherosclerotic lesions (shown in yellow) of the abdominal aorta and lower extremities.
  5101. Peripheral Artery Disease of the Lower Extremities
  5102. Clinical Manifestations
  5103. TABLE 38-1 COMPARISON OF PERIPHERAL ARTERY AND VENOUS DISEASE
  5104. Complications
  5105. Diagnostic Studies
  5106. Collaborative Care
  5107. Risk Factor Modification.
  5108. TABLE 38-2 COLLABORATIVE CARE: Peripheral Artery Disease
  5109. Diagnostic
  5110. Collaborative Therapy
  5111. TABLE 38-3 INTERPRETATION OF ANKLE-BRACHIAL INDEX RESULTS
  5112. Drug Therapy.
  5113. Drug Alert
  5114. Drug Alert
  5115. Exercise Therapy.
  5116. Nutritional Therapy.
  5117. Complementary and Alternative Therapies.
  5118. Care of the Leg With Critical Limb Ischemia.
  5119. Interventional Radiology Catheter-Based Procedures.
  5120. Surgical Therapy.
  5121. Nursing Management Lower Extremity Peripheral Artery Disease
  5122. Nursing Assessment
  5123. FIG. 38-2 A, Femoral-popliteal bypass graft around an occluded superficial femoral artery. B, Femoral–posterior tibial bypass graft around occluded superficial femoral, popliteal, and proximal tibial arteries.
  5124. Nursing Diagnoses
  5125. Planning
  5126. Nursing Implementation
  5127. Health Promotion.
  5128. Acute Intervention.
  5129. TABLE 38-4 NURSING ASSESSMENT: Peripheral Artery Disease
  5130. Ambulatory and Home Care.
  5131. Evaluation
  5132. Acute Arterial Ischemic Disorders
  5133. Etiology and Pathophysiology
  5134. TABLE 38-5 PATIENT & CAREGIVER TEACHING GUIDE: Peripheral Artery Bypass Surgery
  5135. Clinical Manifestations
  5136. Collaborative Care
  5137. Thromboangiitis Obliterans
  5138. Raynaud’s Phenomenon
  5139. FIG. 38-3 Raynaud’s phenomenon.
  5140. Aortic Aneurysms
  5141. Etiology and Pathophysiology
  5142. FIG. 38-4 Angiography demonstrating fusiform abdominal aortic aneurysm. Note calcification of the aortic wall (arrows) and extension of the aneurysm into the common iliac arteries.
  5143.  Genetic Link
  5144. Classification
  5145. FIG. 38-5 A, True fusiform abdominal aortic aneurysm. B, True saccular aortic aneurysm. C, False aneurysm, or pseudoaneurysm. D, Aortic dissection.
  5146. Clinical Manifestations
  5147. Complications
  5148. Diagnostic Studies
  5149. Collaborative Care
  5150. Surgical Therapy.
  5151. FIG. 38-6 Surgical repair of an abdominal aortic aneurysm. A, Incising the aneurysmal sac. B, Insertion of synthetic graft. C, Suturing native aortic wall over synthetic graft.
  5152. Endovascular Graft Procedure.
  5153. Complications.
  5154. FIG. 38-7 Bifurcated (two-branched) endovascular stent grafting of an aneurysm. A, Insertion of a woven polyester tube (graft) covered by a tubular metal web (stent). B, The stent graft is inserted through a large blood vessel (e.g., femoral artery) using a delivery catheter. The catheter is positioned below the renal arteries in the area of the aneurysm. C, The stent graft is slowly released (deployed) into the blood vessel. When the stent comes in contact with the blood vessel, it expands to a preset size. D, A second stent graft can be inserted in the contralateral (opposite) vessel if necessary. E, Fully deployed bifurcated stent graft.
  5155. Nursing Management Aortic Aneurysms
  5156. Nursing Assessment
  5157. Planning
  5158. Nursing Implementation
  5159. Health Promotion.
  5160. Acute Intervention.
  5161. Graft Patency.
  5162. Cardiovascular Status.
  5163. Infection.
  5164. Gastrointestinal Status.
  5165. Neurologic Status.
  5166. Peripheral Perfusion Status.
  5167. Renal Perfusion Status.
  5168. Ambulatory and Home Care
  5169. Evaluation
  5170. Aortic Dissection
  5171. Etiology and Pathophysiology
  5172. FIG. 38-8 Aortic dissection of the thoracic aorta.
  5173. Clinical Manifestations
  5174. Complications
  5175. Diagnostic Studies
  5176. TABLE 38-6 COLLABORATIVE CARE: Aortic Dissection
  5177. Diagnostic
  5178. Collaborative Therapy
  5179. Collaborative Care
  5180. Conservative Therapy.
  5181. Endovascular Dissection Repair.
  5182. Surgical Therapy.
  5183. Nursing Management Aortic Dissection
  5184. Venous Disorders
  5185. Phlebitis
  5186. Venous Thrombosis
  5187. TABLE 38-7 COMPARISON OF SUPERFICIAL VEIN THROMBOSIS AND VENOUS THROMBOEMBOLISM
  5188. Etiology
  5189. Venous Stasis.
  5190. FIG. 38-9 Pathophysiology of venous thromboembolism.
  5191. TABLE 38-8 RISK FACTORS FOR VENOUS THROMBOEMBOLISM
  5192. Venous Stasis
  5193. Endothelial Damage
  5194. Hypercoagulability of Blood
  5195. Endothelial Damage.
  5196. Hypercoagulability of Blood.
  5197. Pathophysiology
  5198. Superficial Vein Thrombosis
  5199. Clinical Manifestations.
  5200. Collaborative Care.
  5201. Venous Thromboembolism
  5202. Clinical Manifestations.
  5203. Complications.
  5204. FIG. 38-10 Lipodermatosclerosis. Skin on lower leg becomes scarred, and the leg becomes tapered like an “inverted bottle.” Hallmark signs of lipodermatosclerosis are leathery skin, brown discoloration, hyperpigmentation and hypopigmentation, and circumferential or near circumferential scarring and shrinking of the extremity.
  5205. Diagnostic Studies.
  5206. Collaborative Care
  5207. Prevention and Prophylaxis.
  5208. TABLE 38-9 DIAGNOSTIC STUDIES: Venous Thromboembolism*
  5209. Drug Therapy.
  5210. Vitamin K Antagonists.
  5211. TABLE 38-10 DRUG THERAPY: Anticoagulant Therapy
  5212.  Complementary & Alternative Therapies
  5213. Scientific Evidence
  5214. Nursing Implications
  5215. Thrombin Inhibitors: Indirect.
  5216. TABLE 38-11 TESTS OF BLOOD COAGULATION
  5217. Thrombin Inhibitors: Direct.
  5218. Factor Xa Inhibitors.
  5219. Anticoagulant Therapy for VTE Prophylaxis.
  5220. Anticoagulant Therapy for VTE Treatment.
  5221. FIG. 38-11 Inferior vena caval interruption technique using Greenfield stainless steel filter to prevent pulmonary embolism. As blood travels up the vena cava, clots are trapped in the filter.
  5222. Evidence-Based Practice Applying the Evidence
  5223. Your Decision and Action
  5224. Reference for Evidence
  5225. Thrombolytic Therapy for VTE Treatment.
  5226. Surgical Therapy.
  5227. TABLE 38-12 NURSING ASSESSMENT: Venous Thromboembolism
  5228. Nursing Management Venous Thromboembolism
  5229. Nursing Assessment
  5230. Nursing Diagnoses
  5231. Planning
  5232. Nursing Implementation
  5233. Acute Intervention.
  5234. Drug Alert
  5235. Safety Alert
  5236. TABLE 38-13 NURSING INTERVENTIONS FOR PATIENTS TAKING ANTICOAGULANTS
  5237. Ambulatory and Home Care.
  5238. Delegation Decisions Caring for the Patient With Venous Thromboembolism (VTE)
  5239. Role of Registered Nurse (RN)
  5240. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  5241. Role of Unlicensed Assistive Personnel (UAP)
  5242. TABLE 38-14 PATIENT & CAREGIVER TEACHING GUIDE: Anticoagulant Therapy
  5243. Evaluation
  5244. Varicose Veins
  5245. Etiology and Pathophysiology
  5246. Clinical Manifestations and Complications
  5247. FIG. 38-12 A, Lateral aspect of varicose veins before treatment. B, Lateral aspect of varicose veins 2 years after initial treatment with sclerotherapy.
  5248. Diagnostic Studies and Collaborative Care
  5249. Nursing Management Varicose Veins
  5250. Chronic Venous Insufficiency and Venous Leg Ulcers
  5251. Etiology and Pathophysiology
  5252. FIG. 38-13 Venous leg ulcer.
  5253. Clinical Manifestations and Complications
  5254. Collaborative Care
  5255. Delegation Decisions Caring for the Patient With Chronic Venous Insufficiency
  5256. Role of Registered Nurse (RN)
  5257. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  5258. Role of Unlicensed Assistive Personnel (UAP)
  5259. Nursing Management Chronic Venous Insufficiency and Venous Leg Ulcers
  5260. Case Study Peripheral Artery Disease
  5261. Patient Profile
  5262. Subjective Data
  5263. Current Medications
  5264. Objective Data
  5265. Physical Examination
  5266. Discussion Questions
  5267. Bridge to NCLEX Examination
  5268. References
  5269. Resources
  5270. Case Study Managing Multiple Patients
  5271. Introduction
  5272. Patients
  5273. Management Discussion Questions
  5274. Case Study Progression
  5275. Pageburst Integrated Resources
  5276. Answer Keys
  5277. Care Plans
  5278. Case Studies
  5279. Concept Map Creator
  5280. Content Updates
  5281. eTables
  5282. Glossary
  5283. Key Points
  5284. Volume 2
  5285. Section 8 Problems of Ingestion, Digestion, Absorption, and Elimination
  5286. Problems of Ingestion, Digestion, Absorption, and Elimination
  5287. Pre-Test – Section 8
  5288. Interactive Review – Section 8
  5289. Chapter 39 Nursing Assessment: Gastrointestinal System
  5290. Learning Outcomes
  5291. Key Terms
  5292. eFigures
  5293. FIG. 39-1 A, Location of organs of the gastrointestinal system. B, Parts of the stomach.
  5294. Structures and Functions of Gastrointestinal System
  5295. Ingestion
  5296. Mouth.
  5297. Pharynx.
  5298. Esophagus.
  5299. Digestion and Absorption
  5300. Stomach.
  5301. Small Intestine.
  5302. Physiology of Digestion.
  5303. TABLE 39-1 GASTROINTESTINAL SECRETIONS
  5304. Elimination
  5305. Large Intestine.
  5306. TABLE 39-2 PHASES OF GASTRIC SECRETION
  5307. TABLE 39-3 HORMONES CONTROLLING GI SECRETION AND MOTILITY
  5308. FIG. 39-2 Anatomic locations of the large intestine.
  5309. FIG. 39-3 Gross structure of the liver, gallbladder, pancreas, and duct system.
  5310. Liver, Biliary Tract, and Pancreas
  5311. Liver.
  5312. Biliary Tract.
  5313. TABLE 39-4 FUNCTIONS OF THE LIVER
  5314. Bilirubin Metabolism.
  5315. Pancreas.
  5316. FIG. 39-4 Bilirubin metabolism and conjugation.
  5317. Gerontologic Considerations
  5318. Effects of Aging on Gastrointestinal System
  5319. TABLE 39-5 GERONTOLOGIC ASSESSMENT DIFFERENCES: Gastrointestinal System
  5320. Assessment of Gastrointestinal System
  5321. Subjective Data
  5322. Important Health Information
  5323. Past Health History.
  5324. Medications.
  5325. Case Study Patient Introduction
  5326. Patient Profile
  5327. Critical Thinking
  5328. TABLE 39-6 HEPATOTOXIC CHEMICALS AND DRUGS
  5329. Surgery or Other Treatments.
  5330. Functional Health Patterns.
  5331. Health Perception–Health Management Pattern.
  5332. TABLE 39-7 SURGERIES OF THE GASTROINTESTINAL SYSTEM
  5333.  Genetic Risk Alert
  5334. Colorectal Cancer
  5335.  Genetic Risk Alert
  5336. Inflammatory Bowel Disease (IBD)
  5337. TABLE 39-8 HEALTH HISTORY: Gastrointestinal System
  5338. Nutritional-Metabolic Pattern.
  5339. Elimination Pattern.
  5340. Activity-Exercise Pattern.
  5341. Sleep-Rest Pattern.
  5342. Cognitive-Perceptual Pattern.
  5343. Self-Perception–Self-Concept Pattern.
  5344. Role-Relationship Pattern.
  5345. Sexuality-Reproductive Pattern.
  5346. Coping–Stress Tolerance Pattern.
  5347. Case Study—cont’d
  5348. Value-Belief Pattern.
  5349. Objective Data
  5350. Physical Examination
  5351. Mouth
  5352. Inspection.
  5353. Palpation.
  5354. Abdomen.
  5355. TABLE 39-9 STRUCTURES LOCATED IN ABDOMINAL REGIONS
  5356. FIG. 39-5 A, Abdominal quadrants. B, Abdominal regions. LLQ, Left lower quadrant; LUQ, left upper quadrant; RLQ, right lower quadrant; RUQ, right upper quadrant.
  5357. Inspection.
  5358. Auscultation.
  5359. FIG. 39-6 Technique for percussion of the abdomen. Moving clockwise, percuss lightly in all four quadrants.
  5360. Percussion.
  5361. FIG. 39-7 A, Technique for light palpation of the abdomen. B, Technique for deep palpation.
  5362. Palpation.
  5363. FIG. 39-8 A, Technique for liver palpation. B, Alternative technique to palpate liver with fingers hooked over the costal region.
  5364. TABLE 39-10 NORMAL PHYSICAL ASSESSMENT OF GASTROINTESTINAL SYSTEM
  5365. Case Study—cont’d
  5366. Rectum and Anus.
  5367. Focused Assessment
  5368. Diagnostic Studies of Gastrointestinal System
  5369. TABLE 39-11 ASSESSMENT ABNORMALITIES: Gastrointestinal System
  5370. FIG. 39-9 Barium enema x-ray showing the large intestine.
  5371. Radiologic Studies
  5372. Upper Gastrointestinal Series.
  5373. Lower Gastrointestinal Series.
  5374. TABLE 39-12 DIAGNOSTIC STUDIES: Gastrointestinal System
  5375. Virtual Colonoscopy.
  5376. Endoscopy
  5377. FIG. 39-10 A, Illustration showing the ileocecal junction and the ileocecal fold. B, Endoscopic image of the ileocecal fold.
  5378. Case Study—cont’d
  5379. FIG. 39-11 Capsule endoscopy. A, The video capsule has its own camera and light source. After it is swallowed, it travels through the GI tract and allows visualization of the small intestine. It sends messages to a monitoring device that is worn on a waist belt (B). During the 8-hour examination, the patient is free to move about. After the test, the images are viewed on a video monitor.
  5380. Liver Biopsy
  5381. Liver Function Studies
  5382. TABLE 39-13 DIAGNOSTIC STUDIES: Liver Function Tests
  5383. Bridge to NCLEX Examination
  5384. References
  5385. Resources
  5386. Pageburst Integrated Resources
  5387. Animations
  5388. Answer Keys
  5389. Concept Map Creator
  5390. Content Updates
  5391. eFigures
  5392. Glossary
  5393. Key Points
  5394. Videos
  5395. Chapter 40 Nursing Management: Nutritional Problems
  5396. Learning Outcomes
  5397. Key Terms
  5398. eTables
  5399. Nutritional Problems
  5400. Normal Nutrition
  5401. FIG. 40-1 MyPlate is the primary food group symbol that serves as a reminder to make healthy food choices and to build a healthy plate at mealtimes. It is a visual cue that identifies the five basic food groups from which to select healthy foods. The plate is divided into four slightly different-sized quadrants, with fruits and vegetables taking up half the space and grains and protein making up the other half. The vegetables and grains portions are the largest of the four. Next to the plate is a blue circle for dairy, which could be a glass of milk or a food such as cheese or yogurt. For more information, see www.choosemyplate.gov
  5402. TABLE 40-1 NUTRITIONAL THERAPY: MyPlate Tips for a Healthy Lifestyle
  5403. FIG. 40-2 Sample of a Nutrition Facts label.
  5404. TABLE 40-2 ESTIMATING DAILY ENERGY (CALORIE) REQUIREMENTS
  5405. TABLE 40-3 GOOD SOURCES OF PROTEIN
  5406. TABLE 40-4 MAJOR MINERALS AND TRACE ELEMENTS
  5407. Special Diet: Vegetarian Diet
  5408. TABLE 40-5 NUTRITIONAL THERAPY: Foods High in Iron*
  5409. Culturally Competent Care
  5410. Nutrition
  5411. Malnutrition
  5412. Etiology of Malnutrition
  5413. FIG. 40-3 Patient with malnutrition.
  5414. Contributing Factors to Malnutrition
  5415. Socioeconomic Factors.
  5416. Physical Illnesses.
  5417. TABLE 40-6 CONDITIONS THAT INCREASE THE RISK FOR MALNUTRITION
  5418. Incomplete Diets.
  5419. Food-Drug Interactions.
  5420. TABLE 40-7 RECOMMENDED DAILY VITAMIN AND CALCIUM INTAKE*
  5421. Pathophysiology of Starvation
  5422. Impact of Inflammation.
  5423. Clinical Manifestations
  5424. FIG. 40-4 Severe malnutrition that results in wasting and extensive loss of adipose tissue.
  5425. Diagnostic Studies
  5426. History and Physical Examination.
  5427. Laboratory Studies.
  5428. TABLE 40-8 NURSING ASSESSMENT: Malnutrition
  5429. Anthropometric Measurements.
  5430. Functional Measurements.
  5431. Nursing and Collaborative Management Malnutrition
  5432. Nursing Assessment
  5433. TABLE 40-9 COMPONENTS OF NUTRITIONAL ASSESSMENT
  5434. Anthropometric Measurements
  5435. Physical Examination
  5436. Health History
  5437. Diet History
  5438. Laboratory Data
  5439. Functional Status
  5440. Healthy People
  5441. Nursing Diagnoses
  5442. Planning
  5443. Nursing Implementation
  5444. Health Promotion.
  5445. Evidence-Based Practice Translating Research Into Practice
  5446. Does Nutritional Education Improve Functional Outcomes in Older Adults?
  5447. Clinical Question
  5448. Best Available Evidence
  5449. Critical Appraisal and Synthesis of Evidence
  5450. Conclusion
  5451. Implications for Nursing Practice
  5452. Reference for Evidence
  5453. Acute Intervention.
  5454. TABLE 40-10 NUTRITIONAL THERAPY*High-Calorie, High-Protein Diet
  5455. Breads and Cereals
  5456. Vegetables
  5457. Fruits
  5458. Meat
  5459. Milk and Milk Products
  5460. Ambulatory and Home Care.
  5461. Evaluation
  5462. Gerontologic Considerations
  5463. Malnutrition
  5464. Types of Specialized Nutritional Support
  5465. Oral Feeding
  5466. FIG. 40-5 Nutritional support algorithm.
  5467. Enteral Nutrition
  5468. Orogastric, Nasogastric, and Nasointestinal Tubes.
  5469. FIG. 40-6 Common enteral feeding tube placement locations.
  5470. Gastrostomy and Jejunostomy Tubes.
  5471. FIG. 40-7 Percutaneous endoscopic gastrostomy. A, Gastrostomy tube placement via percutaneous endoscopy. With use of endoscopy, a gastrostomy tube is inserted through the esophagus into the stomach and then pulled through a stab wound made in the abdominal wall. B, A retention disk and bumper secure the tube.
  5472. TABLE 40-11 PROBLEMS RELATED TO TUBE FEEDINGS
  5473. Tube Feedings and Safety.
  5474. Patient Position.
  5475. Aspiration Risk.
  5476. Residual Volumes.
  5477. Tube Position.
  5478. Complications Related to Tubes and Feedings.
  5479. Delegation Decisions Nasogastric and Gastric Tubes and Enteral Feedings
  5480. Role of Registered Nurse (RN)
  5481. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  5482. Role of Unlicensed Assistive Personnel (UAP)
  5483. Gerontologic Considerations
  5484. Enteral Nutrition
  5485. TABLE 40-12 DECREASING RISK OF ENTERAL FEEDING MISCONNECTIONS
  5486. Parenteral Nutrition
  5487. TABLE 40-13 INDICATIONS FOR PARENTERAL NUTRITION*
  5488. Composition.
  5489. Calories.
  5490. Protein.
  5491. Electrolytes.
  5492. Trace Elements and Vitamins.
  5493. Methods of Administration.
  5494. Central Parenteral Nutrition.
  5495. Peripheral Parenteral Nutrition.
  5496. Comparison of Central and Peripheral Parenteral Nutrition.
  5497. TABLE 40-14 COMPLICATIONS OF PARENTERAL NUTRITION
  5498. Infection
  5499. Metabolic Problems
  5500. Catheter-Related Problems
  5501. Nursing Management Parenteral Nutrition
  5502. Complications
  5503. Home Nutritional Support
  5504. Eating Disorders
  5505. Anorexia Nervosa
  5506. Bulimia Nervosa
  5507. Case Study Undernutrition
  5508. Patient Profile
  5509. Subjective Data
  5510. Objective Data
  5511. Physical Examination
  5512. Laboratory Results
  5513. Discussion Questions
  5514. Bridge to NCLEX Examination
  5515. References
  5516. Resources
  5517. Pageburst Integrated Resources
  5518. Answer Keys
  5519. Care Plans
  5520. Concept Map Creator
  5521. Content Updates
  5522. eTables
  5523. Glossary
  5524. Key Points
  5525. Chapter 41 Nursing Management: Obesity
  5526. Learning Outcomes
  5527. Key Terms
  5528. eFigure
  5529. eTables
  5530. Obesity
  5531. Classifications of Body Weight and Obesity
  5532. Body Mass Index.
  5533. FIG. 41-1 Obesity is an epidemic in the United States.
  5534. Waist Circumference.
  5535. Waist-to-Hip Ratio.
  5536. FIG. 41-2 Body mass index (BMI) chart. Healthy weight: BMI 18 to 24.9 kg/m2; overweight: BMI 25 to 29.9 kg/m2; obesity: BMI 30 kg/m2. BMI = weight (kg)/height (m2).
  5537. Body Shape.
  5538. Epidemiology of Obesity
  5539. TABLE 41-1 CLASSIFICATION OF OVERWEIGHT AND OBESITY
  5540. TABLE 41-2 RELATIONSHIP BETWEEN BODY SHAPE AND HEALTH RISKS
  5541.  Cultural & Ethnic Health Disparities
  5542. Healthy People
  5543. Etiology and Pathophysiology
  5544.  Genetic Link
  5545. FIG. 41-3 Some of the common hormones and peptides that interact with the hypothalamus to control and influence eating patterns, metabolic activities, and digestion. Obesity disrupts this balance (see Table 41-3).
  5546. TABLE 41-3 HORMONES AND PEPTIDES IN OBESITY
  5547. Physiologic Regulatory Mechanisms in Obesity.
  5548. Environmental Factors.
  5549. TABLE 41-4 PORTION SIZES: YESTERDAY VS TODAY
  5550. Psychosocial Factors.
  5551. Health Risks Associated with Obesity
  5552. Cardiovascular Problems
  5553. Diabetes Mellitus
  5554. FIG. 41-4 Health risks associated with obesity.
  5555. Gastrointestinal and Liver Problems
  5556. Respiratory and Sleep Problems
  5557. Musculoskeletal Problems
  5558. Cancer
  5559. Metabolic Syndrome
  5560. Psychosocial Problems
  5561. Nursing and Collaborative Management Obesity
  5562. Nursing Assessment
  5563. TABLE 41-5 NURSING ASSESSMENT: Obese Patient
  5564. Planning
  5565. TABLE 41-6 ASSESSING PATIENTS WITH OBESITY
  5566. Nursing Implementation
  5567. TABLE 41-7 COLLABORATIVE CARE: Obesity
  5568. Diagnostic
  5569. Collaborative Therapy
  5570. Nutritional Therapy.
  5571. TABLE 41-8 NUTRITIONAL THERAPY 1200-Calorie–Restricted Weight-Reduction Diet*
  5572. Exercise.
  5573. Behavior Modification.
  5574. Support Groups.
  5575. Drug Therapy
  5576. Appetite-Suppressing Drugs
  5577. Nutrient Absorption–Blocking Drugs
  5578. Serotonin Agonist
  5579. Phentermine and Topiramate (Qsymia)
  5580. Nursing Interventions Related to Drug Therapy
  5581. Surgical Therapy
  5582. Restrictive Surgeries
  5583. Adjustable Gastric Banding.
  5584. Vertical Sleeve Gastrectomy.
  5585. Combination of Restrictive and Malabsorptive Surgery
  5586. Roux-en-Y Gastric Bypass.
  5587. TABLE 41-9 SURGICAL INTERVENTIONS FOR OBESITY*
  5588. Cosmetic Surgeries to Reduce Fatty Tissue and Skinfolds
  5589. Lipectomy.
  5590. Liposuction.
  5591. FIG. 41-5 Bariatric surgical procedures. A, Adjustable gastric banding (AGB) uses a band to create a gastric pouch. B, Vertical sleeve gastrectomy involves creating a sleeve-shaped stomach by removing about 80% of the stomach. C, Vertical banded gastroplasty (VBG) involves creating a small gastric pouch. D, Biliopancreatic diversion (BPD) with duodenal switch procedure creates an anastomosis between the stomach and the intestine. E, Roux-en-Y gastric bypass procedure involves constructing a gastric pouch whose outlet is a Y-shaped limb of small intestine.
  5592. FIG. 41-6 A, Preoperative view of a 37-year-old woman with massive weight loss who had gastric bypass surgery. B, Postoperative view 2½ years after abdominoplasty. She also underwent breast surgery, thighlift, backlift with excision of excess skin of the lower back and upper buttocks, and upper arm surgery.
  5593. Nursing Management Perioperative Care of the Obese Patient
  5594. Nursing Implementation
  5595. Preoperative Care.
  5596. Special Considerations for Bariatric Surgery.
  5597. Postoperative Care.
  5598. Special Considerations for Bariatric Surgery.
  5599. Ambulatory and Home Care
  5600. Special Considerations for Bariatric Surgery.
  5601. Evaluation
  5602. Evidence-Based Practice Applying the Evidence
  5603. Your Decision and Action
  5604. Reference for Evidence
  5605. Gerontologic Considerations
  5606. Obesity in Older Adults
  5607. TABLE 41-10 CRITERIA FOR METABOLIC SYNDROME*
  5608. Metabolic Syndrome
  5609. Etiology and Pathophysiology
  5610. FIG. 41-7 Relationship among insulin resistance, obesity, diabetes mellitus, and cardiovascular disease. HDL, High-density lipoprotein.
  5611. Clinical Manifestations and Diagnostic Studies
  5612. Nursing and Collaborative Management Metabolic Syndrome
  5613. Case Study Obesity
  5614. Patient Profile
  5615. Subjective Data
  5616. Objective Data
  5617. Physical Examination
  5618. Laboratory Results
  5619. Discussion Questions
  5620. Bridge to NCLEX Examination
  5621. References
  5622. Resources
  5623. Pageburst Integrated Resources
  5624. Answer Keys
  5625. Case Studies
  5626. Concept Map Creator
  5627. Content Updates
  5628. eFigures
  5629. eTables
  5630. Glossary
  5631. Key Points
  5632. Chapter 42 Nursing Management: Upper Gastrointestinal Problems
  5633. Learning Outcomes
  5634. Key Terms
  5635. eFigures
  5636. Nausea and Vomiting
  5637. Etiology and Pathophysiology
  5638. FIG. 42-1 Stimuli involved in the act of vomiting. CTZ, Chemoreceptor trigger zone.
  5639. Clinical Manifestations
  5640. Collaborative Care
  5641. Drug Therapy.
  5642. Drug Alert
  5643. Drug Alert
  5644. TABLE 42-1 DRUG THERAPY: Nausea and Vomiting
  5645. Nutritional Therapy.
  5646. Nondrug Therapy.
  5647.  Complementary & Alternative Therapies
  5648. Scientific Evidence
  5649. Nursing Implications
  5650. Nursing Management Nausea and Vomiting
  5651. Nursing Assessment
  5652. Nursing Diagnoses
  5653. Planning
  5654. Nursing Implementation
  5655. Acute Intervention.
  5656. TABLE 42-2 NURSING ASSESSMENT: Nausea and Vomiting
  5657. Ambulatory and Home Care.
  5658. Evaluation
  5659. Gerontologic Considerations
  5660. Nausea and Vomiting
  5661. Oral Inflammation and Infections
  5662. TABLE 42-3 INFECTIONS AND INFLAMMATION OF THE MOUTH
  5663. Oral Cancer
  5664.  Cultural & Ethnic Health Disparities
  5665. Nausea and Vomiting
  5666. Cancers of Oral Cavity and Pharynx
  5667. Esophageal Cancer
  5668. Stomach Cancer
  5669. Etiology and Pathophysiology
  5670. Clinical Manifestations
  5671. TABLE 42-4 TYPES AND CHARACTERISTICS OF ORAL CANCER
  5672. TABLE 42-5 COLLABORATIVE CARE: Oral Cancer
  5673. Diagnostic
  5674. Collaborative Therapy*
  5675. Diagnostic Studies
  5676. Collaborative Care
  5677. Surgical Therapy.
  5678. Nonsurgical Therapy.
  5679. Nutritional Therapy.
  5680. Nursing Management Oral Cancer
  5681. Nursing Assessment
  5682. TABLE 42-6 NURSING ASSESSMENT: Oral Cancer
  5683. Nursing Diagnoses
  5684. Planning
  5685. Nursing Implementation
  5686. Healthy People
  5687. Evaluation
  5688. Esophageal Disorders
  5689. Gastroesophageal Reflux Disease
  5690. FIG. 42-2 Factors involved in the pathogenesis of gastroesophageal reflux disease (GERD). LES, Lower esophageal sphincter.
  5691. Etiology and Pathophysiology
  5692. Clinical Manifestations
  5693. TABLE 42-7 FACTORS AFFECTING LOWER ESOPHAGEAL SPHINCTER PRESSURE
  5694. Increase Pressure
  5695. Decrease Pressure
  5696. Complications
  5697. FIG. 42-3 Esophagitis with esophageal ulcerations.
  5698. Diagnostic Studies
  5699. Collaborative Care
  5700. Lifestyle Modifications.
  5701. Nutritional Therapy.
  5702. TABLE 42-8 COLLABORATIVE CARE: Gastroesophageal Reflux Disease (GERD) and Hiatal Hernia
  5703. TABLE 42-9 PATIENT & CAREGIVER TEACHING GUIDE: Gastroesophageal Reflux Disease (GERD)
  5704. Drug Therapy.
  5705. Evidence-Based Practice Translating Research Into Practice
  5706. Are Proton Pump Inhibitors Associated With Increased Risk of Diarrhea?
  5707. Clinical Question
  5708. Best Available Evidence
  5709. Critical Appraisal and Synthesis of Evidence
  5710. Conclusion
  5711. Implications for Nursing Practice
  5712. Reference for Evidence
  5713. TABLE 42-10 DRUG THERAPY: Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease (PUD)
  5714. Drug Alert
  5715. FIG. 42-4 Nissen fundoplication for repair of hiatal hernia. A, Fundus of stomach is wrapped around distal esophagus. B, The fundus is then sutured to itself.
  5716. Surgical Therapy.
  5717. Endoscopic Therapy.
  5718. Nursing Management Gastroesophageal Reflux Disease
  5719. Hiatal Hernia
  5720. FIG. 42-5 A, Sliding hiatal hernia. B, Rolling or paraesophageal hernia.
  5721. Etiology and Pathophysiology
  5722. Clinical Manifestations and Complications
  5723. Diagnostic Studies
  5724. Ethical/Legal Dilemmas Guardianship
  5725. Situation
  5726. Ethical/Legal Points for Consideration
  5727. Discussion Questions
  5728. Nursing and Collaborative Management Hiatal Hernia
  5729. Gerontologic Considerations
  5730. Gastroesophageal Reflux Disease and Hiatal Hernia
  5731. Esophageal Cancer
  5732. Etiology and Pathophysiology
  5733. Clinical Manifestations and Complications
  5734. Diagnostic Studies
  5735. Collaborative Care
  5736. TABLE 42-11 COLLABORATIVE CARE: Esophageal Cancer
  5737. Diagnostic
  5738. Collaborative Therapy
  5739. Surgery.
  5740. Endoscopic Procedures.
  5741. Radiation and Chemotherapy.
  5742. Nutritional Therapy.
  5743. Nursing Management Esophageal Cancer
  5744. Nursing Assessment
  5745. Nursing Diagnoses
  5746. Planning
  5747. Nursing Implementation
  5748. Health Promotion.
  5749. Acute Intervention
  5750. Preoperative Care.
  5751. Postoperative Care.
  5752. Ambulatory and Home Care.
  5753. Evaluation
  5754. Other Esophageal Disorders
  5755. Eosinophilic Esophagitis
  5756. Esophageal Diverticula
  5757. FIG. 42-6 Possible sites for esophageal diverticula. These hollow outpouchings may occur just above the upper esophageal sphincter (Zenker’s, the most common type of pulsion diverticulum), near the midpoint of the esophagus (traction), and just above the lower esophageal sphincter (epiphrenic).
  5758. FIG. 42-7 Esophageal achalasia. A, Early stage, showing tapering of lower esophagus. B, Advanced stage, showing dilated, tortuous esophagus.
  5759. Esophageal Strictures
  5760. Achalasia
  5761. FIG. 42-8 Pneumatic dilation attempts to treat achalasia by maintaining an adequate lumen and decreasing lower esophageal sphincter (LES) tone.
  5762. Esophageal Varices
  5763. Disorders of the Stomach and Upper Small Intestine
  5764. Gastritis
  5765. TABLE 42-12 CAUSES OF GASTRITIS
  5766. Drugs
  5767. Diet
  5768. Microorganisms
  5769. Environmental Factors
  5770. Pathophysiologic Conditions
  5771. Other Factors
  5772. Etiology and Pathophysiology
  5773. Risk Factors.
  5774. Drug-Related Gastritis.
  5775. Diet.
  5776. Helicobacter pylori.
  5777. Other Risk Factors.
  5778. Autoimmune Gastritis.
  5779. Clinical Manifestations
  5780. Diagnostic Studies
  5781. TABLE 42-13 DRUG THERAPY: Helicobacter pylori Infection
  5782. Nursing and Collaborative Management Gastritis
  5783. Acute Gastritis
  5784. Chronic Gastritis
  5785. FIG. 42-9 Peptic ulcers, including an erosion, an acute ulcer, and a chronic ulcer. Both the acute ulcer and the chronic ulcer may penetrate the entire wall of the stomach.
  5786. FIG. 42-10 Peptic ulcer of the duodenum.
  5787. Peptic Ulcer Disease
  5788. Types
  5789. Etiology and Pathophysiology
  5790. TABLE 42-14 COMPARISON OF GASTRIC AND DUODENAL ULCERS
  5791. Helicobacter pylori.
  5792. FIG. 42-11 Disruption of gastric mucosa and pathophysiologic consequences of back diffusion of acids.
  5793. Medication-Induced Injury.
  5794. Lifestyle Factors.
  5795. FIG. 42-12 Relationship between mucosal blood flow and disruption of the gastric mucosal barrier.
  5796. Gastric Ulcers.
  5797. Duodenal Ulcers.
  5798. Stress-Related Mucosal Disease (SRMD).
  5799. Clinical Manifestations
  5800. FIG. 42-13 Duodenal ulcer of the posterior wall penetrating into the head of the pancreas, resulting in walled-off perforation.
  5801. Complications
  5802. Hemorrhage.
  5803. Perforation.
  5804. Gastric Outlet Obstruction.
  5805. Diagnostic Studies
  5806. FIG. 42-14 Esophagogastroduodenoscopy (EGD) directly visualizes the mucosal lining of the stomach with a flexible endoscope. Ulcers or tumors can be directly visualized and biopsies taken.
  5807. Collaborative Care Conservative Therapy
  5808. TABLE 42-15 COLLABORATIVE CARE: Peptic Ulcer Disease
  5809. Diagnostic
  5810. Collaborative Therapy
  5811. Drug Therapy.
  5812. Histamine (H2)-Receptor Blockers.
  5813. Proton Pump Inhibitors.
  5814. Antibiotic Therapy.
  5815. Antacids.
  5816. Cytoprotective Drug Therapy.
  5817. Other Drugs.
  5818. Nutritional Therapy.
  5819. Therapy Related to Complications of Peptic Ulcer Disease
  5820. Acute Exacerbation.
  5821. Perforation.
  5822. Gastric Outlet Obstruction.
  5823. Nursing Management Peptic Ulcer Disease
  5824. Nursing Assessment
  5825. Nursing Diagnoses
  5826. Planning
  5827. Nursing Implementation
  5828. Health Promotion.
  5829. TABLE 42-16 NURSING ASSESSMENT: Peptic Ulcer Disease
  5830. Acute Intervention.
  5831. Hemorrhage.
  5832. Perforation.
  5833. Gastric Outlet Obstruction.
  5834. TABLE 42-17 PATIENT & CAREGIVER TEACHING GUIDE: Peptic Ulcer Disease (PUD)
  5835. Ambulatory and Home Care.
  5836. Evaluation
  5837. Collaborative Care Surgical Therapy for Peptic Ulcer Disease
  5838. Postoperative Complications.
  5839. Dumping Syndrome.
  5840. Postprandial Hypoglycemia.
  5841. Bile Reflux Gastritis.
  5842. Nutritional Therapy.
  5843. Nursing Management Surgical Therapy for Peptic Ulcer Disease
  5844. Preoperative Care
  5845. TABLE 42-18 NUTRITIONAL THERAPY: Postgastrectomy Dumping Syndrome
  5846. Postoperative Care
  5847. Gerontologic Considerations
  5848. Peptic Ulcer Disease
  5849. Stomach Cancer
  5850. FIG. 42-15 Stomach carcinoma. Gross photograph showing an ill-defined, excavated central ulcer surrounded by irregular, heaped-up borders.
  5851. Etiology and Pathophysiology
  5852. Clinical Manifestations
  5853. TABLE 42-19 COLLABORATIVE CARE: Stomach Cancer
  5854. Diagnostic
  5855. Collaborative Therapy
  5856. Diagnostic Studies
  5857. Collaborative Care
  5858. Surgical Therapy.
  5859. FIG. 42-16 Total gastrectomy for stomach cancer. A, Normal anatomic structure of the stomach. B, Removal of the stomach (total gastrectomy). C, Anastomosis of the esophagus with the jejunum (esophagojejunostomy).
  5860. Adjuvant Therapy.
  5861. Nursing Management Stomach Cancer
  5862. Nursing Assessment
  5863. Nursing Diagnoses
  5864. Planning
  5865. Nursing Implementation
  5866. Health Promotion.
  5867. Acute Intervention
  5868. Preoperative Care.
  5869. Postoperative Care.
  5870. Ambulatory and Home Care.
  5871. TABLE 42-20 TYPES OF UPPER GASTROINTESTINAL BLEEDING
  5872. Evaluation
  5873. Upper Gastrointestinal Bleeding
  5874. Etiology and Pathophysiology
  5875. TABLE 42-21 COMMON CAUSES OF UPPER GASTROINTESTINAL BLEEDING
  5876. Drug Induced
  5877. Esophagus
  5878. Stomach and Duodenum
  5879. Systemic Diseases
  5880. Esophageal Origin.
  5881. Stomach and Duodenal Origin.
  5882. Diagnostic Studies
  5883. Collaborative Care
  5884. Emergency Assessment and Management.
  5885. Endoscopic Therapy.
  5886. TABLE 42-22 DRUG THERAPY: Acute Gastrointestinal Bleeding*
  5887. Surgical Therapy.
  5888. Drug Therapy.
  5889. Nursing Management Upper Gastrointestinal Bleeding
  5890. Nursing Assessment
  5891. Nursing Diagnoses
  5892. Planning
  5893. Nursing Implementation
  5894. Health Promotion.
  5895. TABLE 42-23 NURSING ASSESSMENT: Upper Gastrointestinal Bleeding
  5896. Acute Intervention.
  5897. Ambulatory and Home Care.
  5898. Evaluation
  5899. Foodborne Illness
  5900. Escherichia coli O157:H7 Poisoning
  5901. TABLE 42-24 BACTERIAL FOOD POISONING
  5902. TABLE 42-25 PATIENT & CAREGIVER TEACHING GUIDE: Prevention of Food Poisoning
  5903. Case Study Peptic Ulcer Disease
  5904. Patient Profile
  5905. Subjective Data
  5906. Objective Data
  5907. Physical Examination
  5908. Diagnostic Studies
  5909. Collaborative Care
  5910. Discussion Questions
  5911. Bridge to NCLEX Examination
  5912. References
  5913. Resources
  5914. Pageburst Integrated Resources
  5915. Answer Keys
  5916. Care Plans
  5917. Case Studies
  5918. Concept Map Creator
  5919. Content Updates
  5920. eFigures
  5921. Glossary
  5922. Key Points
  5923. Chapter 43 Nursing Management: Lower Gastrointestinal Problems
  5924. Learning Outcomes
  5925. Key Terms
  5926. eFigures
  5927. eTables
  5928. Diarrhea
  5929. Etiology and Pathophysiology
  5930. TABLE 43-1 CAUSES OF ACUTE INFECTIOUS DIARRHEA*
  5931. Clinical Manifestations
  5932. Diagnostic Studies
  5933. Collaborative Care
  5934. TABLE 43-2 DRUG THERAPY: Antidiarrheal Drugs
  5935. Clostridium difficile Infection.
  5936. Nursing Management Acute Infectious Diarrhea
  5937. Nursing Assessment
  5938. TABLE 43-3 NURSING ASSESSMENT: Diarrhea
  5939. Nursing Diagnoses
  5940. Planning
  5941. Nursing Implementation
  5942. Fecal Incontinence
  5943. Etiology and Pathophysiology
  5944. TABLE 43-4 CAUSES OF FECAL INCONTINENCE
  5945. Traumatic
  5946. Neurologic
  5947. Inflammatory
  5948. Pelvic Floor Dysfunction
  5949. Functional
  5950. Other
  5951. Diagnostic Studies and Collaborative Care
  5952. Nursing Management Fecal Incontinence
  5953. Nursing Assessment
  5954. Nursing Diagnoses
  5955. Planning
  5956. Nursing Implementation
  5957. Constipation
  5958. Etiology and Pathophysiology
  5959. Clinical Manifestations
  5960. Diagnostic Studies and Collaborative Care
  5961. TABLE 43-5 DRUG THERAPY: Constipation
  5962. Nutritional Therapy.
  5963. TABLE 43-6 NUTRITIONAL THERAPY: High-Fiber Foods
  5964. Nursing Management Constipation
  5965. Nursing Assessment
  5966. Nursing Diagnosis
  5967. TABLE 43-7 NURSING ASSESSMENT: Constipation
  5968. Planning
  5969. Nursing Implementation
  5970. TABLE 43-8 PATIENT & CAREGIVER TEACHING GUIDE: Constipation
  5971. Acute Abdominal Pain
  5972. Etiology and Pathophysiology
  5973. TABLE 43-9 CAUSES OF ACUTE ABDOMINAL PAIN
  5974. Clinical Manifestations
  5975. Diagnostic Studies and Collaborative Care
  5976. Nursing Management Acute Abdominal Pain
  5977. Nursing Assessment
  5978. FIG. 43-1 Etiology of acute abdominal pain and pathophysiologic sequelae.
  5979. Nursing Diagnoses
  5980. Planning
  5981. Nursing Implementation
  5982. Acute Intervention
  5983. Preoperative Care.
  5984. Postoperative Care.
  5985.  TABLE 43-10 EMERGENCY MANAGEMENT: Acute Abdominal Pain
  5986. Inflammation
  5987. Vascular Problems
  5988. Gynecologic Problems
  5989. Infectious Disease
  5990. Other
  5991. Abdominal and Gastrointestinal Findings
  5992. Hypovolemic Shock
  5993. Initial
  5994. Ongoing Monitoring
  5995. Ambulatory and Home Care.
  5996. Evaluation
  5997. Chronic Abdominal Pain
  5998. Gender Differences
  5999. Men
  6000. Women
  6001. Irritable Bowel Syndrome
  6002. Drug Alert
  6003. Abdominal Trauma
  6004. Etiology and Pathophysiology
  6005. Clinical Manifestations
  6006.  TABLE 43-11 EMERGENCY MANAGEMENT: Abdominal Trauma
  6007. Blunt
  6008. Penetrating
  6009. Hypovolemic Shock
  6010. Surface Findings
  6011. Abdominal and Gastrointestinal Findings
  6012. Initial
  6013. Ongoing Monitoring
  6014. Diagnostic Studies
  6015. Nursing and Collaborative Management Abdominal Trauma
  6016. Inflammatory Disorders
  6017. Appendicitis
  6018. Etiology and Pathophysiology
  6019. FIG. 43-2 In appendicitis the blood supply of the appendix is impaired by inflammation and bacterial infection in the wall of the appendix, which may result in gangrene.
  6020. Clinical Manifestations
  6021. Diagnostic Studies and Collaborative Care
  6022. Nursing Management Appendicitis
  6023. TABLE 43-12 CAUSES OF PERITONITIS
  6024. Primary
  6025. Secondary
  6026. Peritonitis
  6027. Etiology and Pathophysiology
  6028. Clinical Manifestations
  6029. Diagnostic Studies and Collaborative Care
  6030. TABLE 43-13 COLLABORATIVE CARE: Peritonitis
  6031. Diagnostic
  6032. Collaborative Therapy
  6033. Nursing Management Peritonitis
  6034. Nursing Assessment
  6035. Nursing Diagnoses
  6036. Planning
  6037. Nursing Implementation
  6038. Gastroenteritis
  6039. Inflammatory Bowel Disease
  6040. TABLE 43-14 COMPARISON OF ULCERATIVE COLITIS AND CROHN’S DISEASE
  6041. Etiology and Pathophysiology
  6042.  Cultural & Ethnic Health Disparities
  6043.  Genetic Link
  6044. FIG. 43-3 Comparison of distribution patterns of Crohn’s disease and ulcerative colitis.
  6045. Pattern of Inflammation in Ulcerative Colitis Versus Crohn’s Disease.
  6046. TABLE 43-15 EXTRAINTESTINAL COMPLICATIONS OF IBD
  6047. Clinical Manifestations
  6048. Complications
  6049. Diagnostic Studies
  6050. Collaborative Care
  6051. Drug Therapy.
  6052. TABLE 43-16 COLLABORATIVE CARE: Inflammatory Bowel Disease
  6053. Diagnostic
  6054. Collaborative Therapy
  6055. Drug Alert
  6056. TABLE 43-17 DRUG THERAPY: Inflammatory Bowel Disease
  6057. TABLE 43-18 INDICATIONS FOR SURGICAL THERAPY FOR IBD
  6058. Surgical Therapy
  6059. Ulcerative Colitis.
  6060. Total Proctocolectomy With Ileal Pouch/Anal Anastomosis (IPAA).
  6061. Total Proctocolectomy With Permanent Ileostomy.
  6062. FIG. 43-4 Ileoanal pouch (reservoir). A, Formation of a pouch. B, Posterior suture lines completed. C, J-shaped configuration for ileoanal pouch (J-pouch). D, S-shaped configuration for ileoanal pouch (S-pouch).
  6063. Crohn’s Disease.
  6064. Postoperative Care.
  6065. Nutritional Therapy.
  6066. Nursing Management Inflammatory Bowel Disease
  6067. Nursing Assessment
  6068. Nursing Diagnoses
  6069. Planning
  6070. TABLE 43-19 NURSING ASSESSMENT: Inflammatory Bowel Disease
  6071. Nursing Implementation
  6072. Evaluation
  6073. Gerontologic Considerations
  6074. Inflammatory Bowel Disease
  6075. Intestinal Obstruction
  6076. Types of Intestinal Obstruction
  6077. Mechanical
  6078. Nonmechanical
  6079. Etiology and Pathophysiology
  6080. FIG. 43-5 Bowel obstructions. A, Adhesions. B, Strangulated inguinal hernia. C, Ileocecal intussusception. D, Intussusception from polyps. E, Mesenteric occlusion. F, Neoplasm. G, Volvulus of the sigmoid colon.
  6081. Clinical Manifestations
  6082. TABLE 43-20 MANIFESTATIONS OF SMALL AND LARGE INTESTINAL OBSTRUCTIONS
  6083. Diagnostic Studies
  6084. Collaborative Care
  6085. Nursing Management Intestinal Obstruction
  6086. Nursing Assessment
  6087. Nursing Diagnoses
  6088. Planning
  6089. Nursing Implementation
  6090. FIG. 43-6 Endoscopic image of pedunculated polyp in descending colon.
  6091. Polyps of Large Intestine
  6092. Types of Polyps
  6093.  Genetic Link
  6094. Diagnostic Studies and Collaborative Care
  6095.  Genetics in Clinical Practice
  6096. Genetic Basis
  6097. Incidence
  6098. Genetic Testing
  6099. Clinical Implications
  6100. Colorectal Cancer
  6101. Etiology and Pathophysiology
  6102.  Cultural & Ethnic Health Disparities
  6103.  Genetics in Clinical Practice
  6104. Genetic Basis
  6105. Incidence
  6106. Genetic Testing
  6107. Clinical Implications
  6108. TABLE 43-21 RISK FACTORS FOR COLORECTAL CANCER
  6109. Clinical Manifestations
  6110. FIG. 43-7 The five stages of colorectal cancer. Stage 0 cancer has not grown beyond the mucosal layer. Stage I cancer has grown beyond the mucosa into the submucosa, but no lymph nodes are involved. Stage II cancer has grown beyond the submucosa into the muscle but there is no lymph node involvement or metastasis. Stage III cancer is any tumor with lymph node involvement but no metastasis. Stage IV cancer is any tumor with lymph node involvement and metastasis.
  6111. FIG. 43-8 Signs and symptoms of colorectal cancer by location of primary cancer.
  6112. Diagnostic Studies
  6113. TABLE 43-22 COLLABORATIVE CARE: Colorectal Cancer
  6114. Diagnostic
  6115. Collaborative Therapy
  6116. Collaborative Care
  6117. TABLE 43-23 TNM CLASSIFICATION OF COLORECTAL CANCER
  6118. TABLE 43-24 CLASSIFICATION SYSTEM USED TO STAGE COLORECTAL CANCER
  6119. Surgical Therapy.
  6120. Chemotherapy and Targeted Therapy.
  6121. Drug Alert
  6122. Radiation Therapy.
  6123. TABLE 43-25 NURSING ASSESSMENT: Colorectal Cancer
  6124. Nursing Management Colorectal Cancer
  6125. Nursing Assessment
  6126. Nursing Diagnoses
  6127. Planning
  6128. Nursing Implementation
  6129. Health Promotion.
  6130. Acute Intervention.
  6131. Ambulatory and Home Care.
  6132. Evaluation
  6133. Ostomy Surgery
  6134. Types
  6135. TABLE 43-26 COMPARISON OF ILEOSTOMY AND COLOSTOMY
  6136. FIG. 43-9 Types of ostomies.
  6137. End Stoma.
  6138. Loop Stoma.
  6139. FIG. 43-10 Sigmoid colostomy. Distal bowel is oversewn and left in place to create Hartmann’s pouch.
  6140. Double-Barreled Stoma.
  6141. Nursing Management Ostomy Surgery
  6142. Preoperative Care
  6143. FIG. 43-11 Loop colostomy.
  6144. Postoperative Care
  6145. TABLE 43-27 CHARACTERISTICS OF STOMA
  6146. Colostomy Care
  6147. Colostomy Irrigations.
  6148. TABLE 43-28 PATIENT & CAREGIVER TEACHING GUIDE: Ostomy Self-Care
  6149. Ileostomy Care
  6150. TABLE 43-29 PATIENT & CAREGIVER TEACHING GUIDE: Colostomy Irrigation
  6151. Delegation Decisions Ostomy Care
  6152. Role of Registered Nurse (RN)
  6153. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  6154. Role of Unlicensed Assistive Personnel (UAP)
  6155. Adaptation To An Ostomy
  6156. Sexual Function After Ostomy Surgery
  6157. Diverticulosis and Diverticulitis
  6158. Etiology and Pathophysiology
  6159. FIG. 43-12 Diverticula are outpouchings of the colon. When they become inflamed, the condition is diverticulitis. The inflammatory process can spread to the surrounding area in the intestine.
  6160. Clinical Manifestations and Complications
  6161. FIG. 43-13 Complications of diverticulitis.
  6162. TABLE 43-30 COLLABORATIVE CARE: Diverticulosis and Diverticulitis
  6163. Diagnostic
  6164. Collaborative Therapy
  6165. Diagnostic Studies
  6166. Nursing and Collaborative Management Diverticulosis and Diverticulitis
  6167. Hernias
  6168. Types
  6169. Gender Differences
  6170. Clinical Manifestations
  6171. Nursing and Collaborative Management Hernias
  6172. FIG. 43-14 A, Umbilical hernia. B, Femoral hernias (note swelling below the inguinal ligaments). C, Right inguinal hernia.
  6173. Malabsorption Syndrome
  6174. TABLE 43-31 CAUSES OF MALABSORPTION
  6175. Biochemical or Enzyme Deficiencies
  6176. Disturbed Lymphatic and Vascular Circulation
  6177. Bacterial Proliferation
  6178. Small Intestinal Mucosal Disruption
  6179. Surface Area Loss
  6180. Celiac Disease
  6181. TABLE 43-32 MANIFESTATIONS OF MALABSORPTION
  6182. Etiology and Pathophysiology
  6183.  Genetic Link
  6184. Clinical Manifestations
  6185. Diagnostic Studies and Collaborative Care
  6186. TABLE 43-33 NUTRITIONAL THERAPY: Celiac Disease
  6187. Foods to Eat*
  6188. Foods to Avoid
  6189. Lactase Deficiency
  6190. Short Bowel Syndrome
  6191. Clinical Manifestations
  6192. Collaborative Care
  6193. Gastrointestinal Stromal Tumors
  6194. Anorectal Problems
  6195. Hemorrhoids
  6196. Etiology and Pathophysiology
  6197. Clinical Manifestations
  6198. FIG. 43-15 Anatomic structures of the rectum and anus with external and internal hemorrhoids.
  6199. Diagnostic Studies and Collaborative Care
  6200. FIG. 43-16 Thrombosed external hemorrhoids.
  6201. Nursing Management Hemorrhoids
  6202. Anal Fissure
  6203. FIG. 43-17 Common sites of anorectal abscesses and fistula formation.
  6204. Anorectal Abscess
  6205. Anal Fistula
  6206. Anal Cancer
  6207. Pilonidal Sinus
  6208. Case Study Colorectal Cancer
  6209. Patient Profile
  6210. Subjective Data
  6211. Objective Data
  6212. Physical Examination
  6213. Laboratory Tests
  6214. Collaborative Care
  6215. Surgical Procedure
  6216. Postoperative
  6217. Follow-Up Treatment
  6218. Discussion Questions
  6219. Bridge to NCLEX Examination
  6220. References
  6221. Resources
  6222. Pageburst Integrated Resources
  6223. Answer Keys
  6224. Care Plans
  6225. Case Studies
  6226. Concept Map Creator
  6227. Content Updates
  6228. eFigures
  6229. eTables
  6230. Glossary
  6231. Key Points
  6232. Chapter 44 Nursing Management: Liver, Pancreas, and Biliary Tract Problems
  6233. Learning Outcomes
  6234. Key Terms
  6235. eFigures
  6236. eTable
  6237. Disorders of the Liver
  6238. Hepatitis
  6239. Viral Hepatitis
  6240. Hepatitis A Virus.
  6241. FIG. 44-1 Jaundiced patient.
  6242. TABLE 44-1 CHARACTERISTICS OF HEPATITIS VIRUSES
  6243. Hepatitis B Virus.
  6244. FIG. 44-2 Course of infection with hepatitis A virus (HAV). ALT, Alanine aminotransferase.
  6245. Hepatitis C Virus.
  6246. FIG. 44-3 Course of infection with hepatitis B virus (HBV). ALT, Alanine aminotransferase; anti-HBc, antibody to hepatitis B core antigen; anti-HBe, antibody to HBeAg; anti-HBs, antibody to HBsAg; HBeAg, hepatitis B e antigen; HBsAg, hepatitis B surface antigen.
  6247. Hepatitis D Virus.
  6248. Hepatitis E Virus.
  6249. Pathophysiology
  6250. Liver.
  6251. Systemic Effects.
  6252. TABLE 44-2 MANIFESTATIONS OF HEPATITIS
  6253. Acute Hepatitis
  6254. Chronic Hepatitis
  6255. Clinical Manifestations
  6256. TABLE 44-3 CLASSIFICATION OF JAUNDICE
  6257. Complications
  6258. Diagnostic Studies
  6259. TABLE 44-4 TESTS FOR VIRAL HEPATITIS
  6260. TABLE 44-5 DIAGNOSTIC FINDINGS IN ACUTE HEPATITIS
  6261. Collaborative Care
  6262. Drug Therapy.
  6263. Chronic Hepatitis B.
  6264. TABLE 44-6 COLLABORATIVE CARE: Viral Hepatitis
  6265. Diagnostic
  6266. Collaborative Therapy
  6267. Interferon.
  6268.  Complementary & Alternative Therapies
  6269. Scientific Evidence
  6270. Nursing Implications
  6271. Nucleoside and Nucleotide Analogs.
  6272. Chronic Hepatitis C.
  6273. Drug Alert
  6274. Nutritional Therapy.
  6275. Nursing Management Viral Hepatitis
  6276. Nursing Assessment
  6277. Nursing Diagnoses
  6278. TABLE 44-7 NURSING ASSESSMENT: Hepatitis*
  6279. Planning
  6280. Nursing Implementation
  6281. Health Promotion.
  6282. TABLE 44-8 PREVENTIVE MEASURES FOR VIRAL HEPATITIS*
  6283. General Measures
  6284. Use of Immune Globulin
  6285. Special Considerations for Health Care Personnel
  6286. Sexual Transmission
  6287. General Measures
  6288. Special Considerations for Health Care Personnel
  6289. Hepatitis A.
  6290. Hepatitis B.
  6291. Hepatitis C.
  6292. Acute Intervention.
  6293. Ambulatory and Home Care.
  6294. Evaluation
  6295. Drug- and Chemical-Induced Liver Diseases
  6296. Drug Alert
  6297. Autoimmune, Genetic, and Metabolic Diseases
  6298. Autoimmune Hepatitis
  6299. Wilson’s Disease
  6300. Hemochromatosis
  6301. Primary Biliary Cirrhosis
  6302. Primary Sclerosing Cholangitis
  6303. Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
  6304. Cirrhosis
  6305. Etiology and Pathophysiology
  6306. FIG. 44-4 Cirrhosis that developed secondary to alcoholism. The characteristic diffuse nodularity of the surface is due to the combination of regeneration and scarring of the liver.
  6307.  Cultural & Ethnic Health Disparities
  6308. Hepatitis
  6309. Cirrhosis
  6310. Liver and Pancreatic Cancer
  6311. Gallbladder Disease
  6312. Clinical Manifestations
  6313. Early Manifestations.
  6314. Later Manifestations.
  6315. Jaundice.
  6316. FIG. 44-5 Continuum of liver dysfunction in cirrhosis and resulting manifestations. ADH, Antidiuretic hormone; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
  6317. Skin Lesions.
  6318. Hematologic Problems.
  6319. Endocrine Problems.
  6320. FIG. 44-6 Systemic clinical manifestations of liver cirrhosis.
  6321. Peripheral Neuropathy.
  6322. Complications
  6323. Portal Hypertension and Esophageal and Gastric Varices.
  6324. Peripheral Edema and Ascites.
  6325. FIG. 44-7 Mechanisms for development of ascites.
  6326. TABLE 44-9 FACTORS INVOLVED IN ASCITES
  6327. FIG. 44-8 Gross ascites.
  6328. Hepatic Encephalopathy.
  6329. TABLE 44-10 FACTORS PRECIPITATING HEPATIC ENCEPHALOPATHY
  6330. Hepatorenal Syndrome.
  6331. Diagnostic Studies
  6332. TABLE 44-11 GRADING SCALE FOR HEPATIC ENCEPHALOPATHY
  6333. TABLE 44-12 COLLABORATIVE CARE: Cirrhosis of the Liver
  6334. Diagnostic
  6335. Collaborative Therapy
  6336. Collaborative Care
  6337. Ascites.
  6338. Esophageal and Gastric Varices.
  6339. Safety Alert
  6340. Shunting Procedures.
  6341. Hepatic Encephalopathy.
  6342. FIG. 44-9 Portosystemic shunts. A, Portacaval shunt. The portal vein is anastomosed to the inferior vena cava, diverting blood from the portal vein to the systemic circulation. B, Distal splenorenal shunt. The splenic vein is anastomosed to the renal vein. The portal venous flow remains intact while esophageal varices are selectively decompressed. (The short gastric veins are decompressed.) The spleen conducts blood from the high pressure of the esophageal and gastric varices to the low-pressure renal vein.
  6343. Drug Therapy.
  6344. Nutritional Therapy.
  6345. TABLE 44-13 DRUG THERAPY: Cirrhosis
  6346. Nursing Management Cirrhosis
  6347. Nursing Assessment
  6348. Nursing Diagnoses
  6349. Planning
  6350. Nursing Implementation
  6351. Health Promotion.
  6352. TABLE 44-14 NURSING ASSESSMENT: Cirrhosis
  6353. Acute Intervention.
  6354. Bleeding Varices.
  6355. Ethical/Legal Dilemmas Rationing
  6356. Situation
  6357. Ethical/Legal Points for Consideration
  6358. Discussion Questions
  6359. Evidence-Based Practice Applying the Evidence
  6360. Your Decision and Action
  6361. Reference for Evidence
  6362. Hepatic Encephalopathy.
  6363. Ambulatory and Home Care.
  6364. Evaluation
  6365. TABLE 44-15 PATIENT & CAREGIVER TEACHING GUIDE: Cirrhosis
  6366. Acute Liver Failure
  6367. Clinical Manifestations and Diagnostic Studies
  6368. Nursing and Collaborative Management Acute Liver Failure
  6369. Liver Cancer (Hepatocellular Cancer)
  6370. FIG. 44-10 Multiple hepatic metastases from a primary colon cancer. A, Gross specimen showing outside of liver. B, Liver section showing metastatic lesions.
  6371. Clinical Manifestations and Diagnostic Studies
  6372. Nursing and Collaborative Management Liver Cancer
  6373. Liver Transplantation
  6374. Gerontologic Considerations
  6375. Liver Disease in the Older Adult
  6376. FIG. 44-11 Pathogenic process of acute pancreatitis.
  6377. Disorders of the Pancreas
  6378. Acute Pancreatitis
  6379. Etiology and Pathophysiology
  6380. FIG. 44-12 In acute pancreatitis, the pancreas appears edematous and is commonly hemorrhagic (H).
  6381. Clinical Manifestations
  6382. Complications
  6383. TABLE 44-16 DIAGNOSTIC STUDIES: Acute Pancreatitis
  6384. Diagnostic Studies
  6385. Collaborative Care
  6386. Conservative Therapy.
  6387. TABLE 44-17 COLLABORATIVE CARE: Acute Pancreatitis
  6388. Diagnostic
  6389. Collaborative Therapy
  6390. Surgical Therapy.
  6391. TABLE 44-18 DRUG THERAPY: Acute and Chronic Pancreatitis
  6392. Drug Therapy.
  6393. Nutritional Therapy.
  6394. Nursing Management Acute Pancreatitis
  6395. Nursing Assessment
  6396. Nursing Diagnoses
  6397. TABLE 44-19 NURSING ASSESSMENT: Acute Pancreatitis
  6398. Planning
  6399. Nursing Implementation
  6400. Health Promotion.
  6401. Acute Intervention.
  6402. Safety Alert
  6403. Ambulatory and Home Care.
  6404. Evaluation
  6405. Chronic Pancreatitis
  6406. Etiology and Pathophysiology
  6407. Clinical Manifestations
  6408. Diagnostic Studies
  6409. Collaborative Care
  6410. Nursing Management Chronic Pancreatitis
  6411. Pancreatic Cancer
  6412. Etiology and Pathophysiology
  6413. Clinical Manifestations
  6414. Diagnostic Studies
  6415. Collaborative Care
  6416. FIG. 44-13 Whipple procedure or radical pancreaticoduodenectomy. This surgical procedure involves resection of the proximal pancreas, adjoining duodenum, distal portion of the stomach, and distal portion of the common bile duct. An anastomosis of the pancreatic duct, common bile duct, and stomach to the jejunum is done.
  6417. Nursing Management Pancreatic Cancer
  6418. FIG. 44-14 Cholesterol gallstones in a gallbladder that was removed.
  6419. Disorders of the Biliary Tract
  6420. Cholelithiasis and Cholecystitis
  6421. Etiology and Pathophysiology
  6422. Cholelithiasis.
  6423. Gender Differences
  6424. TABLE 44-20 MANIFESTATIONS OF OBSTRUCTED BILE FLOW
  6425. Cholecystitis.
  6426. Clinical Manifestations
  6427. Complications.
  6428. Diagnostic Studies
  6429. Collaborative Care
  6430. Conservative Therapy
  6431. Cholelithiasis.
  6432. FIG. 44-15 During endoscopic sphincterotomy, an endoscope is advanced through the mouth and stomach until its tip sits in the duodenum opposite the common bile duct. Inset, After widening the duct mouth by incising the sphincter muscle, the physician advances a basket attachment into the duct and snags the stone.
  6433. Cholecystitis.
  6434. Surgical Therapy.
  6435. TABLE 44-21 COLLABORATIVE CARE: Cholelithiasis and Acute Cholecystitis
  6436. Diagnostic
  6437. Collaborative Therapy
  6438. Transhepatic Biliary Catheter.
  6439. Drug Therapy.
  6440. FIG. 44-16 Placement of T tube. Dotted lines indicate parts removed.
  6441. Nutritional Therapy.
  6442. Nursing Management Gallbladder Disease
  6443. Nursing Assessment
  6444. TABLE 44-22 NURSING ASSESSMENT: Cholecystitis or Cholelithiasis
  6445. Nursing Diagnoses
  6446. Planning
  6447. Nursing Implementation
  6448. Health Promotion.
  6449. Acute Intervention.
  6450. Postoperative Care.
  6451. Ambulatory and Home Care.
  6452. Evaluation
  6453. Gallbladder Cancer
  6454. TABLE 44-23 PATIENT & CAREGIVER TEACHING GUIDE: Postoperative Laparoscopic Cholecystectomy
  6455. Case Study Cirrhosis of the Liver
  6456. Patient Profile
  6457. Subjective Data
  6458. Objective Data
  6459. Physical Examination
  6460. Laboratory Values
  6461. Discussion Questions
  6462. Bridge to NCLEX Examination
  6463. References
  6464. Resources
  6465. Case Study Managing Multiple Patients
  6466. Introduction
  6467. Patients
  6468. Management Discussion Questions
  6469. Case Study Progression
  6470. Pageburst Integrated Resources
  6471. Answer Keys
  6472. Care Plans
  6473. Case Studies
  6474. Concept Map
  6475. Concept Map Creator
  6476. Content Updates
  6477. eFigures
  6478. eTables
  6479. Glossary
  6480. Key Points
  6481. Section 9 Problems of Urinary Function
  6482. Problems of Urinary Function
  6483. Pre-Test – Section 9
  6484. Interactive Review – Section 9
  6485. Chapter 45 Nursing Assessment: Urinary System
  6486. Learning Outcomes
  6487. Key Terms
  6488. Structures and Functions of Urinary System
  6489. Kidneys
  6490. Macrostructure.
  6491. FIG. 45-1 Organs of the urinary system. A, Upper urinary tract in relation to other anatomic structures. B, Male urethra in relation to other pelvic structures. C, Female urethra.
  6492. Microstructure.
  6493. FIG. 45-2 Longitudinal section of the kidney.
  6494. FIG. 45-3 The nephron is the basic functional unit of the kidney. This illustration of a single nephron unit also shows the surrounding blood vessels.
  6495. Blood Supply.
  6496. Physiology of Urine Formation.
  6497. Glomerular Function.
  6498. Tubular Function.
  6499. TABLE 45-1 FUNCTIONS OF NEPHRON SEGMENTS
  6500. FIG. 45-4 Renin-angiotensin-aldosterone system.
  6501. Other Functions of Kidneys.
  6502. Ureters
  6503. FIG. 45-5 Urinary bladder of a male.
  6504. Bladder
  6505. Urethra
  6506. Urethrovesical Unit
  6507. Gerontologic Considerations
  6508. Effects of Aging on Urinary System
  6509. TABLE 45-2 GERONTOLOGIC ASSESSMENT DIFFERENCES: Urinary System
  6510. Assessment of Urinary System
  6511. Subjective Data
  6512. Important Health Information
  6513. Past Health History.
  6514. Focused Assessment
  6515. Subjective
  6516. Objective: Diagnostic
  6517. Objective: Physical Examination
  6518. Inspect
  6519. Palpate
  6520. Percuss
  6521. Auscultate
  6522. Case Study Patient Introduction
  6523. Critical Thinking
  6524. TABLE 45-3 POTENTIALLY NEPHROTOXIC AGENTS
  6525. Medications.
  6526. Surgery or Other Treatments.
  6527. Functional Health Patterns.
  6528. TABLE 45-4 HEALTH HISTORY: Urinary System
  6529. Health Perception–Health Management Pattern.
  6530.  Genetic Risk Alert
  6531. Nutritional-Metabolic Pattern.
  6532. Elimination Pattern.
  6533. Case Study—cont’d
  6534. TABLE 45-5 MANIFESTATIONS OF URINARY SYSTEM DISORDERS
  6535. Activity-Exercise Pattern.
  6536. Sleep-Rest Pattern.
  6537. Cognitive-Perceptual Pattern.
  6538. Self-Perception–Self-Concept Pattern.
  6539. Role-Relationship Pattern.
  6540. Sexuality-Reproductive Pattern.
  6541. Objective Data
  6542. Physical Examination
  6543. Inspection.
  6544. Palpation.
  6545. Percussion.
  6546. FIG. 45-6 Palpating the right kidney.
  6547. Auscultation.
  6548. FIG. 45-7 Indirect fist percussion of the costovertebral angle (CVA). To assess the kidney, place one hand over the twelfth rib at the CVA on the back. Thump that hand with the ulnar edge of the other fist.
  6549. TABLE 45-6 NORMAL PHYSICAL ASSESSMENT OF URINARY SYSTEM
  6550. Case Study—cont’d
  6551. Diagnostic Studies of Urinary System
  6552. Case Study—cont’d
  6553. TABLE 45-7 ASSESSMENT ABNORMALITIES: Urinary System
  6554. TABLE 45-8 DIAGNOSTIC STUDIES: Urinary System
  6555. FIG. 45-8 Renal arteriogram showing stenosis of the right renal artery (arrow).
  6556. FIG. 45-9 Catheter insertion for a renal arteriogram.
  6557. FIG. 45-10 Cystoscopic examination of the bladder in a man. A, Flexible cystonephroscope. B, Scope inserted into bladder.
  6558. Urine Studies
  6559. Urinalysis.
  6560. Creatinine Clearance.
  6561. TABLE 45-9 DIAGNOSTIC STUDIES: Urinalysis
  6562. Urodynamic Studies
  6563. Bridge to NCLEX Examination
  6564. References
  6565. Resources
  6566. Pageburst Integrated Resources
  6567. Answer Keys
  6568. Concept Map Creator
  6569. Content Updates
  6570. Glossary
  6571. Key Points
  6572. Videos
  6573. Chapter 46 Nursing Management: Renal and Urologic Problems
  6574. Learning Outcomes
  6575. Key Terms
  6576. eTables
  6577. Infectious and Inflammatory Disorders of Urinary System
  6578. Urinary Tract Infection
  6579. TABLE 46-1 CAUSES OF URINARY TRACT INFECTIONS
  6580.  Cultural & Ethnic Health Disparities
  6581. Classification of Urinary Tract Infection
  6582. FIG. 46-1 Sites of infectious processes in the upper and lower urinary tracts.
  6583. Etiology and Pathophysiology
  6584. TABLE 46-2 RISK FACTORS FOR URINARY TRACT INFECTIONS
  6585. Clinical Manifestations
  6586. TABLE 46-3 LOWER URINARY TRACT SYMPTOMS (LUTS)
  6587. Diagnostic Studies
  6588. Collaborative Care
  6589. Drug Alert
  6590. TABLE 46-4 COLLABORATIVE CARE: Urinary Tract Infection
  6591. Nursing Management Urinary Tract Infection
  6592. Nursing Assessment
  6593. Nursing Diagnoses
  6594. TABLE 46-5 NURSING ASSESSMENT: Urinary Tract Infection
  6595. Planning
  6596. Nursing Implementation
  6597. Health Promotion.
  6598. Evidence-Based Practice Translating Research Into Practice
  6599. Do Cranberry Products Prevent Urinary Tract Infections?
  6600. Clinical Question
  6601. Best Available Evidence
  6602. Critical Appraisal and Synthesis of Evidence
  6603. Conclusion
  6604. Implications for Nursing Practice
  6605. Reference for Evidence
  6606. Acute Intervention.
  6607. Ambulatory and Home Care.
  6608. TABLE 46-6 PATIENT & CAREGIVER TEACHING GUIDE: Urinary Tract Infection
  6609. Evaluation
  6610. Acute Pyelonephritis
  6611. Etiology and Pathophysiology
  6612. FIG. 46-2 Acute pyelonephritis. Cortical surface shows grayish white areas of inflammation and abscess formation (arrows).
  6613. Clinical Manifestations and Diagnostic Studies
  6614. Collaborative Care
  6615. Nursing Management Acute Pyelonephritis
  6616. Nursing Assessment
  6617. TABLE 46-7 COLLABORATIVE CARE: Acute Pyelonephritis
  6618. Nursing Diagnoses
  6619. Planning
  6620. Nursing Implementation
  6621. Evaluation
  6622. Chronic Pyelonephritis
  6623. Urethritis
  6624. Urethral Diverticula
  6625. Interstitial Cystitis/Painful Bladder Syndrome
  6626. Clinical Manifestations and Diagnostic Studies
  6627. Collaborative Care
  6628. Nursing Management Interstitial Cystitis/Painful Bladder Syndrome
  6629. Renal Tuberculosis
  6630. Immunologic Disorders of Kidney
  6631. Glomerulonephritis
  6632. TABLE 46-8 CAUSES OR RISK FACTORS FOR GLOMERULONEPHRITIS
  6633. Acute Poststreptococcal Glomerulonephritis
  6634. Nursing and Collaborative Management Acute Poststreptococcal Glomerulonephritis
  6635. Goodpasture Syndrome
  6636. Rapidly Progressive Glomerulonephritis
  6637. Chronic Glomerulonephritis
  6638. Nephrotic Syndrome
  6639. Etiology and Clinical Manifestations
  6640. TABLE 46-9 CAUSES OF NEPHROTIC SYNDROME
  6641. Primary Glomerular Disease
  6642. Extrarenal Causes
  6643. Nursing and Collaborative Management Nephrotic Syndrome
  6644. Obstructive Uropathies
  6645. FIG. 46-3 Sites and causes of upper and lower urinary tract obstruction.
  6646. Urinary Tract Calculi
  6647. Etiology and Pathophysiology
  6648. FIG. 46-4 Hydronephrosis of the kidney. Note the marked dilation of the pelvis and calyces and thinning of the renal parenchyma.
  6649. FIG. 46-5 A, Renal staghorn calculus. The renal pelvis is filled with a large calculus that is shaped to its contours, resembling the horns of a stag (S). B, Imbedded staghorn calculus (arrow) in hydronephrotic, infected, nonfunctioning kidney.
  6650. Gender Differences
  6651. TABLE 46-10 RISK FACTORS FOR URINARY TRACT CALCULI
  6652. Types of Urinary Calculi
  6653. Clinical Manifestations
  6654. TABLE 46-11 TYPES OF URINARY TRACT CALCULI
  6655. Diagnostic Studies
  6656. Collaborative Care
  6657. FIG. 46-6 A, Calcium oxalate stones. B, Plain abdominal x-ray showing large bladder calculus.
  6658. Endourologic Procedures.
  6659. Lithotripsy.
  6660. Surgical Therapy.
  6661. TABLE 46-12 NUTRITIONAL THERAPY: Urinary Tract Calculi
  6662. Nutritional Therapy.
  6663. Nursing Management Urinary Tract Calculi
  6664. Nursing Assessment
  6665. TABLE 46-13 NURSING ASSESSMENT: Urinary Tract Calculi
  6666. Nursing Diagnoses
  6667. Planning
  6668. Nursing Implementation
  6669. Evaluation
  6670. Strictures
  6671. Ureteral Strictures
  6672. Urethral Strictures
  6673. Renal Trauma
  6674. Renal Vascular Problems
  6675. Nephrosclerosis
  6676. Renal Artery Stenosis
  6677. Renal Vein Thrombosis
  6678. Hereditary Kidney Diseases
  6679. Polycystic Kidney Disease
  6680.  Genetic Link
  6681.  Genetics In Clinical Practice
  6682. FIG. 46-7 A, Comparison of polycystic kidney with normal kidney. B, Cysts in the liver.
  6683. Nursing and Collaborative Management Polycystic Kidney Disease
  6684. Medullary Cystic Disease
  6685. Alport Syndrome
  6686. Urinary Tract Tumors
  6687. Kidney Cancer
  6688. Clinical Manifestations and Diagnostic Studies
  6689. FIG. 46-8 Cross section of kidney with renal cell carcinoma. The carcinoma (black arrow) is on the pole of the kidney. Note that the renal vein is involved and thrombosed (white arrow).
  6690. Nursing and Collaborative Management Kidney Cancer
  6691. TABLE 46-14 COLLABORATIVE CARE: Renal Cell Carcinoma
  6692. Bladder Cancer
  6693. FIG. 46-9 A, Papillary transitional cell carcinoma (T) seen arising from the dome of the bladder as a cauliflower-like lesion (arrow). B, Opened bladder showing bladder cancer at an advanced stage. Yellow areas represent ulcerations and necrosis (arrows).
  6694. Clinical Manifestations and Diagnostic Studies
  6695. Nursing and Collaborative Management Bladder Cancer
  6696. Surgical Therapy
  6697. TABLE 46-15 COLLABORATIVE CARE: Bladder Cancer
  6698. Radiation Therapy and Chemotherapy
  6699. Intravesical Therapy
  6700. Gender Differences
  6701. Bladder Dysfunction
  6702. Urinary Incontinence
  6703. Etiology and Pathophysiology
  6704. TABLE 46-16 DRUG THERAPY: Drugs Affecting Lower Urinary Tract Function
  6705. Diagnostic Studies
  6706.  Complementary & Alternative Therapies
  6707. Scientific Evidence
  6708. Nursing Implications
  6709. Collaborative Care
  6710. Drug Therapy.
  6711. TABLE 46-17 TYPES OF URINARY INCONTINENCE
  6712. Drug Alert
  6713. Surgical Therapy.
  6714. Nursing Management Urinary Incontinence
  6715. TABLE 46-18 INTERVENTIONS FOR URINARY INCONTINENCE
  6716. TABLE 46-19 PATIENT TEACHING GUIDE: Pelvic Floor Muscle (Kegel) Exercises
  6717. Urinary Retention
  6718. TABLE 46-20 DRUG THERAPY: Voiding Dysfunction*
  6719. Delegation Decisions Caring for the Incontinent Patient
  6720. Role of Registered Nurse (RN)
  6721. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  6722. Role of Unlicensed Assistive Personnel (UAP)
  6723. Etiology and Pathophysiology
  6724. Diagnostic Studies
  6725. Collaborative Care
  6726. Drug Therapy.
  6727. Surgical Therapy.
  6728. Nursing Management Urinary Retention
  6729. TABLE 46-21 INDICATIONS FOR URINARY CATHETERIZATION
  6730. Catheterization
  6731. Indications for and Complications of Catheterization
  6732. FIG. 46-10 Types of urinary catheters. A, Simple urethral catheter. B, Mushroom-tip de Pezzer catheter (can be for suprapubic catheterization). C, Wing-tip Malecot catheter. D, Indwelling urethral catheter with inflated balloon. E, Indwelling Tiemann catheter with coudé-tip–inflated balloon. F, Three-way indwelling catheter (third lumen can be used for irrigation).
  6733. Catheter Construction
  6734. Types of Catheters
  6735. Urethral Catheters
  6736. Delegation Decisions Urinary Catheters
  6737. Role of Registered Nurse (RN)
  6738. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  6739. Role of Unlicensed Assistive Personnel (UAP)
  6740. Ureteral Catheters
  6741. Suprapubic Catheters
  6742. Nephrostomy Tubes
  6743. Intermittent Catheterization
  6744. Surgery of the Urinary Tract
  6745. Renal and Ureteral Surgery
  6746. Surgical Procedure
  6747. Laparoscopic Nephrectomy.
  6748. Preoperative Management
  6749. Postoperative Management
  6750. Urine Output.
  6751. Respiratory Status.
  6752. Abdominal Distention.
  6753. Urinary Diversion
  6754. Incontinent Urinary Diversion
  6755. Continent Urinary Diversions
  6756. TABLE 46-22 URINARY DIVERSION SURGERY
  6757. FIG. 46-11 Methods of urinary diversion. A, Ureteroileosigmoidostomy. B, Ileal loop (ileal conduit). C, Ureterostomy (transcutaneous ureterostomy and bilateral cutaneous ureterostomies). D, Nephrostomy.
  6758. FIG. 46-12 Urinary stoma. Symmetric, no skin breakdown, protrudes about 1.5 cm. Mucosa is healthy red. This configuration is flat when the patient is upright or supine.
  6759. FIG. 46-13 Creation of a Kock pouch with implantation of ureters into one intussuscepted portion of the pouch and creation of a stoma with the other intussuscepted portion.
  6760. Orthotopic Bladder Reconstruction
  6761. Nursing Management Urinary Diversion
  6762. Preoperative Management
  6763. Postoperative Management
  6764. TABLE 46-23 PATIENT & CAREGIVER TEACHING GUIDE: Ileal Conduit Appliances
  6765. FIG. 46-14 Ammonia salt encrustation secondary to alkaline urine.
  6766. FIG. 46-15 Retracted urinary stoma with pressure sore from faceplate above stoma (arrow).
  6767. Case Study Urinary Tract Infection
  6768. Patient Profile
  6769. Subjective Data
  6770. Objective Data
  6771. Physical Examination
  6772. Diagnostic Studies
  6773. Discussion Questions
  6774. Bridge to NCLEX Examination
  6775. References
  6776. Resources
  6777. Pageburst Integrated Resources
  6778. Answer Keys
  6779. Care Plans
  6780. Case Studies
  6781. Concept Map Creator
  6782. Content Updates
  6783. eTables
  6784. Glossary
  6785. Key Points
  6786. Chapter 47 Nursing Management: Acute Kidney Injury and Chronic Kidney Disease
  6787. Learning Outcomes
  6788. Key Terms
  6789. eTables
  6790. Acute Kidney Injury
  6791. TABLE 47-1 COMPARISON OF ACUTE KIDNEY INJURY AND CHRONIC KIDNEY DISEASE
  6792. TABLE 47-2 COMMON CAUSES OF ACUTE KIDNEY INJURY
  6793. Hypovolemia
  6794. Decreased Cardiac Output
  6795. Decreased Peripheral Vascular Resistance
  6796. Decreased Renovascular Blood Flow
  6797. Nephrotoxic Injury
  6798. Interstitial Nephritis
  6799. Other Causes
  6800. Etiology and Pathophysiology
  6801. Prerenal.
  6802. Intrarenal.
  6803. FIG. 47-1 Acute tubular necrosis. The kidneys are swollen and pale.
  6804. Postrenal.
  6805. Clinical Manifestations
  6806. TABLE 47-3 RIFLE CLASSIFICATION FOR STAGING ACUTE KIDNEY INJURY
  6807. Oliguric Phase.
  6808. Urinary Changes.
  6809. Fluid Volume.
  6810. Metabolic Acidosis.
  6811. Sodium Balance.
  6812. Potassium Excess.
  6813. Hematologic Disorders.
  6814. Waste Product Accumulation.
  6815. Neurologic Disorders.
  6816. Diuretic Phase.
  6817. Recovery Phase.
  6818. Diagnostic Studies
  6819. TABLE 47-4 COLLABORATIVE CARE: Acute Kidney Injury
  6820. Diagnostic
  6821. Collaborative Therapy
  6822. Collaborative Care
  6823. TABLE 47-5 THERAPIES FOR ELEVATED POTASSIUM LEVELS
  6824. Nutritional Therapy.
  6825. Nursing Management Acute Kidney Injury
  6826. Nursing Assessment
  6827. Nursing Diagnoses
  6828. Planning
  6829. Nursing Implementation
  6830. Health Promotion.
  6831. Acute Intervention.
  6832. Informatics in Practice Computer Monitoring of Antibiotic Safety
  6833. Ambulatory And Home Care.
  6834. Evaluation
  6835. Gerontologic Considerations
  6836. Acute Kidney Injury
  6837. Chronic Kidney Disease
  6838. TABLE 47-6 STAGES OF CHRONIC KIDNEY DISEASE
  6839. Clinical Manifestations
  6840.  Cultural & Ethnic Health Disparities
  6841. African Americans
  6842. Native Americans
  6843. Hispanics
  6844. Urinary System.
  6845. Metabolic Disturbances
  6846. Waste Product Accumulation.
  6847. Altered Carbohydrate Metabolism.
  6848. FIG. 47-2 Possible clinical manifestations of chronic kidney disease.
  6849. Elevated Triglycerides.
  6850. Electrolyte and Acid-Base Imbalances
  6851. Potassium.
  6852. Sodium.
  6853. Calcium and Phosphate.
  6854. Magnesium.
  6855. Metabolic Acidosis.
  6856. Hematologic System
  6857. Anemia.
  6858. Bleeding Tendencies.
  6859. Infection.
  6860. Cardiovascular System.
  6861. Respiratory System.
  6862. Gastrointestinal System.
  6863. Neurologic System.
  6864. Musculoskeletal System.
  6865. FIG. 47-3 Mechanisms of chronic kidney disease mineral and bone disorder (CKD-MBD). GFR, Glomerular filtration rate; PTH, parathyroid hormone.
  6866. Integumentary System.
  6867. Reproductive System.
  6868. Psychologic Changes.
  6869. Diagnostic Studies
  6870. TABLE 47-7 COLLABORATIVE CARE: Chronic Kidney Disease
  6871. Diagnostic
  6872. Collaborative Therapy
  6873. Collaborative Care
  6874. TABLE 47-8 INDICATORS OF KIDNEY FUNCTION
  6875. TABLE 47-9 RISK FACTORS FOR CHRONIC KIDNEY DISEASE
  6876. Drug Therapy
  6877. Hyperkalemia.
  6878. Hypertension.
  6879. Evidence-Based Practice Translating Research Into Practice
  6880. Can Exercise Improve Physical Fitness in Chronic Kidney Disease?
  6881. Clinical Question
  6882. Best Available Evidence
  6883. Critical Appraisal and Synthesis of Evidence
  6884. Conclusion
  6885. Implications for Nursing Practice
  6886. Reference for Evidence
  6887. CKD-MBD.
  6888. Anemia.
  6889. Dyslipidemia.
  6890. Complications of Drug Therapy.
  6891. Nutritional Therapy
  6892. Protein Restriction.
  6893. TABLE 47-10 NUTRITIONAL THERAPY: Chronic Kidney Disease*
  6894. Water Restriction.
  6895. Sodium and Potassium Restriction.
  6896. Phosphate Restriction.
  6897. Nursing Management Chronic Kidney Disease
  6898. Nursing Assessment
  6899. TABLE 47-11 NUTRITIONAL THERAPY: High-Potassium Foods*
  6900. Nursing Diagnoses
  6901. Planning
  6902. Nursing Implementation
  6903. Health Promotion.
  6904. Acute Intervention.
  6905. Ambulatory And Home Care.
  6906. Healthy People
  6907. TABLE 47-12 PATIENT & CAREGIVER TEACHING GUIDE: Chronic Kidney Disease
  6908. Evaluation
  6909. Dialysis
  6910. TABLE 47-13 COMPARISON OF PERITONEAL DIALYSIS AND HEMODIALYSIS
  6911. General Principles of Dialysis
  6912. FIG. 47-4 Osmosis and diffusion across a semipermeable membrane.
  6913. Peritoneal Dialysis
  6914. Catheter Placement
  6915. FIG. 47-5 Peritoneal dialysis showing peritoneal catheter inserted into peritoneal cavity.
  6916. Dialysis Solutions and Cycles
  6917. FIG. 47-6 Peritoneal catheter exit site.
  6918. Peritoneal Dialysis Systems
  6919. Automated Peritoneal Dialysis.
  6920. Continuous Ambulatory Peritoneal Dialysis.
  6921. Complications of Peritoneal Dialysis
  6922. Exit Site Infection.
  6923. FIG. 47-7 Automated peritoneal dialysis that can be used while the patient is sleeping.
  6924. Peritonitis.
  6925. Hernias.
  6926. Lower Back Problems.
  6927. Bleeding.
  6928. Pulmonary Complications.
  6929. Protein Loss.
  6930. Effectiveness of Chronic Peritoneal Dialysis
  6931. Hemodialysis
  6932. Vascular Access
  6933. Arteriovenous Fistulas and Grafts.
  6934. FIG. 47-8 Vascular access for hemodialysis. A, Arteriovenous fistula. B, Arteriovenous graft.
  6935. Temporary Vascular Access.
  6936. FIG. 47-9 Arteriovenous fistula created by anastomosing an artery and a vein.
  6937. FIG. 47-10 Temporary double-lumen vascular access catheter for acute hemodialysis. A, Soft, flexible double-lumen tube is attached to a Y hub. B, The distance between the arterial intake lumen and the venous return lumen typically provides recirculation rates of 5% or less.
  6938. Dialyzers.
  6939. Procedure for Hemodialysis
  6940. FIG. 47-11 A, Right internal jugular placement for a tunneled, cuffed semipermanent catheter. B, Temporary hemodialysis catheter in place. C, Long-term cuffed hemodialysis catheter.
  6941. FIG. 47-12 Components of a hemodialysis system. Blood is removed via a needle inserted in a fistula or via catheter lumen. It is propelled to the dialyzer by a blood pump. Heparin is infused either as a bolus predialysis or through a heparin pump continuously to prevent clotting. Dialysate is pumped in and flows in the opposite direction of the blood. The dialyzed blood is returned to the patient through a second needle or catheter lumen. Old dialysate and ultrafiltrate are drained and discarded.
  6942. Settings and Schedules for Hemodialysis.
  6943. Complications of Hemodialysis
  6944. Hypotension.
  6945. FIG. 47-13 Home hemodialysis is growing in popularity, and machines are more compact.
  6946. Muscle Cramps.
  6947. Loss of Blood.
  6948. Hepatitis.
  6949. Effectiveness of Hemodialysis
  6950. Continuous Renal Replacement Therapy
  6951. TABLE 47-14 CONTINUOUS RENAL REPLACEMENT THERAPIES
  6952. FIG. 47-14 Basic schematic of continuous venovenous therapies. Blood pump is required to pump blood through the circuit. Replacement ports are used for instilling replacement fluids and can be given prefilter or postfilter. Dialysate port is used for infusing dialysis solution. Regardless of modality, ultrafiltrate is drained via the ultrafiltration drain port.
  6953. Kidney Transplantation
  6954. Recipient Selection
  6955. Histocompatibility Studies
  6956. Donor Sources
  6957. Ethical/Legal Dilemmas Allocation of Resources
  6958. Situation
  6959. Ethical/Legal Points for Consideration
  6960. Discussion Questions
  6961. Live Donors.
  6962. Deceased Donors.
  6963. Surgical Procedure
  6964. Live Donor.
  6965. Kidney Transplant Recipient.
  6966. FIG. 47-15 A, Surgical incision for a renal transplant. B, Surgical placement of transplanted kidney.
  6967. Nursing Management Kidney Transplant Recipient
  6968. Preoperative Care
  6969. Postoperative Care
  6970. Live Donor.
  6971. Kidney Transplant Recipient.
  6972. Immunosuppressive Therapy
  6973. Complications of Transplantation
  6974. Rejection.
  6975. Infection.
  6976. TABLE 47-15 COMPLICATIONS OF DIALYSIS AND TRANSPLANTATION
  6977. Cardiovascular Disease.
  6978. Malignancies.
  6979. Recurrence of Original Kidney Disease.
  6980. Corticosteroid-Related Complications.
  6981. Gerontologic Considerations
  6982. Chronic Kidney Disease
  6983. Ethical/Legal Dilemmas Withdrawing Treatment
  6984. Situation
  6985. Ethical/Legal Points for Consideration
  6986. Discussion Questions
  6987. Case Study Chronic Kidney Disease
  6988. Patient Profile
  6989. Subjective Data
  6990. Objective Data
  6991. Laboratory Data
  6992. Physical Examination
  6993. Discussion Questions
  6994. Bridge to NCLEX Examination
  6995. References
  6996. Resources
  6997. Case Study Managing Multiple Patients
  6998. Introduction
  6999. Patients
  7000. Management Discussion Questions
  7001. Case Study Progression
  7002. Pageburst Integrated Resources
  7003. Answer Keys
  7004. Care Plans
  7005. Case Studies
  7006. Concept Map Creator
  7007. Content Updates
  7008. eTables
  7009. Glossary
  7010. Key Points
  7011. Section 10 Problems Related to Regulatory and Reproductive Mechanisms
  7012. Problems Related to Regulatory and Reproductive Mechanisms
  7013. Pre-Test – Section 10
  7014. Interactive Review – Section 10
  7015. Chapter 48 Nursing Assessment: Endocrine System
  7016. Learning Outcomes
  7017. Key Terms
  7018. eFigure
  7019. Structures and Functions of Endocrine System
  7020. Glands
  7021. Hormones
  7022. FIG. 48-1 Location of the major endocrine glands. The parathyroid glands lie on the posterior surface of the thyroid gland.
  7023. Hormone Receptors.
  7024. Lipid-Soluble and Water-Soluble Hormones.
  7025. FIG. 48-2 The target cell concept. Hormones act only on cells that have receptors specific to that hormone, since the shape of the receptor determines which hormone can react with it. This is an example of the lock-and-key model of biochemical reactions.
  7026. FIG. 48-3 A, Lipid-soluble hormones (e.g., steroid hormones) penetrate the cell membrane and interact with intracellular receptors. B, Water-soluble hormones (e.g., protein hormones) bind to receptors located in the cell membrane. The hormone-receptor interaction stimulates various cell responses.
  7027. TABLE 48-1 ENDOCRINE GLANDS AND HORMONES
  7028. Regulation of Hormonal Secretion.
  7029. Simple Feedback.
  7030. Nervous System Control.
  7031. FIG. 48-4 Feedback mechanism between parathyroid hormone (PTH) and calcium.
  7032. Rhythms.
  7033. Hypothalamus
  7034. Pituitary
  7035. FIG. 48-5 Circadian rhythm of cortisol secretion.
  7036. Anterior Pituitary.
  7037. TABLE 48-2 HORMONES OF THE HYPOTHALAMUS
  7038. Posterior Pituitary.
  7039. FIG. 48-6 Relationship between the hypothalamus, pituitary, and target organs. The hypothalamus communicates with the anterior pituitary via a capillary system and with the posterior pituitary via nerve tracts. The anterior and posterior pituitary hormones are shown with their target tissues. FSH, Follicle-stimulating hormone; LH, luteinizing hormone.
  7040. FIG. 48-7 Relationship of plasma osmolality to antidiuretic hormone (ADH) release and action.
  7041. Pineal Gland
  7042. Thyroid Gland
  7043. Thyroxine and Triiodothyronine.
  7044. FIG. 48-8 Thyroid and parathyroid glands. Note the surrounding structures.
  7045. Calcitonin.
  7046. Parathyroid Glands
  7047. Parathyroid Hormone.
  7048. FIG. 48-9 The adrenal gland is composed of the adrenal cortex and the adrenal medulla.
  7049. Adrenal Glands
  7050. Adrenal Medulla.
  7051. Adrenal Cortex.
  7052. Cortisol.
  7053. Aldosterone.
  7054. Adrenal Androgens.
  7055. Pancreas
  7056. Glucagon.
  7057. Insulin.
  7058. Gerontologic Considerations
  7059. Effects of Aging on Endocrine System
  7060. TABLE 48-3 GERONTOLOGIC ASSESSMENT DIFFERENCES: Endocrine System
  7061. Assessment of Endocrine System
  7062. Subjective Data
  7063. Important Health Information
  7064. Past Health History.
  7065. Case Study Patient Introduction
  7066. Critical Thinking
  7067. TABLE 48-4 HEALTH HISTORY: Endocrine System
  7068. Medications.
  7069. Surgery or Other Treatments.
  7070. Functional Health Patterns.
  7071. Health Perception–Health Management Pattern.
  7072.  Genetic Risk Alert
  7073. Pituitary
  7074. Thyroid
  7075. Multiple Endocrine Neoplasia
  7076. Diabetes Mellitus
  7077. Nutritional-Metabolic Pattern.
  7078. Elimination Pattern.
  7079. Case Study—cont’d
  7080. Activity-Exercise Pattern.
  7081. Sleep-Rest Pattern.
  7082. Cognitive-Perceptual Pattern.
  7083. Self-Perception–Self-Concept Pattern.
  7084. Role-Relationship Pattern.
  7085. Sexuality-Reproductive Pattern.
  7086. Coping–Stress Tolerance Pattern.
  7087. Value-Belief Pattern.
  7088. Objective Data
  7089. Physical Examination.
  7090. Integument.
  7091. Head.
  7092. Neck.
  7093. FIG. 48-10 Posterior palpation of the thyroid gland.
  7094. Thorax.
  7095. Case Study—cont’d
  7096. Focused Assessment
  7097. Subjective
  7098. Objective: Diagnostic
  7099. Objective: Physical Examination
  7100. Inspect/Measure
  7101. Auscultate
  7102. Palpate
  7103. Abdomen.
  7104. Extremities.
  7105. Genitalia.
  7106. Diagnostic Studies of Endocrine System
  7107. TABLE 48-5 ASSESSMENT ABNORMALITIES: Endocrine System
  7108. TABLE 48-6 DIAGNOSTIC STUDIES: Endocrine System
  7109. Case Study—cont’d
  7110. Bridge to NCLEX Examination
  7111. References
  7112. Resources
  7113. Pageburst Integrated Resources
  7114. Answer Keys
  7115. Concept Map Creator
  7116. Content Updates
  7117. eFigures
  7118. Glossary
  7119. Key Points
  7120. Videos
  7121. Chapter 49 Nursing Management: Diabetes Mellitus
  7122. Learning Outcomes
  7123. Key Terms
  7124. eFigure
  7125. eTable
  7126. Diabetes Mellitus
  7127. Etiology and Pathophysiology
  7128. Normal Insulin Metabolism.
  7129. FIG. 49-1 Normal endogenous insulin secretion. In the first hour or two after meals, insulin concentrations rise rapidly in blood and peak at about 1 hour. After meals, insulin concentrations promptly decline toward preprandial values as carbohydrate absorption from the gastrointestinal tract declines. After carbohydrate absorption from the gastrointestinal tract is complete and during the night, insulin concentrations are low and fairly constant, with a slight increase at dawn.
  7130. TABLE 49-1 COMPARISON OF TYPE 1 AND TYPE 2 DIABETES MELLITUS
  7131. Type 1 Diabetes Mellitus.
  7132. Etiology and Pathophysiology.
  7133.  Genetic Link
  7134. FIG. 49-2 Altered mechanisms in type 1 and type 2 diabetes mellitus.
  7135.  Genetics in Clinical Practice
  7136. Onset of Disease.
  7137. Type 2 Diabetes Mellitus.
  7138. Etiology and Pathophysiology.
  7139.  Genetic Link
  7140. Onset of Disease.
  7141. Prediabetes.
  7142. Gestational Diabetes.
  7143. Other Specific Types of Diabetes.
  7144. Clinical Manifestations
  7145. Type 1 Diabetes Mellitus.
  7146. Type 2 Diabetes Mellitus.
  7147. Diagnostic Studies
  7148. Collaborative Care
  7149. TABLE 49-2 COLLABORATIVE CARE: Diabetes Mellitus
  7150. Drug Therapy: Insulin
  7151. Types of Insulin.
  7152. Insulin Regimens.
  7153. TABLE 49-3 DRUG THERAPY: Types of Insulin
  7154. FIG. 49-3 Commercially available insulin preparations showing onset, peak, and duration of action. Individual patient responses to each type of insulin are different and affected by many different factors.
  7155. TABLE 49-4 DRUG THERAPY: Insulin Regimens
  7156. Mealtime Insulin (Bolus).
  7157. Long- or Intermediate-Acting (Basal) Background Insulin.
  7158. Combination Insulin Therapy.
  7159. Storage of Insulin.
  7160. Administration of Insulin.
  7161. Insulin Injection.
  7162. TABLE 49-5 PATIENT & CAREGIVER TEACHING GUIDE: Insulin Therapy
  7163. FIG. 49-4 Mixing insulins. This step-order process avoids the problem of contaminating regular insulin with intermediate-acting insulin.
  7164. FIG. 49-5 Injection sites for insulin.
  7165. Insulin Pump.
  7166. FIG. 49-6 Parts of insulin pen.
  7167. FIG. 49-7 A, OmniPod Insulin Management System. The Pod holds and delivers insulin. B, The Personal Diabetes Manager (PDM) wirelessly programs insulin delivery via the Pod. The PDM has a built-in glucose meter.
  7168. Problems With Insulin Therapy.
  7169. TABLE 49-6 ASSESSING THE PATIENT TREATED WITH GLUCOSE-LOWERING AGENTS
  7170. Allergic Reactions.
  7171. Lipodystrophy.
  7172. Somogyi Effect and Dawn Phenomenon.
  7173. Drug Therapy: Oral and Noninsulin Injectable Agents
  7174. Biguanides.
  7175. Drug Alert
  7176. Sulfonylureas.
  7177. Meglitinides.
  7178. α-Glucosidase Inhibitors.
  7179. Thiazolidinediones.
  7180. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors.
  7181. TABLE 49-7 DRUG THERAPY: Oral Agents and Noninsulin Injectable Agents
  7182. Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors.
  7183. Dopamine Receptor Agonist.
  7184. Combination Oral Therapy.
  7185. Glucagon-Like Peptide Receptor Agonists.
  7186. Drug Alert
  7187. Drug Alert
  7188. Amylin Analog.
  7189. Drug Alert
  7190. Other Drugs Affecting Blood Glucose Levels.
  7191. Nutritional Therapy
  7192. TABLE 49-8 NUTRITIONAL THERAPY: Diabetes Mellitus
  7193. Type 1 Diabetes Mellitus.
  7194. Type 2 Diabetes Mellitus.
  7195. Food Composition.
  7196. Carbohydrates.
  7197. Fats.
  7198. Protein.
  7199. Alcohol.
  7200. Patient Teaching Related to Nutritional Therapy.
  7201. Exercise
  7202. TABLE 49-9 ACTIVITIES THAT AFFECT CALORIC EXPENDITURE
  7203. Monitoring Blood Glucose
  7204. TABLE 49-10 PATIENT & CAREGIVER TEACHING GUIDE: Exercise for Patients With Diabetes Mellitus
  7205. FIG. 49-8 Blood glucose monitors are used to measure blood glucose levels. Medtronic OneTouch UltraLink glucose meter.
  7206. FIG. 49-9 The MiniMed Paradigm® REAL-Time Revel™ Insulin Pump (A) delivers insulin through a thin plastic tubing to an infusion set, which has a cannula (B) that sits under the skin. Continuous glucose monitoring occurs through a tiny sensor (C) inserted under the skin. Sensor data are sent continuously to the insulin pump through wireless technology giving a more complete picture of glucose levels, which can lead to better treatment decisions and better glucose control.
  7207. TABLE 49-11 PATIENT & CAREGIVER TEACHING GUIDE: Self-Monitoring of Blood Glucose (SMBG)
  7208. Bariatric Surgery
  7209. Pancreas Transplantation
  7210. Evidence-Based Practice Translating Research Into Practice
  7211. Bariatric Surgery for Obese Adults With Type 2 Diabetes
  7212. Clinical Question
  7213. Best Available Evidence
  7214. Critical Appraisal and Synthesis of Evidence
  7215. Conclusion
  7216. Implications for Nursing Practice
  7217. Reference for Evidence
  7218. Culturally Competent Care
  7219. Diabetes Mellitus
  7220.  Cultural & Ethnic Health Disparities
  7221. Nursing Management Diabetes Mellitus
  7222. Nursing Assessment
  7223. Nursing Diagnoses
  7224. Planning
  7225. Nursing Implementation
  7226. Health Promotion.
  7227. TABLE 49-12 NURSING ASSESSMENT: Diabetes Mellitus
  7228. TABLE 49-13 TESTING FOR DIABETES IN ASYMPTOMATIC, UNDIAGNOSED INDIVIDUALS
  7229. Healthy People
  7230. Acute Intervention.
  7231. Stress of Acute Illness and Surgery.
  7232. Ambulatory and Home Care.
  7233. Insulin Therapy.
  7234. Oral and Noninsulin Injectable Agents.
  7235. Personal Hygiene.
  7236. Medical Identification and Travel.
  7237. FIG. 49-10 Medical alerts. A patient with diabetes should carry a card and wear a bracelet or necklace that indicates diabetes. If the patient with diabetes is unconscious, these measures will ensure prompt and appropriate attention.
  7238. Patient and Caregiver Teaching.
  7239.  Complementary & Alternative Therapies
  7240. Scientific Evidence*
  7241. Nursing Implications
  7242. Informatics in Practice Patient Teaching Using Gaming
  7243. Evaluation
  7244. TABLE 49-14 PATIENT & CAREGIVER TEACHING GUIDE: Management of Diabetes Mellitus
  7245. Acute Complications of Diabetes Mellitus
  7246. TABLE 49-15 PATIENT & CAREGIVER TEACHING GUIDE: Instructions for Patients With Diabetes Mellitus
  7247. TABLE 49-16 COMPARISON OF HYPERGLYCEMIA AND HYPOGLYCEMIA
  7248. Diabetic Ketoacidosis
  7249. Etiology and Pathophysiology
  7250. Clinical Manifestations
  7251. Collaborative Care
  7252. TABLE 49-17 COLLABORATIVE CARE: Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic Syndrome (HHS)
  7253. FIG. 49-11 Metabolic events leading to diabetic ketoacidosis.
  7254.  TABLE 49-18 EMERGENCY MANAGEMENT Diabetic Ketoacidosis
  7255. Safety Alert
  7256. Hyperosmolar Hyperglycemic Syndrome
  7257. FIG. 49-12 Pathophysiology of hyperosmolar hyperglycemic syndrome.
  7258. Collaborative Care
  7259. Nursing Management Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome
  7260. Hypoglycemia
  7261. Nursing and Collaborative Management Hypoglycemia
  7262. TABLE 49-19 COLLABORATIVE CARE: Hypoglycemia
  7263. Chronic Complications of Diabetes Mellitus
  7264. Angiopathy
  7265. FIG. 49-13 Long-term complications of diabetes mellitus.
  7266. Macrovascular Complications
  7267. TABLE 49-20 MONITORING FOR LONG-TERM COMPLICATIONS OF DIABETES MELLITUS
  7268. Microvascular Complications
  7269. Diabetic Retinopathy
  7270. Etiology and Pathophysiology
  7271. Collaborative Care
  7272. Nephropathy
  7273. Neuropathy
  7274. Etiology and Pathophysiology
  7275. Classification
  7276. Sensory Neuropathy.
  7277. FIG. 49-14 Neuropathy: neurotrophic ulceration.
  7278. Autonomic Neuropathy.
  7279. FIG. 49-15 The necrotic toe developed as a complication of diabetes. A, Before amputation. B, After amputation.
  7280. Complications of Feet and Lower Extremities
  7281. TABLE 49-21 PATIENT & CAREGIVER TEACHING GUIDE*Foot Care
  7282. Integumentary Complications
  7283. Infection
  7284. FIG. 49-16 Necrobiosis lipoidica diabeticorum.
  7285. Psychologic Considerations
  7286. Delegation Decisions Caring for the Patient With Diabetes Mellitus
  7287. Role of Registered Nurse (RN)
  7288. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  7289. Role of Unlicensed Assistive Personnel (UAP)
  7290. Ethical/Legal Dilemmas Durable Power of Attorney for Health Care
  7291. Situation
  7292. Ethical/Legal Points for Consideration
  7293. Discussion Questions
  7294. Gerontologic Considerations
  7295. Diabetes Mellitus
  7296. Case Study Diabetic Ketoacidosis
  7297. Patient Profile
  7298. Subjective Data (Provided by Wife)
  7299. Objective Data
  7300. Physical Examination
  7301. Diagnostic Studies
  7302. Discussion Questions
  7303. Bridge to NCLEX Examination
  7304. References
  7305. Resources
  7306. Pageburst Integrated Resources
  7307. Answer Keys
  7308. Care Plans
  7309. Case Studies
  7310. Concept Map
  7311. Concept Map Creator
  7312. Content Updates
  7313. eFigures
  7314. eTables
  7315. Glossary
  7316. Key Points
  7317. Chapter 50 Nursing Management: Endocrine Problems
  7318. Learning Outcomes
  7319. Key Terms
  7320. eFigures
  7321. Disorders of Anterior Pituitary Gland
  7322. Acromegaly
  7323. Etiology and Pathophysiology
  7324. Clinical Manifestations
  7325. FIG. 50-1 Progressive development of facial changes associated with acromegaly.
  7326. Gender Differences
  7327. Diagnostic Studies
  7328. Collaborative Care
  7329. Surgical Therapy.
  7330. FIG. 50-2 Surgery on the pituitary gland is most commonly performed with the transsphenoidal approach. An incision is made in the inner aspect of the upper lip and gingiva. The sella turcica is entered through the floor of the nose and sphenoid sinuses.
  7331. Radiation Therapy.
  7332. Drug Therapy.
  7333. Nursing Management Acromegaly
  7334. Nursing Assessment
  7335. Nursing Implementation
  7336. Excesses of Other Tropic Hormones
  7337. Hypofunction of Pituitary Gland
  7338. Etiology and Pathophysiology
  7339. Clinical Manifestations and Diagnostic Studies
  7340. TABLE 50-1 CLINICAL MANIFESTATIONS OF HYPOPITUITARISM
  7341. Nursing and Collaborative Management Hypopituitarism
  7342. FIG. 50-3 Pathophysiology of syndrome of inappropriate antidiuretic hormone (SIADH).
  7343. Disorders of Posterior Pituitary Gland
  7344. Syndrome of Inappropriate Antidiuretic Hormone
  7345. Etiology and Pathophysiology
  7346. Clinical Manifestations and Diagnostic Studies
  7347. TABLE 50-2 CAUSES OF SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE
  7348. Malignant Tumors
  7349. Central Nervous System Disorders
  7350. Drug Therapy
  7351. Miscellaneous Conditions
  7352. Nursing and Collaborative Management Syndrome of Inappropriate Antidiuretic Hormone
  7353. Diabetes Insipidus
  7354. Etiology and Pathophysiology
  7355. FIG. 50-4 Pathophysiology of diabetes insipidus (DI).
  7356. TABLE 50-3 TYPES OF DIABETES INSIPIDUS
  7357. Clinical Manifestations
  7358. Diagnostic Studies
  7359. Nursing and Collaborative Management Diabetes Insipidus
  7360. FIG. 50-5 Continuum of thyroid dysfunction.
  7361. Disorders of Thyroid Gland
  7362. Goiter
  7363. TABLE 50-4 GOITROGENS
  7364. Thyroid Inhibitors
  7365. Other Drugs
  7366. Foods*
  7367. FIG. 50-6 Exophthalmos and goiter of Graves’ disease.
  7368. Thyroiditis
  7369. Hyperthyroidism
  7370. Etiology and Pathophysiology
  7371. Graves’ Disease.
  7372. TABLE 50-5 CLINICAL MANIFESTATIONS OF THYROID DYSFUNCTION
  7373. Clinical Manifestations
  7374. Complications
  7375. TABLE 50-6 LABORATORY RESULTS FOR HYPERTHYROID AND HYPOTHYROID PATIENTS
  7376. Diagnostic Studies
  7377. TABLE 50-7 COMPARISON OF HYPERTHYROIDISM IN YOUNGER AND OLDER ADULTS
  7378. FIG. 50-7 Thyroid acropachy. Digital clubbing and swelling of fingers.
  7379. Collaborative Care
  7380. Drug Therapy.
  7381. Antithyroid Drugs.
  7382. TABLE 50-8 COLLABORATIVE CARE: Hyperthyroidism
  7383. Diagnostic
  7384. Collaborative Therapy
  7385. Iodine.
  7386. β-Adrenergic Blockers.
  7387. Radioactive Iodine Therapy.
  7388. FIG. 50-8 Subtotal thyroidectomy. Part of the thyroid gland is removed.
  7389. Surgical Therapy.
  7390. Nutritional Therapy.
  7391. Nursing Management Hyperthyroidism
  7392. Nursing Assessment
  7393. TABLE 50-9 NURSING ASSESSMENT: Hyperthyroidism
  7394. Nursing Diagnoses
  7395. Planning
  7396. Nursing Implementation
  7397. Acute Intervention.
  7398. Acute Thyrotoxicosis.
  7399. Thyroid Surgery.
  7400. Postoperative Care.
  7401. Safety Alert
  7402. Ambulatory and Home Care.
  7403. Evaluation
  7404. Hypothyroidism
  7405. Etiology and Pathophysiology
  7406. Clinical Manifestations
  7407. FIG. 50-9 Common features of myxedema. Dull, puffy skin; coarse, sparse hair; periorbital edema; and prominent tongue.
  7408. TABLE 50-10 COLLABORATIVE CARE: Hypothyroidism
  7409. Diagnostic
  7410. Collaborative Therapy
  7411. Complications
  7412. Diagnostic Studies
  7413. Collaborative Care
  7414. Drug Alert
  7415. Nursing Management Hypothyroidism
  7416. Nursing Assessment
  7417. Nursing Diagnoses
  7418. Planning
  7419. Nursing Implementation
  7420. Health Promotion.
  7421. Acute intervention.
  7422. Ambulatory and Home Care.
  7423. TABLE 50-11 PATIENT & CAREGIVER TEACHING GUIDE: Hypothyroidism
  7424. Evaluation
  7425. Thyroid Nodules and Cancer
  7426. Types of Thyroid Cancer
  7427. Clinical Manifestations and Diagnostic Studies
  7428. Nursing and Collaborative Management Thyroid Cancer
  7429. Multiple Endocrine Neoplasia
  7430. Disorders of Parathyroid Glands
  7431. Hyperparathyroidism
  7432. Etiology and Pathophysiology
  7433. TABLE 50-12 CLINICAL MANIFESTATIONS OF PARATHYROID DYSFUNCTION
  7434. Clinical Manifestations and Complications
  7435. Diagnostic Studies
  7436. Collaborative Care
  7437. Surgical Therapy.
  7438. Nonsurgical Therapy.
  7439. Nursing Management Hyperparathyroidism
  7440. Hypoparathyroidism
  7441. Nursing and Collaborative Management Hypoparathyroidism
  7442. Disorders of Adrenal Cortex
  7443. Cushing Syndrome
  7444. Etiology and Pathophysiology
  7445. Clinical Manifestations
  7446. TABLE 50-13 CLINICAL MANIFESTATIONS OF ADRENOCORTICAL DYSFUNCTION
  7447. FIG. 50-10 Cushing syndrome. Facies include a rounded face (“moon face”) with thin, reddened skin. Hirsutism may also be present.
  7448. FIG. 50-11 Common characteristics of Cushing syndrome.
  7449. FIG. 50-12 Cushing syndrome. Truncal obesity; broad, purple striae; and easy bruising (left antecubital fossa).
  7450. Diagnostic Studies
  7451. Collaborative Care
  7452. TABLE 50-14 COLLABORATIVE CARE: Cushing Syndrome
  7453. Diagnostic
  7454. Collaborative Therapy*
  7455. Nursing Management Cushing Syndrome
  7456. Nursing Assessment
  7457. Nursing Diagnoses
  7458. TABLE 50-15 NURSING ASSESSMENT: Cushing Syndrome
  7459. Planning
  7460. Nursing Implementation
  7461. Health Promotion.
  7462. Acute Intervention.
  7463. Preoperative Care.
  7464. Postoperative Care.
  7465. Ambulatory and Home Care.
  7466. Evaluation
  7467. Adrenocortical Insufficiency
  7468. Etiology and Pathophysiology
  7469. Clinical Manifestations
  7470. Complications
  7471. FIG. 50-13 Hyperpigmentation typically seen in Addison’s disease.
  7472. Diagnostic Studies
  7473. Collaborative Care
  7474. Nursing Management Addison’s Disease
  7475. Nursing Implementation
  7476. Acute intervention.
  7477. TABLE 50-16 COLLABORATIVE CARE: Addison’s Disease
  7478. Diagnostic
  7479. Collaborative Therapy
  7480. Ambulatory and Home Care.
  7481. TABLE 50-17 PATIENT & CAREGIVER TEACHING GUIDE: Addison’s Disease
  7482. Corticosteroid Therapy
  7483. TABLE 50-18 DRUG THERAPY: Diseases and Disorders Treated With Corticosteroids
  7484. Drug Alert
  7485. TABLE 50-19 DRUG THERAPY: Effects and Side Effects of Corticosteroids
  7486. Hyperaldosteronism
  7487. TABLE 50-20 PATIENT & CAREGIVER TEACHING GUIDE: Corticosteroid Therapy
  7488. Nursing and Collaborative Management Primary Hyperaldosteronism
  7489. Disorders of Adrenal Medulla
  7490. Pheochromocytoma
  7491. Nursing and Collaborative Management Pheochromocytoma
  7492. Case Study Graves’ Disease
  7493. Patient Profile
  7494. Subjective Data
  7495. Objective Data
  7496. Physical Examination
  7497. Collaborative Care
  7498. Discussion Questions
  7499. Bridge to NCLEX Examination
  7500. References
  7501. Resources
  7502. Pageburst Integrated Resources
  7503. Answer Keys
  7504. Care Plans
  7505. Case Studies
  7506. Concept Map Creator
  7507. Content Updates
  7508. eFigures
  7509. Glossary
  7510. Key Points
  7511. Chapter 51 Nursing Assessment: Reproductive System
  7512. Learning Outcomes
  7513. Key Terms
  7514. Structures and Functions of Male and Female Reproductive Systems
  7515. Male Reproductive System
  7516. FIG. 51-1 Male reproductive tract.
  7517. Testes.
  7518. Ducts.
  7519. FIG. 51-2 Seminiferous tubules, testis, epididymis, and ductus (vas) deferens in the male.
  7520. Glands.
  7521. External Genitalia.
  7522. Female Reproductive System
  7523. Pelvic Organs
  7524. Ovaries.
  7525. Fallopian Tubes.
  7526. Uterus.
  7527. FIG. 51-3 Female reproductive tract.
  7528. Vagina.
  7529. Pelvis.
  7530. External Genitalia.
  7531. Breasts.
  7532. FIG. 51-4 External female genitalia.
  7533. FIG. 51-5 The lactating female breast. A, Glandular structures are anchored to the overlying skin and the pectoralis muscle by suspensory ligaments of Cooper. Each lobule of glandular tissue is drained by a lactiferous duct that eventually opens through the nipple. B, Anterior view of a lactating breast. In nonlactating breasts, glandular tissue is less evident with adipose tissue comprising most of the breast.
  7534. Neuroendocrine Regulation of Reproductive System
  7535. FIG. 51-6 Hypothalamic-pituitary-gonadal axis. Only the major pituitary hormone actions are depicted. FSH, Follicle-stimulating hormone; GnRH, gonadotropin-releasing hormone; ICSH, interstitial cell–stimulating hormone; LH, luteinizing hormone.
  7536. TABLE 51-1 GONADAL FEEDBACK MECHANISMS
  7537. Menarche
  7538. FIG. 51-7 Events of the menstrual cycle. The lines depict the changes in blood hormone levels, the development of the follicles, and the changes in the endometrium during the cycle. FSH, Follicle-stimulating hormone; LH, luteinizing hormone.
  7539. Menstrual Cycle
  7540. TABLE 51-2 PATIENT TEACHING GUIDE: Characteristics of Menstruation
  7541. Menopause
  7542. Phases of Sexual Response
  7543. Male Sexual Response.
  7544. Female Sexual Response.
  7545. Gerontologic Considerations
  7546. Effects of Aging on Reproductive Systems
  7547. TABLE 51-3 GERONTOLOGIC ASSESSMENT DIFFERENCES: Reproductive Systems
  7548. Assessment of Male and Female Reproductive Systems
  7549. Subjective Data
  7550. Important Health Information.
  7551. Past Health History.
  7552. Gender Differences
  7553. Medications.
  7554. Case Study Patient Introduction
  7555. Critical Thinking
  7556. Surgery or Other Treatments.
  7557. TABLE 51-4 SURGERIES OF THE REPRODUCTIVE SYSTEMS
  7558. Functional Health Patterns.
  7559. Health Perception–Health Management Pattern.
  7560.  Genetic Risk Alert
  7561. TABLE 51-5 HEALTH HISTORY: Reproductive System
  7562. Nutritional-Metabolic Pattern.
  7563. Elimination Pattern.
  7564. Activity-Exercise Pattern.
  7565. Sleep-Rest Pattern.
  7566. Cognitive-Perceptual Pattern.
  7567. Self-Perception–Self-Concept Pattern.
  7568. Role-Relationship Pattern.
  7569. Sexuality-Reproductive Pattern.
  7570. TABLE 51-6 SEXUAL HISTORY FORMAT
  7571. Coping–Stress Tolerance Pattern.
  7572. Value-Belief Pattern.
  7573. Objective Data
  7574. Physical Examination: Male.
  7575. Pubis.
  7576. Case Study—cont’d
  7577. Penis.
  7578. Scrotum and Testes.
  7579. Inguinal Region and Spermatic Cord.
  7580. Anus and Prostate.
  7581. Physical Examination: Female.
  7582. Breasts.
  7583. External Genitalia.
  7584. Internal Pelvic Examination.
  7585. Focused Assessment
  7586. Subjective
  7587. Objective: Diagnostic
  7588. Objective: Physical Examination
  7589. Inspect
  7590. Palpate
  7591. Case Study—cont’d
  7592. Diagnostic Studies of Reproductive Systems
  7593. Urine Studies
  7594. Pregnancy Testing.
  7595. TABLE 51-7 NORMAL PHYSICAL ASSESSMENT OF REPRODUCTIVE SYSTEM
  7596. Hormone Studies.
  7597. Blood Studies
  7598. Hormone Studies.
  7599. Tumor Markers.
  7600. TABLE 51-8 ASSESSMENT ABNORMALITIES: Breast
  7601. TABLE 51-9 ASSESSMENT ABNORMALITIES: Female Reproductive System
  7602. Serology Tests for Syphilis.
  7603. TABLE 51-10 ASSESSMENT ABNORMALITIES: Male Reproductive System
  7604. Cultures and Smears
  7605. TABLE 51-11 DIAGNOSTIC STUDIES: Male and Female Reproductive Systems
  7606. FIG. 51-8 Laparoscopic views of the female pelvis. A, Normal image. B, Pelvic inflammatory disease. Note reddish inflammatory membrane covering and fixing the ovary and uterus to the surrounding structures.
  7607. Case Study—cont’d
  7608. Radiologic Studies
  7609. Mammography.
  7610. Ultrasound.
  7611. Bridge to NCLEX Examination
  7612. References
  7613. Resources
  7614. Pageburst Integrated Resources
  7615. Animations
  7616. Answer Keys
  7617. Concept Map Creator
  7618. Content Updates
  7619. Glossary
  7620. Key Points
  7621. Videos
  7622. Chapter 52 Nursing Management: Breast Disorders
  7623. Learning Outcomes
  7624. Key Terms
  7625. Assessment of Breast Disorders
  7626. Breast Cancer Screening Guidelines
  7627. FIG. 52-1 Breast self-examination and patient instruction. 1, Lie down and place your left arm behind your head. Lying down spreads breast tissue evenly and thinly over the chest wall, making it easier to feel the tissue. 2, Use finger pads of three middle fingers on your right hand to feel for lumps in left breast. Use overlapping dime-sized circular motions to feel the breast tissue. Use three different levels of pressure to feel the breast tissue. Light pressure to feel tissue closest to the skin; medium pressure to feel a little deeper; and firm pressure to feel tissue closest to the chest and ribs. A firm ridge in the lower curve of each breast is normal. 3, The up-and-down (vertical) pattern is recommended for examining the entire breast. Move around the breast in an up-and-down pattern starting at an imaginary line straight down your side from the underarm (including the tail of Spence, which is the triangular breast tissue projecting into the axilla), and moving across the breast to the middle of the sternum. Examine the entire breast going down until you feel only ribs and up to the neck or clavicle. Repeat procedure while examining your right breast. 4, Stand in front of a mirror. Place your hands firmly on your hips, which will tighten the pectoralis muscles. Look at your breasts for size, shape, redness, scaliness, or dimpling of the breast skin or nipple. 5, Examine each underarm while standing or sitting with arm slightly raised. Check for any lump, hard knot, or thickening of tissue.
  7628. Diagnostic Studies
  7629. Radiologic Studies.
  7630. FIG. 52-2 Screening mammogram showing dense breast tissue and benign, scattered microcalcifications of a 57-year-old. A, Using conventional x-rays. B, Using digital x-rays.
  7631. Biopsies.
  7632. Benign Breast Disorders
  7633. Mastalgia
  7634. Breast Infections
  7635. Mastitis
  7636. Lactational Breast Abscess
  7637. TABLE 52-1 BENIGN BREAST DISORDERS*
  7638. FIG. 52-3 A, Normal breast tissue. B, Fibrocystic breast tissue.
  7639. Fibrocystic Changes
  7640. Nursing and Collaborative Management Fibrocystic Changes
  7641. Fibroadenoma
  7642. Nipple Discharge
  7643. Intraductal Papilloma
  7644. Ductal Ectasia
  7645. Gynecomastia in Men
  7646. Senescent Gynecomastia
  7647. Gerontologic Considerations
  7648. Age-Related Breast Changes
  7649. Breast Cancer
  7650. Etiology and Risk Factors
  7651. Risk Factors for Women.
  7652. TABLE 52-2 RISK FACTORS FOR BREAST CANCER
  7653.  Genetic Link
  7654.  Genetics in Clinical Practice
  7655. Genetic Basis
  7656. Incidence
  7657. Genetic Testing
  7658. Clinical Implications
  7659. Risk Factors for Men.
  7660. TABLE 52-3 TYPES OF BREAST CANCER
  7661. Prophylactic Oophorectomy and Mastectomy.
  7662. Pathophysiology
  7663. Types of Breast Cancer
  7664. Noninvasive Breast Cancer.
  7665. Invasive (Infiltrating) Ductal Carcinoma.
  7666. Inflammatory Breast Cancer.
  7667. Paget’s Disease.
  7668. Invasive (Infiltrating) Lobular Carcinoma.
  7669. Clinical Manifestations
  7670. FIG. 52-4 Distribution of where breast cancer occurs.
  7671. Complications
  7672. Diagnostic Studies
  7673. TABLE 52-4 SITES OF BREAST CANCER RECURRENCE AND METASTASIS
  7674. FIG. 52-5 Lymph nodes and drainage in the axilla. The sentinel lymph node is usually found in the external mammary nodes. A complete axillary dissection would remove all nodes.
  7675. Collaborative Care
  7676. TABLE 52-5 COLLABORATIVE CARE: Breast Cancer
  7677. Staging of Breast Cancer.
  7678. Surgical Therapy.
  7679. Breast-Conserving Surgery.
  7680. TABLE 52-6 STAGING OF BREAST CANCER
  7681. TABLE 52-7 SURGICAL PROCEDURES FOR BREAST CANCER
  7682. FIG. 52-6 Breast cancer surgery. A, Preoperative. B, Lumpectomy. C, Modified radical mastectomy.
  7683. Evidence-Based Practice Applying the Evidence
  7684. Your Decision and Action
  7685. Reference for Evidence
  7686. Axillary Lymph Node Dissection.
  7687. Modified Radical Mastectomy.
  7688. FIG. 52-7 Lymphedema. Accumulation of fluid in the tissue after excision of lymph nodes.
  7689. Postmastectomy Pain Syndrome.
  7690. Radiation Therapy.
  7691. Primary Radiation Therapy.
  7692. Brachytherapy.
  7693. Palliative Radiation Therapy.
  7694. Drug Therapy.
  7695. FIG. 52-8 High-dose brachytherapy for breast cancer. The MammoSite system involves the insertion of a single small balloon catheter (B) at the time of the lumpectomy or shortly thereafter into the tumor resection cavity (the space that is left after the surgeon removes the tumor). A tiny radioactive seed (A) is inserted into the balloon, connected to a machine called an afterloader (C), and delivers the radiation therapy.
  7696. Chemotherapy.
  7697. Drug Alert
  7698. Hormone Therapy.
  7699. Estrogen Receptor Blockers.
  7700. Drug Alert
  7701. TABLE 52-8 DRUG THERAPY: Breast Cancer
  7702. Aromatase Inhibitors.
  7703. Estrogen Receptor Modulator and Others.
  7704. Biologic and Targeted Therapy.
  7705. Drug Alert
  7706. Follow-up and Survivorship Care.
  7707. Evidence-Based Practice Translating Research Into Practice
  7708. What Is the Effect of Physical Activity in Cancer Survivors?
  7709. Clinical Question
  7710. Best Available Evidence
  7711. Critical Appraisal and Synthesis of Evidence
  7712. Conclusion
  7713. Implications for Nursing Practice
  7714. Reference for Evidence
  7715. Culturally Competent Care
  7716. Breast Cancer
  7717.  Cultural & Ethnic Health Disparities
  7718. Nursing Management Breast Cancer
  7719. Nursing Assessment
  7720. Nursing Diagnoses
  7721. Planning
  7722. TABLE 52-9 NURSING ASSESSMENT: Breast Cancer
  7723. Nursing Implementation
  7724. Health Promotion.
  7725. Acute Intervention.
  7726. FIG. 52-9 Postoperative exercises for the patient with a mastectomy or lumpectomy with axillary lymph node dissection.
  7727. Emotional and Psychologic Care.
  7728. Ambulatory and Home Care.
  7729.  Complementary & Alternative Therapies
  7730. Scientific Evidence*
  7731. Nursing Implications
  7732. Evaluation
  7733. Gerontologic Considerations
  7734. Breast Cancer
  7735. Mammoplasty
  7736. Breast Reconstruction
  7737. Indications.
  7738. Types of Reconstruction
  7739. Breast Implants and Tissue Expansion.
  7740. FIG. 52-10 A, Appearance of chest after bilateral mastectomy. B, Postoperative breast reconstruction before nipple-areolar reconstruction. C, Postoperative breast reconstruction after nipple-areolar reconstruction.
  7741. FIG. 52-11 A, Tissue expander with gradual expansion. B, Tissue expander in place after mastectomy.
  7742. Tissue Flap Procedures.
  7743. Nipple-Areolar Reconstruction.
  7744. Breast Augmentation
  7745. Breast Reduction
  7746. FIG. 52-12 Transverse rectus abdominis musculocutaneous (TRAM) flap. A, TRAM flap is planned. B, The abdominal tissue, while attached to the rectus muscle, nerve, and blood supply, is tunneled through the abdomen to the chest. C, The flap is trimmed to shape the breast. The lower abdominal incision is closed. D, Nipple and areola are reconstructed after the breast is healed.
  7747. Case Study Breast Cancer
  7748. Patient Profile
  7749. Collaborative Care
  7750. Preoperative
  7751. Operative Procedure
  7752. Postoperative
  7753. Follow-up Findings and Treatment
  7754. Discussion Questions
  7755. Nursing Management Breast Augmentation and Reduction
  7756. Bridge to NCLEX Examination
  7757. References
  7758. Resources
  7759. Pageburst Integrated Resources
  7760. Answer Keys
  7761. Care Plans
  7762. Case Studies
  7763. Concept Map
  7764. Concept Map Creator
  7765. Content Updates
  7766. Glossary
  7767. Key Points
  7768. Chapter 53 Nursing Management: Sexually Transmitted Infections
  7769. Learning Outcomes
  7770. Key Terms
  7771. Factors Affecting Incidence of Sexually Transmitted Infections
  7772. TABLE 53-1 CAUSES OF SEXUALLY TRANSMITTED INFECTIONS
  7773. Bacterial Infections
  7774. Gonorrhea
  7775.  Cultural & Ethnic Health Disparities
  7776. Etiology and Pathophysiology
  7777. Clinical Manifestations
  7778. Men.
  7779. Women.
  7780. FIG. 53-1 Profuse, purulent drainage in a patient with gonorrhea.
  7781. FIG. 53-2 Endocervical gonorrhea. Cervical redness and edema with discharge.
  7782. General.
  7783. Complications
  7784. Diagnostic Studies
  7785. FIG. 53-3 Skin lesions with disseminated gonococcal infection. A, On the hand. B, On the fifth toe.
  7786. Gender Differences
  7787. Collaborative Care
  7788. Drug Therapy.
  7789. TABLE 53-2 COLLABORATIVE CARE: Gonorrhea
  7790. Drug Alert
  7791. Syphilis
  7792. Etiology and Pathophysiology
  7793. Clinical Manifestations
  7794. Complications
  7795. Diagnostic Studies
  7796. TABLE 53-3 STAGES OF SYPHILIS
  7797. FIG. 53-4 Primary syphilis chancre.
  7798. FIG. 53-5 Secondary syphilis. Mucous patch in the mouth.
  7799. FIG. 53-6 Destructive skin gummas associated with tertiary syphilis.
  7800. TABLE 53-4 COLLABORATIVE CARE: Syphilis
  7801. Collaborative Care
  7802. Drug Therapy.
  7803. Chlamydial Infections
  7804. Etiology and Pathophysiology
  7805. TABLE 53-5 RISK FACTORS FOR CHLAMYDIAL INFECTION
  7806. Evidence-Based Practice Translating Research Into Practice
  7807. What Strategies Improve Screening Rates for Repeat Chlamydial Infections?
  7808. Clinical Question
  7809. Best Available Evidence
  7810. Critical Appraisal and Synthesis of Evidence
  7811. Conclusion
  7812. Implications for Nursing Practice
  7813. Reference for Evidence
  7814. Clinical Manifestations
  7815. FIG. 53-7 Chlamydial epididymitis. Red, swollen scrotum.
  7816. Complications
  7817. Diagnostic Studies
  7818. TABLE 53-6 COLLABORATIVE CARE: Chlamydial Infection
  7819. Collaborative Care
  7820. Drug Therapy.
  7821. Viral Infections
  7822. Genital Herpes
  7823. Etiology and Pathophysiology
  7824. Clinical Manifestations
  7825. Primary Episode.
  7826. FIG. 53-8 Unruptured vesicles of herpes simplex virus type 2 (HSV-2). A, Vulvar area. B, Perianal area. C, Penile herpes simplex, ulcerative stage.
  7827. Recurrent Episodes.
  7828. Complications
  7829. Diagnostic Studies and Collaborative Care
  7830. FIG. 53-9 Autoinoculation of herpes simplex virus (HSV) to the lips.
  7831. Drug Therapy.
  7832. TABLE 53-7 COLLABORATIVE CARE: Genital Herpes
  7833. Genital Warts
  7834. Clinical Manifestations and Complications
  7835. Diagnostic Studies and Collaborative Care
  7836. FIG. 53-10 Genital warts. A, Severe vulvar warts. B, Perineal wart. C, Multiple genital warts of the glans penis.
  7837. HPV Vaccines.
  7838. Nursing Management Sexually Transmitted Infections
  7839. Nursing Assessment
  7840. Nursing Diagnoses
  7841. Planning
  7842. Nursing Implementation
  7843. Health Promotion.
  7844. Evidence-Based Practice Applying the Evidence
  7845. Your Decision and Action
  7846. Reference for Evidence
  7847. Healthy People
  7848. Measures to Prevent Infection.
  7849. TABLE 53-8 NURSING ASSESSMENT: Sexually Transmitted Infections
  7850. TABLE 53-9 PATIENT TEACHING GUIDE: Sexually Transmitted Infections
  7851. Screening Programs.
  7852. Case Finding.
  7853. Educational and Research Programs.
  7854. Acute Intervention
  7855. Psychologic Support.
  7856. Follow-up.
  7857. Hygiene Measures.
  7858. Sexual Activity.
  7859. Ethical/Legal Dilemmas Confidentiality and HIPAA
  7860. Situation
  7861. Ethical/Legal Points for Consideration
  7862. Discussion Questions
  7863. Ambulatory and Home Care.
  7864. Evaluation
  7865. Case Study Gonorrhea and Chlamydial Infection
  7866. Patient Profile
  7867. Subjective Data
  7868. Objective Data
  7869. Collaborative Care
  7870. Discussion Questions
  7871. Bridge to NCLEX Examination
  7872. References
  7873. Resources
  7874. Pageburst Integrated Resources
  7875. Answer Keys
  7876. Concept Map Creator
  7877. Content Updates
  7878. Glossary
  7879. Key Points
  7880. Chapter 54 Nursing Management: Female Reproductive Problems
  7881. Learning Outcomes
  7882. Key Terms
  7883. Infertility
  7884. Etiology and Pathophysiology
  7885. TABLE 54-1 COLLABORATIVE CARE: Infertility
  7886. Diagnostic Studies
  7887. Ovulatory Studies.
  7888. Tubal Patency Studies.
  7889. Postcoital Studies.
  7890. TABLE 54-2 DRUG THERAPY: Infertility
  7891. Nursing and Collaborative Management Infertility
  7892. Abortion
  7893. Spontaneous Abortion
  7894. Induced Abortion
  7895. TABLE 54-3 METHODS FOR INDUCING ABORTION
  7896. Problems Related to Menstruation
  7897. Premenstrual Syndrome
  7898. Etiology and Pathophysiology
  7899. Clinical Manifestations
  7900. Diagnostic Studies and Collaborative Care
  7901. TABLE 54-4 COLLABORATIVE CARE: Premenstrual Syndrome (PMS)
  7902. Drug Therapy.
  7903. Drug Alert
  7904. Dysmenorrhea
  7905. Etiology and Pathophysiology
  7906. Clinical Manifestations
  7907. Nursing and Collaborative Management Dysmenorrhea
  7908. Abnormal Vaginal Bleeding
  7909. Types of Irregular Bleeding
  7910. Oligomenorrhea and Amenorrhea.
  7911. Menorrhagia.
  7912. TABLE 54-5 CAUSES OF AMENORRHEA
  7913. Metrorrhagia.
  7914. Diagnostic Studies and Collaborative Care
  7915. Surgical Therapy.
  7916. FIG. 54-1 Balloon thermotherapy for treatment of menorrhagia. A, Balloon-tipped catheter is inserted into the uterus through the vagina and the cervix. B, The balloon is inflated with a sterile fluid that expands to fit the size and shape of the uterus. The fluid is heated to 188° F (87° C) and maintained for 8 minutes while the uterine lining is treated. C, Fluid is withdrawn from the balloon and the catheter is removed.
  7917. Nursing Management Abnormal Vaginal Bleeding
  7918. FIG. 54-2 Ectopic pregnancy occurring in the fallopian tube.
  7919. Ectopic Pregnancy
  7920. Etiology and Pathophysiology
  7921. Clinical Manifestations
  7922. Diagnostic Studies
  7923. Nursing and Collaborative Management Ectopic Pregnancy
  7924. FIG. 54-3 Laparoscopic treatment of ectopic pregnancy in the right fallopian tube.
  7925. Perimenopause and Postmenopause
  7926. Clinical Manifestations
  7927. TABLE 54-6 MANIFESTATIONS OF PERIMENOPAUSE AND POSTMENOPAUSE
  7928. TABLE 54-7 MANIFESTATIONS OF ESTROGEN DEFICIENCY
  7929. Collaborative Care
  7930. Drug Therapy.
  7931. Drug Alert
  7932. Nonhormonal Therapy.
  7933. Nutritional Therapy.
  7934.  Complementary & Alternative Therapies
  7935. Nursing Management Perimenopause and Postmenopause
  7936. Culturally Competent Care
  7937. Menopause
  7938. Conditions of Vulva, Vagina, and Cervix
  7939. Etiology and Pathophysiology
  7940. Clinical Manifestations
  7941. TABLE 54-8 INFECTIONS OF THE LOWER GENITAL TRACT
  7942. Collaborative Care
  7943. Nursing Management Conditions of Vulva, Vagina, and Cervix
  7944. Pelvic Inflammatory Disease
  7945. Etiology and Pathophysiology
  7946. Clinical Manifestations
  7947. FIG. 54-4 Pelvic inflammatory disease. Acute infection of the fallopian tubes and the ovaries. The tubes and the ovaries have become an inflamed mass attached to the uterus. A tubo-ovarian abscess is also present.
  7948. Complications
  7949. Collaborative Care
  7950. Nursing Management Pelvic Inflammatory Disease
  7951. TABLE 54-9 NURSING ASSESSMENT: Pelvic Inflammatory Disease
  7952. Chronic Pelvic Pain
  7953. Endometriosis
  7954. FIG. 54-5 Common sites of endometriosis.
  7955. Etiology and Pathophysiology
  7956. Clinical Manifestations
  7957. Collaborative Care
  7958. TABLE 54-10 COLLABORATIVE CARE: Endometriosis
  7959. Drug Therapy.
  7960. Drug Alert
  7961. Surgical Therapy.
  7962. Nursing Management Endometriosis
  7963. Benign Tumors of the Female Reproductive System
  7964. Leiomyomas
  7965. Etiology and Pathophysiology
  7966. Clinical Manifestations
  7967. FIG. 54-6 Leiomyomas. Uterine section showing whorl-like appearance and locations of leiomyomas.
  7968. Collaborative Care
  7969. Cervical Polyps
  7970. FIG. 54-7 Large ovarian cyst.
  7971. Benign Ovarian Tumors
  7972. Polycystic Ovary Syndrome
  7973. FIG. 54-8 Polycystic ovary syndrome. Multiple fluid-filled cysts in the ovary.
  7974. Drug Alert
  7975. Cancers of the Female Reproductive System
  7976. Cervical Cancer
  7977.  Cultural & Ethnic Health Disparities
  7978. Ovarian Cancer
  7979. Endometrial Cancer
  7980. Cervical Cancer
  7981. Etiology and Pathophysiology
  7982. Clinical Manifestations
  7983. Diagnostic Studies
  7984. FIG. 54-9 Cervical cancer. View through a speculum inserted into the vagina.
  7985. TABLE 54-11 STAGING AND TREATMENT OF CERVICAL CANCER
  7986. Collaborative Care
  7987. Endometrial Cancer
  7988. Evidence-Based Practice Applying the Evidence
  7989. Your Action and Decision
  7990. Reference for Evidence
  7991. Etiology and Pathophysiology
  7992. Clinical Manifestations
  7993. Collaborative Care
  7994. Ovarian Cancer
  7995. Etiology and Pathophysiology
  7996.  Genetic Link
  7997.  Genetics in Clinical Practice
  7998. Genetic Basis
  7999. Incidence
  8000. Genetic Testing
  8001. Clinical Implications
  8002. TABLE 54-12 COLLABORATIVE CARE: Ovarian Cancer
  8003. Clinical Manifestations
  8004. Diagnostic Studies
  8005. Collaborative Care
  8006. Vaginal Cancer
  8007. Vulvar Cancer
  8008. TABLE 54-13 SURGICAL PROCEDURES INVOLVING THE FEMALE REPRODUCTIVE SYSTEM
  8009. Surgical Procedures: Female Reproductive System
  8010. FIG. 54-10 A, Cross section of subtotal hysterectomy. Note that cervical stump, fallopian tubes, and ovaries remain. B, Cross section of total hysterectomy. Note that fallopian tubes and ovaries remain. C, Cross section of vaginal hysterectomy. Note that fallopian tubes and ovaries remain. D, Total hysterectomy, salpingectomy, and oophorectomy. Note that uterus, fallopian tubes, and ovaries are completely removed.
  8011. Radiation Therapy: Cancers of Female Reproductive System
  8012. External Radiation Therapy
  8013. Brachytherapy
  8014. Nursing Management Cancers of Female Reproductive System
  8015. Nursing Assessment
  8016. Nursing Diagnoses
  8017. Planning
  8018. Nursing Implementation
  8019. Health Promotion.
  8020. Acute Intervention Related to Surgery.
  8021. Hysterectomy.
  8022. Salpingectomy and Oophorectomy.
  8023. Vulvectomy.
  8024. FIG. 54-11 Total exenteration is removal of all pelvic organs with creation of an ileal conduit and a colostomy.
  8025. Pelvic Exenteration.
  8026. Acute Intervention with Radiation Therapy.
  8027. Evaluation
  8028. Problems with Pelvic Support
  8029. Uterine Prolapse
  8030. FIG. 54-12 Uterine prolapse. A, First-degree prolapse. B, Second-degree prolapse. C, Third-degree prolapse.
  8031. FIG. 54-13 A, Cystocele. B, Bladder has prolapsed into the vagina, causing a uterine prolapse.
  8032. Cystocele and Rectocele
  8033. FIG. 54-14 A, Rectocele. B, Rectum has prolapsed into the vagina.
  8034. Nursing Management Problems with Pelvic Support
  8035. Fistula
  8036. FIG. 54-15 Common fistulas involving the vagina.
  8037. Nursing Management Fistulas
  8038. Sexual Assault
  8039. Clinical Manifestations
  8040. Physical.
  8041.  TABLE 54-14 EMERGENCY MANAGEMENT: Sexual Assault
  8042. Initial
  8043. Ongoing Monitoring
  8044. Psychologic.
  8045. Collaborative Care
  8046. Nursing Management Sexual Assault
  8047. TABLE 54-15 EVALUATION OF ALLEGED SEXUAL ASSAULT
  8048. TABLE 54-16 PATIENT TEACHING GUIDE: Sexual Assault Prevention
  8049. Case Study Uterine Prolapse and Vaginal Hysterectomy
  8050. Jupiterimages/Photos.com/Thinkstock
  8051. Patient Profile
  8052. Subjective Data
  8053. Objective Data
  8054. Physical Examination
  8055. Laboratory Studies
  8056. Postoperative Status
  8057. Discussion Questions
  8058. Bridge to NCLEX Examination
  8059. References
  8060. Resources
  8061. Pageburst Integrated Resources
  8062. Answer Keys
  8063. Care Plans
  8064. Case Studies
  8065. Concept Map Creator
  8066. Content Updates
  8067. Glossary
  8068. Key Points
  8069. Chapter 55 Nursing Management: Male Reproductive Problems
  8070. Learning Outcomes
  8071. Key Terms
  8072. eFigures
  8073. Problems of the Prostate Gland
  8074. Benign Prostatic Hyperplasia
  8075. Etiology and Pathophysiology
  8076. FIG. 55-1 Areas of the male reproductive system in which problems are likely to develop.
  8077. FIG. 55-2 Benign prostatic hyperplasia. The enlarged prostate compresses the urethra.
  8078. FIG. 55-3 Views of the prostate by cystoscopy. A, Normal appearance. B, Moderate benign prostatic hyperplasia with urethral obstruction.
  8079. Clinical Manifestations
  8080. TABLE 55-1 AUA SYMPTOM INDEX TO DETERMINE SEVERITY OF PROSTATIC PROBLEMS
  8081. Complications
  8082. Diagnostic Studies
  8083. TABLE 55-2 COLLABORATIVE CARE: Benign Prostatic Hyperplasia
  8084. Collaborative Care
  8085. Drug Therapy.
  8086. 5α-Reductase Inhibitors.
  8087. Drug Alert
  8088. α-Adrenergic Receptor Blockers.
  8089. Erectogenic Drugs.
  8090. Herbal Therapy.
  8091. Minimally Invasive Therapy.
  8092. Transurethral Microwave Thermotherapy.
  8093. TABLE 55-3 TREATMENT FOR BENIGN PROSTATIC HYPERPLASIA
  8094. Transurethral Needle Ablation.
  8095. Laser Prostatectomy.
  8096. Intraprostatic Urethral Stents.
  8097. Invasive Therapy (Surgery).
  8098. Transurethral Resection of the Prostate.
  8099. FIG. 55-4 Transurethral resection of the prostate.
  8100. Transurethral Incision of the Prostate.
  8101. Nursing Management Benign Prostatic Hyperplasia
  8102. Nursing Assessment
  8103. Nursing Diagnoses
  8104. TABLE 55-4 NURSING ASSESSMENT: Benign Prostatic Hyperplasia
  8105. Planning
  8106. Nursing Implementation
  8107. Health Promotion.
  8108. Acute Intervention.
  8109. Preoperative Care.
  8110. Postoperative Care.
  8111. Ambulatory and Home Care.
  8112. Evaluation
  8113. Prostate Cancer
  8114. Etiology and Pathophysiology
  8115.  Cultural & Ethnic Health Disparities
  8116. Prostate Cancer
  8117. Testicular Cancer
  8118.  Genetic Link
  8119. Clinical Manifestations and Complications
  8120. FIG. 55-5 Metastasis of prostate cancer to the pelvis and lumbar spine indicated by arrows.
  8121. Diagnostic Studies
  8122. Collaborative Care
  8123. Active Surveillance.
  8124. TABLE 55-5 STAGE GROUPING OF PROSTATE CANCER
  8125. TABLE 55-6 COLLABORATIVE CARE: Prostate Cancer
  8126. Surgical Therapy
  8127. Radical Prostatectomy.
  8128. Evidence-Based Practice Applying the Evidence
  8129. Your Decision and Action
  8130. Reference for Evidence
  8131. FIG. 55-6 Common approaches used to perform a prostatectomy. A, Retropubic approach involves a midline abdominal incision. B, Perineal approach involves an incision between the scrotum and the anus.
  8132. Nerve-Sparing Procedure.
  8133. Cryotherapy.
  8134. Radiation Therapy.
  8135. External Beam Radiation.
  8136. Brachytherapy.
  8137. Drug Therapy.
  8138. Androgen Deprivation Therapy.
  8139. FIG. 55-7 A, Prostate brachytherapy. Implantation of radioactive seeds with a needle guided by ultrasound and a template grid. B, Radioactive seeds.
  8140. Androgen Synthesis Inhibitors.
  8141. TABLE 55-7 DRUG THERAPY: Androgen Deprivation Therapy for Prostate Cancer
  8142. Androgen Receptor Blockers.
  8143. Chemotherapy.
  8144. Radiotherapy.
  8145. Orchiectomy.
  8146. Culturally Competent Care
  8147. Prostate Cancer
  8148. Delegation Decisions Caring for the Patient Receiving Bladder Irrigation
  8149. Role of Registered Nurse (RN)
  8150. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  8151. Role of Unlicensed Assistive Personnel (UAP)
  8152. Nursing Management Prostate Cancer
  8153. Nursing Assessment
  8154. Nursing Diagnoses
  8155. TABLE 55-8 NURSING ASSESSMENT: Prostate Cancer
  8156. Planning
  8157. Nursing Implementation
  8158. Health Promotion.
  8159. Acute Intervention.
  8160. Ambulatory and Home Care.
  8161. Evaluation
  8162. Prostatitis
  8163. Etiology and Pathophysiology
  8164. Clinical Manifestations and Complications
  8165. Diagnostic Studies
  8166. Nursing and Collaborative Management Prostatitis
  8167. Problems of the Penis
  8168. Congenital Problems
  8169. Problems of Prepuce
  8170. FIG. 55-8 A, Phimosis: inability to retract the foreskin due to secondary lesions on the prepuce. B, Paraphimosis: ulcer with edema from foreskin remaining contracted over the prepuce.
  8171. Problems of Erectile Mechanism
  8172. Cancer of Penis
  8173. Problems of Scrotum and Testes
  8174. Inflammatory and Infectious Problems
  8175. Skin Problems
  8176. Epididymitis
  8177. Orchitis
  8178. FIG. 55-9 Scrotal masses.
  8179. Congenital Problems
  8180. Acquired Problems
  8181. Hydrocele
  8182. Spermatocele
  8183. Varicocele
  8184. FIG. 55-10 Hydrocele.
  8185. Testicular Torsion
  8186. Testicular Cancer
  8187. Etiology and Pathophysiology
  8188. Clinical Manifestations and Complications
  8189. Diagnostic Studies
  8190. Nursing and Collaborative Management Testicular Cancer
  8191. Testicular Self-Examination
  8192. Collaborative Care
  8193. TABLE 55-9 PATIENT TEACHING GUIDE: Testicular Self-Examination
  8194. FIG. 55-11 Testicular self-examination.
  8195. FIG. 55-12 Vasectomy procedure. The ductus deferens is ligated or resected for the purpose of sterilization.
  8196. Sexual Function
  8197. Vasectomy
  8198. Erectile Dysfunction
  8199. Ethical/Legal Dilemmas Sterilization
  8200. Situation
  8201. Ethical/Legal Points for Consideration
  8202. Discussion Questions
  8203. Etiology and Pathophysiology
  8204. Evidence-Based Practice Translating Research Into Practice
  8205. Do Lifestyle Changes and Cardiovascular Medication Improve Erectile Dysfunction?
  8206. Clinical Question
  8207. Best Available Evidence
  8208. Critical Appraisal and Synthesis of Evidence
  8209. Conclusion
  8210. Implications for Nursing Practice
  8211. Reference for Evidence
  8212. Clinical Manifestations and Complications
  8213. Diagnostic Studies
  8214. TABLE 55-10 RISK FACTORS FOR ERECTILE DYSFUNCTION
  8215. Collaborative Care
  8216. TABLE 55-11 COLLABORATIVE CARE: Erectile Dysfunction
  8217. Erectogenic Drugs.
  8218. Drug Alert
  8219. Vacuum Constriction Devices.
  8220. Intraurethral Devices.
  8221. Penile Implants.
  8222. Sexual Counseling.
  8223. Nursing Management Erectile Dysfunction
  8224. Andropause
  8225. FIG. 55-13 Changes in testosterone plasma level in men as they age.
  8226. Infertility
  8227. Case Study Benign Prostatic Hyperplasia With Acute Urinary Retention
  8228. iStockphoto/Thinkstock
  8229. Patient Profile
  8230. Subjective Data
  8231. Objective Data
  8232. Collaborative Care
  8233. Discussion Questions
  8234. Bridge to NCLEX Examination
  8235. References
  8236. Resources
  8237. Case Study Managing Multiple Patients
  8238. Introduction
  8239. Patients
  8240. iStockphoto/Thinkstock
  8241. iStockphoto/Thinkstock
  8242. iStockphoto/Thinkstock
  8243. iStockphoto/Thinkstock
  8244. Jupiterimages/Photos.com/Thinkstock
  8245. Jupiterimages/Photos.com/Thinkstock
  8246. Management Discussion Questions
  8247. Case Study Progression
  8248. Pageburst Integrated Resources
  8249. Answer Keys
  8250. Care Plans
  8251. Case Studies
  8252. Concept Map Creator
  8253. Content Updates
  8254. eFigures
  8255. Glossary
  8256. Key Points
  8257. Section 11 Problems Related to Movement and Coordination
  8258. Problems Related to Movement and Coordination
  8259. Pre-Test – Section 11
  8260. Interactive Review – Section 11
  8261. Chapter 56 Nursing Assessment: Nervous System
  8262. Learning Outcomes
  8263. Key Terms
  8264. eFigure
  8265. eTable
  8266. Structures and Functions of Nervous System
  8267. Cells of Nervous System
  8268. Neurons.
  8269. FIG. 56-1 Structural features of neurons: dendrites, cell body, and axons.
  8270. Glial Cells.
  8271. Nerve Regeneration
  8272. Nerve Impulse
  8273. Synapse.
  8274. Neurotransmitters.
  8275. Central Nervous System
  8276. Spinal Cord.
  8277. TABLE 56-1 NEUROTRANSMITTERS*
  8278. Ascending Tracts.
  8279. FIG. 56-2 Basic diagram of the patellar “knee jerk” reflex arc, including the (1) sensory stretch receptor, (2) afferent sensory neuron, (3) interneuron, (4) efferent motor neuron, and (5) quadriceps muscle (effector organ).
  8280. Descending Tracts.
  8281. Lower and Upper Motor Neurons.
  8282. FIG. 56-3 Left hemisphere of cerebrum, lateral surface, showing major lobes and areas of the brain.
  8283. Reflex Arc.
  8284. Brain.
  8285. Cerebrum.
  8286. TABLE 56-2 FUNCTION OF CEREBRUM
  8287. FIG. 56-4 Major divisions of the central nervous system (CNS).
  8288. Brainstem.
  8289. Cerebellum.
  8290. Ventricles and Cerebrospinal Fluid.
  8291. Peripheral Nervous System
  8292. Spinal Nerves.
  8293. FIG. 56-5 Cross section of spinal cord showing attachments of spinal nerves and coverings of the spinal cord.
  8294. Cranial Nerves.
  8295. Autonomic Nervous System.
  8296. TABLE 56-3 CRANIAL NERVES
  8297. FIG. 56-6 Dermatomes of the body.
  8298. FIG. 56-7 The cranial nerves are numbered according to the order in which they leave the brain.
  8299. FIG. 56-8 Arteries of the head and neck. Brachiocephalic artery, right common carotid artery, right subclavian artery, and their branches. The major arteries to the head are the common carotid and vertebral arteries.
  8300. Cerebral Circulation
  8301. Blood-Brain Barrier.
  8302. FIG. 56-9 Arteries at the base of the brain. The arteries that compose the circle of Willis are the two anterior cerebral arteries joined to each other by the anterior communicating cerebral artery and to the posterior cerebral arteries by the posterior communicating arteries.
  8303. Protective Structures
  8304. Meninges.
  8305. Skull.
  8306. Vertebral Column.
  8307. FIG. 56-10 The vertebral column (three views).
  8308. Gerontologic Considerations
  8309. Effects of Aging on Nervous System
  8310. Assessment of Nervous System
  8311. Subjective Data
  8312. Important Health Information
  8313. Past Health History.
  8314. Medications.
  8315. Surgery or Other Treatments.
  8316. Functional Health Patterns.
  8317. Health Perception–Health Management Pattern.
  8318. TABLE 56-4 GERONTOLOGIC ASSESSMENT DIFFERENCES: Nervous System
  8319. Case Study Patient Introduction
  8320. Critical Thinking
  8321.  Genetic Risk Alert
  8322. Nutritional-Metabolic Pattern.
  8323. Elimination Pattern.
  8324. TABLE 56-5 HEALTH HISTORY: Nervous System
  8325. Activity-Exercise Pattern.
  8326. Sleep-Rest Pattern.
  8327. Cognitive-Perceptual Pattern.
  8328. Self-Perception–Self-Concept Pattern.
  8329. Role-Relationship Pattern.
  8330. Sexuality-Reproductive Pattern.
  8331. Coping–Stress Tolerance Pattern.
  8332. Value-Belief Pattern.
  8333. Objective Data
  8334. Physical Examination.
  8335. Case Study—cont’d
  8336. Mental Status.
  8337. Cranial Nerves.
  8338. Olfactory Nerve.
  8339. Optic Nerve.
  8340. FIG. 56-11 A, Nurse checking visual fields. B, Nurse checking extraocular movement (EOM).
  8341. Oculomotor, Trochlear, and Abducens Nerves.
  8342. Trigeminal Nerve.
  8343. FIG. 56-12 A pupilometer can be used to measure the pupillary response using a light stimulus.
  8344. Facial Nerve.
  8345. Vestibulocochlear (Acoustic) Nerve.
  8346. Glossopharyngeal and Vagus Nerves.
  8347. Accessory Nerve.
  8348. Hypoglossal Nerve.
  8349. Motor System.
  8350. Sensory System.
  8351. Touch, Pain, and Temperature.
  8352. Vibration Sense.
  8353. Position Sense.
  8354. Cortical Sensory Functions.
  8355. Reflexes.
  8356. FIG. 56-13 The examiner strikes a swift blow over a stretched tendon to elicit a stretch reflex. A, Biceps reflex. B, Patellar reflex.
  8357. Diagnostic Studies of Nervous System
  8358. TABLE 56-6 NORMAL PHYSICAL ASSESSMENT OF NERVOUS SYSTEM*
  8359. Case Study—cont’d
  8360. Cerebrospinal Fluid Analysis
  8361. Lumbar Puncture.
  8362. TABLE 56-7 ASSESSMENT ABNORMALITIES: Nervous System
  8363. Focused Assessment
  8364. Subjective
  8365. Objective: Diagnostic
  8366. Objective: Physical Examination
  8367. Inspect/Observe
  8368. Palpate
  8369. Percuss
  8370. Radiologic Studies
  8371. Computed Tomography.
  8372. Magnetic Resonance Imaging.
  8373. Cerebral Angiography.
  8374. Case Study—cont’d
  8375. Electrographic Studies
  8376. Electroencephalography.
  8377. Electromyography and Nerve Conduction Studies.
  8378. TABLE 56-8 DIAGNOSTIC STUDIES: Nervous System
  8379. TABLE 56-9 NORMAL CEREBROSPINAL FLUID VALUES
  8380. FIG. 56-14 Cerebral angiogram illustrating an arteriovenous malformation (arrow).
  8381. FIG. 56-15 Normal images of the brain. A, Computed tomography scan. B, Magnetic resonance imaging.
  8382. Evoked Potentials.
  8383. Bridge to NCLEX Examination
  8384. References
  8385. Resources
  8386. Pageburst Integrated Resources
  8387. Animations
  8388. Answer Keys
  8389. Concept Map Creator
  8390. Content Updates
  8391. eFigures
  8392. eTables
  8393. Glossary
  8394. Key Points
  8395. Videos
  8396. Chapter 57 Nursing Management: Acute Intracranial Problems
  8397. Learning Outcomes
  8398. Key Terms
  8399. eFigure
  8400. Intracranial Pressure
  8401. FIG. 57-1 Components of the brain.
  8402. Regulation and Maintenance of Intracranial Pressure
  8403. Normal Intracranial Pressure.
  8404. Normal Compensatory Adaptations.
  8405. TABLE 57-1 CALCULATION OF CEREBRAL PERFUSION PRESSURE
  8406. Cerebral Blood Flow
  8407. Autoregulation of Cerebral Blood Flow.
  8408. FIG. 57-2 Intracranial pressure-volume curve. (See text for descriptions of 1, 2, 3, and 4.)
  8409. Pressure Changes.
  8410. Factors Affecting Cerebral Blood Flow.
  8411. Increased Intracranial Pressure
  8412. Mechanisms of Increased Intracranial Pressure
  8413. FIG. 57-3 Progression of increased intracranial pressure (ICP).
  8414. Cerebral Edema
  8415. FIG. 57-4 Herniation. A, Normal relationship of intracranial structures. B, Shift of intracranial structures.
  8416. TABLE 57-2 CAUSES OF CEREBRAL EDEMA
  8417. Vasogenic Cerebral Edema.
  8418. Cytotoxic Cerebral Edema.
  8419. Interstitial Cerebral Edema.
  8420. Clinical Manifestations
  8421. Change in Level of Consciousness.
  8422. Changes in Vital Signs.
  8423. Ocular Signs.
  8424. Decrease in Motor Function.
  8425. Headache.
  8426. Vomiting.
  8427. FIG. 57-5 Decorticate and decerebrate posturing. A, Decorticate response. Flexion of arms, wrists, and fingers with adduction in upper extremities. Extension, internal rotation, and plantar flexion in lower extremities. B, Decerebrate response. All four extremities in rigid extension, with hyperpronation of forearms and plantar flexion of feet. C, Decorticate response on right side of body and decerebrate response on left side of body. D, Opisthotonic posturing.
  8428. Complications
  8429. Diagnostic Studies
  8430. TABLE 57-3 COLLABORATIVE CARE: Increased Intracranial Pressure
  8431. Monitoring Intracranial Pressure and Cerebral Oxygenation
  8432. Indications for Intracranial Pressure Monitoring.
  8433. Methods of Measuring Intracranial Pressure.
  8434. FIG. 57-6 Coronal section of brain showing potential sites for placement of intracranial pressure monitoring devices.
  8435. FIG. 57-7 Intracranial pressure (ICP) monitoring can be used to continuously measure ICP. The ICP tracing shows normal, elevated, and plateau waves. At high ICP the P2 peak is higher than the P1 peak, and the peaks become less distinct and plateau.
  8436. FIG. 57-8 Ventriculostomy in place. Cerebrospinal fluid (CSF) can be drained via a ventriculostomy when intracranial pressure (ICP) exceeds the upper pressure parameter set by the physician. Intermittent drainage involves opening the three-way stopcock to allow CSF to flow into the drainage bag for brief periods (30 to 120 seconds) until the pressure is below the upper pressure parameters.
  8437. TABLE 57-4 NORMAL INTRACRANIAL PRESSURE WAVEFORMS*
  8438. FIG. 57-9 A, Leveling a ventriculostomy. B, Cerebrospinal fluid is drained into a drainage system.
  8439. Cerebrospinal Fluid Drainage.
  8440. Cerebral Oxygenation Monitoring.
  8441. Collaborative Care
  8442. FIG. 57-10 A, The LICOX brain tissue oxygen system involves a catheter inserted through an intracranial bolt. B, The system measures oxygen in the brain (PbtO2), brain tissue temperature, and intracranial pressure.
  8443. Drug Therapy.
  8444. Nutritional Therapy.
  8445. Nursing Management Increased Intracranial Pressure
  8446. Nursing Assessment
  8447. Glasgow Coma Scale.
  8448. TABLE 57-5 GLASGOW COMA SCALE
  8449. Neurologic Assessment.
  8450. FIG. 57-11 Pupillary check for size and response.
  8451. FIG. 57-12 Common abnormal respiratory patterns associated with coma.
  8452. Nursing Diagnoses
  8453. Planning
  8454. Nursing Implementation
  8455. Acute Intervention
  8456. Respiratory Function.
  8457. Safety Alert
  8458. Fluid and Electrolyte Balance.
  8459. Monitoring Intracranial Pressure.
  8460. Body Position.
  8461. Protection From Injury.
  8462. Psychologic Considerations.
  8463. Evaluation
  8464. Head Injury
  8465. Types of Head Injuries
  8466. Scalp Lacerations.
  8467. Skull Fractures.
  8468. TABLE 57-6 TYPES OF SKULL FRACTURES
  8469. TABLE 57-7 MANIFESTATIONS OF SKULL FRACTURES
  8470. FIG. 57-13 A, Raccoon eyes and rhinorrhea. B, Battle’s sign (postauricular ecchymosis) with otorrhea. C, Battle’s sign. D, Halo or ring sign (see text).
  8471. Head Trauma.
  8472. Diffuse Injury.
  8473. Diffuse Axonal Injury.
  8474. Focal Injury.
  8475. FIG. 57-14 Coup-contrecoup injury. After the head strikes the wall, a coup injury occurs as the brain strikes the skull (primary impact). The contrecoup injury (the secondary impact) occurs when the brain strikes the skull surface opposite the site of the original impact.
  8476. Complications
  8477. Epidural Hematoma.
  8478. FIG. 57-15 Locations of epidural, subdural, and subarachnoid hematomas.
  8479. FIG. 57-16 Epidural hematoma covering a portion of the dura. Multiple small contusions are seen in the temporal lobe.
  8480. Subdural Hematoma.
  8481. TABLE 57-8 TYPES OF SUBDURAL HEMATOMAS
  8482. Intracerebral Hematoma.
  8483. Diagnostic Studies and Collaborative Care
  8484.  TABLE 57-9 EMERGENCY MANAGEMENT: Head Injury
  8485. Blunt
  8486. Penetrating
  8487. Surface Findings
  8488. Respiratory
  8489. Central Nervous System
  8490. Initial
  8491. Ongoing Monitoring
  8492. Nursing Management Head Injury
  8493. Nursing Assessment
  8494. Nursing Diagnoses
  8495. TABLE 57-10 NURSING ASSESSMENT: Head Injury
  8496. Planning
  8497. Ethical/Legal Dilemmas Brain Death
  8498. Situation
  8499. Ethical/Legal Points for Consideration
  8500. Discussion Questions
  8501. Nursing Implementation
  8502. Health Promotion.
  8503. Acute Intervention.
  8504. TABLE 57-11 PATIENT & CAREGIVER TEACHING GUIDE: Head Injury
  8505. Ambulatory and Home Care.
  8506. Evaluation
  8507. Brain Tumors
  8508. Types
  8509.  Cultural & Ethnic Health Disparities
  8510. TABLE 57-12 TYPES OF BRAIN TUMORS
  8511. FIG. 57-17 A, A large glioblastoma (G) arises from one cerebral hemisphere and has grown to fill the ventricular system. B, Meningioma. These two different sections from different levels in the same brain show a meningioma (M) compressing the frontal lobe and distorting underlying brain.
  8512. FIG. 57-18 Each area of the brain controls a particular activity.
  8513. Clinical Manifestations and Complications
  8514. TABLE 57-13 MANIFESTATIONS OF BRAIN TUMORS
  8515. Diagnostic Studies
  8516. Collaborative Care
  8517. Surgical Therapy.
  8518. Ventricular Shunts.
  8519. Radiation Therapy and Stereotactic Radiosurgery.
  8520. Chemotherapy and Targeted Therapy.
  8521. Drug Alert
  8522. Other Therapies.
  8523. Nursing Management Brain Tumors
  8524. Nursing Assessment
  8525. Nursing Diagnoses
  8526. Planning
  8527. Nursing Implementation
  8528. Evaluation
  8529. TABLE 57-14 INDICATIONS FOR CRANIAL SURGERY
  8530. TABLE 57-15 TYPES OF CRANIAL SURGERY
  8531. Cranial Surgery
  8532. Types
  8533. Craniotomy.
  8534. Stereotactic Radiosurgery.
  8535. Nursing Management Cranial Surgery
  8536. Nursing Implementation
  8537. Acute Intervention.
  8538. FIG. 57-19 A, Patient in a stereotactic frame. B, Elekta’s Fraxion head frame helps ensure accuracy and precision in stereotactic radiation therapy (SRT) of cancer targets in the brain and cranium.
  8539. Ethical/Legal Dilemmas Withholding Treatment
  8540. Situation
  8541. Ethical/Legal Points for Consideration
  8542. Discussion Questions
  8543. Ambulatory and Home Care.
  8544. TABLE 57-16 COMPARISON OF CEREBRAL INFLAMMATORY CONDITIONS
  8545. Inflammatory Conditions of the Brain
  8546. Brain Abscess
  8547. Bacterial Meningitis
  8548. Etiology and Pathophysiology
  8549. Clinical Manifestations
  8550. Complications
  8551. Diagnostic Studies
  8552. Collaborative Care
  8553. TABLE 57-17 COLLABORATIVE CARE: Bacterial Meningitis
  8554. Nursing Management Bacterial Meningitis
  8555. Nursing Assessment
  8556. Nursing Diagnoses
  8557. Planning
  8558. Nursing Implementation
  8559. Health Promotion.
  8560. Acute Intervention.
  8561. Ambulatory and Home Care.
  8562. Evaluation
  8563. Viral Meningitis
  8564. Encephalitis
  8565. Clinical Manifestations and Diagnostic Studies
  8566. Nursing and Collaborative Management Encephalitis
  8567. Rabies
  8568. Case Study Traumatic Brain Injury
  8569. Patient Profile
  8570. Subjective Data
  8571. Objective Data
  8572. Diagnostic Studies
  8573. Discussion Questions
  8574. Bridge to NCLEX Examination
  8575. References
  8576. Resources
  8577. Pageburst Integrated Resources
  8578. Animations
  8579. Answer Keys
  8580. Care Plans
  8581. Case Studies
  8582. Concept Map Creator
  8583. Content Updates
  8584. eFigures
  8585. Glossary
  8586. Key Points
  8587. Chapter 58 Nursing Management: Stroke
  8588. Learning Outcomes
  8589. Key Terms
  8590. TABLE 58-1 PATIENT & CAREGIVER TEACHING GUIDE: Warning Signs of Stroke
  8591. Pathophysiology of Stroke
  8592. Anatomy of Cerebral Circulation
  8593. Regulation of Cerebral Blood Flow
  8594. FIG. 58-1 Cerebral arteries and the circle of Willis. The top of the temporal lobe has been removed to show the course of the middle cerebral artery.
  8595. Risk Factors for Stroke
  8596. Nonmodifiable Risk Factors
  8597. Gender Differences
  8598.  Cultural & Ethnic Health Disparities
  8599. African Americans
  8600. Other Ethnicities
  8601. Modifiable Risk Factors
  8602. Transient Ischemic Attack
  8603. Types of Stroke
  8604. Ischemic Stroke
  8605. Thrombotic Stroke.
  8606. TABLE 58-2 TYPES OF STROKE
  8607. FIG. 58-2 Major types of stroke.
  8608. Embolic Stroke.
  8609. Hemorrhagic Stroke
  8610. Intracerebral Hemorrhage.
  8611. FIG. 58-3 Massive hypertensive hemorrhage rupturing into a lateral ventricle of the brain.
  8612. Subarachnoid Hemorrhage.
  8613. Safety Alert
  8614. Clinical Manifestations of Stroke
  8615. Motor Function
  8616. TABLE 58-3 STROKE MANIFESTATIONS RELATED TO ARTERY INVOLVEMENT
  8617. FIG. 58-4 Manifestations of right-brain and left-brain stroke.
  8618. Communication
  8619. Affect
  8620. Intellectual Function
  8621. TABLE 58-4 TYPES OF APHASIA
  8622. Spatial-Perceptual Alterations
  8623. Elimination
  8624. Diagnostic Studies for Stroke
  8625. TABLE 58-5 DIAGNOSTIC STUDIES: Stroke
  8626. Collaborative Care for Stroke
  8627. Preventive Therapy
  8628. TABLE 58-6 COLLABORATIVE CARE: Stroke
  8629. Healthy People
  8630. Preventive Drug Therapy.
  8631. Evidence-Based Practice Translating Research Into Practice
  8632. Can Mirror Therapy Improve Functioning After Stroke?
  8633. Clinical Question
  8634. Best Available Evidence
  8635. Critical Appraisal and Synthesis of Evidence
  8636. Conclusion
  8637. Implications for Nursing Practice
  8638. Reference for Evidence
  8639. Drug Alert
  8640. Surgical Therapy for TIA and Stroke Prevention.
  8641. FIG. 58-5 Carotid endarterectomy is performed to prevent impending cerebral infarction. A, A tube is inserted above and below the blockage to reroute the blood flow. B, Atherosclerotic plaque in the common carotid artery is removed. C, Once the artery is stitched closed, the tube can be removed. A surgeon may also perform the technique without rerouting the blood flow.
  8642. FIG. 58-6 Brain stent used to treat blockages in cerebral blood flow. A, A balloon catheter is used to implant the stent into an artery of the brain. B, The balloon catheter is moved to the blocked area of the artery and then inflated. The stent expands due to inflation of the balloon. C, The balloon is deflated and withdrawn, leaving the stent permanently in place holding the artery open and improving the flow of blood.
  8643. Acute Care for Ischemic Stroke
  8644.  TABLE 58-7 EMERGENCY MANAGEMENT: Stroke
  8645. Initial
  8646. Ongoing Monitoring
  8647. Drug Therapy for Ischemic Stroke.
  8648. Surgical Therapy for Ischemic Stroke.
  8649. FIG. 58-7 The MERCI retriever removes blood clots in patients who are experiencing ischemic strokes. The retriever is a long, thin wire that is threaded through a catheter into the femoral artery. The wire is pushed through the end of the catheter up to the carotid artery. The wire reshapes itself into tiny loops that latch onto the clot, and the clot can then be pulled out. To prevent the clot from breaking off, a balloon at the end of the catheter inflates to stop blood flow through the artery. MERCI, Mechanical embolus removal in cerebral ischemia.
  8650. Acute Care for Hemorrhagic Stroke
  8651. Drug Therapy for Hemorrhagic Stroke.
  8652. Surgical Therapy for Hemorrhagic Stroke.
  8653. FIG. 58-8 Clipping of aneurysms.
  8654. FIG. 58-9 Guglielmi detachable coil (GDC). A, A coil is used to occlude an aneurysm. Coils are made of soft, springlike platinum. The softness of the platinum allows the coil to assume the shape of irregularly shaped aneurysms while posing little threat of rupture of the aneurysm. B, A catheter is inserted through an introducer (small tube) in an artery in the leg. The catheter is threaded up to the cerebral blood vessels. C, Platinum coils attached to a thin wire are inserted into the catheter and then placed in the aneurysm until the aneurysm is filled with coils. Packing the aneurysm with coils prevents the blood from circulating through the aneurysm, reducing the risk of rupture.
  8655. Drug Alert
  8656. Rehabilitation Care
  8657. Nursing Management Stroke
  8658. Nursing Assessment
  8659. TABLE 58-8 NURSING ASSESSMENT: Stroke
  8660. Nursing Diagnoses
  8661. TABLE 58-9 NATIONAL INSTITUTES OF HEALTH STROKE SCALE (NIHSS)
  8662. Planning
  8663. Nursing Implementation
  8664. Health Promotion.
  8665. Acute Intervention
  8666. Respiratory System.
  8667.  Nursing Care Plan 58-1
  8668. Patient With Stroke
  8669. Nursing Diagnosis*
  8670. Patient Goal
  8671. Tissue Perfusion: Cerebral
  8672. Measurement Scale
  8673. Cerebral Perfusion Promotion
  8674. Nursing Diagnosis
  8675. Patient Goals
  8676. Respiratory Status: Airway Patency
  8677. Measurement Scale
  8678. Aspiration Precautions
  8679. Airway Management
  8680. Nursing Diagnosis
  8681. Patient Goals
  8682. Mobility
  8683. Exercise Therapy: Muscle Control
  8684. Nursing Diagnosis
  8685. Patient Goals
  8686. Communication
  8687. Communication Enhancement: Speech Deficit
  8688. Nursing Diagnosis
  8689. Patient Goals
  8690. Heedfulness of Affected Side
  8691. Unilateral Neglect Management
  8692. Nursing Diagnosis
  8693. Patient Goals
  8694. Urinary Continence
  8695. Measurement Scale
  8696. Urinary Habit Training
  8697. Nursing Diagnosis
  8698. Patient Goal
  8699. Swallowing Status
  8700. Measurement Scale
  8701. Swallowing Therapy
  8702. Nursing Diagnosis
  8703. Patient Goals
  8704. Self-Esteem
  8705. Self-Esteem Enhancement
  8706. Neurologic System.
  8707. Cardiovascular System.
  8708. Musculoskeletal System.
  8709. Integumentary System.
  8710. Delegation Decisions Caring for the Patient With an Acute Stroke
  8711. Role of Registered Nurse (RN)
  8712. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  8713. Role of Unlicensed Assistive Personnel (UAP)
  8714. Gastrointestinal System.
  8715. Urinary System.
  8716. Nutrition.
  8717. Safety Alert
  8718. Communication.
  8719. FIG. 58-10 Assistive devices for eating. A, The curved fork fits over the hand. The rounded plate helps keep food on the plate. Special grips and swivel handles are helpful for some persons. B, Knives with rounded blades are rocked back and forth to cut food. The person does not need a fork in one hand and a knife in the other. C, Plate guards help keep food on the plate. D, Cup with special handle.
  8720. Sensory-Perceptual Alterations.
  8721. FIG. 58-11 Spatial and perceptual deficits in stroke. Perception of a patient with homonymous hemianopsia shows that food on the left side is not seen and thus is ignored.
  8722. TABLE 58-10 COMMUNICATION WITH A PATIENT WITH APHASIA
  8723. Coping.
  8724. Ambulatory and Home Care.
  8725. Rehabilitation.
  8726. Musculoskeletal Function.
  8727. Informatics in Practice Video Games for Stroke Recovery
  8728. FIG. 58-12 Loss of postural stability is common after stroke. When the nondominant hemisphere is involved, walking apraxia and loss of postural control are usually apparent. The patient is unable to sit upright and tends to fall sideways. Provide appropriate support with pillows or cushions.
  8729. Stroke Survivorship and Coping.
  8730. Sexual Function.
  8731. Community Integration.
  8732. Gerontologic Considerations
  8733. Stroke
  8734. Case Study Stroke
  8735. Patient Profile
  8736. Subjective Data
  8737. Objective Data
  8738. Past Medical History
  8739. Discussion Questions
  8740. Bridge to NCLEX Examination
  8741. References
  8742. Resources
  8743. Pageburst Integrated Resources
  8744. Answer Keys
  8745. Care Plans
  8746. Case Studies
  8747. Concept Map
  8748. Concept Map Creator
  8749. Content Updates
  8750. Glossary
  8751. Key Points
  8752. Chapter 59 Nursing Management: Chronic Neurologic Problems
  8753. Learning Outcomes
  8754. Key Terms
  8755. eFigure
  8756. Headaches
  8757. TABLE 59-1 COMPARISON OF TYPES OF HEADACHES
  8758. Tension-Type Headache
  8759. Etiology and Pathophysiology
  8760. Clinical Manifestations
  8761. Diagnostic Studies
  8762. FIG. 59-1 Location of pain for common headache syndromes. A, Tension headache is often described as feeling of a weight in or on the head or a band squeezing the head. B, Migraine headache is described as an intense throbbing or pounding pain that involves one temple. The pain usually is unilateral (on one side of the head), although it can be bilateral. C, Cluster headache pain is focused in and around one eye and is often described as sharp, penetrating, or burning.
  8763. TABLE 59-2 DIAGNOSTIC STUDIES: Headaches
  8764. Gender Differences
  8765. Migraine Headache
  8766. Etiology and Pathophysiology
  8767. Clinical Manifestations
  8768. Diagnostic Studies
  8769. Cluster Headache
  8770. Etiology and Pathophysiology
  8771. Clinical Manifestations
  8772. Diagnostic Studies
  8773. Other Types of Headaches
  8774. Collaborative Care for Headaches
  8775. Drug Therapy
  8776. Tension-Type Headache.
  8777. Migraine Headache.
  8778. Drug Alert
  8779. TABLE 59-3 COLLABORATIVE CARE: Headaches
  8780. Drug Alert
  8781. Cluster Headache.
  8782. Evidence-Based Practice Translating Research Into Practice
  8783. Can Botulinum Toxin A Prevent Headaches?
  8784. Clinical Question
  8785. Best Available Evidence
  8786. Critical Appraisal and Synthesis of Evidence
  8787. Conclusion
  8788. Implications for Nursing Practice
  8789. Reference for Evidence
  8790. Other Headaches.
  8791. TABLE 59-4 NURSING ASSESSMENT: Headaches
  8792. Nursing Management Headaches
  8793. Nursing Assessment
  8794. Nursing Diagnoses
  8795. Planning
  8796. Nursing Implementation
  8797. TABLE 59-5 PATIENT & CAREGIVER TEACHING GUIDE: Headaches
  8798. Evaluation
  8799. Chronic Neurologic Disorders
  8800. Seizure Disorders and Epilepsy
  8801. Etiology and Pathophysiology
  8802.  Genetic Link
  8803. TABLE 59-6 CLASSIFICATION OF SEIZURE DISORDERS
  8804. Clinical Manifestations
  8805. Generalized Seizures.
  8806. Tonic-Clonic Seizures.
  8807. Typical Absence Seizures.
  8808. Atypical Absence Seizures.
  8809. FIG. 59-2 Algorithm for classification of seizures.
  8810. Other Types of Generalized Seizures.
  8811. Focal Seizures.
  8812. Psychogenic Seizures.
  8813. Complications
  8814. Physical.
  8815. Psychosocial.
  8816. Diagnostic Studies
  8817. TABLE 59-7 COLLABORATIVE CARE: Seizure Disorders and Epilepsy
  8818. Collaborative Care
  8819. Drug Therapy.
  8820.  TABLE 59-8 EMERGENCY MANAGEMENT: Tonic-Clonic Seizures
  8821. Head Trauma
  8822. Drug-Related Processes
  8823. Infectious Processes
  8824. Intracranial Events
  8825. Metabolic Imbalances
  8826. Medical Disorders
  8827. Other
  8828. Initial
  8829. Ongoing Monitoring
  8830. TABLE 59-9 DRUG THERAPY: Seizure Disorders and Epilepsy
  8831. Drug Alert
  8832. Drug Alert
  8833. Gerontologic Considerations
  8834. Drug Therapy for Seizure Disorders
  8835. TABLE 59-10 SURGERY FOR SEIZURE DISORDERS
  8836. Surgical Therapy.
  8837. Other Therapies.
  8838. Nursing Management Seizure Disorders and Epilepsy
  8839. Nursing Assessment
  8840. Nursing Diagnoses
  8841. Planning
  8842. Nursing Implementation
  8843. Health Promotion.
  8844. Acute Intervention.
  8845. TABLE 59-11 NURSING ASSESSMENT: Seizure Disorders and Epilepsy
  8846. Delegation Decisions Caring for the Patient With a Seizure Disorder
  8847. Role of Registered Nurse (RN)
  8848. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  8849. Role of Unlicensed Assistive Personnel (UAP)
  8850. Safety Alert
  8851. Ambulatory and Home Care.
  8852. TABLE 59-12 PATIENT & CAREGIVER TEACHING GUIDE: Seizure Disorders and Epilepsy
  8853. Evaluation
  8854. Restless Legs Syndrome
  8855. Etiology and Pathophysiology
  8856. Clinical Manifestations
  8857. Diagnostic Studies
  8858. Nursing and Collaborative Management Restless Legs Syndrome
  8859. Degenerative Neurologic Disorders
  8860. Multiple Sclerosis
  8861. Etiology and Pathophysiology
  8862. FIG. 59-3 Pathogenesis of multiple sclerosis. A, Normal nerve cell with myelin sheath. B, Normal axon. C, Myelin breakdown. D, Myelin totally disrupted; axon not functioning.
  8863. Clinical Manifestations
  8864. FIG. 59-4 Chronic multiple sclerosis. Demyelination plaque (P) at gray-white junction and adjacent partially remyelinated shadow plaque (V).
  8865. TABLE 59-13 PATTERNS OF MULTIPLE SCLEROSIS
  8866. Diagnostic Studies
  8867. TABLE 59-14 COLLABORATIVE CARE: Multiple Sclerosis
  8868. Collaborative Care
  8869. Drug Therapy.
  8870. Drug Alert
  8871. TABLE 59-15 DRUG THERAPY: Multiple Sclerosis
  8872. FIG. 59-5 Water therapy provides exercise and recreation for the patient with a chronic neurologic disease.
  8873. Other Therapies.
  8874. Nursing Management Multiple Sclerosis
  8875. Nursing Assessment
  8876. TABLE 59-16 NURSING ASSESSMENT: Multiple Sclerosis
  8877. Nursing Diagnoses
  8878. Planning
  8879. Informatics in Practice Phone Applications in Multiple Sclerosis
  8880. Nursing Implementation
  8881. Evaluation
  8882. Parkinson’s Disease
  8883. Etiology and Pathophysiology
  8884.  Genetic Link
  8885. FIG. 59-6 Nigrostriatal disorders produce parkinsonism. Left-sided view of the human brain showing the substantia nigra and the corpus striatum (shaded area) lying deep within the cerebral hemisphere. Nerve fibers extend upward from the substantia nigra, divide into many branches, and carry dopamine to all regions of the corpus striatum.
  8886. FIG. 59-7 In Parkinson’s disease there is a deficit in dopamine. These deficits create an imbalance between dopamine and the excitatory neurotransmitter acetylcholine. A, In a healthy person, dopamine (DA) released from neurons originating in the substantia nigra inhibits the firing of neurons in the striatum that release γ-aminobutyric acid (GABA). Conversely, neurons located within the striatum, which release acetylcholine (ACh), excite the GABAergic neurons. Under normal conditions, the inhibitory actions of DA are balanced by the excitatory actions of ACh, and controlled movement results. B, In Parkinson’s disease, the neurons in the substantia nigra that supply DA to the striatum degenerate. When there is a deficit of DA, the excitatory effects of ACh go unopposed, resulting in disturbed movements (tremor, rigidity).
  8887. Clinical Manifestations
  8888. Tremor.
  8889. FIG. 59-8 In Parkinson’s disease, positron emission tomography (PET) scan showing reduced fluorodopa uptake in the basal ganglia (right) compared with a normal control (left).
  8890. Rigidity.
  8891. Bradykinesia.
  8892. FIG. 59-9 Characteristic appearance of a patient with Parkinson’s disease.
  8893. Complications
  8894. Diagnostic Studies
  8895. Collaborative Care
  8896. Drug Therapy.
  8897. TABLE 59-17 COLLABORATIVE CARE: Parkinson’s Disease
  8898. Drug Alert
  8899. Drug Alert
  8900. TABLE 59-18 DRUG THERAPY: Parkinson’s Disease
  8901. Surgical Therapy.
  8902. FIG. 59-10 A deep brain stimulator can be used to treat the tremors and uncontrolled movements in Parkinson’s disease. Electrodes are surgically placed in the brain and connected to a neurostimulator (pacemaker device) in the chest.
  8903. Nutritional Therapy.
  8904. Nursing Management Parkinson’s Disease
  8905. Nursing Assessment
  8906. TABLE 59-19 NURSING ASSESSMENT: Parkinson’s Disease
  8907. Nursing Diagnoses
  8908. Planning
  8909. Nursing Implementation
  8910. Safety Alert
  8911. Evaluation
  8912. Myasthenia Gravis
  8913. Etiology and Pathophysiology
  8914. Clinical Manifestations and Complications
  8915. FIG. 59-11 “Peek” sign in myasthenia gravis. During sustained forced eyelid closure he is unable to bury his eyelashes (left) and, after 30 sec, he is unable to keep the lids fully closed (right).
  8916. Diagnostic Studies
  8917. Collaborative Care
  8918. Drug Therapy.
  8919. TABLE 59-20 COLLABORATIVE CARE: Myasthenia Gravis
  8920. Surgical Therapy.
  8921. Other Therapies.
  8922. Nursing Management Myasthenia Gravis
  8923. Nursing Assessment
  8924. Nursing Diagnoses
  8925. Planning
  8926. Nursing Implementation
  8927. TABLE 59-21 COMPARISON OF MYASTHENIC AND CHOLINERGIC CRISES
  8928. Evaluation
  8929. Amyotrophic Lateral Sclerosis
  8930.  Genetics in Clinical Practice
  8931. Genetic Basis
  8932. Incidence
  8933. Genetic Testing
  8934. Clinical Implications
  8935. Huntington’s Disease
  8936. Informatics in Practice Social Networking in Huntington’s Disease
  8937. Case Study Epilepsy With Headache
  8938. Patient Profile
  8939. Subjective Data
  8940. Objective Data
  8941. Discussion Questions
  8942. Bridge to NCLEX Examination
  8943. References
  8944. Resources
  8945. Pageburst Integrated Resources
  8946. Answer Keys
  8947. Care Plans
  8948. Case Studies
  8949. Concept Map
  8950. Concept Map Creator
  8951. Content Updates
  8952. eFigures
  8953. Glossary
  8954. Key Points
  8955. Chapter 60 Nursing Management: Alzheimer’s Disease, Dementia, and Delirium
  8956. Learning Outcomes
  8957. Key Terms
  8958. eTable
  8959. Dementia
  8960. TABLE 60-1 COMPARISON OF DEMENTIA, DELIRIUM, AND DEPRESSION
  8961. FIG. 60-1 Causes of dementia.
  8962. Etiology and Pathophysiology
  8963. Risk Factors.
  8964. TABLE 60-2 CAUSES OF DEMENTIA
  8965. Clinical Manifestations
  8966. Diagnostic Studies
  8967. Nursing and Collaborative Management Dementia
  8968. Alzheimer’s Disease
  8969. Etiology and Pathophysiology
  8970. Gender Differences
  8971.  Genetics in Clinical Practice
  8972. Genetic Basis
  8973. Early Onset (Familial) (<60 Yr Old at Onset)
  8974. Late Onset (Sporadic) (>60 Yr Old at Onset)
  8975. Incidence
  8976. Early Onset
  8977. Late Onset
  8978. Genetic Testing
  8979. Early Onset
  8980. Late Onset
  8981. Clinical Implications
  8982. FIG. 60-2 Pathologic changes in Alzheimer’s disease A, Plaque with central amyloid core (white arrow) next to a neurofibrillary tangle (red arrow) on the histologic specimen from a brain autopsy. B, Schematic representation of amyloid plaque and neurofibrillary tangle.
  8983.  Genetic Link
  8984. FIG. 60-3 Current etiologic theories for the development of Alzheimer’s disease. A, Abnormal amounts of β-amyloid are cleaved from the amyloid precursor protein (APP) and released into the circulation. The β-amyloid fragments come together in clumps to form plaques that attach to the neuron. Microglia react to the plaque, and an inflammatory response results. B, Tau proteins provide structural support for the neuron microtubules. Chemical changes in the neuron produce structural changes in tau proteins. This results in twisting and tangling (neurofibrillary tangles).
  8985. Environmental Factors.
  8986. Clinical Manifestations
  8987. FIG. 60-4 Effects of Alzheimer’s disease on the brain. This figure compares a normal brain (left) with a brain that has been affected by Alzheimer’s disease (right).
  8988. Retrogenesis.
  8989. TABLE 60-3 PATIENT & CAREGIVER TEACHING GUIDE: Early Warning Signs of Alzheimer’s Disease
  8990. Diagnostic Criteria for Alzheimer’s Disease
  8991. TABLE 60-4 STAGES OF ALZHEIMER’S DISEASE
  8992. TABLE 60-5 COMPARISON OF NORMAL FORGETFULNESS AND MEMORY LOSS
  8993. TABLE 60-6 RETROGENESIS IN ALZHEIMER’S DISEASE
  8994. TABLE 60-7 DIAGNOSTIC CRITERIA FOR ALZHEIMER’S DISEASE*
  8995. Preclinical Stage.
  8996. Mild Cognitive Impairment.
  8997. Diagnostic Studies
  8998. TABLE 60-8 COLLABORATIVE CARE: Alzheimer’s Disease
  8999. Diagnostic
  9000. Collaborative Therapy
  9001. FIG. 60-5 Positron emission tomography (PET) scan can be used to assist in the diagnosis of Alzheimer’s disease (AD). Radioactive fluorine is applied to glucose (fluorodeoxyglucose), and the yellow areas indicate metabolically active cells. A, A normal brain. B, Advanced AD is recognized by hypometabolism in many areas of the brain.
  9002. TABLE 60-9 THE MINI-COG
  9003. FIG. 60-6 Clock drawing is a simple test that can be used as an assessment technique in dementia. The person undergoing testing is asked to draw a clock, put in all of the numbers, and set the hands at 10 past 11. A, Shows a clock drawn by a person with no dementia. B and C show clocks drawn by people with dementia.
  9004. Collaborative Care
  9005. Drug Therapy.
  9006. TABLE 60-10 DRUG THERAPY: Alzheimer’s Disease
  9007. FIG. 60-7 Mechanism of action of cholinesterase inhibitors. A, Acetylcholine is released from the nerve synapses and carries a message across the synapse. B, Cholinesterase breaks down acetylcholine. C, Cholinesterase inhibitors block cholinesterase, thus giving acetylcholine more time to transmit the message.
  9008. Nursing Management Alzheimer’s Disease
  9009. Nursing Assessment
  9010. Nursing Diagnoses
  9011. Planning
  9012. Nursing Implementation
  9013. Health Promotion.
  9014. TABLE 60-11 NURSING ASSESSMENT: Alzheimer’s Disease
  9015. Acute Intervention.
  9016. Ambulatory and Home Care.
  9017. Behavioral Problems.
  9018. Safety.
  9019. Safety Alert
  9020. Delegation Decisions Caring for the Patient With Alzheimer’s Disease
  9021. Role of Registered Nurse (RN)
  9022. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  9023. Role of Unlicensed Assistive Personnel (UAP)
  9024. Pain Management.
  9025. Eating and Swallowing Difficulties.
  9026. Oral Care.
  9027. Infection Prevention.
  9028. Skin Care.
  9029. Elimination Problems.
  9030. Caregiver Support.
  9031. FIG. 60-8 Caregivers of patients with dementia face an incredible challenge that often causes deterioration in their own physical and emotional health.
  9032. TABLE 60-12 FAMILY & CAREGIVER TEACHING GUIDE: Alzheimer’s Disease
  9033. Evaluation
  9034. TABLE 60-13 GUIDELINES FOR DEALING WITH DEMENTIA PATIENTS
  9035. FIG. 60-9 Support groups are an effective way to help caregivers cope.
  9036. Other Neurodegenerative Diseases
  9037. Evidence-Based Practice Translating Research Into Practice
  9038. Does Cognitive Reframing Help Caregivers of Patients With Dementia?
  9039. Clinical Question
  9040. Best Available Evidence
  9041. Critical Appraisal and Synthesis of Evidence
  9042. Conclusion
  9043. Implications for Nursing Practice
  9044. Reference for Evidence
  9045. Delirium
  9046. TABLE 60-14 FACTORS THAT PRECIPITATE DELIRIUM
  9047. Demographic Characteristics
  9048. Cognitive Status
  9049. Environmental
  9050. Functional Status
  9051. Sensory
  9052. Decreased Oral Intake
  9053. Drugs
  9054. Coexisting Medical Conditions
  9055. Surgery
  9056. Etiology and Pathophysiology
  9057. TABLE 60-15 MNEMONIC FOR CAUSES OF DELIRIUM
  9058. Clinical Manifestations
  9059. Diagnostic Studies
  9060. TABLE 60-16 CONFUSION ASSESSMENT METHOD (CAM)
  9061. Nursing And Collaborative Management Delirium
  9062. Ethical/Legal Dilemmas Board of Nursing Disciplinary Action
  9063. Situation
  9064. Ethical/Legal Points for Consideration
  9065. Discussion Questions
  9066. Drug Therapy
  9067. Case Study Alzheimer’s Disease
  9068. Patient Profile
  9069. Subjective Data
  9070. Objective Data
  9071. Physical Examination
  9072. Diagnostic Studies
  9073. Discussion Questions
  9074. Bridge to NCLEX Examination
  9075. References
  9076. Resources
  9077. Pageburst Integrated Resources
  9078. Answer Keys
  9079. Care Plans
  9080. Case Studies
  9081. Concept Map Creator
  9082. Content Updates
  9083. eTables
  9084. Glossary
  9085. Key Points
  9086. Chapter 61 Nursing Management: Peripheral Nerve and Spinal Cord Problems
  9087. Learning Outcomes
  9088. Key Terms
  9089. eFigures
  9090. eTable
  9091. Cranial Nerve Disorders
  9092. Trigeminal Neuralgia
  9093. Etiology and Pathophysiology
  9094. FIG. 61-1 A, Trigeminal (fifth cranial) nerve and its three main divisions: ophthalmic, maxillary, and mandibular nerves. B, Cutaneous innervation of the head.
  9095. Clinical Manifestations
  9096. Diagnostic Studies
  9097. Collaborative Care
  9098. Drug Therapy.
  9099. TABLE 61-1 COLLABORATIVE CARE: Trigeminal Neuralgia
  9100. TABLE 61-2 SURGICAL THERAPY FOR TRIGEMINAL NEURALGIA
  9101. Conservative Therapy.
  9102. Surgical Therapy.
  9103. FIG. 61-2 A, Patient with trigeminal neuralgia having needle placed. B, Physician injecting glycerol.
  9104. Nursing Management Trigeminal Neuralgia
  9105. Bell’s Palsy
  9106. Etiology and Pathophysiology
  9107. FIG. 61-3 Facial characteristics of Bell’s palsy. A, At rest the face may look almost normal, but the patient is not able to wrinkle her forehead on the affected side and the right corner of the mouth droops. B, When she is asked to close her eyes and show her teeth, the differences between the affected and unaffected sides become more obvious.
  9108. Clinical Manifestations and Diagnostic Studies
  9109. Collaborative Care
  9110. Nursing Management Bell’s Palsy
  9111. Polyneuropathies
  9112. Guillain-Barré Syndrome
  9113. Etiology and Pathophysiology
  9114. Clinical Manifestations and Complications
  9115. Diagnostic Studies
  9116. Nursing and Collaborative Management Guillain-Barré Syndrome
  9117. Botulism
  9118. Tetanus
  9119. Neurosyphilis
  9120. Spinal Cord Problems
  9121. Spinal Cord Injury
  9122. Etiology and Pathophysiology
  9123. Types of Injury.
  9124. Primary Injury.
  9125. Secondary Injury.
  9126. Ethical/Legal Dilemmas Right to Refuse Treatment
  9127. Situation
  9128. Ethical/Legal Points for Consideration
  9129. Discussion Questions
  9130. FIG. 61-4 Cascade of metabolic and cellular events that leads to spinal cord ischemia and hypoxia of secondary injury. RBCs, Red blood cells; SCBF, spinal cord blood flow.
  9131. Spinal and Neurogenic Shock.
  9132. Classification of Spinal Cord Injury.
  9133. Mechanisms of Injury.
  9134. Level of Injury.
  9135. Degree of Injury.
  9136. Clinical Manifestations
  9137. American Spinal Injury Association (ASIA) Impairment Scale.
  9138. Respiratory System.
  9139. FIG. 61-5 Mechanisms of spinal cord injury. Many situations may produce these injuries. This only shows some examples. A, Flexion injury of the cervical spine ruptures the posterior ligaments. B, Hyperextension injury of the cervical spine ruptures the anterior ligaments. C, Compression fractures crush the vertebrae and force bony fragments into the spinal canal. D, Flexion-rotation injury of the cervical spine often results in tearing of ligamentous structures that normally stabilize the spine.
  9140. Cardiovascular System.
  9141. FIG. 61-6 Symptoms, degree of paralysis, and potential for rehabilitation depend on the level of the injury.
  9142. FIG. 61-7 The American Spinal Injury Association Impairment Scale. See eFig. 61-2 on the website for this chapter for standard neurologic classification of spinal cord injury.
  9143. Urinary System.
  9144. Gastrointestinal System.
  9145. TABLE 61-3 INCOMPLETE SPINAL CORD INJURY SYNDROMES
  9146. Integumentary System.
  9147. TABLE 61-4 LEVEL OF SPINAL CORD INJURY AND REHABILITATION POTENTIAL
  9148. Thermoregulation.
  9149. Metabolic Needs.
  9150. Peripheral Vascular Problems.
  9151. Diagnostic Studies
  9152. Collaborative Care
  9153.  TABLE 61-5 EMERGENCY MANAGEMENT: Spinal Cord Injury
  9154. Blunt Trauma
  9155. Penetrating Trauma
  9156. Initial
  9157. Ongoing Monitoring
  9158. TABLE 61-6 COLLABORATIVE CARE: Cervical Cord Injury
  9159. Acute Care
  9160. Rehabilitation and Home Care
  9161. Nonoperative Stabilization.
  9162. Surgical Therapy.
  9163. Drug Therapy.
  9164. Nursing Management Spinal Cord Injury
  9165. Nursing Assessment
  9166. Nursing Diagnoses
  9167. Planning
  9168. Nursing Implementation
  9169. Health Promotion.
  9170. Acute Intervention.
  9171. TABLE 61-7 NURSING ASSESSMENT: Spinal Cord Injury
  9172. Immobilization.
  9173. Safety Alert
  9174. FIG. 61-8 Cervical traction is attached to tongs inserted in the skull.
  9175. FIG. 61-9 The RotoRest Therapy System helps prevent and treat pulmonary complications for immobile patients, including those with unstable cervical, thoracic, and lumbar fractures. Kinetic therapy, the continual side-to-side bilateral rotation of the patient, redistributes pulmonary blood flow and mobilizes secretions to improve ventilation and perfusion matching. The therapy system also helps to prevent pressure ulcers.
  9176. Respiratory Dysfunction.
  9177. FIG. 61-10 Sternal-occipital-mandibular immobilizer brace.
  9178. FIG. 61-11 Halo vest. The halo traction brace immobilizes the cervical spine, which allows the patient to ambulate and participate in self-care.
  9179. Cardiovascular Instability.
  9180. Fluid and Nutritional Maintenance.
  9181. Bladder and Bowel Management.
  9182. Evidence-Based Practice Applying the Evidence
  9183. Your Decision and Action
  9184. References for Evidence
  9185. Temperature Control.
  9186. Stress Ulcers.
  9187. Sensory Deprivation.
  9188. Reflexes.
  9189. Autonomic Dysreflexia.
  9190. Rehabilitation and Home Care.
  9191. Respiratory Rehabilitation.
  9192. TABLE 61-8 PATIENT & CAREGIVER TEACHING GUIDE: Autonomic Dysreflexia
  9193. Neurogenic Bladder.
  9194. FIG. 61-12 Patient participating in occupational therapy.
  9195. TABLE 61-9 TYPES OF NEUROGENIC BLADDER
  9196. TABLE 61-10 COLLABORATIVE CARE: Neurogenic Bladder
  9197. TABLE 61-11 PATIENT & CAREGIVER TEACHING GUIDE: Bowel Management After Spinal Cord Injury
  9198. Neurogenic Bowel.
  9199. Neurogenic Skin.
  9200. TABLE 61-12 PATIENT & CAREGIVER TEACHING GUIDE: Skin Care After Spinal Cord Injury
  9201. Sexuality.
  9202. TABLE 61-13 PATIENT & CAREGIVER TEACHING GUIDE: Halo Vest Care
  9203. Grief and Depression.
  9204. TABLE 61-14 GRIEF RESPONSE IN SPINAL CORD INJURY
  9205. Evaluation
  9206. Gerontologic Considerations
  9207. Spinal Cord Injury
  9208. Spinal Cord Tumors
  9209. Etiology and Pathophysiology
  9210. FIG. 61-13 Types of spinal cord tumors.
  9211. TABLE 61-15 CLASSIFICATION OF SPINAL CORD TUMORS
  9212. Clinical Manifestations
  9213. Nursing and Collaborative Management Spinal Cord Tumors
  9214. Case Study Spinal Cord Injury
  9215. Patient Profile
  9216. Acute Phase
  9217. Subjective Data
  9218. Objective Data
  9219. Physical Examination
  9220. Diagnostic Studies
  9221. Collaborative Care
  9222. Discussion Questions (Acute Phase)
  9223. Patient Profile
  9224. Rehabilitation Phase
  9225. Subjective Data
  9226. Objective Data
  9227. Physical Examination
  9228. Discussion Questions (Rehabilitation Phase)
  9229. Bridge to NCLEX Examination
  9230. References
  9231. Resources
  9232. Pageburst Integrated Resources
  9233. Answer Keys
  9234. Care Plans
  9235. Case Studies
  9236. Concept Map Creator
  9237. Content Updates
  9238. eFigures
  9239. eTables
  9240. Glossary
  9241. Key Points
  9242. Chapter 62 Nursing Assessment: Musculoskeletal System
  9243. Learning Outcomes
  9244. Key Terms
  9245. Structures and Functions of Musculoskeletal System
  9246. Bone
  9247. Function.
  9248. Microscopic Structure.
  9249. Gross Structure.
  9250. FIG. 62-1 Bone structure. A, Cortical (compact) bone showing numerous structural units called osteons. B, Anatomy of a long bone (tibia) showing cancellous and compact bone.
  9251. Types.
  9252. Joints
  9253. FIG. 62-2 Classification of joints. A to C, Synarthrotic (immovable) and amphiarthrotic (slightly movable) joints. D and E, Diarthrodial (freely movable) joints.
  9254. Cartilage
  9255. Muscle
  9256. Types.
  9257. FIG. 62-3 Structure of diarthrodial (synovial) joint.
  9258. FIG. 62-4 Types of diarthrodial (synovial) joints.
  9259. Structure.
  9260. Contractions.
  9261. FIG. 62-5 Structure of a muscle.
  9262. Neuromuscular Junction.
  9263. Energy Source.
  9264. FIG. 62-6 Neuromuscular junction.
  9265. Ligaments and Tendons
  9266. Fascia
  9267. Bursae
  9268. Gerontologic Considerations
  9269. Effects of Aging on Musculoskeletal System
  9270. TABLE 62-1 GERONTOLOGIC ASSESSMENT DIFFERENCES: Musculoskeletal System
  9271. Assessment of Musculoskeletal System
  9272. Subjective Data
  9273. Important Health Information.
  9274. Past Health History.
  9275. Case Study Patient Introduction
  9276. Critical Thinking
  9277. Medications.
  9278. Surgery or Other Treatments.
  9279. Functional Health Patterns.
  9280. Health Perception–Health Management Pattern.
  9281. TABLE 62-2 HEALTH HISTORY: Musculoskeletal System
  9282.  Genetic Risk Alert
  9283. Autoimmune Diseases
  9284. Osteoporosis
  9285. Osteoarthritis, Gout, and Scoliosis
  9286. Muscular Dystrophy
  9287. Nutritional-Metabolic Pattern.
  9288. Elimination Pattern.
  9289. Activity-Exercise Pattern.
  9290. Sleep-Rest Pattern.
  9291. Cognitive-Perceptual Pattern.
  9292. Self-Perception–Self-Concept Pattern.
  9293. Role-Relationship Pattern.
  9294. Sexuality-Reproductive Pattern.
  9295. Coping–Stress Tolerance Pattern.
  9296. Case Study—cont’d
  9297. Value-Belief Pattern.
  9298. Objective Data
  9299. Physical Examination.
  9300. Inspection.
  9301. Palpation.
  9302. FIG. 62-7 A, Goniometer. B, Measurement of joint range of motion using a goniometer.
  9303. Motion.
  9304. TABLE 62-3 SYNOVIAL JOINT MOVEMENTS
  9305. Muscle-Strength Testing.
  9306. Measurement.
  9307. TABLE 62-4 MUSCLE STRENGTH SCALE
  9308. Other.
  9309. FIG. 62-8 Scoliosis in a standing erect posture.
  9310. TABLE 62-5 NORMAL PHYSICAL ASSESSMENT OF THE MUSCULOSKELETAL SYSTEM
  9311. Focused Assessment
  9312. Subjective
  9313. Objective: Diagnostic
  9314. Objective: Physical Examination
  9315. Inspect and Palpate
  9316. Diagnostic Studies of Musculoskeletal System
  9317. Case Study—cont’d
  9318. FIG. 62-9 Knee arthroscopy in progress. Notice the monitor in the background.
  9319. TABLE 62-6 ASSESSMENT ABNORMALITIES: Musculoskeletal System
  9320. TABLE 62-7 DIAGNOSTIC STUDIES: Musculoskeletal System
  9321. Case Study—cont’d
  9322. Bridge to NCLEX Examination
  9323. References
  9324. Resources
  9325. Pageburst Integrated Resources
  9326. Animations
  9327. Answer Keys
  9328. Concept Map Creator
  9329. Content Updates
  9330. Glossary
  9331. Key Points
  9332. Videos
  9333. Chapter 63 Nursing Management: Musculoskeletal Trauma and Orthopedic Surgery
  9334. Learning Outcomes
  9335. Key Terms
  9336. eFigures
  9337. Safety Alert
  9338. TABLE 63-1 PATIENT & CAREGIVER TEACHING GUIDE: Prevention of Musculoskeletal Problems in Older Adults
  9339. Soft Tissue Injuries
  9340. Sprains and Strains
  9341. TABLE 63-2 SPORTS-RELATED INJURIES
  9342. Nursing Management Sprains and Strains
  9343. Nursing Implementation
  9344. Health Promotion.
  9345. Acute Intervention.
  9346. Healthy People
  9347.  TABLE 63-3 EMERGENCY MANAGEMENT: Acute Soft Tissue Injury
  9348. Initial
  9349. Ongoing Monitoring
  9350. Ambulatory and Home Care.
  9351. Dislocation and Subluxation
  9352. FIG. 63-1 Soft tissue injury of the hip. A, Normal. B, Subluxation (partial dislocation). C, Dislocation.
  9353. Nursing and Collaborative Management Dislocation
  9354. Repetitive Strain Injury
  9355. Carpal Tunnel Syndrome
  9356. FIG. 63-2 Wrist structures involved in carpal tunnel syndrome. Median nerve distribution. Shaded areas depict the locations of pain in carpal tunnel syndrome.
  9357. Nursing and Collaborative Management Carpal Tunnel Syndrome
  9358. Rotator Cuff Injury
  9359. FIG. 63-3 A torn rotator cuff is repaired using arthroscopic surgery.
  9360. Meniscus Injury
  9361. FIG. 63-4 Arthroscopic views of the meniscus. A, Normal meniscus. B, Torn meniscus. C, Surgically repaired meniscus.
  9362. Nursing and Collaborative Management Meniscus Injury
  9363. Anterior Cruciate Ligament Injury
  9364. Nursing and Collaborative Management Anterior Cruciate Ligament Injury
  9365. FIG. 63-5 Anterior cruciate ligament (ACL) injury. A, Partial tear. B, Complete tear. C, Avulsion.
  9366. Bursitis
  9367. Fractures
  9368. Classification
  9369. FIG. 63-6 Fracture classification according to communication with the external environment.
  9370. FIG. 63-7 Types of fractures. A, Transverse fracture: the line of the fracture extends across the bone shaft at a right angle to the longitudinal axis. B, Spiral fracture: the line of the fracture extends in a spiral direction along the bone shaft. C, Greenstick fracture: an incomplete fracture with one side splintered and the other side bent. D, Comminuted fracture: a fracture with more than two fragments. The smaller fragments appear to be floating. E, Oblique fracture: the line of the fracture extends in an oblique direction. F, Pathologic fracture: a spontaneous fracture at the site of a bone disease. G, Stress fracture: occurs in normal or abnormal bone that is subject to repeated stress, such as from jogging or running.
  9371. Clinical Manifestations
  9372. TABLE 63-4 MANIFESTATIONS OF FRACTURE
  9373. Fracture Healing
  9374. FIG. 63-8 Bone healing (schematic representation). A, Bleeding at fractured ends of the bone with subsequent hematoma formation. B, Organization of hematoma into fibrous network. C, Invasion of osteoblasts, lengthening of collagen strands, and deposition of calcium. D, Callus formation: new bone is built up as osteoclasts destroy dead bone. E, Remodeling is accomplished as excess callus is resorbed and trabecular bone is laid down.
  9375. TABLE 63-5 COMPLICATIONS OF FRACTURE HEALING
  9376. TABLE 63-6 COLLABORATIVE CARE: Fractures
  9377. Diagnostic
  9378. Collaborative Therapy
  9379. Fracture Immobilization
  9380. Open Fractures
  9381. Collaborative Care
  9382. Fracture Reduction
  9383. Closed Reduction.
  9384. Open Reduction.
  9385. Traction.
  9386. FIG. 63-9 Buck’s traction is most commonly used for fractures of the hip and femur.
  9387. Delegation Decisions Caring for the Patient With a Cast or Traction
  9388. Role of Registered Nurse (RN)
  9389. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  9390. Role of Unlicensed Assistive Personnel (UAP)
  9391. FIG. 63-10 Balanced suspension skeletal traction. Most commonly used for fractures of the femur, hip, and lower leg.
  9392. Fracture Immobilization.
  9393. Casts.
  9394. FIG. 63-11 Common types of casts.
  9395. Upper Extremity Injuries.
  9396. Vertebral Injuries.
  9397. Lower Extremity Injuries.
  9398. FIG. 63-12 Knee immobilizer.
  9399. External Fixation.
  9400. Internal Fixation.
  9401. Electrical Bone Growth Stimulation.
  9402. FIG. 63-13 External fixators. A, Stabilization of hand injury. B, Stabilization of a tibial fracture.
  9403. FIG. 63-14 Views of internal fixation devices to stabilize a fractured tibia and fibula.
  9404. Drug Therapy.
  9405. Nutritional Therapy.
  9406. Nursing Management Fractures
  9407. Nursing Assessment
  9408. Neurovascular Assessment.
  9409.  TABLE 63-7 EMERGENCY MANAGEMENT: Fractured Extremity
  9410. Blunt Trauma
  9411. Penetrating Trauma
  9412. Other
  9413. Initial
  9414. Ongoing Monitoring
  9415. Nursing Diagnoses
  9416. Planning
  9417. Nursing Implementation
  9418. Health Promotion.
  9419. Acute Intervention.
  9420. TABLE 63-8 NURSING ASSESSMENT: Fracture
  9421. Preoperative Management.
  9422. Postoperative Management.
  9423. Evidence-Based Practice Translating Research Into Practice
  9424. Do Vitamin D Supplements Improve Strength in Older Adults?
  9425. Clinical Question
  9426. Best Available Evidence
  9427. Critical Appraisal and Synthesis of Evidence
  9428. Conclusion
  9429. Implications for Nursing Practice
  9430. Reference for Evidence
  9431. Other Measures.
  9432. Traction.
  9433. Informatics in Practice Staying Connected While Immobilized
  9434. Ambulatory and Home Care
  9435. Cast Care.
  9436. Psychosocial Problems.
  9437. TABLE 63-9 PATIENT & CAREGIVER TEACHING GUIDE: Cast Care
  9438. TABLE 63-10 PROBLEMS ASSOCIATED WITH MUSCULOSKELETAL INJURIES
  9439. Ambulation.
  9440. Assistive Devices.
  9441. Counseling and Referrals.
  9442. Evaluation
  9443. Complications of Fractures
  9444. Infection
  9445. Compartment Syndrome
  9446. Clinical Manifestations.
  9447. Collaborative Care.
  9448. FIG. 63-15 Fasciotomy associated with compartment syndrome. Stabilization of fracture with external fixator.
  9449. Venous Thromboembolism
  9450. Fat Embolism Syndrome
  9451. Clinical Manifestations.
  9452. Collaborative Care.
  9453. Types of Fractures
  9454. Colles’ Fracture
  9455. FIG. 63-16 Colles’ fracture. Fracture of the distal radius (R) and ulnar (U) styloid from patient falling on the outstretched hand.
  9456. Fracture of Humerus
  9457. Fracture of Pelvis
  9458. Ethical/Legal Dilemmas Entitlement to Treatment
  9459. Situation
  9460. Ethical/Legal Points for Consideration
  9461. Discussion Questions
  9462. FIG. 63-17 Femur with location of various types of fracture.
  9463. Fracture of Hip
  9464. Clinical Manifestations
  9465. Collaborative Care
  9466. FIG. 63-18 Types of surgical repair for a hip fracture.
  9467. FIG. 63-19 Total hip replacement (arthroplasty) with a cementless femoral prosthesis of metal alloy with a plastic acetabular socket.
  9468. Nursing Management Hip Fracture
  9469. Nursing Implementation
  9470. Preoperative Management.
  9471. Postoperative Management.
  9472. TABLE 63-11 PATIENT & CAREGIVER TEACHING GUIDE: Hip Replacement*
  9473. FIG. 63-20 Maintaining postoperative abduction following total hip replacement.
  9474. Ambulatory and Home Care.
  9475. Evaluation
  9476. Gerontologic Considerations
  9477. Hip Fracture
  9478. Femoral Shaft Fracture
  9479. Fracture of Tibia
  9480. Stable Vertebral Fracture
  9481. Facial Fracture
  9482. Mandibular Fracture
  9483. TABLE 63-12 MANIFESTATIONS OF FACIAL FRACTURES
  9484. Nursing Management Mandibular Fracture
  9485. FIG. 63-21 Intermaxillary fixation.
  9486. Amputation
  9487. Clinical Indications
  9488. TABLE 63-13 COLLABORATIVE CARE: Amputation
  9489. Diagnostic
  9490. Collaborative Therapy
  9491. Surgical
  9492. Rehabilitation
  9493. Diagnostic Studies
  9494. Collaborative Care
  9495. FIG. 63-22 Location and description of amputation sites of the upper and lower extremities. AKA, Above-the-knee amputation.
  9496. Nursing Management Amputation
  9497. Nursing Assessment
  9498. Nursing Diagnoses
  9499. Planning
  9500. Nursing Implementation
  9501. Health Promotion.
  9502. Acute Intervention.
  9503. Preoperative Management.
  9504. Postoperative Management.
  9505. FIG. 63-23 A double amputee fitted with prostheses.
  9506. FIG. 63-24 Mirror therapy, a type of treatment that may reduce phantom limb sensation and pain.
  9507. FIG. 63-25 Bandaging for the above-the-knee amputation residual limb. Figure-eight style covers progressive areas of the residual limb. Two elastic wraps are required.
  9508. Ambulatory and Home Care.
  9509. Special Considerations in Upper Limb Amputation.
  9510. TABLE 63-14 PATIENT & CAREGIVER TEACHING GUIDE: Following an Amputation
  9511. Evaluation
  9512. Gerontologic Considerations
  9513. Amputation
  9514. Common Joint Surgical Procedures
  9515. Types of Joint Surgeries
  9516. Synovectomy
  9517. Osteotomy
  9518. Debridement
  9519. Arthroplasty
  9520. Hip Arthroplasty.
  9521. Hip Resurfacing.
  9522. Knee Arthroplasty.
  9523. Finger Joint Arthroplasty.
  9524. Elbow and Shoulder Arthroplasty.
  9525. Ankle Arthroplasty.
  9526. Arthrodesis
  9527. Complications of Joint Surgery
  9528. Collaborative Care
  9529. Preoperative Management.
  9530. Postoperative Management.
  9531. Nursing Management Joint Surgery
  9532. Case Study Hip Fracture Surgery
  9533. Patient Profile
  9534. Subjective Data
  9535. Collaborative Care
  9536. Preoperative
  9537. Operative Procedure
  9538. Postoperative
  9539. Discussion Questions
  9540. Bridge to NCLEX Examination
  9541. References
  9542. Resources
  9543. Pageburst Integrated Resources
  9544. Answer Keys
  9545. Care Plans
  9546. Case Studies
  9547. Concept Map Creator
  9548. Content Updates
  9549. eFigures
  9550. Glossary
  9551. Key Points
  9552. Chapter 64 Nursing Management: Musculoskeletal Problems
  9553. Learning Outcomes
  9554. Key Terms
  9555. Osteomyelitis
  9556. Etiology and Pathophysiology
  9557. TABLE 64-1 ORGANISMS CAUSING OSTEOMYELITIS
  9558. Clinical Manifestations and Complications
  9559. FIG. 64-1 Development of osteomyelitis infection with involucrum and sequestrum.
  9560. Diagnostic Studies
  9561. FIG. 64-2 Resection of femur due to osteomyelitis.
  9562. Collaborative Care
  9563. Drug Alert
  9564. Nursing Management Osteomyelitis
  9565. Nursing Assessment
  9566. Nursing Diagnoses
  9567. TABLE 64-2 NURSING ASSESSMENT: Osteomyelitis
  9568. Planning
  9569. Nursing Implementation
  9570. Health Promotion.
  9571. Acute Intervention.
  9572. Ambulatory and Home Care.
  9573. Evaluation
  9574. Bone Tumors
  9575. Benign Bone Tumors
  9576. Osteochondroma
  9577. Malignant Bone Tumors
  9578. Osteosarcoma
  9579. TABLE 64-3 TYPES OF PRIMARY BONE TUMORS
  9580. FIG. 64-3 A, Osteosarcoma. B, Chondrosarcoma.
  9581. Metastatic Bone Cancer
  9582. Nursing Management Bone Cancer
  9583. Muscular Dystrophy
  9584.  Genetic Link
  9585. TABLE 64-4 TYPES OF MUSCULAR DYSTROPHY
  9586. Low Back Pain
  9587.  Genetics in Clinical Practice
  9588. Genetic Basis
  9589. Incidence
  9590. Genetic Testing
  9591. Clinical Implications
  9592. Acute Low Back Pain
  9593. Nursing and Collaborative Management Acute Low Back Pain
  9594. Nursing Assessment
  9595. Nursing Implementation
  9596. Health Promotion.
  9597. TABLE 64-5 NURSING ASSESSMENT: Low Back Pain
  9598. Healthy People
  9599. Acute Intervention.
  9600. TABLE 64-6 PATIENT & CAREGIVER TEACHING GUIDE: Low Back Problems
  9601. Ambulatory and Home Care.
  9602. Chronic Low Back Pain
  9603. Spinal Stenosis
  9604. Nursing and Collaborative Management Chronic Low Back Pain
  9605. Evidence-Based Practice Translating Research Into Practice
  9606. Can Yoga Improve Chronic Low Back Pain?
  9607. Clinical Question
  9608. Best Available Evidence
  9609. Critical Appraisal and Synthesis of Evidence
  9610. Conclusion
  9611. Implications for Nursing Practice
  9612. Reference for Evidence
  9613. Intervertebral Disc Disease
  9614. Etiology and Pathophysiology
  9615. Clinical Manifestations
  9616. FIG. 64-4 Common causes of degenerative disc damage.
  9617. Diagnostic Studies
  9618. Collaborative Care
  9619. Surgical Therapy.
  9620. TABLE 64-7 MANIFESTATIONS OF LUMBAR DISC HERNIATION*
  9621. TABLE 64-8 COLLABORATIVE CARE: Intervertebral Disc Disease
  9622. FIG. 64-5 The Charité artificial disc, used in degenerative disc disease to replace a damaged intervertebral disc. The Charité artificial disc consists of two cobalt-chromium alloy endplates sandwiched around a movable high-density plastic core. The disc’s design helps align the spine and preserve its natural ability to move.
  9623. Nursing Management Vertebral Disc Surgery
  9624. Neck Pain
  9625. TABLE 64-9 CAUSES OF NECK PAIN
  9626. TABLE 64-10 PATIENT & CAREGIVER TEACHING GUIDE: Neck Exercises
  9627. Foot Disorders
  9628. Nursing Management Foot Disorders
  9629. Nursing Implementation
  9630. Health Promotion.
  9631. Acute Intervention.
  9632. FIG. 64-6 A, Severe hallux valgus with bursa formation. B, Postoperative correction.
  9633. FIG. 64-7 Postoperative supportive dressing for a moderate forefoot deformity. Dressing must be conforming and binding enough to hold toe in exact position.
  9634. TABLE 64-11 COMMON FOOT DISORDERS
  9635. Ambulatory and Home Care.
  9636. Gerontologic Considerations
  9637. Foot Problems
  9638. Metabolic Bone Diseases
  9639. Osteomalacia
  9640. Osteoporosis
  9641. FIG. 64-8 A, Normal bone. B, Osteoporotic bone.
  9642. Etiology and Pathophysiology
  9643.  Cultural & Ethnic Health Disparities
  9644. TABLE 64-12 RISK FACTORS FOR OSTEOPOROSIS
  9645. Clinical Manifestations
  9646. Gender Differences
  9647. FIG. 64-9 The effects of osteoporosis. A, Comparison of young woman with an older woman. B, Severe fixed kyphosis producing a question-mark appearance.
  9648. Diagnostic Studies
  9649. Nursing and Collaborative Management Osteoporosis
  9650. TABLE 64-13 COLLABORATIVE CARE: Osteoporosis
  9651. TABLE 64-14 NUTRITIONAL THERAPY: Sources of Calcium
  9652. TABLE 64-15 ELEMENTAL CALCIUM CONTENT OF CALCIUM PREPARATIONS
  9653. Drug Therapy
  9654. Evidence-Based Practice Applying the Evidence
  9655. Your Action and Decision
  9656. Reference for Evidence
  9657. Drug Alert
  9658. Paget’s Disease
  9659. Safety Alert
  9660. Gerontologic Considerations
  9661. Metabolic Bone Diseases
  9662. Case Study Osteoporosis
  9663. Patient Profile
  9664. Subjective Data
  9665. Objective Data
  9666. Diagnostic Studies
  9667. Collaborative Care
  9668. Discussion Questions
  9669. Bridge to NCLEX Examination
  9670. References
  9671. Resources
  9672. Pageburst Integrated Resources
  9673. Answer Keys
  9674. Care Plans
  9675. Case Studies
  9676. Concept Map Creator
  9677. Content Updates
  9678. Glossary
  9679. Key Points
  9680. Chapter 65 Nursing Management: Arthritis and Connective Tissue Diseases
  9681. Learning Outcomes
  9682. Key Terms
  9683. eFigure
  9684. Arthritis
  9685. Osteoarthritis
  9686. Etiology and Pathophysiology
  9687. TABLE 65-1 CAUSES OF OSTEOARTHRITIS
  9688. Clinical Manifestations
  9689. Systemic.
  9690. Joints.
  9691. Gender Differences
  9692. FIG. 65-1 Pathologic changes in osteoarthritis. A, Normal synovial joint. B, Early change in osteoarthritis is destruction of articular cartilage and narrowing of the joint space. There is inflammation and thickening of the joint capsule and synovium. C, With time, thickening of subarticular bone occurs, caused by constant friction of the two bone surfaces. Osteophytes form around the periphery of the joint by irregular overgrowths of bone. D, In osteoarthritis of the hands, osteophytes on the distal interphalangeal joints of the fingers, termed Heberden’s nodes, appear as small nodules.
  9693. Deformity.
  9694. Diagnostic Studies
  9695. FIG. 65-2 Joints most frequently involved in osteoarthritis.
  9696. Collaborative Care
  9697. Rest and Joint Protection.
  9698. Heat and Cold Applications.
  9699. TABLE 65-2 COLLABORATIVE CARE: Osteoarthritis
  9700. Nutritional Therapy and Exercise.
  9701. Complementary and Alternative Therapies.
  9702. Drug Therapy.
  9703.  Complementary & Alternative Therapies
  9704. Scientific Evidence*
  9705. Nursing Implications
  9706.  Complementary & Alternative Therapies
  9707. Scientific Evidence*
  9708. Nursing Implications
  9709. TABLE 65-3 DRUG THERAPY: Arthritis and Connective Tissue Disorders*
  9710. Surgical Therapy.
  9711. Nursing Management Osteoarthritis
  9712. Nursing Assessment
  9713. Nursing Diagnoses
  9714. Planning
  9715. Nursing Implementation
  9716. Health Promotion.
  9717. TABLE 65-4 PATIENT & CAREGIVER TEACHING GUIDE: Joint Protection and Energy Conservation
  9718. Healthy People
  9719. Acute Intervention.
  9720. Ambulatory and Home Care.
  9721. Evaluation
  9722. Rheumatoid Arthritis
  9723. Etiology and Pathophysiology
  9724.  Cultural & Ethnic Health Disparities
  9725. TABLE 65-5 ANATOMIC STAGES OF RHEUMATOID ARTHRITIS
  9726. FIG. 65-3 Rheumatoid arthritis. A, Early pathologic change in rheumatoid arthritis is rheumatoid synovitis. The synovium is inflamed. Lymphocytes and plasma cells increase greatly. B, With time, articular cartilage destruction occurs, vascular granulation tissue grows across the surface of the cartilage (pannus) from the edges of the joint, and the articular surface shows loss of cartilage beneath the extending pannus, most marked at joint margins. C, Inflammatory pannus causes focal destruction of bone. At edges of the joint there is osteolytic destruction of bone, responsible for erosions seen on x-rays. This phase is associated with joint deformity. D, Multiple deformities of the foot associated with rheumatoid arthritis.
  9727.  Genetic Link
  9728. Clinical Manifestations
  9729. Joints.
  9730. TABLE 65-6 COMPARISON OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS
  9731. Extraarticular Manifestations.
  9732. Diagnostic Studies
  9733. FIG. 65-4 Typical deformities of rheumatoid arthritis. A, Ulnar drift. B, Boutonnière deformity. C, Hallux valgus. D, Swan neck deformity.
  9734. FIG. 65-5 Extraarticular manifestations of rheumatoid arthritis.
  9735. Collaborative Care
  9736. TABLE 65-7 DIAGNOSTIC CRITERIA FOR RHEUMATOID ARTHRITIS*
  9737. TABLE 65-8 COLLABORATIVE CARE: Rheumatoid Arthritis
  9738. Drug Therapy
  9739. Disease-Modifying Antirheumatic Drugs.
  9740. Biologic and Targeted Therapies.
  9741. Drug Alert
  9742. Drug Alert
  9743. Other Drug Therapy.
  9744. Nutritional Therapy.
  9745. Surgical Therapy.
  9746. Nursing Management Rheumatoid Arthritis
  9747. Nursing Assessment
  9748. Nursing Diagnoses
  9749. Planning
  9750. Nursing Implementation
  9751. Health Promotion.
  9752. Acute Intervention.
  9753. TABLE 65-9 NURSING ASSESSMENT: Rheumatoid Arthritis
  9754. Ambulatory and Home Care
  9755. Rest.
  9756. Joint Protection.
  9757. TABLE 65-10 PATIENT & CAREGIVER TEACHING GUIDE: Protection of Small Joints
  9758. Heat and Cold Therapy and Exercise.
  9759. Psychologic Support.
  9760. Gerontologic Considerations
  9761. Arthritis
  9762. Gout
  9763. TABLE 65-11 CAUSES OF HYPERURICEMIA
  9764. Etiology and Pathophysiology
  9765. Clinical Manifestations and Complications
  9766. Gender Differences
  9767. FIG. 65-6 Tophi associated with chronic gout. Nodules are painless and filled with uric acid crystals.
  9768. Diagnostic Studies
  9769. Collaborative Care
  9770. TABLE 65-12 COLLABORATIVE CARE: Gout
  9771. Drug Therapy.
  9772. Nutritional Therapy.
  9773. Nursing Management Gout
  9774. Lyme Disease
  9775. FIG. 65-7 Erythema migrans. Characteristic skin lesion of Lyme disease that occurs at the site of tick bite.
  9776. TABLE 65-13 PATIENT & CAREGIVER TEACHING GUIDE: Prevention and Early Treatment of Lyme Disease
  9777. Septic Arthritis
  9778. Spondyloarthropathies
  9779. Ankylosing Spondylitis
  9780. Etiology and Pathophysiology
  9781. Clinical Manifestations and Complications
  9782. FIG. 65-8 Advanced ankylosing spondylitis. Kyphotic posture causes many patients to have a protuberant abdomen secondary to pulmonary restriction.
  9783.  Genetics in Clinical Practice
  9784. Genetic Basis
  9785. Incidence
  9786. Genetic Testing
  9787. Clinical Implications
  9788. Diagnostic Studies
  9789. Collaborative Care
  9790. Nursing Management Ankylosing Spondylitis
  9791. Psoriatic Arthritis
  9792. Reactive Arthritis
  9793. Systemic Lupus Erythematosus
  9794. Etiology and Pathophysiology
  9795. Clinical Manifestations and Complications
  9796. Dermatologic Problems.
  9797. Musculoskeletal Problems.
  9798. Cardiopulmonary Problems.
  9799. Renal Problems.
  9800. FIG. 65-9 Multisystem involvement in systemic lupus erythematosus.
  9801. FIG. 65-10 Butterfly rash of systemic lupus erythematosus.
  9802. Nervous System Problems.
  9803. Hematologic Problems.
  9804. Infection.
  9805. TABLE 65-14 DIAGNOSTIC CRITERIA FOR SYSTEMIC LUPUS ERYTHEMATOSUS*
  9806. Diagnostic Studies
  9807. Collaborative Care
  9808. Drug Therapy.
  9809. Nursing Management Systemic Lupus Erythematosus
  9810. Nursing Assessment
  9811. TABLE 65-15 COLLABORATIVE CARE: Systemic Lupus Erythematosus
  9812. Nursing Diagnoses
  9813. Planning
  9814. Nursing Implementation
  9815. Health Promotion.
  9816. Acute Intervention.
  9817. TABLE 65-16 NURSING ASSESSMENT: Systemic Lupus Erythematosus
  9818. Ambulatory and Home Care.
  9819. Lupus and Pregnancy.
  9820. TABLE 65-17 PATIENT & CAREGIVER TEACHING GUIDE: Systemic Lupus Erythematosus
  9821. Psychosocial Issues.
  9822. Evaluation
  9823. Scleroderma
  9824. Etiology and Pathophysiology
  9825. FIG. 65-11 Skin changes in scleroderma.
  9826. Clinical Manifestations
  9827. Raynaud’s Phenomenon.
  9828. FIG. 65-12 Hand of a patient with scleroderma showing sclerodactyly.
  9829. Skin and Joint Changes.
  9830. Internal Organ Involvement.
  9831. Diagnostic Studies
  9832. Collaborative Care
  9833. Drug Therapy.
  9834. TABLE 65-18 COLLABORATIVE CARE: Scleroderma
  9835. Nursing Management Scleroderma
  9836. Polymyositis and Dermatomyositis
  9837. Etiology and Pathophysiology
  9838. Clinical Manifestations and Complications
  9839. Muscular.
  9840. Dermal.
  9841. Other Manifestations.
  9842. FIG. 65-13 Dermatomyositis skin changes. Gottron’s papules.
  9843. Diagnostic Studies
  9844. Nursing and Collaborative Management Polymyositis and Dermatomyositis
  9845. Mixed (Overlapping) Connective Tissue Disease
  9846. Sjögren’s Syndrome
  9847. Myofascial Pain Syndrome
  9848. Fibromyalgia
  9849. Etiology and Pathophysiology
  9850. TABLE 65-19 COMMONALITIES BETWEEN FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME
  9851. Clinical Manifestations and Complications
  9852. FIG. 65-14 Tender points in fibromyalgia.
  9853. Diagnostic Studies
  9854. Collaborative Care
  9855. Nursing Management Fibromyalgia
  9856. Chronic Fatigue Syndrome
  9857. Etiology and Pathophysiology
  9858. Clinical Manifestations
  9859. Diagnostic Studies
  9860. TABLE 65-20 DIAGNOSTIC CRITERIA FOR CHRONIC FATIGUE SYNDROME*
  9861. Nursing and Collaborative Management Chronic Fatigue Syndrome
  9862. Case Study Rheumatoid Arthritis
  9863. Patient Profile
  9864. Subjective Data
  9865. Objective Data
  9866. Physical Examination
  9867. Diagnostic Studies
  9868. Collaborative Care
  9869. Discussion Questions
  9870. Bridge to NCLEX Examination
  9871. References
  9872. Resources
  9873. Case Study Managing Multiple Patients
  9874. Patients
  9875. iStockphoto/Thinkstock
  9876. Purestock/Thinkstock
  9877. iStockphoto/Thinkstock
  9878. iStockphoto/Thinkstock
  9879. Jupiterimages/Comstock/Thinkstock
  9880. Management Discussion Questions
  9881. Case Study Progression
  9882. Pageburst Integrated Resources
  9883. Answer Keys
  9884. Care Plans
  9885. Case Studies
  9886. Concept Map
  9887. Concept Map Creator
  9888. Content Updates
  9889. eFigures
  9890. Glossary
  9891. Key Points
  9892. Section 12 Nursing Care in Critical Care Settings
  9893. Nursing Care in Critical Care Settings
  9894. Pre-Test – Section 12
  9895. Interactive Review – Section 12
  9896. Chapter 66 Nursing Management: Critical Care
  9897. Learning Outcomes
  9898. Key Terms
  9899. eFigures
  9900. eTable
  9901. eSupplement
  9902. Critical Care Nursing
  9903. FIG. 66-1 Tele-intensive care unit control room.
  9904. Critical Care Units
  9905. FIG. 66-2 Typical intensive care unit.
  9906. Critical Care Nurse
  9907. Critical Care Patient
  9908. Common Problems of Critical Care Patients.
  9909. Nutrition.
  9910. Anxiety.
  9911. Pain.
  9912. Informatics in Practice Smart Infusion Pumps
  9913. Impaired Communication.
  9914. Sensory-Perceptual Problems.
  9915. Sleep Problems.
  9916. Issues Related to Caregivers
  9917. Ethical/Legal Dilemmas Family Presence and Visitation in the Adult ICU
  9918. Situation
  9919. Ethical/Legal Points for Consideration
  9920. Discussion Questions
  9921. Culturally Competent Care
  9922. Critical Care Patients
  9923. Hemodynamic Monitoring
  9924. Hemodynamic Terminology
  9925. Cardiac Output and Cardiac Index.
  9926. TABLE 66-1 RESTING HEMODYNAMIC PARAMETERS
  9927. Preload.
  9928. Afterload.
  9929. Vascular Resistance.
  9930. Contractility.
  9931. FIG. 66-3 Components of a pressure monitoring system. The cannula, shown entering the radial artery, is connected via pressure (nondistensible) tubing to the transducer. The transducer converts the pressure wave into an electronic signal. The transducer is wired to the electronic monitoring system, which amplifies, conditions, displays, and records the signal. Stopcocks are inserted into the line for specimen withdrawal and for referencing and zero-balancing procedures. A flush system, consisting of a pressurized bag of IV fluid, tubing, and a flush device, is connected to the system. The flush system provides continuous slow (approximately 3 mL/hr) flushing and provides a mechanism for fast flushing of lines.
  9932. Principles of Invasive Pressure Monitoring
  9933. FIG. 66-4 Identification of the phlebostatic axis. A, Phlebostatic axis is an external landmark used to identify the level of the atria in the supine patient. It is defined as the intersection of two imaginary lines: one drawn horizontally from the axilla, midway between the anterior and posterior chest walls, and the other drawn vertically through the fourth intercostal space along the lateral chest wall. B, Air-fluid interface (zeroing the stopcock) is level with the phlebostatic axis using a carpenter’s or laser level.
  9934. FIG. 66-5 Optimally damped system. Dynamic response test (square wave test) using the fast flush system: normal response. No adjustment in the monitoring system is required.
  9935. TABLE 66-2 INVASIVE ARTERIAL BLOOD PRESSURE MEASUREMENT
  9936. Safety Alert
  9937. Types of Invasive Pressure Monitoring
  9938. Arterial Blood Pressure.
  9939. Measurements.
  9940. Complications.
  9941. FIG. 66-6 A, Simultaneously recorded electrocardiogram (ECG) tracing and B, systemic arterial pressure tracing. Systolic pressure is the peak pressure. The dicrotic notch indicates aortic valve closure. Diastolic pressure is the lowest value before contraction. Mean pressure is the average pressure over time calculated by the monitoring equipment.
  9942. Arterial Pressure–Based Cardiac Output.
  9943. FIG. 66-7 FloTrac sensor and Vigileo monitor.
  9944. Measurements.
  9945. Pulmonary Artery Flow-Directed Catheter.
  9946. TABLE 66-3 INDICATIONS AND CONTRAINDICATIONS FOR PULMONARY ARTERY CATHETERIZATION*
  9947. FIG. 66-8 Pulmonary artery (PA) catheter. A, Illustrated catheter has five lumens. When properly positioned, the distal lumen exit port is in the PA and the proximal lumen ports are in the right atrium and right ventricle. The distal and one of the proximal ports are used to measure PA and central venous pressures, respectively. A balloon surrounds the catheter near the distal end. The balloon inflation valve is used to inflate the balloon with air to allow reading of the pulmonary artery wedge pressure. A thermistor located near the distal tip senses PA temperature and is used to measure thermodilution cardiac output when solution cooler than body temperature is injected into a proximal port. B, Photo of an actual catheter.
  9948. Pulmonary Artery Catheter Insertion.
  9949. Central Venous or Right Atrial Pressure Measurement.
  9950. FIG. 66-9 Position of the pulmonary artery flow-directed catheter during progressive stages of insertion with corresponding pressure waveforms.
  9951. Venous Oxygen Saturation Monitoring.
  9952. FIG. 66-10 Cardiac events that produce the central venous pressure (CVP) waveform with a, c, and v waves. The a wave represents atrial contraction. The x descent represents atrial relaxation. The c wave represents the bulging of the closed tricuspid valve into the right atrium during ventricular systole. The v wave represents atrial filling. The y descent represents opening of the tricuspid valve and filling of the ventricle.
  9953. Noninvasive Arterial Oxygenation Monitoring
  9954. TABLE 66-4 INTERPRETATION OF ScvO2/SvO2 * MEASUREMENTS
  9955. Noninvasive Hemodynamic Monitoring: Impedance Cardiography
  9956. Nursing Management Hemodynamic Monitoring
  9957. Circulatory Assist Devices
  9958. Intraaortic Balloon Pump
  9959. TABLE 66-5 INDICATIONS AND CONTRAINDICATIONS FOR IABP THERAPY*
  9960. FIG. 66-11 Intraaortic balloon pump machine.
  9961. Effects of Counterpulsation.
  9962. Complications With IABP Therapy.
  9963. FIG. 66-12 Intraaortic balloon pump. A, During systole the balloon is deflated, which facilitates ejection of blood into the periphery. B, In early diastole, the balloon begins to inflate. C, In late diastole, the balloon is totally inflated, which augments aortic pressure and increases the coronary perfusion pressure with the end result of increased coronary and cerebral blood flow.
  9964. TABLE 66-6 HEMODYNAMIC EFFECTS OF COUNTERPULSATION
  9965. TABLE 66-7 MANAGING COMPLICATIONS OF IABP THERAPY
  9966. Ventricular Assist Devices
  9967. FIG. 66-13 Schematic diagram of a biventricular assist device (BVAD).
  9968. Implantable Artificial Heart
  9969. Nursing Management Circulatory Assist Devices
  9970. Artificial Airways
  9971. Endotracheal Tubes
  9972. FIG. 66-14 Endotracheal tube. A, Parts of an endotracheal tube. B, Tube in place with cuff deflated. C, Tube in place with the cuff inflated. D, Photo of tube before placement.
  9973. Evidence-Based Practice Translating Research Into Practice
  9974. Does Timing of Tracheotomy Affect Critically Ill Patient Outcomes?
  9975. Clinical Question
  9976. Best Available Evidence
  9977. Critical Appraisal and Synthesis of Evidence
  9978. Conclusion
  9979. Implications for Nursing Practice
  9980. Reference for Evidence
  9981. Endotracheal Intubation Procedure
  9982. FIG. 66-15 Closed tracheal suction system.
  9983. Nursing Management Artificial Airway
  9984. Maintaining Correct Tube Placement
  9985. Safety Alert
  9986. Maintaining Proper Cuff Inflation
  9987. Monitoring Oxygenation and Ventilation
  9988. TABLE 66-8 SUCTIONING PROCEDURES FOR PATIENT ON MECHANICAL VENTILATOR
  9989. Maintaining Tube Patency
  9990. Providing Oral Care and Maintaining Skin Integrity
  9991. TABLE 66-9 ORAL CARE PROCEDURES FOR PATIENT ON MECHANICAL VENTILATOR
  9992. Fostering Comfort and Communication
  9993. Complications of Endotracheal Intubation
  9994. Safety Alert
  9995. FIG. 66-16 Continuous subglottal suctioning can be provided by the Hi Lo Evac Tube. A dorsal lumen above the cuff allows for suctioning of secretions from the subglottic area.
  9996. Mechanical Ventilation
  9997. FIG. 66-17 Negative pressure ventilator.
  9998. Types of Mechanical Ventilation
  9999. Negative Pressure Ventilation.
  10000. Positive Pressure Ventilation.
  10001. Volume Ventilation.
  10002. FIG. 66-18 Patient receiving mechanical ventilation.
  10003. Pressure Ventilation.
  10004. Settings of Mechanical Ventilators
  10005. Modes of Volume Ventilation
  10006. TABLE 66-10 SETTINGS OF MECHANICAL VENTILATION
  10007. Assist-Control Mechanical Ventilation.
  10008. TABLE 66-11 INTERPRETING MECHANICAL VENTILATION ALARMS
  10009. Synchronized Intermittent Mandatory Ventilation.
  10010. TABLE 66-12 MODES OF MECHANICAL VENTILATION
  10011. Modes of Pressure Ventilation
  10012. Pressure Support Ventilation.
  10013. Pressure-Control Inverse Ratio Ventilation.
  10014. Airway Pressure Release Ventilation.
  10015. Other Modes.
  10016. Other Ventilatory Maneuvers
  10017. Positive End-Expiratory Pressure.
  10018. Continuous Positive Airway Pressure.
  10019. Automatic Tube Compensation.
  10020. Bilevel Positive Airway Pressure.
  10021. High-Frequency Oscillatory Ventilation.
  10022. Nitric Oxide.
  10023. Prone Positioning.
  10024. Extracorporeal Membrane Oxygenation.
  10025. Complications of Positive Pressure Ventilation
  10026. Cardiovascular System.
  10027. Pulmonary System
  10028. Barotrauma.
  10029. Volutrauma.
  10030. Alveolar Hypoventilation.
  10031. Alveolar Hyperventilation.
  10032. Ventilator-Associated Pneumonia.
  10033. Sodium and Water Imbalance.
  10034. Neurologic System.
  10035. Gastrointestinal System.
  10036. Musculoskeletal System.
  10037. Psychosocial Needs.
  10038. FIG. 66-19 Placement of electrodes along ulnar nerve.
  10039. Machine Disconnection or Malfunction.
  10040. Nutritional Therapy: Patient Receiving Positive Pressure Ventilation
  10041. Delegation Decisions Caring for the Patient Requiring Mechanical Ventilation
  10042. Role of Registered Nurse (RN)
  10043. Role of Licensed Practical/Vocational Nurse (LPN/LVN)
  10044. Role of Unlicensed Assistive Personnel (UAP)
  10045. Weaning From Positive Pressure Ventilation and Extubation
  10046. TABLE 66-13 INDICATORS FOR WEANING
  10047. Chronic Mechanical Ventilation
  10048. Nursing Management Mechanical Ventilation
  10049. Other Critical Care Content
  10050. TABLE 66-14 CROSS-REFERENCES TO CRITICAL CARE CONTENT
  10051. Case Study Critical Care and Mechanical Ventilation
  10052. Patient Profile
  10053. Subjective Data
  10054. Objective Data
  10055. Physical Examination
  10056. Diagnostic Studies
  10057. Collaborative Care
  10058. Discussion Questions
  10059. Bridge to NCLEX Examination
  10060. References
  10061. Resources
  10062. Pageburst Integrated Resources
  10063. Answer Keys
  10064. Care Plans
  10065. Case Studies
  10066. Concept Map Creator
  10067. Content Updates
  10068. eFigures
  10069. eTables
  10070. Glossary
  10071. Key Points
  10072. Chapter 67 Nursing Management: Shock, Systemic Inflammatory Response Syndrome, and Multiple Organ Dysfunction Syndrome
  10073. Learning Outcomes
  10074. Key Terms
  10075. eFigures
  10076. Shock
  10077. Classification of Shock
  10078. FIG. 67-1 Relationship of shock, systemic inflammatory response syndrome, and multiple organ dysfunction syndrome. CNS, Central nervous system. (See Table 67-1 for causes of shock states.)
  10079. TABLE 67-1 CLASSIFICATION OF SHOCK STATES
  10080. Cardiogenic Shock.
  10081. FIG. 67-2 The pathophysiology of cardiogenic shock.
  10082. Hypovolemic Shock.
  10083. TABLE 67-2 DIAGNOSTIC STUDIES: Laboratory Changes in Shock
  10084. Distributive Shock
  10085. Neurogenic Shock.
  10086. TABLE 67-3 CLINICAL PRESENTATION OF TYPES OF SHOCK
  10087. FIG. 67-3 The pathophysiology of hypovolemic shock.
  10088. Anaphylactic Shock.
  10089. FIG. 67-4 The pathophysiology of neurogenic shock.
  10090. Septic Shock.
  10091. TABLE 67-4 DIAGNOSTIC CRITERIA FOR SEPSIS
  10092. Obstructive Shock.
  10093. Stages of Shock
  10094. Compensatory Stage.
  10095. FIG. 67-5 The pathophysiology of septic shock. CNS, Central nervous system.
  10096. FIG. 67-6 The pathophysiology of obstructive shock.
  10097. TABLE 67-5 MANIFESTATIONS OF STAGES OF SHOCK*
  10098. Progressive Stage.
  10099. Irreversible Stage.
  10100. Diagnostic Studies
  10101. Collaborative Care: General Measures
  10102. Oxygen and Ventilation.
  10103. Fluid Resuscitation.
  10104.  TABLE 67-6 EMERGENCY MANAGEMENT: Shock
  10105. Surgical
  10106. Medical
  10107. Trauma
  10108. Initial
  10109. Ongoing Monitoring
  10110. TABLE 67-7 FLUID THERAPY IN SHOCK
  10111. Safety Alert
  10112. Drug Therapy.
  10113. Sympathomimetic Drugs.
  10114. TABLE 67-8 DRUG THERAPY: Shock
  10115. Vasodilator Drugs.
  10116. Nutritional Therapy.
  10117. Collaborative Care: Specific Measures
  10118. Cardiogenic Shock.
  10119. Hypovolemic Shock.
  10120. Septic Shock.
  10121. Drug Alert
  10122. TABLE 67-9 COLLABORATIVE CARE: Shock
  10123. Neurogenic Shock.
  10124. Anaphylactic Shock.
  10125. Obstructive Shock.
  10126. Nursing Management Shock
  10127. Nursing Assessment
  10128. Nursing Diagnoses
  10129. Planning
  10130. Nursing Implementation
  10131. Health Promotion.
  10132. Safety Alert
  10133. Acute Intervention.
  10134. Neurologic Status.
  10135. Cardiovascular Status.
  10136. Respiratory Status.
  10137. Renal Status.
  10138. Body Temperature and Skin Changes.
  10139. Gastrointestinal Status.
  10140. Personal Hygiene.
  10141. Emotional Support and Comfort.
  10142. Ambulatory and Home Care.
  10143. Evaluation
  10144. Systemic Inflammatory Response Syndrome and Multiple Organ Dysfunction Syndrome
  10145. Etiology and Pathophysiology
  10146. Organ and Metabolic Dysfunction.
  10147. Clinical Manifestations of SIRS and MODS
  10148. Nursing and Collaborative Management Sirs and Mods
  10149. Prevention and Treatment of Infection
  10150. Maintenance of Tissue Oxygenation
  10151. Nutritional and Metabolic Needs
  10152. Support of Failing Organs
  10153. TABLE 67-10 MANIFESTATIONS AND MANAGEMENT OF SIRS AND MODS
  10154. Case Study Shock
  10155. Patient Profile
  10156. Subjective Data
  10157. Objective Data
  10158. Physical Examination
  10159. Diagnostic Studies
  10160. Collaborative Care (in the ED)
  10161. Surgical Procedure
  10162. Discussion Questions
  10163. Bridge to NCLEX Examination
  10164. References
  10165. Resources
  10166. Pageburst Integrated Resources
  10167. Answer Keys
  10168. Care Plans
  10169. Case Studies
  10170. Concept Map Creator
  10171. Content Updates
  10172. eFigures
  10173. Glossary
  10174. Key Points
  10175. Chapter 68 Nursing Management: Respiratory Failure and Acute Respiratory Distress Syndrome
  10176. Learning Outcomes
  10177. Key Terms
  10178. eTable
  10179. Acute Respiratory Failure
  10180. FIG. 68-1 Normal gas exchange unit in the lung.
  10181. Etiology and Pathophysiology
  10182. Hypoxemic Respiratory Failure.
  10183. Ventilation-Perfusion Mismatch.
  10184. FIG. 68-2 Classification of respiratory failure.
  10185. TABLE 68-1 CAUSES OF HYPOXEMIC AND HYPERCAPNIC RESPIRATORY FAILURE*
  10186. Respiratory System
  10187. Cardiac System
  10188. Respiratory System
  10189. Central Nervous System
  10190. Chest Wall
  10191. Neuromuscular System
  10192. FIG. 68-3 Regional V/Q differences in the normal lung. At the lung apex, the V/Q ratio is 3.3, at the midpoint 1.0, and at the base 0.63. This difference causes the PaO2 to be higher at the apex of the lung and lower at the base. Values for PaCO2 are the opposite (i.e., lower at the apex and higher at the base). Blood that exits the lung is a mixture of these values.
  10193. FIG. 68-4 Range of ventilation-to-perfusion (V/Q) relationships. A, Absolute shunt, no ventilation because of fluid filling the alveoli. B, V/Q mismatch, ventilation partially compromised by secretions in the airway. C, Normal lung unit. D, V/Q mismatch, perfusion partially compromised by emboli obstructing blood flow. E, Dead space, no perfusion because of obstruction of the pulmonary capillary.
  10194. Shunt.
  10195. Diffusion Limitation.
  10196. FIG. 68-5 Diffusion limitation. Exchange of CO2 and O2 cannot occur because of the thickened alveolar-capillary membrane.
  10197. Alveolar Hypoventilation.
  10198. Interrelationship of Mechanisms.
  10199. Hypercapnic Respiratory Failure.
  10200. Airway and Alveoli Abnormalities.
  10201. Central Nervous System Abnormalities.
  10202. Chest Wall Abnormalities.
  10203. Neuromuscular Conditions.
  10204. Tissue Oxygen Needs.
  10205. Clinical Manifestations
  10206. TABLE 68-2 MANIFESTATIONS OF HYPOXEMIA AND HYPERCAPNIA*
  10207. Consequences of Hypoxemia and Hypoxia.
  10208. Specific Clinical Manifestations.
  10209. FIG. 68-6 Tripod positioning is used to increase chest and lung expansion and decrease work of breathing for patients with COPD or asthma.
  10210. Diagnostic Studies
  10211. Nursing and Collaborative Management Acute Respiratory Failure
  10212. Nursing Assessment
  10213. Nursing Diagnoses
  10214. TABLE 68-3 NURSING ASSESSMENT: Acute Respiratory Failure
  10215. Planning
  10216. Prevention
  10217. Respiratory Therapy
  10218. Oxygen Therapy.
  10219. TABLE 68-4 COLLABORATIVE CARE: Acute Respiratory Failure
  10220. Mobilization of Secretions.
  10221. Effective Coughing and Positioning.
  10222. FIG. 68-7 Augmented coughing is performed by placing one or both hands on the anterolateral base of the lungs. After the patient takes a deep inspiration and at the beginning of expiration, move the hand(s) forcefully upward. This increases abdominal pressure and aids in producing a forceful cough.
  10223. Hydration and Humidification.
  10224. Chest Physiotherapy.
  10225. Airway Suctioning.
  10226. Positive Pressure Ventilation.
  10227. FIG. 68-8 Noninvasive bilevel positive pressure ventilation. A mask is placed over the nose or nose and mouth. Positive pressure from a mechanical ventilator assists the patient’s breathing efforts, decreasing the work of breathing.
  10228. Drug Therapy
  10229. Relief of Bronchospasm.
  10230. Reduction of Airway Inflammation.
  10231. Drug Alert
  10232. Reduction of Pulmonary Congestion.
  10233. Treatment of Pulmonary Infections.
  10234. Reduction of Severe Anxiety, Pain, and Agitation.
  10235. Safety Alert
  10236. Safety Alert
  10237. Medical Supportive Therapy
  10238. Treating the Underlying Cause.
  10239. Maintaining Adequate Cardiac Output.
  10240. Maintaining Adequate Hemoglobin Concentration.
  10241. Nutritional Therapy
  10242. Evaluation
  10243. Gerontologic Considerations
  10244. Respiratory Failure
  10245. Acute Respiratory Distress Syndrome
  10246. FIG. 68-9 Stages of edema formation in acute respiratory distress syndrome. A, Normal alveolus and pulmonary capillary. B, Interstitial edema occurs with increased flow of fluid into the interstitial space. C, Alveolar edema occurs when the fluid crosses the blood-gas barrier.
  10247. TABLE 68-5 PREDISPOSING CONDITIONS TO ARDS
  10248. Etiology and Pathophysiology
  10249. FIG. 68-10 Pathophysiology of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS).
  10250. Injury or Exudative Phase.
  10251. Reparative or Proliferative Phase.
  10252. Fibrotic Phase.
  10253. Clinical Progression
  10254. Clinical Manifestations and Diagnostic Studies
  10255. TABLE 68-6 DIAGNOSTIC FINDINGS IN ALI AND ARDS
  10256. FIG. 68-11 Chest x-ray of a patient with acute respiratory distress syndrome (ARDS). The x-ray shows new, bilateral, diffuse, homogeneous pulmonary infiltrates without cardiac failure, fluid overload, chest infection, or chronic lung disease.
  10257. Complications
  10258. Ventilator-Associated Pneumonia.
  10259. TABLE 68-7 COMPLICATIONS ASSOCIATED WITH ARDS
  10260. TABLE 68-8 COMPONENTS OF A VENTILATOR BUNDLE
  10261. Barotrauma.
  10262. Evidence-Based Practice Translating Research Into Practice
  10263. How Effective Is Subglottic Secretion Drainage on Ventilator-Associated Pneumonia?
  10264. Clinical Question
  10265. Best Available Evidence
  10266. Critical Appraisal and Synthesis of Evidence
  10267. Conclusion
  10268. Implications for Nursing Practice
  10269. Reference for Evidence
  10270. Volutrauma.
  10271. Stress Ulcers.
  10272. Renal Failure.
  10273. Nursing and Collaborative Management Acute Respiratory Distress Syndrome
  10274. TABLE 68-9 COLLABORATIVE CARE: Acute Respiratory Distress Syndrome
  10275. Nursing Assessment
  10276. Nursing Diagnoses
  10277. Planning
  10278. Oxygen Administration.
  10279. Positive Pressure Ventilation.
  10280. Positioning Strategies.
  10281. FIG. 68-12 A, Turning patient prone on Vollman Prone Positioner. B, Patient lying prone on Vollman Prone Positioner.
  10282. Medical Supportive Therapy
  10283. Maintenance of Cardiac Output and Tissue Perfusion.
  10284. Maintenance of Nutrition and Fluid Balance.
  10285. FIG. 68-13 TotalCare SpO2RT Bed System offers continuous lateral rotation therapy and percussion and vibration therapies. Patients can easily and quickly be repositioned.
  10286. Evaluation
  10287. Case Study Acute Respiratory Distress Syndrome
  10288. Patient Profile
  10289. Past Medical History
  10290. Postoperative Orders
  10291. Postoperative Day 1
  10292. Subjective Data
  10293. Objective Data
  10294. Physical Assessment
  10295. Diagnostic Findings
  10296. Discussion Questions
  10297. Bridge to NCLEX Examination
  10298. References
  10299. Resources
  10300. Pageburst Integrated Resources
  10301. Answer Keys
  10302. Care Plans
  10303. Case Studies
  10304. Concept Map Creator
  10305. Content Updates
  10306. eTables
  10307. Glossary
  10308. Key Points
  10309. Chapter 69 Nursing Management: Emergency, Terrorism, and Disaster Nursing
  10310. Learning Outcomes
  10311. Key Terms
  10312. eTables
  10313.  TABLE 69-1 EMERGENCY MANAGEMENT Emergency Management Tables
  10314. Care of Emergency Patient
  10315. Triage
  10316. TABLE 69-2 FIVE-LEVEL EMERGENCY SEVERITY INDEX (ESI)
  10317. TABLE 69-3 EMERGENCY ASSESSMENT: PRIMARY SURVEY
  10318. Primary Survey
  10319. TABLE 69-4 POTENTIAL LIFE-THREATENING CONDITIONS FOUND DURING PRIMARY SURVEY*
  10320. A = Airway With Cervical Spine Stabilization and/or Immobilization.
  10321. FIG. 69-1 Jaw-thrust maneuver is the recommended procedure for opening the airway of an unconscious patient with a possible neck or spinal injury. With the patient lying supine, kneel at the top of the head. Place one hand on each side of the patient’s head, resting your elbows on the surface. Grasp the angles of the patient’s lower jaw and lift the jaw forward with both hands without tilting the head.
  10322. B = Breathing.
  10323. C = Circulation.
  10324. D = Disability.
  10325. E = Exposure or Environmental Control.
  10326. Secondary Survey
  10327. F = Full Set of Vital Signs, Focused Adjuncts, Facilitate Family Presence.
  10328. G = Give Comfort Measures.
  10329. H = History and Head-to-Toe Assessment.
  10330. TABLE 69-5 EMERGENCY ASSESSMENT: SECONDARY SURVEY
  10331. Head, Neck, and Face.
  10332. Chest.
  10333. Abdomen and Flanks.
  10334. Pelvis and Perineum.
  10335. Extremities.
  10336. I = Inspect Posterior Surfaces.
  10337. Intervention and Evaluation
  10338. TABLE 69-6 TETANUS VACCINES AND TIG FOR WOUND MANAGEMENT
  10339. Post–Cardiac Arrest Hypothermia
  10340. Evidence-Based Practice Applying the Evidence
  10341. Your Decision and Action
  10342. Reference for Evidence
  10343. Death in the Emergency Department
  10344. Gerontologic Considerations
  10345. Emergency Care
  10346. Environmental Emergencies
  10347. TABLE 69-7 RISK FACTORS FOR HEAT-RELATED EMERGENCIES
  10348. Heat-Related Emergencies
  10349. Heat Cramps
  10350. Heat Exhaustion
  10351.  TABLE 69-8 EMERGENCY MANAGEMENT: Hyperthermia
  10352. Environmental
  10353. Trauma
  10354. Metabolic
  10355. Drugs
  10356. Other
  10357. Heat Cramps
  10358. Heat Exhaustion
  10359. Heatstroke
  10360. Initial
  10361. Ongoing Monitoring
  10362. Heatstroke
  10363. Collaborative Care.
  10364. Cold-Related Emergencies
  10365. Frostbite
  10366. FIG. 69-2 Edema and blister formation 24 hours after frostbite injury occurring in an area covered by a tightly fitted boot.
  10367. FIG. 69-3 Gangrenous necrosis 6 weeks after the frostbite injury shown in Fig. 69-2.
  10368. Hypothermia
  10369.  TABLE 69-9 EMERGENCY MANAGEMENT: Hypothermia
  10370. Environmental
  10371. Metabolic
  10372. Health Care Associated
  10373. Other
  10374. Initial
  10375. Ongoing Monitoring
  10376. Collaborative Care.
  10377. Submersion Injuries
  10378. Collaborative Care
  10379. FIG. 69-4 Pathophysiology of submersion injury.
  10380. Stings and Bites
  10381.  TABLE 69-10 EMERGENCY MANAGEMENT: Submersion Injuries
  10382. Pulmonary
  10383. Cardiac
  10384. Other
  10385. Initial
  10386. Ongoing Monitoring
  10387. Hymenopteran Stings
  10388. Safety Alert
  10389. FIG. 69-5 Tick removal. A, Use tweezers to grasp the tick close to the skin. B, With a steady motion, pull the tick’s body up and away from the skin. Do not be alarmed if the tick’s mouthparts remain in the skin. Once the mouthparts are removed from the rest of the tick, it can no longer transmit disease.
  10390. Tick Bites
  10391. Animal and Human Bites
  10392. FIG. 69-6 Probable human bite injury, though denied by patient. Human bites cause extensor tendon injuries, fractures, and joint capsule injuries and can harbor foreign bodies.
  10393. Collaborative Care.
  10394. Drug Alert
  10395. Poisonings
  10396. TABLE 69-11 COMMON POISONS
  10397. Violence
  10398. Agents of Terrorism
  10399. Emergency and Mass Casualty Incident Preparedness
  10400. FIG. 69-7 American Red Cross.
  10401. Ethical/Legal Dilemmas Good Samaritan
  10402. Situation
  10403. Ethical/Legal Points for Consideration
  10404. Discussion Questions
  10405. Case Study Trauma
  10406. Patient Profile
  10407. Subjective Data
  10408. Objective Data
  10409. Physical Examination
  10410. Discussion Questions
  10411. Bridge to NCLEX Examination
  10412. References
  10413. Resources
  10414. Case Study Managing Multiple Patients
  10415. Patients
  10416. Management Discussion Questions
  10417. Case Study Progression
  10418. Pageburst Integrated Resources
  10419. Answer Keys
  10420. Case Studies
  10421. Concept Map Creator
  10422. Content Updates
  10423. eTables
  10424. Glossary
  10425. Key Points
  10426. Appendixes
  10427. Appendix A Basic Life Support for Health Care Providers
  10428. Cardiopulmonary Resuscitation
  10429. Chest Compressions
  10430. FIG. A-1 The head tilt–chin lift maneuver is used to open the victim’s airway to give rescue breaths. A, Rescuer places one hand on the victim’s forehead and applies firm, backward pressure with the palm to tilt the head back. The chin is lifted and brought forward with the fingers of the other hand. B, Mouth-to-barrier device: Rescuer places the device tightly over the victim’s mouth and nose and delivers a regular breath. C, Mouth-to-mouth technique: Rescuer pinches the victim’s nostrils, tightly seals mouth over victim’s mouth, and delivers a regular breath. NOTE: Rescuer should observe for a rise in the victim’s chest (blue arrows).
  10431. TABLE A-1 ADULT ONE- AND TWO-RESCUER BASIC LIFE SUPPORT WITH AUTOMATIC EXTERNAL DEFIBRILLATOR (AED)
  10432. Defibrillation
  10433. FIG. A-2 Cardiopulmonary resuscitation. A, Position of the hands during chest compressions. B, When pressure is applied, the sternum is displaced posteriorly with the heel of the hand. C, Arms are kept straight and the rescuer pushes deep (at least 2 in) and fast (a rate of at least 100 compressions per minute).
  10434. FIG. A-3 Automatic external defibrillator (AED) located in a shopping center.
  10435. Airway and Breathing
  10436. TABLE A-2 MANAGEMENT OF THE ADULT CHOKING VICTIM
  10437. FIG. A-4 Abdominal thrusts (Heimlich maneuver) administered to a conscious (standing) choking victim.
  10438. Hands-Only CPR
  10439. References
  10440. Resources
  10441. Appendix B Nursing Diagnoses
  10442. Appendix C Laboratory Reference Intervals
  10443. TABLE C-1 SERUM, PLASMA, AND WHOLE BLOOD CHEMISTRIES
  10444. TABLE C-2 HEMATOLOGY
  10445. TABLE C-3 SEROLOGY-IMMUNOLOGY
  10446. TABLE C-4 URINE CHEMISTRY
  10447. TABLE C-5 FECAL ANALYSIS
  10448. TABLE C-6 CEREBROSPINAL FLUID ANALYSIS
  10449. Glossary
  10450. Glossary
  10451. A
  10452. B
  10453. C
  10454. D
  10455. E
  10456. F
  10457. G
  10458. H
  10459. I
  10460. J
  10461. K
  10462. L
  10463. M
  10464. N
  10465. O
  10466. P
  10467. R
  10468. S
  10469. T
  10470. U
  10471. V
  10472. W
  10473. Illustration Credits
  10474. Illustration Credits
  10475. Chapter 1
  10476. Chapter 2
  10477. Chapter 3
  10478. Chapter 4
  10479. Chapter 5
  10480. Chapter 8
  10481. Chapter 9
  10482. Chapter 10
  10483. Chapter 12
  10484. Chapter 13
  10485. Chapter 14
  10486. Chapter 15
  10487. Chapter 16
  10488. Chapter 17
  10489. Chapter 18
  10490. Chapter 19
  10491. Chapter 20
  10492. Chapter 21
  10493. Chapter 22
  10494. Chapter 23
  10495. Chapter 24
  10496. Chapter 25
  10497. Chapter 26
  10498. Chapter 27
  10499. Chapter 28
  10500. Chapter 29
  10501. Chapter 30
  10502. Chapter 31
  10503. Chapter 32
  10504. Chapter 33
  10505. Chapter 34
  10506. Chapter 35
  10507. Chapter 36
  10508. Chapter 37
  10509. Chapter 38
  10510. Chapter 39
  10511. Chapter 40
  10512. Chapter 41
  10513. Chapter 42
  10514. Chapter 43
  10515. Chapter 44
  10516. Chapter 45
  10517. Chapter 46
  10518. Chapter 47
  10519. Chapter 48
  10520. Chapter 49
  10521. Chapter 50
  10522. Chapter 51
  10523. Chapter 52
  10524. Chapter 53
  10525. Chapter 54
  10526. Chapter 55
  10527. Chapter 56
  10528. Chapter 57
  10529. Chapter 58
  10530. Chapter 59
  10531. Chapter 60
  10532. Chapter 61
  10533. Chapter 62
  10534. Chapter 63
  10535. Chapter 64
  10536. Chapter 65
  10537. Chapter 66
  10538. Chapter 67
  10539. Chapter 68
  10540. Chapter 69
  10541. Index
  10542. Index
  10543. A
  10544. B
  10545. C
  10546. D
  10547. E
  10548. F
  10549. G
  10550. H
  10551. I
  10552. J
  10553. K
  10554. L
  10555. M
  10556. N
  10557. O
  10558. P
  10559. Q
  10560. R
  10561. S
  10562. T
  10563. U
  10564. V
  10565. W
  10566. X
  10567. Y
  10568. Z
  10569. Abbreviations
  10570. Abbreviations

 

People Also Search:

medical surgical nursing assessment and management of clinical problems

medical surgical nursing assessment and management of clinical problems 9th edition

medical surgical nursing assessment and management of clinical problems download scribd

medical surgical nursing assessment and management of clinical problems testbank download pdf

Instant download after Payment is complete

Main Menu